*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1al6_c01 CITRATE SYNTHASE user 1 4 # 1 244 SER B 72 SER~? 11.29 CH3 ACT B 801 274 HIS A 53 HIS~? 13.16 CA CA A 202 320 HIS A 51 HIS~? 12.20 CA CA A 202 375 ASP A 38 ASP~? -3.36 CA CA A 202s coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 4.20 25.43 45.78 2.18 24.15 45.83 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.33 26.57 50.59 7.78 25.45 51.45 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 17.98 27.94 47.81 19.27 26.33 47.47 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 14.49 17.18 50.40 16.42 16.29 49.93 1al6_c01 source 1al6 CITRATE SYNTHASE : 1 hits 1al6_c01 naa= 4 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 1 4 # 1 A 133 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 175 GLU A 5 GLU~? 25.21 CA CA A 202 A 204 ASP A 4 ASP~? 21.72 CA CA A 202 A 236 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 7.06 3.02 44.15 5.29 1.89 44.11 22.09 39.77 43.94 22.07 41.64 42.98 coo 5.26 3.96 48.13 7.21 3.45 47.51 23.31 38.61 48.39 22.38 40.48 47.97 coo 1.26 2.66 46.42 2.28 1.24 45.18 25.57 34.71 45.51 26.38 33.70 43.83 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 2 4 # 2 A 133 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 175 GLU A 5 GLU~? 25.21 CA CA A 202 A 204 ASP A 4 ASP~? 21.72 CA CA A 202 A 236 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 7.06 3.02 44.15 5.29 1.89 44.11 22.09 39.77 43.94 22.07 41.64 42.98 coo 5.26 3.96 48.13 7.21 3.45 47.51 23.31 38.61 48.39 22.38 40.48 47.97 coo 1.26 2.66 46.42 2.28 1.24 45.18 25.57 34.71 45.51 26.38 33.70 43.83 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 3 4 # 3 A 133 HIS A 43 HIS.? 6.83 CA CA A 202 A 175 GLU A 40 GLU.? 3.38 CA CA A 202s A 204 ASP A 38 ASP~? -3.36 CA CA A 202s A 236 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 7.06 3.02 44.15 5.29 1.89 44.11 20.15 20.72 47.43 19.82 19.00 48.57 coo 5.26 3.96 48.13 7.21 3.45 47.51 19.19 19.98 52.16 20.07 18.13 52.69 coo 1.26 2.66 46.42 2.28 1.24 45.18 14.49 17.18 50.40 16.42 16.29 49.93 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 4 4 # 4 A 133 HIS B 2 HIS~? 26.00 CH3 ACT B 802 A 175 GLU B 5 GLU~? 21.97 CH3 ACT B 802 A 204 ASP B 4 ASP~? 21.62 CA CA B 201 A 236 LYS B 52 LYS~? 20.44 CA CA B 201 coo 7.06 3.02 44.15 5.29 1.89 44.11 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 5.26 3.96 48.13 7.21 3.45 47.51 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 1.26 2.66 46.42 2.28 1.24 45.18 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 5 4 # 5 A 133 HIS B 43 HIS.? 6.84 CA CA B 201 A 175 GLU B 40 GLU.? 3.43 CA CA B 201s A 204 ASP B 38 ASP~? -3.30 CA CA B 201s A 236 LYS B 52 LYS~? 20.44 CA CA B 201 coo 7.06 3.02 44.15 5.29 1.89 44.11 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 5.26 3.96 48.13 7.21 3.45 47.51 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 1.26 2.66 46.42 2.28 1.24 45.18 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -3.85 31.32 74.04 -1.50 34.25 78.56 1bs0_c00 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 5 hits 1bs0_c00 naa= 4 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 1 4 # 1 70 SER B 47 SER~? 15.49 CA CA B 201 73 LYS B 46 LYS.? 7.77 CA CA B 201 130 SER B 49 SER~? 17.16 CA CA B 201 166 GLU A 83 GLU~? 18.60 CA CA B 201 coo 9.07 4.77 36.50 9.47 6.77 37.81 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 4.86 1.62 38.78 8.40 6.54 40.49 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 5.59 9.57 39.68 6.91 9.21 37.66 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 11.82 4.41 43.29 12.22 5.15 41.33 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 2 4 # 2 70 SER B 47 SER~? 15.49 CA CA B 201 73 LYS B 48 LYS~? 22.74 CA CA B 201 130 SER A 78 SER~? 22.09 CA CA B 201 166 GLU A 83 GLU~? 18.60 CA CA B 201 coo 9.07 4.77 36.50 9.47 6.77 37.81 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 4.86 1.62 38.78 8.40 6.54 40.49 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 5.59 9.57 39.68 6.91 9.21 37.66 0.59 30.86 84.57 0.46 32.77 83.16 coo 11.82 4.41 43.29 12.22 5.15 41.33 -4.99 25.05 87.76 -3.42 23.71 87.32 1btl_c00 source 1btl BETA-LACTAMASE TEM1 (E.C.3.5.2.6) : 2 hits 1btl_c00 naa= 4 ULMN 4 1cel_c00 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE user 1 4 # 1 A 212 GLU A 5 GLU~? 25.21 CA CA A 202 A 214 ASP A 4 ASP~? 21.72 CA CA A 202 A 217 GLU A 8 GLU~? 21.63 CA CA A 202 A 228 HIS A 2 HIS~? 23.51 OXT ACT B 801 coo 32.57 58.65 63.05 30.62 58.54 62.21 23.31 38.61 48.39 22.38 40.48 47.97 coo 30.35 61.22 66.96 30.09 60.30 65.11 25.57 34.71 45.51 26.38 33.70 43.83 coo 27.06 63.54 66.15 26.40 61.67 65.50 26.55 33.36 50.86 27.60 35.12 50.29 coo 30.54 55.13 65.88 28.73 56.18 66.05 22.09 39.77 43.94 22.07 41.64 42.98 ULMN 4 1cel_c00 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE user 2 4 # 2 A 212 GLU B 5 GLU~? 21.97 CH3 ACT B 802 A 214 ASP B 4 ASP~? 21.62 CA CA B 201 A 217 GLU B 8 GLU~? 16.54 CH3 ACT B 802 A 228 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo 32.57 58.65 63.05 30.62 58.54 62.21 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 30.35 61.22 66.96 30.09 60.30 65.11 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 27.06 63.54 66.15 26.40 61.67 65.50 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 30.54 55.13 65.88 28.73 56.18 66.05 -12.31 39.90 79.94 -12.15 41.88 80.62 1cel_c00 source 1cel 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE I (CELLULA: 2 hits 1cel_c00 naa= 4 ULMN 4 1cel_c01 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE user 1 4 # 1 B 212 GLU A 5 GLU~? 25.21 CA CA A 202 B 214 ASP A 4 ASP~? 21.72 CA CA A 202 B 217 GLU A 8 GLU~? 21.63 CA CA A 202 B 228 HIS A 2 HIS~? 23.51 OXT ACT B 801 coo -6.37 15.57 7.12 -8.28 15.49 6.19 23.31 38.61 48.39 22.38 40.48 47.97 coo -8.63 18.10 10.92 -8.87 17.22 9.05 25.57 34.71 45.51 26.38 33.70 43.83 coo -11.99 20.43 10.12 -12.58 18.53 9.49 26.55 33.36 50.86 27.60 35.12 50.29 coo -8.34 12.05 9.82 -10.16 13.07 10.00 22.09 39.77 43.94 22.07 41.64 42.98 ULMN 4 1cel_c01 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE user 2 4 # 2 B 212 GLU B 5 GLU~? 21.97 CH3 ACT B 802 B 214 ASP B 4 ASP~? 21.62 CA CA B 201 B 217 GLU B 8 GLU~? 16.54 CH3 ACT B 802 B 228 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo -6.37 15.57 7.12 -8.28 15.49 6.19 -13.74 38.60 75.53 -12.83 40.48 75.93 coo -8.63 18.10 10.92 -8.87 17.22 9.05 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -11.99 20.43 10.12 -12.58 18.53 9.49 -16.78 33.39 73.09 -17.99 35.10 73.27 coo -8.34 12.05 9.82 -10.16 13.07 10.00 -12.31 39.90 79.94 -12.15 41.88 80.62 1cel_c01 source 1cel 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE I (CELLULA: 2 hits 1cel_c01 naa= 4 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 4 # 1 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 5 GLU~? 25.21 CA CA A 202 345 LYS A 48 LYS~? 17.72 OXT ACT B 801 373 HIS A 2 HIS~? 23.51 OXT ACT B 801 coo 93.43 51.01 30.24 95.07 49.77 29.67 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.65 44.62 30.04 93.01 45.95 29.66 23.31 38.61 48.39 22.38 40.48 47.97 coo 103.59 43.46 23.85 98.61 47.18 23.58 15.60 31.02 44.27 16.30 36.87 43.73 coo 97.00 42.72 29.81 95.87 44.35 30.62 22.09 39.77 43.94 22.07 41.64 42.98 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 2 4 # 2 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 11 GLU~? 14.95 CA CA A 202 345 LYS A 46 LYS.? 7.73 CA CA A 202 373 HIS A 10 HIS~? 10.31 CA CA A 202 coo 93.43 51.01 30.24 95.07 49.77 29.67 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.65 44.62 30.04 93.01 45.95 29.66 26.25 27.59 54.14 27.19 27.48 52.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 17.72 24.61 42.81 16.30 19.73 46.29 coo 97.00 42.72 29.81 95.87 44.35 30.62 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 3 4 # 3 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 11 GLU~? 14.95 CA CA A 202 345 LYS A 48 LYS~? 17.72 OXT ACT B 801 373 HIS A 10 HIS~? 10.31 CA CA A 202 coo 93.43 51.01 30.24 95.07 49.77 29.67 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.65 44.62 30.04 93.01 45.95 29.66 26.25 27.59 54.14 27.19 27.48 52.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 15.60 31.02 44.27 16.30 36.87 43.73 coo 97.00 42.72 29.81 95.87 44.35 30.62 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 4 4 # 4 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 11 GLU~? 14.95 CA CA A 202 345 LYS A 52 LYS~? 15.73 OXT ACT B 801 373 HIS A 10 HIS~? 10.31 CA CA A 202 coo 93.43 51.01 30.24 95.07 49.77 29.67 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.65 44.62 30.04 93.01 45.95 29.66 26.25 27.59 54.14 27.19 27.48 52.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 13.41 31.22 50.01 11.37 34.80 45.78 coo 97.00 42.72 29.81 95.87 44.35 30.62 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 5 4 # 5 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 5 GLU~? 21.97 CH3 ACT B 802 345 LYS B 48 LYS~? 22.74 CA CA B 201 373 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo 93.43 51.01 30.24 95.07 49.77 29.67 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.65 44.62 30.04 93.01 45.95 29.66 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 103.59 43.46 23.85 98.61 47.18 23.58 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 97.00 42.72 29.81 95.87 44.35 30.62 -12.31 39.90 79.94 -12.15 41.88 80.62 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 6 4 # 6 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 11 GLU~? 12.56 CH3 ACT B 802 345 LYS B 46 LYS.? 7.77 CA CA B 201 373 HIS B 10 HIS~? 10.24 CA CA B 201 coo 93.43 51.01 30.24 95.07 49.77 29.67 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.65 44.62 30.04 93.01 45.95 29.66 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 103.59 43.46 23.85 98.61 47.18 23.58 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 97.00 42.72 29.81 95.87 44.35 30.62 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 7 4 # 7 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 11 GLU~? 12.56 CH3 ACT B 802 345 LYS B 48 LYS~? 22.74 CA CA B 201 373 HIS B 10 HIS~? 10.24 CA CA B 201 coo 93.43 51.01 30.24 95.07 49.77 29.67 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.65 44.62 30.04 93.01 45.95 29.66 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 103.59 43.46 23.85 98.61 47.18 23.58 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 97.00 42.72 29.81 95.87 44.35 30.62 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 8 4 # 8 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 11 GLU~? 12.56 CH3 ACT B 802 345 LYS B 52 LYS~? 20.44 CA CA B 201 373 HIS B 10 HIS~? 10.24 CA CA B 201 coo 93.43 51.01 30.24 95.07 49.77 29.67 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.65 44.62 30.04 93.01 45.95 29.66 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 103.59 43.46 23.85 98.61 47.18 23.58 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 97.00 42.72 29.81 95.87 44.35 30.62 -9.62 27.46 71.20 -8.83 25.53 71.16 1els_c01 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 8 hits 1els_c01 naa= 4 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 4 # 1 B 95 ASP A 38 ASP~? -3.36 CA CA A 202s B 117 GLU A 36 GLU~? 11.24 CA CA A 202 B 131 GLU A 40 GLU.? 3.38 CA CA A 202s B 213 HIS A 10 HIS~? 10.31 CA CA A 202 coo 39.14 56.64 24.68 38.62 56.32 26.77 14.49 17.18 50.40 16.42 16.29 49.93 coo 40.54 62.45 29.38 39.23 60.98 30.16 8.53 16.97 55.87 6.50 17.32 56.35 coo 38.13 52.78 25.48 37.33 50.83 25.51 19.19 19.98 52.16 20.07 18.13 52.69 coo 35.79 48.48 32.46 36.87 50.29 32.45 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 4 # 2 B 95 ASP A 38 ASP~? -3.36 CA CA A 202s B 117 GLU A 36 GLU~? 11.24 CA CA A 202 B 131 GLU A 40 GLU.? 3.38 CA CA A 202s B 213 HIS A 51 HIS~? 12.20 CA CA A 202 coo 39.14 56.64 24.68 38.62 56.32 26.77 14.49 17.18 50.40 16.42 16.29 49.93 coo 40.54 62.45 29.38 39.23 60.98 30.16 8.53 16.97 55.87 6.50 17.32 56.35 coo 38.13 52.78 25.48 37.33 50.83 25.51 19.19 19.98 52.16 20.07 18.13 52.69 coo 35.79 48.48 32.46 36.87 50.29 32.45 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 4 # 3 B 95 ASP B 38 ASP~? -3.30 CA CA B 201s B 117 GLU B 36 GLU~? 11.20 CA CA B 201 B 131 GLU B 40 GLU.? 3.43 CA CA B 201s B 213 HIS B 10 HIS~? 10.24 CA CA B 201 coo 39.14 56.64 24.68 38.62 56.32 26.77 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 40.54 62.45 29.38 39.23 60.98 30.16 1.18 16.63 68.50 3.14 16.97 67.89 coo 38.13 52.78 25.48 37.33 50.83 25.51 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 35.79 48.48 32.46 36.87 50.29 32.45 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 4 # 4 B 95 ASP B 38 ASP~? -3.30 CA CA B 201s B 117 GLU B 36 GLU~? 11.20 CA CA B 201 B 131 GLU B 40 GLU.? 3.43 CA CA B 201s B 213 HIS B 51 HIS~? 12.10 CA CA B 201 coo 39.14 56.64 24.68 38.62 56.32 26.77 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 40.54 62.45 29.38 39.23 60.98 30.16 1.18 16.63 68.50 3.14 16.97 67.89 coo 38.13 52.78 25.48 37.33 50.83 25.51 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 35.79 48.48 32.46 36.87 50.29 32.45 -8.32 27.87 76.15 -9.65 26.27 76.41 1f6d_c01 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 4 hits 1f6d_c01 naa= 4 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 4 # 1 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 5 GLU~? 25.21 CA CA A 202 345 LYS A 48 LYS~? 17.72 OXT ACT B 801 373 HIS A 2 HIS~? 23.51 OXT ACT B 801 coo 93.06 51.30 30.12 94.58 49.94 29.58 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.99 44.43 29.92 93.23 45.97 29.33 23.31 38.61 48.39 22.38 40.48 47.97 coo 103.66 43.57 23.68 98.86 47.65 23.32 15.60 31.02 44.27 16.30 36.87 43.73 coo 97.15 42.73 29.83 95.81 44.24 30.44 22.09 39.77 43.94 22.07 41.64 42.98 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 4 # 2 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 11 GLU~? 14.95 CA CA A 202 345 LYS A 17 LYS~? 8.75 CA CA A 202 373 HIS A 10 HIS~? 10.31 CA CA A 202 coo 93.06 51.30 30.12 94.58 49.94 29.58 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.99 44.43 29.92 93.23 45.97 29.33 26.25 27.59 54.14 27.19 27.48 52.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 19.68 24.92 63.26 19.27 20.80 60.44 coo 97.15 42.73 29.83 95.81 44.24 30.44 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 3 4 # 3 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 11 GLU~? 14.95 CA CA A 202 345 LYS A 46 LYS.? 7.73 CA CA A 202 373 HIS A 10 HIS~? 10.31 CA CA A 202 coo 93.06 51.30 30.12 94.58 49.94 29.58 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.99 44.43 29.92 93.23 45.97 29.33 26.25 27.59 54.14 27.19 27.48 52.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 17.72 24.61 42.81 16.30 19.73 46.29 coo 97.15 42.73 29.83 95.81 44.24 30.44 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 4 4 # 4 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 11 GLU~? 14.95 CA CA A 202 345 LYS A 48 LYS~? 17.72 OXT ACT B 801 373 HIS A 10 HIS~? 10.31 CA CA A 202 coo 93.06 51.30 30.12 94.58 49.94 29.58 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.99 44.43 29.92 93.23 45.97 29.33 26.25 27.59 54.14 27.19 27.48 52.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 15.60 31.02 44.27 16.30 36.87 43.73 coo 97.15 42.73 29.83 95.81 44.24 30.44 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 5 4 # 5 168 GLU A 8 GLU~? 21.63 CA CA A 202 211 GLU A 11 GLU~? 14.95 CA CA A 202 345 LYS A 52 LYS~? 15.73 OXT ACT B 801 373 HIS A 10 HIS~? 10.31 CA CA A 202 coo 93.06 51.30 30.12 94.58 49.94 29.58 26.55 33.36 50.86 27.60 35.12 50.29 coo 91.99 44.43 29.92 93.23 45.97 29.33 26.25 27.59 54.14 27.19 27.48 52.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 13.41 31.22 50.01 11.37 34.80 45.78 coo 97.15 42.73 29.83 95.81 44.24 30.44 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 6 4 # 6 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 5 GLU~? 21.97 CH3 ACT B 802 345 LYS B 48 LYS~? 22.74 CA CA B 201 373 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo 93.06 51.30 30.12 94.58 49.94 29.58 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.99 44.43 29.92 93.23 45.97 29.33 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 103.66 43.57 23.68 98.86 47.65 23.32 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 97.15 42.73 29.83 95.81 44.24 30.44 -12.31 39.90 79.94 -12.15 41.88 80.62 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 7 4 # 7 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 11 GLU~? 12.56 CH3 ACT B 802 345 LYS B 46 LYS.? 7.77 CA CA B 201 373 HIS B 10 HIS~? 10.24 CA CA B 201 coo 93.06 51.30 30.12 94.58 49.94 29.58 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.99 44.43 29.92 93.23 45.97 29.33 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 103.66 43.57 23.68 98.86 47.65 23.32 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 97.15 42.73 29.83 95.81 44.24 30.44 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 8 4 # 8 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 11 GLU~? 12.56 CH3 ACT B 802 345 LYS B 48 LYS~? 22.74 CA CA B 201 373 HIS B 10 HIS~? 10.24 CA CA B 201 coo 93.06 51.30 30.12 94.58 49.94 29.58 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.99 44.43 29.92 93.23 45.97 29.33 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 103.66 43.57 23.68 98.86 47.65 23.32 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 97.15 42.73 29.83 95.81 44.24 30.44 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 9 4 # 9 168 GLU B 8 GLU~? 16.54 CH3 ACT B 802 211 GLU B 11 GLU~? 12.56 CH3 ACT B 802 345 LYS B 52 LYS~? 20.44 CA CA B 201 373 HIS B 10 HIS~? 10.24 CA CA B 201 coo 93.06 51.30 30.12 94.58 49.94 29.58 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 91.99 44.43 29.92 93.23 45.97 29.33 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 103.66 43.57 23.68 98.86 47.65 23.32 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 97.15 42.73 29.83 95.81 44.24 30.44 -9.62 27.46 71.20 -8.83 25.53 71.16 5enl_c01 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 9 hits 5enl_c01 naa= 4 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 114 HIS A 43 HIS.? 6.83 CA CA A 202 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 19.28 27.48 52.70 18.40 25.59 52.72 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 20.81 34.16 44.49 19.85 28.53 41.75 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 114 HIS A 53 HIS~? 13.16 CA CA A 202 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 19.28 27.48 52.70 18.40 25.59 52.72 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 20.81 34.16 44.49 19.85 28.53 41.75 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 17 LYS~? 8.75 CA CA A 202 B 114 HIS A 43 HIS.? 6.83 CA CA A 202 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 19.28 27.48 52.70 18.40 25.59 52.72 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 19.68 24.92 63.26 19.27 20.80 60.44 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 4 3 # 4 B 13 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 17 LYS~? 8.75 CA CA A 202 B 114 HIS A 53 HIS~? 13.16 CA CA A 202 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 19.28 27.48 52.70 18.40 25.59 52.72 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 19.68 24.92 63.26 19.27 20.80 60.44 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 5 3 # 5 B 13 HIS A 43 HIS.? 6.83 CA CA A 202 B 40 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 114 HIS A 45 HIS.? 16.70 CA CA A 202 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 20.15 20.72 47.43 19.82 19.00 48.57 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 13.41 31.22 50.01 11.37 34.80 45.78 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 6 3 # 6 B 13 HIS A 45 HIS.? 16.70 CA CA A 202 B 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 114 HIS A 43 HIS.? 6.83 CA CA A 202 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 22.98 23.53 40.00 25.00 23.74 39.51 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 20.81 34.16 44.49 19.85 28.53 41.75 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 7 3 # 7 B 13 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 3 LYS~? 17.03 CA CA B 201 B 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 8 3 # 8 B 13 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 3 LYS~? 17.03 CA CA B 201 B 114 HIS B 53 HIS~? 13.80 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 9 3 # 9 B 13 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 17 LYS~? 8.61 CA CA B 201 B 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -9.98 24.92 60.71 -9.24 20.80 63.54 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 10 3 # 10 B 13 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 17 LYS~? 8.61 CA CA B 201 B 114 HIS B 53 HIS~? 13.80 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -9.98 24.92 60.71 -9.24 20.80 63.54 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 11 3 # 11 B 13 HIS B 43 HIS.? 6.84 CA CA B 201 B 40 LYS B 52 LYS~? 20.44 CA CA B 201 B 114 HIS B 45 HIS.? 16.95 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 12 3 # 12 B 13 HIS B 45 HIS.? 16.95 CA CA B 201 B 40 LYS A 79 LYS~? 16.33 CA CA B 201 B 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 13 3 # 13 B 13 HIS B 45 HIS.? 16.95 CA CA B 201 B 40 LYS B 3 LYS~? 17.03 CA CA B 201 B 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 14 3 # 14 B 13 HIS B 51 HIS~? 12.10 CA CA B 201 B 40 LYS A 79 LYS~? 16.33 CA CA B 201 B 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 15 3 # 15 B 13 HIS B 53 HIS~? 13.80 CA CA B 201 B 40 LYS A 79 LYS~? 16.33 CA CA B 201 B 114 HIS B 10 HIS~? 10.24 CA CA B 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 0.46 27.04 73.26 2.14 26.33 72.22 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -9.62 27.46 71.20 -8.83 25.53 71.16 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 15 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 10 HIS~? 10.31 CA CA A 202 E 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 E 114 HIS A 43 HIS.? 6.83 CA CA A 202 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 19.28 27.48 52.70 18.40 25.59 52.72 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 20.81 34.16 44.49 19.85 28.53 41.75 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS A 10 HIS~? 10.31 CA CA A 202 E 40 LYS A 17 LYS~? 8.75 CA CA A 202 E 114 HIS A 43 HIS.? 6.83 CA CA A 202 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 19.28 27.48 52.70 18.40 25.59 52.72 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 19.68 24.92 63.26 19.27 20.80 60.44 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS A 43 HIS.? 6.83 CA CA A 202 E 40 LYS A 52 LYS~? 15.73 OXT ACT B 801 E 114 HIS A 45 HIS.? 16.70 CA CA A 202 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 20.15 20.72 47.43 19.82 19.00 48.57 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 13.41 31.22 50.01 11.37 34.80 45.78 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 4 3 # 4 E 13 HIS A 45 HIS.? 16.70 CA CA A 202 E 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 E 114 HIS A 43 HIS.? 6.83 CA CA A 202 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 22.98 23.53 40.00 25.00 23.74 39.51 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 20.81 34.16 44.49 19.85 28.53 41.75 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 5 3 # 5 E 13 HIS B 10 HIS~? 10.24 CA CA B 201 E 40 LYS B 3 LYS~? 17.03 CA CA B 201 E 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 6 3 # 6 E 13 HIS B 10 HIS~? 10.24 CA CA B 201 E 40 LYS B 17 LYS~? 8.61 CA CA B 201 E 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 7 3 # 7 E 13 HIS B 43 HIS.? 6.84 CA CA B 201 E 40 LYS B 52 LYS~? 20.44 CA CA B 201 E 114 HIS B 45 HIS.? 16.95 CA CA B 201 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 8 3 # 8 E 13 HIS B 45 HIS.? 16.95 CA CA B 201 E 40 LYS A 79 LYS~? 16.33 CA CA B 201 E 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 9 3 # 9 E 13 HIS B 45 HIS.? 16.95 CA CA B 201 E 40 LYS B 3 LYS~? 17.03 CA CA B 201 E 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 10 3 # 10 E 13 HIS B 51 HIS~? 12.10 CA CA B 201 E 40 LYS A 79 LYS~? 16.33 CA CA B 201 E 114 HIS B 43 HIS.? 6.84 CA CA B 201 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -10.59 20.73 76.53 -10.28 19.02 75.37 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 10 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 40 GLU.? 3.38 CA CA A 202s A 60 ASP A 18 ASP~? 11.52 CA CA A 202 A 175 TYR A 34 TYR~? 7.34 CA CA A 202 coo 46.10 28.27 19.27 45.48 26.99 20.84 19.19 19.98 52.16 20.07 18.13 52.69 coo 56.42 28.06 12.93 55.01 27.92 14.50 23.94 22.65 63.18 23.40 21.50 61.45 coo 45.02 22.04 15.38 46.16 24.00 13.76 14.67 22.85 56.72 17.08 23.07 55.48 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 40 GLU.? 3.43 CA CA B 201s A 60 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 175 TYR B 34 TYR~? 7.28 CA CA B 201 coo 46.10 28.27 19.27 45.48 26.99 20.84 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 56.42 28.06 12.93 55.01 27.92 14.50 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 45.02 22.04 15.38 46.16 24.00 13.76 -4.97 22.79 67.30 -7.41 23.00 68.45 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 2 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 34 TYR~? 7.34 CA CA A 202 A 125 HIS A 10 HIS~? 10.31 CA CA A 202 A 156 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 14.67 22.85 56.72 17.08 23.07 55.48 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 19.28 27.48 52.70 18.40 25.59 52.72 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 34 TYR~? 7.28 CA CA B 201 A 125 HIS B 10 HIS~? 10.24 CA CA B 201 A 156 LYS B 52 LYS~? 20.44 CA CA B 201 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -3.85 31.32 74.04 -1.50 34.25 78.56 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c00 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 34 TYR~? 7.34 CA CA A 202 C 125 HIS A 10 HIS~? 10.31 CA CA A 202 C 156 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 14.67 22.85 56.72 17.08 23.07 55.48 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 19.28 27.48 52.70 18.40 25.59 52.72 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 34 TYR~? 7.28 CA CA B 201 C 125 HIS B 10 HIS~? 10.24 CA CA B 201 C 156 LYS B 52 LYS~? 20.44 CA CA B 201 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -3.85 31.32 74.04 -1.50 34.25 78.56 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 34 TYR~? 7.34 CA CA A 202 D 125 HIS A 10 HIS~? 10.31 CA CA A 202 D 156 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 54.10 1.42 85.16 54.14 4.17 85.62 14.67 22.85 56.72 17.08 23.07 55.48 coo 61.27 5.43 85.32 62.73 6.38 86.49 19.28 27.48 52.70 18.40 25.59 52.72 coo 60.28 4.62 76.00 58.35 6.41 80.65 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR B 34 TYR~? 7.28 CA CA B 201 D 125 HIS B 10 HIS~? 10.24 CA CA B 201 D 156 LYS B 52 LYS~? 20.44 CA CA B 201 coo 54.10 1.42 85.16 54.14 4.17 85.62 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 61.27 5.43 85.32 62.73 6.38 86.49 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 60.28 4.62 76.00 58.35 6.41 80.65 -3.85 31.32 74.04 -1.50 34.25 78.56 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER B 42 SER.? 8.82 CA CA B 201 B 228 ASP B 38 ASP~? -3.30 CA CA B 201s B 257 HIS B 43 HIS.? 6.84 CA CA B 201 coo 28.35 71.07 3.94 30.08 69.46 4.49 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 32.76 68.02 0.70 31.21 68.44 2.05 -10.59 20.73 76.53 -10.28 19.02 75.37 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 54 ALA~? 9.99 CA CA A 202 19 HIS A 51 HIS~? 12.20 CA CA A 202 22 HIS A 10 HIS~? 10.31 CA CA A 202 coo 53.27 36.51 45.29 51.98 36.45 44.47 13.75 26.68 52.93 15.03 26.06 52.36 coo 46.88 33.59 48.26 46.24 34.32 46.40 17.98 27.94 47.81 19.27 26.33 47.47 coo 48.05 31.12 44.60 48.20 33.05 43.77 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA B 54 ALA~? 9.98 CA CA B 201 19 HIS B 51 HIS~? 12.10 CA CA B 201 22 HIS B 10 HIS~? 10.24 CA CA B 201 coo 53.27 36.51 45.29 51.98 36.45 44.47 -4.07 26.74 71.12 -5.32 26.04 71.64 coo 46.88 33.59 48.26 46.24 34.32 46.40 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 48.05 31.12 44.60 48.20 33.05 43.77 -9.62 27.46 71.20 -8.83 25.53 71.16 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 2 hits 1a8h_c02 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 43 HIS.? 6.83 CA CA A 202 A 262 HIS A 10 HIS~? 10.31 CA CA A 202 A 312 ASP A 38 ASP~? -3.36 CA CA A 202s coo 29.33 36.13 69.70 30.07 34.20 70.11 20.15 20.72 47.43 19.82 19.00 48.57 coo 38.54 36.60 66.38 37.88 34.77 67.15 19.28 27.48 52.70 18.40 25.59 52.72 coo 30.62 37.23 61.07 30.08 35.73 62.49 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 53 HIS~? 13.16 CA CA A 202 A 262 HIS A 10 HIS~? 10.31 CA CA A 202 A 312 ASP A 38 ASP~? -3.36 CA CA A 202s coo 29.33 36.13 69.70 30.07 34.20 70.11 9.33 26.57 50.59 7.78 25.45 51.45 coo 38.54 36.60 66.38 37.88 34.77 67.15 19.28 27.48 52.70 18.40 25.59 52.72 coo 30.62 37.23 61.07 30.08 35.73 62.49 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS B 43 HIS.? 6.84 CA CA B 201 A 262 HIS B 10 HIS~? 10.24 CA CA B 201 A 312 ASP B 38 ASP~? -3.30 CA CA B 201s coo 29.33 36.13 69.70 30.07 34.20 70.11 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 38.54 36.60 66.38 37.88 34.77 67.15 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 30.62 37.23 61.07 30.08 35.73 62.49 -4.95 17.23 73.65 -6.90 16.31 73.97 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 3 hits 1aj8_c00 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 43 HIS.? 6.83 CA CA A 202 320 HIS A 10 HIS~? 10.31 CA CA A 202 375 ASP A 38 ASP~? -3.36 CA CA A 202s coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 20.15 20.72 47.43 19.82 19.00 48.57 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 19.28 27.48 52.70 18.40 25.59 52.72 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 53 HIS~? 13.16 CA CA A 202 320 HIS A 10 HIS~? 10.31 CA CA A 202 375 ASP A 38 ASP~? -3.36 CA CA A 202s coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.33 26.57 50.59 7.78 25.45 51.45 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 19.28 27.48 52.70 18.40 25.59 52.72 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS A 53 HIS~? 13.16 CA CA A 202 320 HIS A 51 HIS~? 12.20 CA CA A 202 375 ASP A 38 ASP~? -3.36 CA CA A 202s coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.33 26.57 50.59 7.78 25.45 51.45 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 17.98 27.94 47.81 19.27 26.33 47.47 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS B 43 HIS.? 6.84 CA CA B 201 320 HIS B 10 HIS~? 10.24 CA CA B 201 375 ASP B 38 ASP~? -3.30 CA CA B 201s coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -4.95 17.23 73.65 -6.90 16.31 73.97 1al6_c00 source 1al6 CITRATE SYNTHASE : 4 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 38 ASP~? -3.36 CA CA A 202s 187 GLU A 50 GLU~? 11.43 OXT ACT B 801 229 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo -52.57 56.60 47.75 -51.52 54.87 46.95 14.49 17.18 50.40 16.42 16.29 49.93 coo -45.08 48.37 46.81 -46.53 49.74 45.96 12.68 24.99 44.98 13.54 23.53 43.68 coo -47.40 44.36 48.48 -50.80 49.18 46.20 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 87 ASP~? 24.31 CA CA B 201 187 GLU A 82 GLU~? 19.14 CA CA B 201 229 LYS A 79 LYS~? 16.33 CA CA B 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -7.78 26.60 94.58 -7.92 24.72 93.60 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -6.39 30.15 85.63 -6.65 30.56 83.58 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -1.65 27.80 84.43 -2.82 22.46 85.13 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 38 ASP~? -3.30 CA CA B 201s 187 GLU B 50 GLU~? 12.54 CA CA B 201 229 LYS B 48 LYS~? 22.74 CA CA B 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -6.08 30.98 79.72 -6.69 36.84 80.65 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 3 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 69 ASP~? 23.19 CA CA B 201 35 SER A 67 SER~? 18.51 CA CA B 201 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo -7.18 8.92 145.10 -8.77 8.81 143.59 11.02 26.78 74.77 12.23 26.87 76.45 coo -12.30 10.35 145.24 -10.75 8.55 145.88 7.12 29.60 71.54 4.89 29.99 70.85 coo -8.20 12.64 138.30 -8.86 10.97 139.38 11.73 20.36 70.40 10.57 19.24 69.08 1am5_c04 source 1am5 PEPSIN : 1 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 24 ASP.? 26.42 CA CA A 202 214 ASP A 86 ASP~? 21.59 CA CA B 201 289 ASP A 69 ASP~? 23.19 CA CA B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 20.63 21.72 77.63 20.78 20.24 79.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 9.42 68.07 30.27 7.35 68.27 30.10 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 24 ASP.? 26.42 CA CA A 202 214 ASP B 27 ASP.? 17.39 CA CA B 201 289 ASP A 69 ASP~? 23.19 CA CA B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 20.63 21.72 77.63 20.78 20.24 79.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 24 ASP.? 15.33 OXT ACT B 802 214 ASP A 27 ASP.? 17.47 CA CA A 202 289 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo -0.62 65.95 29.97 0.31 67.47 31.05 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 26.86 59.76 46.36 25.42 58.23 45.92 11.73 20.36 70.40 10.57 19.24 69.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -0.95 26.94 49.29 -2.15 27.04 47.60 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 3 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 27 ASP.? 17.47 CA CA A 202 227 GLU A 70 GLU~? 24.16 CA CA B 201 289 ASP A 24 ASP.? 26.42 CA CA A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 11.73 20.36 70.40 10.57 19.24 69.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 7.07 31.83 76.89 8.40 32.80 78.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 27 ASP.? 17.39 CA CA B 201 227 GLU B 70 GLU~? 15.15 CH3 ACT B 801 289 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 2.91 32.18 47.37 1.68 33.21 45.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -10.90 21.62 46.30 -10.75 20.16 44.81 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 69 ASP~? 23.19 CA CA B 201 E 36 SER A 67 SER~? 18.51 CA CA B 201 E 213 ASP A 27 ASP.? 17.47 CA CA A 202 coo 26.30 12.96 16.78 25.46 12.99 18.72 11.02 26.78 74.77 12.23 26.87 76.45 coo 28.33 15.15 21.27 28.70 13.12 19.97 7.12 29.60 71.54 4.89 29.99 70.85 coo 20.15 16.04 19.79 21.65 14.49 19.86 11.73 20.36 70.40 10.57 19.24 69.08 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 1 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS B 53 HIS~? 13.80 CA CA B 201 254 LYS B 48 LYS~? 22.74 CA CA B 201 333 ARG A 76 ARG~? 16.28 CA CA B 201 coo 28.11 -1.15 8.51 29.21 0.63 8.34 0.46 27.04 73.26 2.14 26.33 72.22 coo 26.09 4.87 14.60 27.89 3.33 10.26 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 37.35 7.47 11.84 34.90 6.11 10.60 4.46 22.84 83.40 3.22 20.31 82.22 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 1 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 67 SER~? 18.51 CA CA B 201 A 292 ASP A 18 ASP~? 11.52 CA CA A 202 A 322 HIS B 10 HIS~? 10.24 CA CA B 201 coo 36.34 32.23 39.60 36.43 34.62 39.93 7.12 29.60 71.54 4.89 29.99 70.85 coo 19.73 19.18 41.39 21.50 18.65 40.34 23.94 22.65 63.18 23.40 21.50 61.45 coo 41.69 45.14 46.60 41.78 47.19 46.18 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 67 SER~? 18.51 CA CA B 201 A 292 ASP A 18 ASP~? 11.52 CA CA A 202 A 322 HIS B 51 HIS~? 12.10 CA CA B 201 coo 36.34 32.23 39.60 36.43 34.62 39.93 7.12 29.60 71.54 4.89 29.99 70.85 coo 19.73 19.18 41.39 21.50 18.65 40.34 23.94 22.65 63.18 23.40 21.50 61.45 coo 41.69 45.14 46.60 41.78 47.19 46.18 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 78 SER~? 22.09 CA CA B 201 A 292 ASP A 24 ASP.? 26.42 CA CA A 202 A 322 HIS B 45 HIS.? 16.95 CA CA B 201 coo 36.34 32.23 39.60 36.43 34.62 39.93 0.59 30.86 84.57 0.46 32.77 83.16 coo 19.73 19.18 41.39 21.50 18.65 40.34 20.63 21.72 77.63 20.78 20.24 79.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 78 SER~? 22.09 CA CA B 201 A 292 ASP A 27 ASP.? 17.47 CA CA A 202 A 322 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo 36.34 32.23 39.60 36.43 34.62 39.93 0.59 30.86 84.57 0.46 32.77 83.16 coo 19.73 19.18 41.39 21.50 18.65 40.34 11.73 20.36 70.40 10.57 19.24 69.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 -12.31 39.90 79.94 -12.15 41.88 80.62 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 47 SER~? 15.49 CA CA B 201 A 292 ASP A 27 ASP.? 17.47 CA CA A 202 A 322 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo 36.34 32.23 39.60 36.43 34.62 39.93 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 19.73 19.18 41.39 21.50 18.65 40.34 11.73 20.36 70.40 10.57 19.24 69.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 -12.31 39.90 79.94 -12.15 41.88 80.62 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 67 SER~? 20.12 CA CA A 202 A 292 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 322 HIS A 10 HIS~? 10.31 CA CA A 202 coo 36.34 32.23 39.60 36.43 34.62 39.93 2.68 29.83 52.62 3.84 31.35 54.03 coo 19.73 19.18 41.39 21.50 18.65 40.34 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 41.69 45.14 46.60 41.78 47.19 46.18 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 67 SER~? 20.12 CA CA A 202 A 292 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 322 HIS A 51 HIS~? 12.20 CA CA A 202 coo 36.34 32.23 39.60 36.43 34.62 39.93 2.68 29.83 52.62 3.84 31.35 54.03 coo 19.73 19.18 41.39 21.50 18.65 40.34 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 41.69 45.14 46.60 41.78 47.19 46.18 17.98 27.94 47.81 19.27 26.33 47.47 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 7 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 67 SER~? 18.51 CA CA B 201 B 292 ASP A 18 ASP~? 11.52 CA CA A 202 B 322 HIS B 10 HIS~? 10.24 CA CA B 201 coo 35.42 71.28 22.94 36.24 69.06 22.37 7.12 29.60 71.54 4.89 29.99 70.85 coo 24.74 78.07 5.59 24.32 79.03 7.46 23.94 22.65 63.18 23.40 21.50 61.45 coo 48.81 64.16 26.34 49.30 62.16 26.73 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 67 SER~? 18.51 CA CA B 201 B 292 ASP A 18 ASP~? 11.52 CA CA A 202 B 322 HIS B 51 HIS~? 12.10 CA CA B 201 coo 35.42 71.28 22.94 36.24 69.06 22.37 7.12 29.60 71.54 4.89 29.99 70.85 coo 24.74 78.07 5.59 24.32 79.03 7.46 23.94 22.65 63.18 23.40 21.50 61.45 coo 48.81 64.16 26.34 49.30 62.16 26.73 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 78 SER~? 22.09 CA CA B 201 B 292 ASP A 24 ASP.? 26.42 CA CA A 202 B 322 HIS B 45 HIS.? 16.95 CA CA B 201 coo 35.42 71.28 22.94 36.24 69.06 22.37 0.59 30.86 84.57 0.46 32.77 83.16 coo 24.74 78.07 5.59 24.32 79.03 7.46 20.63 21.72 77.63 20.78 20.24 79.08 coo 48.81 64.16 26.34 49.30 62.16 26.73 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 67 SER~? 20.12 CA CA A 202 B 292 ASP B 18 ASP~? 9.64 OXT ACT B 802 B 322 HIS A 10 HIS~? 10.31 CA CA A 202 coo 35.42 71.28 22.94 36.24 69.06 22.37 2.68 29.83 52.62 3.84 31.35 54.03 coo 24.74 78.07 5.59 24.32 79.03 7.46 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 48.81 64.16 26.34 49.30 62.16 26.73 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 67 SER~? 20.12 CA CA A 202 B 292 ASP B 18 ASP~? 9.64 OXT ACT B 802 B 322 HIS A 51 HIS~? 12.20 CA CA A 202 coo 35.42 71.28 22.94 36.24 69.06 22.37 2.68 29.83 52.62 3.84 31.35 54.03 coo 24.74 78.07 5.59 24.32 79.03 7.46 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 48.81 64.16 26.34 49.30 62.16 26.73 17.98 27.94 47.81 19.27 26.33 47.47 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 5 hits 1aql_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 69 ASP~? 23.19 CA CA B 201 A 35 SER A 67 SER~? 18.51 CA CA B 201 A 217 ASP A 27 ASP.? 17.47 CA CA A 202 coo -10.06 2.54 49.69 -8.83 3.73 50.96 11.02 26.78 74.77 12.23 26.87 76.45 coo -11.96 5.74 52.90 -10.55 6.74 51.22 7.12 29.60 71.54 4.89 29.99 70.85 coo -5.22 1.43 56.08 -5.36 2.84 54.49 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 35 SER B 67 SER~? 20.12 CA CA A 202 A 217 ASP B 27 ASP.? 17.39 CA CA B 201 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -0.95 26.94 49.29 -2.15 27.04 47.60 coo -11.96 5.74 52.90 -10.55 6.74 51.22 2.68 29.83 52.62 3.84 31.35 54.03 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -1.83 20.43 53.73 -0.68 19.31 55.10 1avf_c04 source 1avf GASTRICSIN : 2 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 69 ASP~? 23.19 CA CA B 201 J 35 SER A 67 SER~? 18.51 CA CA B 201 J 217 ASP A 27 ASP.? 17.47 CA CA A 202 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 11.02 26.78 74.77 12.23 26.87 76.45 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 7.12 29.60 71.54 4.89 29.99 70.85 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 J 35 SER B 67 SER~? 20.12 CA CA A 202 J 217 ASP B 27 ASP.? 17.39 CA CA B 201 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -0.95 26.94 49.29 -2.15 27.04 47.60 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 2.68 29.83 52.62 3.84 31.35 54.03 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -1.83 20.43 53.73 -0.68 19.31 55.10 1avf_c05 source 1avf GASTRICSIN : 2 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 56 PHE~? 17.60 CA CA A 202 A 223 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 265 LYS B 17 LYS~? 8.61 CA CA B 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 8.62 30.56 55.11 6.08 30.87 56.13 coo 30.70 47.50 67.53 29.83 49.47 67.39 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 19.99 54.53 64.11 20.55 58.78 68.33 -9.98 24.92 60.71 -9.24 20.80 63.54 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 56 PHE~? 17.42 CA CA B 201 A 223 ASP A 69 ASP~? 23.19 CA CA B 201 A 265 LYS A 17 LYS~? 8.75 CA CA A 202 coo 39.74 52.86 65.74 41.15 55.14 66.52 1.08 30.45 68.86 3.64 30.39 67.74 coo 30.70 47.50 67.53 29.83 49.47 67.39 11.02 26.78 74.77 12.23 26.87 76.45 coo 19.99 54.53 64.11 20.55 58.78 68.33 19.68 24.92 63.26 19.27 20.80 60.44 1ax4_c04 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 56 PHE~? 17.60 CA CA A 202 B 223 ASP B 69 ASP~? 15.19 CH3 ACT B 801 B 265 LYS B 17 LYS~? 8.61 CA CA B 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 8.62 30.56 55.11 6.08 30.87 56.13 coo 10.43 61.66 91.81 9.80 60.04 90.61 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 5.43 58.06 80.08 8.57 53.00 79.37 -9.98 24.92 60.71 -9.24 20.80 63.54 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 56 PHE~? 17.42 CA CA B 201 B 223 ASP A 69 ASP~? 23.19 CA CA B 201 B 265 LYS A 17 LYS~? 8.75 CA CA A 202 coo 7.48 54.94 99.62 7.67 52.27 100.42 1.08 30.45 68.86 3.64 30.39 67.74 coo 10.43 61.66 91.81 9.80 60.04 90.61 11.02 26.78 74.77 12.23 26.87 76.45 coo 5.43 58.06 80.08 8.57 53.00 79.37 19.68 24.92 63.26 19.27 20.80 60.44 1ax4_c05 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 56 PHE~? 17.60 CA CA A 202 C 223 ASP B 69 ASP~? 15.19 CH3 ACT B 801 C 265 LYS B 17 LYS~? 8.61 CA CA B 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 8.62 30.56 55.11 6.08 30.87 56.13 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -0.95 26.94 49.29 -2.15 27.04 47.60 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -9.98 24.92 60.71 -9.24 20.80 63.54 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 56 PHE~? 17.42 CA CA B 201 C 223 ASP A 69 ASP~? 23.19 CA CA B 201 C 265 LYS A 17 LYS~? 8.75 CA CA A 202 coo -6.55 73.45 23.60 -6.77 71.48 21.66 1.08 30.45 68.86 3.64 30.39 67.74 coo -9.52 75.74 33.62 -8.85 73.74 33.93 11.02 26.78 74.77 12.23 26.87 76.45 coo -4.44 67.20 42.32 -7.50 62.41 40.49 19.68 24.92 63.26 19.27 20.80 60.44 1ax4_c06 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 56 PHE~? 17.60 CA CA A 202 D 223 ASP B 69 ASP~? 15.19 CH3 ACT B 801 D 265 LYS B 17 LYS~? 8.61 CA CA B 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 8.62 30.56 55.11 6.08 30.87 56.13 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -0.95 26.94 49.29 -2.15 27.04 47.60 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -9.98 24.92 60.71 -9.24 20.80 63.54 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 56 PHE~? 17.42 CA CA B 201 D 223 ASP A 69 ASP~? 23.19 CA CA B 201 D 265 LYS A 17 LYS~? 8.75 CA CA A 202 coo -38.60 55.38 52.70 -40.06 57.72 53.04 1.08 30.45 68.86 3.64 30.39 67.74 coo -29.46 51.67 48.51 -28.63 53.31 49.56 11.02 26.78 74.77 12.23 26.87 76.45 coo -18.87 56.53 54.79 -19.47 62.22 53.03 19.68 24.92 63.26 19.27 20.80 60.44 1ax4_c07 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER B 42 SER.? 8.82 CA CA B 201 A 266 ASP B 38 ASP~? -3.30 CA CA B 201s A 294 HIS B 43 HIS.? 6.84 CA CA B 201 coo 32.07 25.76 77.83 34.46 26.05 77.46 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 33.07 35.01 79.81 33.39 33.02 79.13 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 35.53 30.26 79.89 34.62 28.71 78.80 -10.59 20.73 76.53 -10.28 19.02 75.37 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 1 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER B 42 SER.? 8.82 CA CA B 201 B 266 ASP B 38 ASP~? -3.30 CA CA B 201s B 294 HIS B 43 HIS.? 6.84 CA CA B 201 coo 51.18 33.22 36.61 49.29 31.79 37.02 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 44.19 39.32 34.54 45.21 37.66 35.38 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 45.79 34.26 34.63 47.54 33.80 35.70 -10.59 20.73 76.53 -10.28 19.02 75.37 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 1 hits 1azw_c01 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS B 43 HIS.? 6.84 CA CA B 201 A 171 ARG A 76 ARG~? 16.28 CA CA B 201 A 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 13.63 3.81 28.83 14.49 2.91 31.59 4.46 22.84 83.40 3.22 20.31 82.22 coo 24.97 7.47 37.69 21.24 10.69 35.89 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS B 43 HIS.? 6.84 CA CA B 201 A 171 ARG A 80 ARG~? 24.83 CA CA B 201 A 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 13.63 3.81 28.83 14.49 2.91 31.59 1.65 24.64 89.61 4.49 24.81 90.71 coo 24.97 7.47 37.69 21.24 10.69 35.89 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS B 45 HIS.? 16.95 CA CA B 201 A 171 ARG A 76 ARG~? 16.28 CA CA B 201 A 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 13.63 3.81 28.83 14.49 2.91 31.59 4.46 22.84 83.40 3.22 20.31 82.22 coo 24.97 7.47 37.69 21.24 10.69 35.89 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS B 45 HIS.? 16.95 CA CA B 201 A 171 ARG A 80 ARG~? 24.83 CA CA B 201 A 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 13.63 3.81 28.83 14.49 2.91 31.59 1.65 24.64 89.61 4.49 24.81 90.71 coo 24.97 7.47 37.69 21.24 10.69 35.89 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 5 3 # 5 A 85 HIS B 51 HIS~? 12.10 CA CA B 201 A 171 ARG A 76 ARG~? 16.28 CA CA B 201 A 190 LYS B 52 LYS~? 20.44 CA CA B 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 13.63 3.81 28.83 14.49 2.91 31.59 4.46 22.84 83.40 3.22 20.31 82.22 coo 24.97 7.47 37.69 21.24 10.69 35.89 -3.85 31.32 74.04 -1.50 34.25 78.56 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 5 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS B 43 HIS.? 6.84 CA CA B 201 B 171 ARG A 76 ARG~? 16.28 CA CA B 201 B 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 2.83 4.83 10.84 1.96 4.32 7.97 4.46 22.84 83.40 3.22 20.31 82.22 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS B 43 HIS.? 6.84 CA CA B 201 B 171 ARG A 80 ARG~? 24.83 CA CA B 201 B 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 2.83 4.83 10.84 1.96 4.32 7.97 1.65 24.64 89.61 4.49 24.81 90.71 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS B 45 HIS.? 16.95 CA CA B 201 B 171 ARG A 76 ARG~? 16.28 CA CA B 201 B 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 2.83 4.83 10.84 1.96 4.32 7.97 4.46 22.84 83.40 3.22 20.31 82.22 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 4 3 # 4 B 85 HIS B 45 HIS.? 16.95 CA CA B 201 B 171 ARG A 80 ARG~? 24.83 CA CA B 201 B 190 LYS B 46 LYS.? 7.77 CA CA B 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 2.83 4.83 10.84 1.96 4.32 7.97 1.65 24.64 89.61 4.49 24.81 90.71 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 5 3 # 5 B 85 HIS B 51 HIS~? 12.10 CA CA B 201 B 171 ARG A 76 ARG~? 16.28 CA CA B 201 B 190 LYS B 52 LYS~? 20.44 CA CA B 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 2.83 4.83 10.84 1.96 4.32 7.97 4.46 22.84 83.40 3.22 20.31 82.22 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -3.85 31.32 74.04 -1.50 34.25 78.56 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 5 hits 1azy_c01 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 53 HIS~? 13.16 CA CA A 202 A 58 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 92 HIS A 43 HIS.? 6.83 CA CA A 202 coo 12.70 27.74 1.76 10.77 27.11 1.24 9.33 26.57 50.59 7.78 25.45 51.45 coo 11.38 23.30 3.20 9.27 23.34 3.13 12.68 24.99 44.98 13.54 23.53 43.68 coo 2.67 19.36 1.56 3.51 21.24 1.94 20.15 20.72 47.43 19.82 19.00 48.57 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 1 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 53 HIS~? 13.16 CA CA A 202 B 58 GLU A 50 GLU~? 11.43 OXT ACT B 801 B 92 HIS A 43 HIS.? 6.83 CA CA A 202 coo 10.74 36.24 16.20 9.81 34.52 16.97 9.33 26.57 50.59 7.78 25.45 51.45 coo 5.02 36.40 17.74 5.55 34.41 17.37 12.68 24.99 44.98 13.54 23.53 43.68 coo 0.68 29.04 20.43 2.46 29.56 19.46 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS B 53 HIS~? 13.80 CA CA B 201 B 58 GLU B 50 GLU~? 12.54 CA CA B 201 B 92 HIS B 43 HIS.? 6.84 CA CA B 201 coo 10.74 36.24 16.20 9.81 34.52 16.97 0.46 27.04 73.26 2.14 26.33 72.22 coo 5.02 36.40 17.74 5.55 34.41 17.37 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 0.68 29.04 20.43 2.46 29.56 19.46 -10.59 20.73 76.53 -10.28 19.02 75.37 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 23 PHE.? 21.62 CA CA A 202 A 159 ASP A 27 ASP.? 17.47 CA CA A 202 A 188 LYS A 17 LYS~? 8.75 CA CA A 202 coo 13.91 34.58 14.67 12.95 36.00 12.47 21.09 25.12 72.44 22.15 27.43 71.35 coo 20.97 28.40 16.26 20.19 30.15 15.34 11.73 20.36 70.40 10.57 19.24 69.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 19.68 24.92 63.26 19.27 20.80 60.44 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 23 PHE.? 21.62 CA CA A 202 A 159 ASP A 69 ASP~? 23.19 CA CA B 201 A 188 LYS A 17 LYS~? 8.75 CA CA A 202 coo 13.91 34.58 14.67 12.95 36.00 12.47 21.09 25.12 72.44 22.15 27.43 71.35 coo 20.97 28.40 16.26 20.19 30.15 15.34 11.02 26.78 74.77 12.23 26.87 76.45 coo 22.55 41.65 15.60 18.92 37.20 14.63 19.68 24.92 63.26 19.27 20.80 60.44 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE B 23 PHE.? 7.12 OXT ACT B 802 A 159 ASP B 27 ASP.? 17.39 CA CA B 201 A 188 LYS B 17 LYS~? 8.61 CA CA B 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.47 25.16 51.60 -12.77 27.41 52.70 coo 20.97 28.40 16.26 20.19 30.15 15.34 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 22.55 41.65 15.60 18.92 37.20 14.63 -9.98 24.92 60.71 -9.24 20.80 63.54 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE B 23 PHE.? 7.12 OXT ACT B 802 A 159 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 188 LYS B 17 LYS~? 8.61 CA CA B 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.47 25.16 51.60 -12.77 27.41 52.70 coo 20.97 28.40 16.26 20.19 30.15 15.34 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 -9.98 24.92 60.71 -9.24 20.80 63.54 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 4 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 69 ASP~? 23.19 CA CA B 201 35 SER A 67 SER~? 18.51 CA CA B 201 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo 61.19 45.85 78.73 62.86 45.48 77.48 11.02 26.78 74.77 12.23 26.87 76.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 7.12 29.60 71.54 4.89 29.99 70.85 coo 63.61 40.10 74.06 64.05 42.07 74.70 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 69 ASP~? 23.19 CA CA B 201 35 SER A 72 SER~? 18.54 CA CA B 201 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo 61.19 45.85 78.73 62.86 45.48 77.48 11.02 26.78 74.77 12.23 26.87 76.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 5.94 24.99 78.50 7.74 23.37 78.35 coo 63.61 40.10 74.06 64.05 42.07 74.70 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 35 SER B 67 SER~? 20.12 CA CA A 202 215 ASP B 27 ASP.? 17.39 CA CA B 201 coo 61.19 45.85 78.73 62.86 45.48 77.48 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 66.00 46.17 80.29 64.31 47.92 79.91 2.68 29.83 52.62 3.84 31.35 54.03 coo 63.61 40.10 74.06 64.05 42.07 74.70 -1.83 20.43 53.73 -0.68 19.31 55.10 1bbs_c06 source 1bbs RENIN : 3 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 69 ASP~? 23.19 CA CA B 201 35 SER A 67 SER~? 18.51 CA CA B 201 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo 61.19 45.85 78.73 62.86 45.48 77.48 11.02 26.78 74.77 12.23 26.87 76.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 7.12 29.60 71.54 4.89 29.99 70.85 coo 63.61 40.10 74.06 64.05 42.07 74.70 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 69 ASP~? 23.19 CA CA B 201 35 SER A 72 SER~? 18.54 CA CA B 201 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo 61.19 45.85 78.73 62.86 45.48 77.48 11.02 26.78 74.77 12.23 26.87 76.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 5.94 24.99 78.50 7.74 23.37 78.35 coo 63.61 40.10 74.06 64.05 42.07 74.70 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 35 SER B 67 SER~? 20.12 CA CA A 202 215 ASP B 27 ASP.? 17.39 CA CA B 201 coo 61.19 45.85 78.73 62.86 45.48 77.48 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 66.00 46.17 80.29 64.31 47.92 79.91 2.68 29.83 52.62 3.84 31.35 54.03 coo 63.61 40.10 74.06 64.05 42.07 74.70 -1.83 20.43 53.73 -0.68 19.31 55.10 1bbs_c07 source 1bbs RENIN : 3 hits 1bbs_c07 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 4 ASP~? 21.72 CA CA A 202 16 HIS A 2 HIS~? 23.51 OXT ACT B 801 67 GLY A 59 GLY~? 16.87 CA CA A 202 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 25.57 34.71 45.51 26.38 33.70 43.83 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 22.09 39.77 43.94 22.07 41.64 42.98 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 12.94 30.92 60.55 12.49 30.19 60.50 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 4 ASP~? 21.72 CA CA A 202 16 HIS A 2 HIS~? 23.51 OXT ACT B 801 67 GLY B 75 GLY.? 6.25 CH3 ACT B 801 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 25.57 34.71 45.51 26.38 33.70 43.83 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 22.09 39.77 43.94 22.07 41.64 42.98 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 6.69 25.77 40.85 5.83 25.81 40.83 1be1_c02 source 1be1 GLUTAMATE MUTASE : 2 hits 1be1_c02 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 5 GLU~? 25.21 CA CA A 202 70 HIS A 2 HIS~? 23.51 OXT ACT B 801 281 HIS B 25 HIS.? 17.04 CH3 ACT B 801 coo 66.09 46.17 155.81 66.77 48.19 155.70 23.31 38.61 48.39 22.38 40.48 47.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 22.09 39.77 43.94 22.07 41.64 42.98 coo 100.93 36.73 156.02 100.47 38.42 157.18 -6.96 18.75 45.30 -7.92 17.57 43.86 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU A 50 GLU~? 11.43 OXT ACT B 801 70 HIS A 51 HIS~? 12.20 CA CA A 202 281 HIS B 10 HIS~? 10.24 CA CA B 201 coo 66.09 46.17 155.81 66.77 48.19 155.70 12.68 24.99 44.98 13.54 23.53 43.68 coo 69.05 50.55 157.03 68.00 52.29 156.51 17.98 27.94 47.81 19.27 26.33 47.47 coo 100.93 36.73 156.02 100.47 38.42 157.18 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU B 5 GLU~? 21.97 CH3 ACT B 802 70 HIS B 2 HIS~? 26.00 CH3 ACT B 802 281 HIS A 25 HIS.? 26.12 CA CA B 201 coo 66.09 46.17 155.81 66.77 48.19 155.70 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 69.05 50.55 157.03 68.00 52.29 156.51 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 100.93 36.73 156.02 100.47 38.42 157.18 16.66 18.79 78.66 17.26 17.28 79.97 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU B 50 GLU~? 12.54 CA CA B 201 70 HIS B 51 HIS~? 12.10 CA CA B 201 281 HIS A 10 HIS~? 10.31 CA CA A 202 coo 66.09 46.17 155.81 66.77 48.19 155.70 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 69.05 50.55 157.03 68.00 52.29 156.51 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 100.93 36.73 156.02 100.47 38.42 157.18 19.28 27.48 52.70 18.40 25.59 52.72 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 4 hits 1bfd_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 36 GLU~? 11.24 CA CA A 202 A 503 TYR A 34 TYR~? 7.34 CA CA A 202 A 537 GLU A 35 GLU~? 5.06 CA CA A 202 coo 24.06 146.21 11.09 22.89 146.18 9.36 8.53 16.97 55.87 6.50 17.32 56.35 coo 15.91 140.69 8.32 15.71 143.39 9.13 14.67 22.85 56.72 17.08 23.07 55.48 coo 16.65 144.44 13.24 18.34 145.22 12.33 14.74 18.03 58.46 16.79 18.12 57.91 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 36 GLU~? 11.20 CA CA B 201 A 503 TYR B 34 TYR~? 7.28 CA CA B 201 A 537 GLU B 35 GLU~? 4.98 CA CA B 201 coo 24.06 146.21 11.09 22.89 146.18 9.36 1.18 16.63 68.50 3.14 16.97 67.89 coo 15.91 140.69 8.32 15.71 143.39 9.13 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 16.65 144.44 13.24 18.34 145.22 12.33 -5.01 17.82 65.60 -7.08 17.81 66.03 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 36 GLU~? 11.24 CA CA A 202 A 504 TYR A 34 TYR~? 7.34 CA CA A 202 A 540 GLU A 35 GLU~? 5.06 CA CA A 202 coo 81.34 87.29 87.22 82.36 86.09 88.61 8.53 16.97 55.87 6.50 17.32 56.35 coo 80.85 81.34 94.77 81.70 80.16 92.41 14.67 22.85 56.72 17.08 23.07 55.48 coo 79.94 80.46 88.84 81.11 81.36 87.27 14.74 18.03 58.46 16.79 18.12 57.91 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 36 GLU~? 11.20 CA CA B 201 A 504 TYR B 34 TYR~? 7.28 CA CA B 201 A 540 GLU B 35 GLU~? 4.98 CA CA B 201 coo 81.34 87.29 87.22 82.36 86.09 88.61 1.18 16.63 68.50 3.14 16.97 67.89 coo 80.85 81.34 94.77 81.70 80.16 92.41 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.01 17.82 65.60 -7.08 17.81 66.03 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 76 ARG~? 16.28 CA CA B 201 A 451 GLU A 83 GLU~? 18.60 CA CA B 201 A 540 GLU B 50 GLU~? 12.54 CA CA B 201 coo 79.04 80.20 80.81 79.58 81.40 83.63 4.46 22.84 83.40 3.22 20.31 82.22 coo 81.34 87.29 87.22 82.36 86.09 88.61 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 79.94 80.46 88.84 81.11 81.36 87.27 -3.14 24.90 79.07 -4.11 23.58 80.41 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 80 ARG~? 24.83 CA CA B 201 A 451 GLU A 82 GLU~? 19.14 CA CA B 201 A 540 GLU A 83 GLU~? 18.60 CA CA B 201 coo 79.04 80.20 80.81 79.58 81.40 83.63 1.65 24.64 89.61 4.49 24.81 90.71 coo 81.34 87.29 87.22 82.36 86.09 88.61 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 79.94 80.46 88.84 81.11 81.36 87.27 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 80 ARG~? 24.83 CA CA B 201 A 451 GLU B 50 GLU~? 12.54 CA CA B 201 A 540 GLU A 83 GLU~? 18.60 CA CA B 201 coo 79.04 80.20 80.81 79.58 81.40 83.63 1.65 24.64 89.61 4.49 24.81 90.71 coo 81.34 87.29 87.22 82.36 86.09 88.61 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 79.94 80.46 88.84 81.11 81.36 87.27 -4.99 25.05 87.76 -3.42 23.71 87.32 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 80 ARG~? 24.83 CA CA B 201 B 451 GLU A 82 GLU~? 19.14 CA CA B 201 B 540 GLU A 83 GLU~? 18.60 CA CA B 201 coo 82.21 41.07 119.14 83.95 40.66 116.59 1.65 24.64 89.61 4.49 24.81 90.71 coo 86.52 35.28 112.74 87.08 36.38 110.99 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 83.38 41.19 112.55 85.47 40.59 112.72 -4.99 25.05 87.76 -3.42 23.71 87.32 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c05 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 10 HIS~? 10.31 CA CA A 202 A 105 GLU A 40 GLU.? 3.38 CA CA A 202s A 109 HIS A 43 HIS.? 6.83 CA CA A 202 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 19.28 27.48 52.70 18.40 25.59 52.72 coo 43.60 31.12 0.44 42.42 31.86 -1.18 19.19 19.98 52.16 20.07 18.13 52.69 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS A 43 HIS.? 6.83 CA CA A 202 A 105 GLU A 40 GLU.? 3.38 CA CA A 202s A 109 HIS A 10 HIS~? 10.31 CA CA A 202 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 20.15 20.72 47.43 19.82 19.00 48.57 coo 43.60 31.12 0.44 42.42 31.86 -1.18 19.19 19.98 52.16 20.07 18.13 52.69 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1bol_c00 RIBONUCLEASE RH user 3 3 # 3 A 46 HIS A 51 HIS~? 12.20 CA CA A 202 A 105 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 109 HIS A 53 HIS~? 13.16 CA CA A 202 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 17.98 27.94 47.81 19.27 26.33 47.47 coo 43.60 31.12 0.44 42.42 31.86 -1.18 12.68 24.99 44.98 13.54 23.53 43.68 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1bol_c00 RIBONUCLEASE RH user 4 3 # 4 A 46 HIS A 53 HIS~? 13.16 CA CA A 202 A 105 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 109 HIS A 51 HIS~? 12.20 CA CA A 202 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 9.33 26.57 50.59 7.78 25.45 51.45 coo 43.60 31.12 0.44 42.42 31.86 -1.18 12.68 24.99 44.98 13.54 23.53 43.68 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1bol_c00 RIBONUCLEASE RH user 5 3 # 5 A 46 HIS B 10 HIS~? 10.24 CA CA B 201 A 105 GLU B 40 GLU.? 3.43 CA CA B 201s A 109 HIS B 43 HIS.? 6.84 CA CA B 201 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1bol_c00 RIBONUCLEASE RH user 6 3 # 6 A 46 HIS B 43 HIS.? 6.84 CA CA B 201 A 105 GLU B 40 GLU.? 3.43 CA CA B 201s A 109 HIS B 10 HIS~? 10.24 CA CA B 201 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1bol_c00 RIBONUCLEASE RH user 7 3 # 7 A 46 HIS B 51 HIS~? 12.10 CA CA B 201 A 105 GLU B 50 GLU~? 12.54 CA CA B 201 A 109 HIS B 53 HIS~? 13.80 CA CA B 201 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1bol_c00 RIBONUCLEASE RH user 8 3 # 8 A 46 HIS B 53 HIS~? 13.80 CA CA B 201 A 105 GLU B 50 GLU~? 12.54 CA CA B 201 A 109 HIS B 51 HIS~? 12.10 CA CA B 201 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 0.46 27.04 73.26 2.14 26.33 72.22 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -8.32 27.87 76.15 -9.65 26.27 76.41 1bol_c00 source 1bol RIBONUCLEASE RH : 8 hits 1bol_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 80 ARG~? 24.83 CA CA B 201 A 128 GLU A 82 GLU~? 19.14 CA CA B 201 A 225 GLU A 83 GLU~? 18.60 CA CA B 201 coo 38.56 19.11 14.83 37.12 21.00 16.76 1.65 24.64 89.61 4.49 24.81 90.71 coo 36.48 24.43 22.02 36.86 26.34 21.13 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 40.16 23.71 17.01 38.52 24.96 17.40 -4.99 25.05 87.76 -3.42 23.71 87.32 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS B 43 HIS.? 6.84 CA CA B 201 A 168 ARG A 76 ARG~? 16.28 CA CA B 201 A 187 LYS B 46 LYS.? 7.77 CA CA B 201 coo 62.47 12.00 59.65 61.76 10.14 60.31 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 55.10 8.37 73.00 55.48 9.59 70.20 4.46 22.84 83.40 3.22 20.31 82.22 coo 66.76 10.09 66.23 61.80 8.06 65.82 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS B 45 HIS.? 16.95 CA CA B 201 A 168 ARG A 80 ARG~? 24.83 CA CA B 201 A 187 LYS B 46 LYS.? 7.77 CA CA B 201 coo 62.47 12.00 59.65 61.76 10.14 60.31 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 55.10 8.37 73.00 55.48 9.59 70.20 1.65 24.64 89.61 4.49 24.81 90.71 coo 66.76 10.09 66.23 61.80 8.06 65.82 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS B 53 HIS~? 13.80 CA CA B 201 A 168 ARG A 80 ARG~? 24.83 CA CA B 201 A 187 LYS B 48 LYS~? 22.74 CA CA B 201 coo 62.47 12.00 59.65 61.76 10.14 60.31 0.46 27.04 73.26 2.14 26.33 72.22 coo 55.10 8.37 73.00 55.48 9.59 70.20 1.65 24.64 89.61 4.49 24.81 90.71 coo 66.76 10.09 66.23 61.80 8.06 65.82 -6.08 30.98 79.72 -6.69 36.84 80.65 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 3 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS B 51 HIS~? 12.10 CA CA B 201 B1168 ARG A 76 ARG~? 16.28 CA CA B 201 B1187 LYS B 46 LYS.? 7.77 CA CA B 201 coo 35.03 5.72 103.61 36.82 5.00 102.79 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 41.91 5.48 91.85 40.59 6.81 94.28 4.46 22.84 83.40 3.22 20.31 82.22 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -8.20 24.59 81.13 -6.93 19.58 77.81 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 1 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 71 PHE~? 16.87 CA CA B 201 A 205 ASP B 38 ASP~? -3.30 CA CA B 201s A 236 LYS B 46 LYS.? 7.77 CA CA B 201 coo 4.14 2.10 36.34 6.69 3.08 36.92 2.73 28.74 74.75 1.20 30.86 73.64 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 71 PHE~? 16.66 CH3 ACT B 801 A 205 ASP A 38 ASP~? -3.36 CA CA A 202s A 236 LYS A 46 LYS.? 7.73 CA CA A 202 coo 4.14 2.10 36.34 6.69 3.08 36.92 7.21 29.24 49.58 8.41 31.42 50.73 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 14.49 17.18 50.40 16.42 16.29 49.93 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 17.72 24.61 42.81 16.30 19.73 46.29 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 2 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 12 GLN~? 18.84 CA CA A 202 A 91 LEU A 9 LEU~? 18.30 CA CA A 202 A 133 GLU A 11 GLU~? 14.95 CA CA A 202 coo 43.58 43.67 66.73 42.32 42.78 68.15 25.41 32.42 57.56 27.07 31.52 58.54 coo 38.58 45.09 70.44 38.28 45.21 72.59 20.27 33.94 53.67 18.93 35.01 54.97 coo 44.05 36.87 70.65 43.15 38.64 69.97 26.25 27.59 54.14 27.19 27.48 52.23 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 12 GLN~? 18.84 CA CA A 202 B 591 LEU A 9 LEU~? 18.30 CA CA A 202 B 633 GLU A 11 GLU~? 14.95 CA CA A 202 coo 88.06 44.34 57.19 89.06 45.53 55.74 25.41 32.42 57.56 27.07 31.52 58.54 coo 86.70 48.66 52.61 87.15 48.69 50.51 20.27 33.94 53.67 18.93 35.01 54.97 coo 95.42 44.52 54.43 93.46 45.31 54.70 26.25 27.59 54.14 27.19 27.48 52.23 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 12 GLN~? 18.84 CA CA A 202 C1091 LEU A 9 LEU~? 18.30 CA CA A 202 C1133 GLU A 11 GLU~? 14.95 CA CA A 202 coo 68.29 34.44 43.03 66.67 34.74 44.37 25.41 32.42 57.56 27.07 31.52 58.54 coo 65.83 38.95 47.05 65.46 38.90 49.20 20.27 33.94 53.67 18.93 35.01 54.97 coo 63.14 29.39 46.25 63.84 31.31 45.74 26.25 27.59 54.14 27.19 27.48 52.23 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 24 ASP.? 26.42 CA CA A 202 A 16 HIS A 25 HIS.? 26.12 CA CA B 201 A 67 GLY A 22 GLY~? 18.52 CA CA A 202 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 20.63 21.72 77.63 20.78 20.24 79.08 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 16.66 18.79 78.66 17.26 17.28 79.97 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 23.21 21.10 70.07 22.50 21.48 70.30 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP B 24 ASP.? 15.33 OXT ACT B 802 A 16 HIS B 25 HIS.? 17.04 CH3 ACT B 801 A 67 GLY B 22 GLY~? 8.09 OXT ACT B 802 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -6.96 18.75 45.30 -7.92 17.57 43.86 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -13.40 21.13 53.86 -12.71 21.54 53.62 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 24 ASP.? 26.42 CA CA A 202 C 16 HIS A 25 HIS.? 26.12 CA CA B 201 C 67 GLY A 22 GLY~? 18.52 CA CA A 202 coo 10.04 44.27 88.44 9.47 42.32 89.03 20.63 21.72 77.63 20.78 20.24 79.08 coo 6.38 39.80 88.71 6.88 38.89 86.87 16.66 18.79 78.66 17.26 17.28 79.97 coo 17.63 42.50 89.25 18.11 42.29 88.64 23.21 21.10 70.07 22.50 21.48 70.30 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP B 24 ASP.? 15.33 OXT ACT B 802 C 16 HIS B 25 HIS.? 17.04 CH3 ACT B 801 C 67 GLY B 22 GLY~? 8.09 OXT ACT B 802 coo 10.04 44.27 88.44 9.47 42.32 89.03 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 6.38 39.80 88.71 6.88 38.89 86.87 -6.96 18.75 45.30 -7.92 17.57 43.86 coo 17.63 42.50 89.25 18.11 42.29 88.64 -13.40 21.13 53.86 -12.71 21.54 53.62 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c07 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 76 ARG~? 16.28 CA CA B 201 127 ARG A 80 ARG~? 24.83 CA CA B 201 270 GLU A 82 GLU~? 19.14 CA CA B 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 4.46 22.84 83.40 3.22 20.31 82.22 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 1.65 24.64 89.61 4.49 24.81 90.71 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -6.39 30.15 85.63 -6.65 30.56 83.58 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 1 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 24 ASP.? 26.42 CA CA A 202 264 GLU A 35 GLU~? 5.06 CA CA A 202 328 ASP A 27 ASP.? 17.47 CA CA A 202 coo 45.62 80.42 43.69 45.65 82.01 45.07 20.63 21.72 77.63 20.78 20.24 79.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 14.74 18.03 58.46 16.79 18.12 57.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 24 ASP.? 15.33 OXT ACT B 802 264 GLU B 35 GLU~? 4.98 CA CA B 201 328 ASP B 27 ASP.? 17.39 CA CA B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 59.69 92.71 39.85 58.53 92.03 41.47 -5.01 17.82 65.60 -7.08 17.81 66.03 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.83 20.43 53.73 -0.68 19.31 55.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 24 ASP.? 15.33 OXT ACT B 802 264 GLU B 70 GLU~? 15.15 CH3 ACT B 801 328 ASP B 27 ASP.? 17.39 CA CA B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 59.69 92.71 39.85 58.53 92.03 41.47 2.91 32.18 47.37 1.68 33.21 45.95 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.83 20.43 53.73 -0.68 19.31 55.10 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 3 hits 1cdg_c00 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 10 HIS~? 10.31 CA CA A 202 A 262 GLU A 40 GLU.? 3.38 CA CA A 202s A 358 GLU A 35 GLU~? 5.06 CA CA A 202 coo 26.19 60.87 43.98 27.48 59.27 43.30 19.28 27.48 52.70 18.40 25.59 52.72 coo 27.13 54.07 50.45 26.96 54.19 48.35 19.19 19.98 52.16 20.07 18.13 52.69 coo 27.06 50.43 44.36 27.99 52.27 44.74 14.74 18.03 58.46 16.79 18.12 57.91 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS A 51 HIS~? 12.20 CA CA A 202 A 262 GLU A 8 GLU~? 21.63 CA CA A 202 A 358 GLU A 5 GLU~? 25.21 CA CA A 202 coo 26.19 60.87 43.98 27.48 59.27 43.30 17.98 27.94 47.81 19.27 26.33 47.47 coo 27.13 54.07 50.45 26.96 54.19 48.35 26.55 33.36 50.86 27.60 35.12 50.29 coo 27.06 50.43 44.36 27.99 52.27 44.74 23.31 38.61 48.39 22.38 40.48 47.97 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS A 51 HIS~? 12.20 CA CA A 202 A 262 GLU A 8 GLU~? 21.63 CA CA A 202 A 358 GLU A 11 GLU~? 14.95 CA CA A 202 coo 26.19 60.87 43.98 27.48 59.27 43.30 17.98 27.94 47.81 19.27 26.33 47.47 coo 27.13 54.07 50.45 26.96 54.19 48.35 26.55 33.36 50.86 27.60 35.12 50.29 coo 27.06 50.43 44.36 27.99 52.27 44.74 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS A 51 HIS~? 12.20 CA CA A 202 A 262 GLU A 11 GLU~? 14.95 CA CA A 202 A 358 GLU A 8 GLU~? 21.63 CA CA A 202 coo 26.19 60.87 43.98 27.48 59.27 43.30 17.98 27.94 47.81 19.27 26.33 47.47 coo 27.13 54.07 50.45 26.96 54.19 48.35 26.25 27.59 54.14 27.19 27.48 52.23 coo 27.06 50.43 44.36 27.99 52.27 44.74 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS B 10 HIS~? 10.24 CA CA B 201 A 262 GLU B 40 GLU.? 3.43 CA CA B 201s A 358 GLU B 35 GLU~? 4.98 CA CA B 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 27.13 54.07 50.45 26.96 54.19 48.35 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 27.06 50.43 44.36 27.99 52.27 44.74 -5.01 17.82 65.60 -7.08 17.81 66.03 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 A 232 HIS B 45 HIS.? 16.95 CA CA B 201 A 262 GLU A 82 GLU~? 19.14 CA CA B 201 A 358 GLU A 83 GLU~? 18.60 CA CA B 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 27.13 54.07 50.45 26.96 54.19 48.35 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 27.06 50.43 44.36 27.99 52.27 44.74 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 A 232 HIS B 45 HIS.? 16.95 CA CA B 201 A 262 GLU A 82 GLU~? 19.14 CA CA B 201 A 358 GLU B 50 GLU~? 12.54 CA CA B 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 27.13 54.07 50.45 26.96 54.19 48.35 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 27.06 50.43 44.36 27.99 52.27 44.74 -3.14 24.90 79.07 -4.11 23.58 80.41 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 A 232 HIS B 45 HIS.? 16.95 CA CA B 201 A 262 GLU A 83 GLU~? 18.60 CA CA B 201 A 358 GLU A 82 GLU~? 19.14 CA CA B 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 27.13 54.07 50.45 26.96 54.19 48.35 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 27.06 50.43 44.36 27.99 52.27 44.74 -6.39 30.15 85.63 -6.65 30.56 83.58 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 A 232 HIS B 45 HIS.? 16.95 CA CA B 201 A 262 GLU A 83 GLU~? 18.60 CA CA B 201 A 358 GLU B 50 GLU~? 12.54 CA CA B 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 27.13 54.07 50.45 26.96 54.19 48.35 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 27.06 50.43 44.36 27.99 52.27 44.74 -3.14 24.90 79.07 -4.11 23.58 80.41 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 A 232 HIS B 51 HIS~? 12.10 CA CA B 201 A 262 GLU A 82 GLU~? 19.14 CA CA B 201 A 358 GLU A 83 GLU~? 18.60 CA CA B 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 27.06 50.43 44.36 27.99 52.27 44.74 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 11 3 # 11 A 232 HIS B 51 HIS~? 12.10 CA CA B 201 A 262 GLU B 8 GLU~? 16.54 CH3 ACT B 802 A 358 GLU B 5 GLU~? 21.97 CH3 ACT B 802 coo 26.19 60.87 43.98 27.48 59.27 43.30 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 27.06 50.43 44.36 27.99 52.27 44.74 -13.74 38.60 75.53 -12.83 40.48 75.93 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 12 3 # 12 A 232 HIS B 51 HIS~? 12.10 CA CA B 201 A 262 GLU B 8 GLU~? 16.54 CH3 ACT B 802 A 358 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 26.19 60.87 43.98 27.48 59.27 43.30 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 27.06 50.43 44.36 27.99 52.27 44.74 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 13 3 # 13 A 232 HIS B 51 HIS~? 12.10 CA CA B 201 A 262 GLU B 11 GLU~? 12.56 CH3 ACT B 802 A 358 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 26.19 60.87 43.98 27.48 59.27 43.30 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 27.06 50.43 44.36 27.99 52.27 44.74 -16.78 33.39 73.09 -17.99 35.10 73.27 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 13 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 10 HIS~? 10.31 CA CA A 202 B 262 GLU A 8 GLU~? 21.63 CA CA A 202 B 358 GLU A 5 GLU~? 25.21 CA CA A 202 coo 44.98 77.01 48.39 44.42 78.67 47.18 19.28 27.48 52.70 18.40 25.59 52.72 coo 41.60 83.57 54.16 42.46 83.24 52.25 26.55 33.36 50.86 27.60 35.12 50.29 coo 44.05 87.61 48.73 43.15 85.67 48.52 23.31 38.61 48.39 22.38 40.48 47.97 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 10 HIS~? 10.31 CA CA A 202 B 262 GLU A 40 GLU.? 3.38 CA CA A 202s B 358 GLU A 35 GLU~? 5.06 CA CA A 202 coo 44.98 77.01 48.39 44.42 78.67 47.18 19.28 27.48 52.70 18.40 25.59 52.72 coo 41.60 83.57 54.16 42.46 83.24 52.25 19.19 19.98 52.16 20.07 18.13 52.69 coo 44.05 87.61 48.73 43.15 85.67 48.52 14.74 18.03 58.46 16.79 18.12 57.91 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS A 51 HIS~? 12.20 CA CA A 202 B 262 GLU A 8 GLU~? 21.63 CA CA A 202 B 358 GLU A 5 GLU~? 25.21 CA CA A 202 coo 44.98 77.01 48.39 44.42 78.67 47.18 17.98 27.94 47.81 19.27 26.33 47.47 coo 41.60 83.57 54.16 42.46 83.24 52.25 26.55 33.36 50.86 27.60 35.12 50.29 coo 44.05 87.61 48.73 43.15 85.67 48.52 23.31 38.61 48.39 22.38 40.48 47.97 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS A 51 HIS~? 12.20 CA CA A 202 B 262 GLU A 8 GLU~? 21.63 CA CA A 202 B 358 GLU A 11 GLU~? 14.95 CA CA A 202 coo 44.98 77.01 48.39 44.42 78.67 47.18 17.98 27.94 47.81 19.27 26.33 47.47 coo 41.60 83.57 54.16 42.46 83.24 52.25 26.55 33.36 50.86 27.60 35.12 50.29 coo 44.05 87.61 48.73 43.15 85.67 48.52 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS A 51 HIS~? 12.20 CA CA A 202 B 262 GLU A 11 GLU~? 14.95 CA CA A 202 B 358 GLU A 8 GLU~? 21.63 CA CA A 202 coo 44.98 77.01 48.39 44.42 78.67 47.18 17.98 27.94 47.81 19.27 26.33 47.47 coo 41.60 83.57 54.16 42.46 83.24 52.25 26.25 27.59 54.14 27.19 27.48 52.23 coo 44.05 87.61 48.73 43.15 85.67 48.52 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 B 232 HIS B 10 HIS~? 10.24 CA CA B 201 B 262 GLU B 40 GLU.? 3.43 CA CA B 201s B 358 GLU B 35 GLU~? 4.98 CA CA B 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 41.60 83.57 54.16 42.46 83.24 52.25 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 44.05 87.61 48.73 43.15 85.67 48.52 -5.01 17.82 65.60 -7.08 17.81 66.03 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 B 232 HIS B 45 HIS.? 16.95 CA CA B 201 B 262 GLU A 82 GLU~? 19.14 CA CA B 201 B 358 GLU A 83 GLU~? 18.60 CA CA B 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 41.60 83.57 54.16 42.46 83.24 52.25 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 44.05 87.61 48.73 43.15 85.67 48.52 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 B 232 HIS B 45 HIS.? 16.95 CA CA B 201 B 262 GLU A 82 GLU~? 19.14 CA CA B 201 B 358 GLU B 50 GLU~? 12.54 CA CA B 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 41.60 83.57 54.16 42.46 83.24 52.25 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 44.05 87.61 48.73 43.15 85.67 48.52 -3.14 24.90 79.07 -4.11 23.58 80.41 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 B 232 HIS B 45 HIS.? 16.95 CA CA B 201 B 262 GLU A 83 GLU~? 18.60 CA CA B 201 B 358 GLU A 82 GLU~? 19.14 CA CA B 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 41.60 83.57 54.16 42.46 83.24 52.25 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 44.05 87.61 48.73 43.15 85.67 48.52 -6.39 30.15 85.63 -6.65 30.56 83.58 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 B 232 HIS B 45 HIS.? 16.95 CA CA B 201 B 262 GLU A 83 GLU~? 18.60 CA CA B 201 B 358 GLU B 50 GLU~? 12.54 CA CA B 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 41.60 83.57 54.16 42.46 83.24 52.25 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 44.05 87.61 48.73 43.15 85.67 48.52 -3.14 24.90 79.07 -4.11 23.58 80.41 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 11 3 # 11 B 232 HIS B 51 HIS~? 12.10 CA CA B 201 B 262 GLU A 82 GLU~? 19.14 CA CA B 201 B 358 GLU A 83 GLU~? 18.60 CA CA B 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 44.05 87.61 48.73 43.15 85.67 48.52 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 12 3 # 12 B 232 HIS B 51 HIS~? 12.10 CA CA B 201 B 262 GLU B 8 GLU~? 16.54 CH3 ACT B 802 B 358 GLU B 5 GLU~? 21.97 CH3 ACT B 802 coo 44.98 77.01 48.39 44.42 78.67 47.18 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 44.05 87.61 48.73 43.15 85.67 48.52 -13.74 38.60 75.53 -12.83 40.48 75.93 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 13 3 # 13 B 232 HIS B 51 HIS~? 12.10 CA CA B 201 B 262 GLU B 8 GLU~? 16.54 CH3 ACT B 802 B 358 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 44.98 77.01 48.39 44.42 78.67 47.18 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 44.05 87.61 48.73 43.15 85.67 48.52 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 14 3 # 14 B 232 HIS B 51 HIS~? 12.10 CA CA B 201 B 262 GLU B 11 GLU~? 12.56 CH3 ACT B 802 B 358 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 44.98 77.01 48.39 44.42 78.67 47.18 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 44.05 87.61 48.73 43.15 85.67 48.52 -16.78 33.39 73.09 -17.99 35.10 73.27 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 14 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 75 GLY~? 19.13 CA CA B 201 A 228 SER A 72 SER~? 18.54 CA CA B 201 A 549 ASP A 69 ASP~? 23.19 CA CA B 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 2.98 28.86 80.60 3.46 28.58 81.25 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 5.94 24.99 78.50 7.74 23.37 78.35 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 75 GLY~? 19.13 CA CA B 201 A 228 SER A 73 SER~? 22.81 CA CA B 201 A 549 ASP A 69 ASP~? 23.19 CA CA B 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 2.98 28.86 80.60 3.46 28.58 81.25 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 7.90 26.85 81.17 9.44 28.34 79.99 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 75 GLY.? 6.25 CH3 ACT B 801 A 228 SER B 72 SER~? 11.29 CH3 ACT B 801 A 549 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 6.69 25.77 40.85 5.83 25.81 40.83 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 4.20 25.43 45.78 2.18 24.15 45.83 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 75 GLY.? 6.25 CH3 ACT B 801 A 228 SER B 73 SER~? 11.38 CH3 ACT B 801 A 549 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 6.69 25.77 40.85 5.83 25.81 40.83 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 2.10 27.36 43.24 -0.07 27.79 43.89 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -0.95 26.94 49.29 -2.15 27.04 47.60 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 75 GLY~? 19.13 CA CA B 201 B1228 SER A 72 SER~? 18.54 CA CA B 201 B1549 ASP A 69 ASP~? 23.19 CA CA B 201 coo 126.34 72.75 125.66 125.95 73.27 126.11 2.98 28.86 80.60 3.46 28.58 81.25 coo 131.65 74.68 129.41 130.31 72.73 128.82 5.94 24.99 78.50 7.74 23.37 78.35 coo 134.72 69.43 130.42 133.03 70.65 130.08 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 75 GLY~? 19.13 CA CA B 201 B1228 SER A 73 SER~? 22.81 CA CA B 201 B1549 ASP A 69 ASP~? 23.19 CA CA B 201 coo 126.34 72.75 125.66 125.95 73.27 126.11 2.98 28.86 80.60 3.46 28.58 81.25 coo 131.65 74.68 129.41 130.31 72.73 128.82 7.90 26.85 81.17 9.44 28.34 79.99 coo 134.72 69.43 130.42 133.03 70.65 130.08 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 75 GLY.? 6.25 CH3 ACT B 801 B1228 SER B 72 SER~? 11.29 CH3 ACT B 801 B1549 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 126.34 72.75 125.66 125.95 73.27 126.11 6.69 25.77 40.85 5.83 25.81 40.83 coo 131.65 74.68 129.41 130.31 72.73 128.82 4.20 25.43 45.78 2.18 24.15 45.83 coo 134.72 69.43 130.42 133.03 70.65 130.08 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 75 GLY.? 6.25 CH3 ACT B 801 B1228 SER B 73 SER~? 11.38 CH3 ACT B 801 B1549 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 126.34 72.75 125.66 125.95 73.27 126.11 6.69 25.77 40.85 5.83 25.81 40.83 coo 131.65 74.68 129.41 130.31 72.73 128.82 2.10 27.36 43.24 -0.07 27.79 43.89 coo 134.72 69.43 130.42 133.03 70.65 130.08 -0.95 26.94 49.29 -2.15 27.04 47.60 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 69 ASP~? 23.19 CA CA B 201 37 SER A 67 SER~? 18.51 CA CA B 201 216 ASP A 27 ASP.? 17.47 CA CA A 202 coo 16.90 26.20 29.49 16.22 24.50 28.41 11.02 26.78 74.77 12.23 26.87 76.45 coo 12.23 24.31 30.40 14.55 23.96 31.03 7.12 29.60 71.54 4.89 29.99 70.85 coo 13.93 25.52 22.10 14.75 24.44 23.75 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP B 69 ASP~? 15.19 CH3 ACT B 801 37 SER B 67 SER~? 20.12 CA CA A 202 216 ASP B 27 ASP.? 17.39 CA CA B 201 coo 16.90 26.20 29.49 16.22 24.50 28.41 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 12.23 24.31 30.40 14.55 23.96 31.03 2.68 29.83 52.62 3.84 31.35 54.03 coo 13.93 25.52 22.10 14.75 24.44 23.75 -1.83 20.43 53.73 -0.68 19.31 55.10 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 2 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 89 GLU B 68 GLU~? 14.14 CA CA A 202 A 120 SER B 72 SER~? 11.29 CH3 ACT B 801 coo -24.35 9.53 67.64 -25.07 11.29 68.60 12.68 24.99 44.98 13.54 23.53 43.68 coo -31.18 6.91 75.60 -32.39 8.51 74.91 3.52 24.40 53.24 5.54 24.28 52.66 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.20 25.43 45.78 2.18 24.15 45.83 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 89 GLU B 70 GLU~? 15.15 CH3 ACT B 801 A 120 SER B 72 SER~? 11.29 CH3 ACT B 801 coo -24.35 9.53 67.64 -25.07 11.29 68.60 12.68 24.99 44.98 13.54 23.53 43.68 coo -31.18 6.91 75.60 -32.39 8.51 74.91 2.91 32.18 47.37 1.68 33.21 45.95 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.20 25.43 45.78 2.18 24.15 45.83 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 68 GLU~? 14.30 CA CA B 201 A 89 GLU A 70 GLU~? 24.16 CA CA B 201 A 120 SER A 73 SER~? 22.81 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.28 24.34 70.76 4.27 24.24 71.35 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.07 31.83 76.89 8.40 32.80 78.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 70 GLU~? 24.16 CA CA B 201 A 89 GLU B 50 GLU~? 12.54 CA CA B 201 A 120 SER A 78 SER~? 22.09 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 7.07 31.83 76.89 8.40 32.80 78.24 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -34.73 8.57 68.21 -33.63 9.08 70.28 0.59 30.86 84.57 0.46 32.77 83.16 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU A 83 GLU~? 18.60 CA CA B 201 A 89 GLU B 50 GLU~? 12.54 CA CA B 201 A 120 SER A 78 SER~? 22.09 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -4.99 25.05 87.76 -3.42 23.71 87.32 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -34.73 8.57 68.21 -33.63 9.08 70.28 0.59 30.86 84.57 0.46 32.77 83.16 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 50 GLU~? 12.54 CA CA B 201 A 89 GLU A 68 GLU~? 14.30 CA CA B 201 A 120 SER A 72 SER~? 18.54 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.28 24.34 70.76 4.27 24.24 71.35 coo -34.73 8.57 68.21 -33.63 9.08 70.28 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 50 GLU~? 12.54 CA CA B 201 A 89 GLU A 70 GLU~? 24.16 CA CA B 201 A 120 SER A 72 SER~? 18.54 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.07 31.83 76.89 8.40 32.80 78.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 50 GLU~? 12.54 CA CA B 201 A 89 GLU A 70 GLU~? 24.16 CA CA B 201 A 120 SER A 73 SER~? 22.81 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.07 31.83 76.89 8.40 32.80 78.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU B 50 GLU~? 12.54 CA CA B 201 A 89 GLU A 70 GLU~? 24.16 CA CA B 201 A 120 SER A 78 SER~? 22.09 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.07 31.83 76.89 8.40 32.80 78.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 0.59 30.86 84.57 0.46 32.77 83.16 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU B 50 GLU~? 12.54 CA CA B 201 A 89 GLU A 82 GLU~? 19.14 CA CA B 201 A 120 SER A 78 SER~? 22.09 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -6.39 30.15 85.63 -6.65 30.56 83.58 coo -34.73 8.57 68.21 -33.63 9.08 70.28 0.59 30.86 84.57 0.46 32.77 83.16 ULMN 3 1cns_c00 CHITINASE user 11 3 # 11 A 67 GLU B 50 GLU~? 12.54 CA CA B 201 A 89 GLU A 83 GLU~? 18.60 CA CA B 201 A 120 SER A 78 SER~? 22.09 CA CA B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -4.99 25.05 87.76 -3.42 23.71 87.32 coo -34.73 8.57 68.21 -33.63 9.08 70.28 0.59 30.86 84.57 0.46 32.77 83.16 1cns_c00 source 1cns CHITINASE : 11 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 50 GLU~? 11.43 OXT ACT B 801 B 89 GLU B 68 GLU~? 14.14 CA CA A 202 B 120 SER B 73 SER~? 11.38 CH3 ACT B 801 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 12.68 24.99 44.98 13.54 23.53 43.68 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 3.52 24.40 53.24 5.54 24.28 52.66 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 2.10 27.36 43.24 -0.07 27.79 43.89 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 70 GLU~? 24.16 CA CA B 201 B 89 GLU B 50 GLU~? 12.54 CA CA B 201 B 120 SER A 78 SER~? 22.09 CA CA B 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 7.07 31.83 76.89 8.40 32.80 78.24 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 0.59 30.86 84.57 0.46 32.77 83.16 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 50 GLU~? 12.54 CA CA B 201 B 89 GLU A 68 GLU~? 14.30 CA CA B 201 B 120 SER A 72 SER~? 18.54 CA CA B 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.28 24.34 70.76 4.27 24.24 71.35 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 50 GLU~? 12.54 CA CA B 201 B 89 GLU A 68 GLU~? 14.30 CA CA B 201 B 120 SER A 73 SER~? 22.81 CA CA B 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.28 24.34 70.76 4.27 24.24 71.35 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 50 GLU~? 12.54 CA CA B 201 B 89 GLU A 70 GLU~? 24.16 CA CA B 201 B 120 SER A 72 SER~? 18.54 CA CA B 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 7.07 31.83 76.89 8.40 32.80 78.24 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU B 68 GLU~? 14.14 CA CA A 202 B 89 GLU B 70 GLU~? 15.15 CH3 ACT B 801 B 120 SER A 49 SER~? 11.81 OXT ACT B 801 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.52 24.40 53.24 5.54 24.28 52.66 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 2.91 32.18 47.37 1.68 33.21 45.95 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 12.01 30.11 45.26 9.74 29.35 44.91 1cns_c01 source 1cns CHITINASE : 6 hits 1cns_c01 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 63 ALA~? 21.13 CA CA A 202 A 74 ASN A 60 ASN~? 18.55 CA CA A 202 A 75 GLY A 59 GLY~? 16.87 CA CA A 202 coo -1.80 62.71 122.76 -1.88 63.70 123.92 10.26 30.81 66.29 9.58 31.78 65.43 coo 1.20 66.40 122.20 2.03 64.53 121.46 8.60 29.15 60.20 6.72 29.87 60.34 coo 4.68 65.84 125.52 4.11 65.60 126.05 12.94 30.92 60.55 12.49 30.19 60.50 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 63 ALA~? 18.50 CH3 ACT B 802 A 74 ASN B 60 ASN~? 18.39 CA CA B 201 A 75 GLY B 59 GLY~? 16.07 CH3 ACT B 802 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -0.49 30.91 57.78 0.13 31.85 58.64 coo 1.20 66.40 122.20 2.03 64.53 121.46 1.10 29.32 63.94 3.07 29.39 63.42 coo 4.68 65.84 125.52 4.11 65.60 126.05 -3.24 30.93 63.51 -2.79 30.21 63.56 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 63 ALA~? 21.13 CA CA A 202 B 74 ASN A 60 ASN~? 18.55 CA CA A 202 B 75 GLY A 59 GLY~? 16.87 CA CA A 202 coo 39.21 14.97 27.55 40.19 16.01 27.08 10.26 30.81 66.29 9.58 31.78 65.43 coo 43.06 12.94 25.74 42.26 11.81 27.44 8.60 29.15 60.20 6.72 29.87 60.34 coo 46.38 13.54 29.18 46.14 14.29 29.26 12.94 30.92 60.55 12.49 30.19 60.50 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 63 ALA~? 18.50 CH3 ACT B 802 B 74 ASN B 60 ASN~? 18.39 CA CA B 201 B 75 GLY B 59 GLY~? 16.07 CH3 ACT B 802 coo 39.21 14.97 27.55 40.19 16.01 27.08 -0.49 30.91 57.78 0.13 31.85 58.64 coo 43.06 12.94 25.74 42.26 11.81 27.44 1.10 29.32 63.94 3.07 29.39 63.42 coo 46.38 13.54 29.18 46.14 14.29 29.26 -3.24 30.93 63.51 -2.79 30.21 63.56 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 63 ALA~? 21.13 CA CA A 202 C 74 ASN A 60 ASN~? 18.55 CA CA A 202 C 75 GLY A 59 GLY~? 16.87 CA CA A 202 coo 16.14 15.08 36.63 15.28 14.65 37.81 10.26 30.81 66.29 9.58 31.78 65.43 coo 11.60 16.13 36.70 12.80 17.74 35.96 8.60 29.15 60.20 6.72 29.87 60.34 coo 10.99 19.23 40.32 11.50 18.77 40.74 12.94 30.92 60.55 12.49 30.19 60.50 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 63 ALA~? 18.50 CH3 ACT B 802 C 74 ASN B 60 ASN~? 18.39 CA CA B 201 C 75 GLY B 59 GLY~? 16.07 CH3 ACT B 802 coo 16.14 15.08 36.63 15.28 14.65 37.81 -0.49 30.91 57.78 0.13 31.85 58.64 coo 11.60 16.13 36.70 12.80 17.74 35.96 1.10 29.32 63.94 3.07 29.39 63.42 coo 10.99 19.23 40.32 11.50 18.77 40.74 -3.24 30.93 63.51 -2.79 30.21 63.56 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c06 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 177 GLU A 11 GLU~? 14.95 CA CA A 202 A 201 LEU A 7 LEU~? 15.61 CA CA A 202 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 20.81 34.16 44.49 19.85 28.53 41.75 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 26.25 27.59 54.14 27.19 27.48 52.23 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 23.29 30.26 48.25 22.61 29.09 46.50 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 17 LYS~? 8.75 CA CA A 202 A 177 GLU A 28 GLU.? 17.79 CA CA A 202 A 201 LEU A 21 LEU~? 13.60 CA CA A 202 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 19.68 24.92 63.26 19.27 20.80 60.44 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 14.93 15.17 68.81 13.76 15.16 70.59 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 20.08 20.23 66.75 18.34 19.83 65.53 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 177 GLU A 5 GLU~? 25.21 CA CA A 202 A 201 LEU A 6 LEU~? 17.51 CA CA A 202 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 15.60 31.02 44.27 16.30 36.87 43.73 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 23.31 38.61 48.39 22.38 40.48 47.97 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 18.94 33.56 48.46 16.91 32.94 48.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 177 GLU A 8 GLU~? 21.63 CA CA A 202 A 201 LEU A 6 LEU~? 17.51 CA CA A 202 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 15.60 31.02 44.27 16.30 36.87 43.73 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 26.55 33.36 50.86 27.60 35.12 50.29 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 18.94 33.56 48.46 16.91 32.94 48.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 177 GLU A 5 GLU~? 25.21 CA CA A 202 A 201 LEU A 6 LEU~? 17.51 CA CA A 202 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 13.41 31.22 50.01 11.37 34.80 45.78 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 23.31 38.61 48.39 22.38 40.48 47.97 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 18.94 33.56 48.46 16.91 32.94 48.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS B 17 LYS~? 8.61 CA CA B 201 A 177 GLU B 28 GLU.? 17.90 CA CA B 201 A 201 LEU B 21 LEU~? 11.20 OXT ACT B 802 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -4.88 15.15 55.19 -3.87 15.18 53.31 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -10.34 20.33 57.22 -8.69 19.85 58.46 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS B 48 LYS~? 22.74 CA CA B 201 A 177 GLU B 5 GLU~? 21.97 CH3 ACT B 802 A 201 LEU B 6 LEU~? 17.55 CA CA B 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -9.33 33.64 75.45 -7.31 32.96 75.30 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS B 48 LYS~? 22.74 CA CA B 201 A 177 GLU B 8 GLU~? 16.54 CH3 ACT B 802 A 201 LEU B 6 LEU~? 17.55 CA CA B 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -9.33 33.64 75.45 -7.31 32.96 75.30 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS B 52 LYS~? 20.44 CA CA B 201 A 177 GLU B 5 GLU~? 21.97 CH3 ACT B 802 A 201 LEU B 6 LEU~? 17.55 CA CA B 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -9.33 33.64 75.45 -7.31 32.96 75.30 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 9 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 17 LYS~? 8.75 CA CA A 202 B 177 GLU A 28 GLU.? 17.79 CA CA A 202 B 201 LEU A 21 LEU~? 13.60 CA CA A 202 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 19.68 24.92 63.26 19.27 20.80 60.44 coo 27.00 6.35 51.01 26.30 4.53 50.18 14.93 15.17 68.81 13.76 15.16 70.59 coo 23.74 1.68 49.50 22.87 -0.24 49.97 20.08 20.23 66.75 18.34 19.83 65.53 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 177 GLU A 5 GLU~? 25.21 CA CA A 202 B 201 LEU A 6 LEU~? 17.51 CA CA A 202 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 15.60 31.02 44.27 16.30 36.87 43.73 coo 27.00 6.35 51.01 26.30 4.53 50.18 23.31 38.61 48.39 22.38 40.48 47.97 coo 23.74 1.68 49.50 22.87 -0.24 49.97 18.94 33.56 48.46 16.91 32.94 48.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 177 GLU A 5 GLU~? 25.21 CA CA A 202 B 201 LEU A 6 LEU~? 17.51 CA CA A 202 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 13.41 31.22 50.01 11.37 34.80 45.78 coo 27.00 6.35 51.01 26.30 4.53 50.18 23.31 38.61 48.39 22.38 40.48 47.97 coo 23.74 1.68 49.50 22.87 -0.24 49.97 18.94 33.56 48.46 16.91 32.94 48.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS B 17 LYS~? 8.61 CA CA B 201 B 177 GLU B 28 GLU.? 17.90 CA CA B 201 B 201 LEU B 21 LEU~? 11.20 OXT ACT B 802 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 27.00 6.35 51.01 26.30 4.53 50.18 -4.88 15.15 55.19 -3.87 15.18 53.31 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -10.34 20.33 57.22 -8.69 19.85 58.46 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 48 LYS~? 22.74 CA CA B 201 B 177 GLU B 5 GLU~? 21.97 CH3 ACT B 802 B 201 LEU B 6 LEU~? 17.55 CA CA B 201 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.00 6.35 51.01 26.30 4.53 50.18 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -9.33 33.64 75.45 -7.31 32.96 75.30 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS B 52 LYS~? 20.44 CA CA B 201 B 177 GLU B 5 GLU~? 21.97 CH3 ACT B 802 B 201 LEU B 6 LEU~? 17.55 CA CA B 201 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 27.00 6.35 51.01 26.30 4.53 50.18 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -9.33 33.64 75.45 -7.31 32.96 75.30 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 6 hits 1daa_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS A 43 HIS.? 6.83 CA CA A 202 A 63 HIS A 51 HIS~? 12.20 CA CA A 202 A 89 ASP A 38 ASP~? -3.36 CA CA A 202s coo 49.66 36.74 42.37 48.88 35.30 43.64 20.15 20.72 47.43 19.82 19.00 48.57 coo 49.93 35.76 35.94 51.58 36.96 35.47 17.98 27.94 47.81 19.27 26.33 47.47 coo 46.15 35.33 47.12 47.46 33.99 46.29 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS B 43 HIS.? 6.84 CA CA B 201 A 63 HIS B 51 HIS~? 12.10 CA CA B 201 A 89 ASP B 38 ASP~? -3.30 CA CA B 201s coo 49.66 36.74 42.37 48.88 35.30 43.64 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 49.93 35.76 35.94 51.58 36.96 35.47 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 46.15 35.33 47.12 47.46 33.99 46.29 -4.95 17.23 73.65 -6.90 16.31 73.97 1dco_c00 source 1dco DCOH : 2 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 43 HIS.? 6.83 CA CA A 202 D 646 ASP A 38 ASP~? -3.36 CA CA A 202s D 739 GLY B 75 GLY.? 6.25 CH3 ACT B 801 coo -30.51 33.83 43.05 -30.50 33.12 45.03 20.15 20.72 47.43 19.82 19.00 48.57 coo -25.73 33.05 39.28 -27.50 34.05 39.88 14.49 17.18 50.40 16.42 16.29 49.93 coo -27.66 47.32 40.66 -27.81 47.01 41.41 6.69 25.77 40.85 5.83 25.81 40.83 1ddj_c15 source 1ddj PLASMINOGEN : 1 hits 1ddj_c15 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS A 53 HIS~? 13.16 CA CA A 202 A 96 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 137 HIS A 10 HIS~? 10.31 CA CA A 202 coo 1.83 2.95 4.76 1.26 0.98 4.81 9.33 26.57 50.59 7.78 25.45 51.45 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 12.68 24.99 44.98 13.54 23.53 43.68 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 2 3 # 2 A 50 HIS A 53 HIS~? 13.16 CA CA A 202 A 96 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 137 HIS A 43 HIS.? 6.83 CA CA A 202 coo 1.83 2.95 4.76 1.26 0.98 4.81 9.33 26.57 50.59 7.78 25.45 51.45 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 12.68 24.99 44.98 13.54 23.53 43.68 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 3 3 # 3 A 50 HIS B 53 HIS~? 13.80 CA CA B 201 A 96 GLU B 50 GLU~? 12.54 CA CA B 201 A 137 HIS B 10 HIS~? 10.24 CA CA B 201 coo 1.83 2.95 4.76 1.26 0.98 4.81 0.46 27.04 73.26 2.14 26.33 72.22 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 4 3 # 4 A 50 HIS B 53 HIS~? 13.80 CA CA B 201 A 96 GLU B 50 GLU~? 12.54 CA CA B 201 A 137 HIS B 43 HIS.? 6.84 CA CA B 201 coo 1.83 2.95 4.76 1.26 0.98 4.81 0.46 27.04 73.26 2.14 26.33 72.22 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -10.59 20.73 76.53 -10.28 19.02 75.37 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 4 hits 1de3_c00 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER B 42 SER.? 8.82 CA CA B 201 A 208 ASP B 38 ASP~? -3.30 CA CA B 201s A 236 HIS B 43 HIS.? 6.84 CA CA B 201 coo 49.19 42.85 125.39 50.92 43.54 123.63 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 57.80 42.94 129.59 56.47 43.28 127.93 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 55.54 41.70 125.00 53.71 42.50 124.53 -10.59 20.73 76.53 -10.28 19.02 75.37 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 1 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER B 42 SER.? 8.82 CA CA B 201 B 208 ASP B 38 ASP~? -3.30 CA CA B 201s B 236 HIS B 43 HIS.? 6.84 CA CA B 201 coo 55.25 19.46 97.60 53.04 19.32 98.76 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 57.34 11.46 102.30 56.11 13.10 101.70 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 55.03 16.17 103.08 54.39 17.23 101.45 -10.59 20.73 76.53 -10.28 19.02 75.37 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 1 hits 1dwo_c01 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 10 HIS~? 10.31 CA CA A 202 B 43 HIS A 51 HIS~? 12.20 CA CA A 202 B 65 GLU A 8 GLU~? 21.63 CA CA A 202 coo 20.15 22.08 34.36 20.84 20.10 34.21 19.28 27.48 52.70 18.40 25.59 52.72 coo 19.55 18.91 30.27 18.21 18.65 31.84 17.98 27.94 47.81 19.27 26.33 47.47 coo 10.90 21.31 28.81 12.14 22.15 30.31 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 51 HIS~? 12.20 CA CA A 202 B 43 HIS A 10 HIS~? 10.31 CA CA A 202 B 65 GLU A 8 GLU~? 21.63 CA CA A 202 coo 20.15 22.08 34.36 20.84 20.10 34.21 17.98 27.94 47.81 19.27 26.33 47.47 coo 19.55 18.91 30.27 18.21 18.65 31.84 19.28 27.48 52.70 18.40 25.59 52.72 coo 10.90 21.31 28.81 12.14 22.15 30.31 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS A 51 HIS~? 12.20 CA CA A 202 B 43 HIS A 10 HIS~? 10.31 CA CA A 202 B 65 GLU A 11 GLU~? 14.95 CA CA A 202 coo 20.15 22.08 34.36 20.84 20.10 34.21 17.98 27.94 47.81 19.27 26.33 47.47 coo 19.55 18.91 30.27 18.21 18.65 31.84 19.28 27.48 52.70 18.40 25.59 52.72 coo 10.90 21.31 28.81 12.14 22.15 30.31 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS A 51 HIS~? 12.20 CA CA A 202 B 43 HIS A 10 HIS~? 10.31 CA CA A 202 B 65 GLU A 40 GLU.? 3.38 CA CA A 202s coo 20.15 22.08 34.36 20.84 20.10 34.21 17.98 27.94 47.81 19.27 26.33 47.47 coo 19.55 18.91 30.27 18.21 18.65 31.84 19.28 27.48 52.70 18.40 25.59 52.72 coo 10.90 21.31 28.81 12.14 22.15 30.31 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS B 10 HIS~? 10.24 CA CA B 201 B 43 HIS B 51 HIS~? 12.10 CA CA B 201 B 65 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 20.15 22.08 34.36 20.84 20.10 34.21 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 19.55 18.91 30.27 18.21 18.65 31.84 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 10.90 21.31 28.81 12.14 22.15 30.31 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS B 51 HIS~? 12.10 CA CA B 201 B 43 HIS B 10 HIS~? 10.24 CA CA B 201 B 65 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 20.15 22.08 34.36 20.84 20.10 34.21 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 19.55 18.91 30.27 18.21 18.65 31.84 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 10.90 21.31 28.81 12.14 22.15 30.31 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS B 51 HIS~? 12.10 CA CA B 201 B 43 HIS B 10 HIS~? 10.24 CA CA B 201 B 65 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 20.15 22.08 34.36 20.84 20.10 34.21 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 19.55 18.91 30.27 18.21 18.65 31.84 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 10.90 21.31 28.81 12.14 22.15 30.31 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 8 3 # 8 B 41 HIS B 51 HIS~? 12.10 CA CA B 201 B 43 HIS B 10 HIS~? 10.24 CA CA B 201 B 65 GLU B 40 GLU.? 3.43 CA CA B 201s coo 20.15 22.08 34.36 20.84 20.10 34.21 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 19.55 18.91 30.27 18.21 18.65 31.84 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 10.90 21.31 28.81 12.14 22.15 30.31 -9.63 20.01 71.75 -10.53 18.20 71.23 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 8 hits 1e7l_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 69 ASP~? 23.19 CA CA B 201 A 35 SER A 67 SER~? 18.51 CA CA B 201 A 218 ASP A 27 ASP.? 17.47 CA CA A 202 coo 47.22 22.34 8.57 45.16 22.02 9.13 11.02 26.78 74.77 12.23 26.87 76.45 coo 43.58 20.85 5.15 44.62 23.01 5.76 7.12 29.60 71.54 4.89 29.99 70.85 coo 44.05 16.99 12.67 44.05 18.89 11.74 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 35 SER B 67 SER~? 20.12 CA CA A 202 A 218 ASP B 27 ASP.? 17.39 CA CA B 201 coo 47.22 22.34 8.57 45.16 22.02 9.13 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 43.58 20.85 5.15 44.62 23.01 5.76 2.68 29.83 52.62 3.84 31.35 54.03 coo 44.05 16.99 12.67 44.05 18.89 11.74 -1.83 20.43 53.73 -0.68 19.31 55.10 1eag_c04 source 1eag PEPTIDE INHIBITOR : 2 hits 1eag_c04 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 79 LYS~? 16.33 CA CA B 201 A 207 LYS B 46 LYS.? 7.77 CA CA B 201 A 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 79 LYS~? 16.33 CA CA B 201 A 207 LYS B 48 LYS~? 22.74 CA CA B 201 A 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS B 46 LYS.? 7.77 CA CA B 201 A 207 LYS A 79 LYS~? 16.33 CA CA B 201 A 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS B 46 LYS.? 7.77 CA CA B 201 A 207 LYS B 48 LYS~? 22.74 CA CA B 201 A 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -9.65 28.18 90.30 -9.88 28.72 88.34 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 4 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 79 LYS~? 16.33 CA CA B 201 B 207 LYS B 46 LYS.? 7.77 CA CA B 201 B 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 79 LYS~? 16.33 CA CA B 201 B 207 LYS B 48 LYS~? 22.74 CA CA B 201 B 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS B 46 LYS.? 7.77 CA CA B 201 B 207 LYS A 79 LYS~? 16.33 CA CA B 201 B 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 46 LYS.? 7.77 CA CA B 201 B 207 LYS B 48 LYS~? 22.74 CA CA B 201 B 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -9.65 28.18 90.30 -9.88 28.72 88.34 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 4 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 79 LYS~? 16.33 CA CA B 201 D 207 LYS B 46 LYS.? 7.77 CA CA B 201 D 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 79 LYS~? 16.33 CA CA B 201 D 207 LYS B 48 LYS~? 22.74 CA CA B 201 D 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS B 46 LYS.? 7.77 CA CA B 201 D 207 LYS A 79 LYS~? 16.33 CA CA B 201 D 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS B 46 LYS.? 7.77 CA CA B 201 D 207 LYS B 48 LYS~? 22.74 CA CA B 201 D 366 ASP A 86 ASP~? 21.59 CA CA B 201 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -9.65 28.18 90.30 -9.88 28.72 88.34 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 4 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 177 ASP A 4 ASP~? 21.72 CA CA A 202 A 203 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 8.74 45.76 47.19 9.33 46.93 45.56 22.09 39.77 43.94 22.07 41.64 42.98 coo 11.68 42.31 52.96 12.05 43.92 51.65 25.57 34.71 45.51 26.38 33.70 43.83 coo 18.07 52.81 49.62 14.17 49.99 48.07 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 177 ASP A 4 ASP~? 21.72 CA CA A 202 A 203 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 8.74 45.76 47.19 9.33 46.93 45.56 22.09 39.77 43.94 22.07 41.64 42.98 coo 11.68 42.31 52.96 12.05 43.92 51.65 25.57 34.71 45.51 26.38 33.70 43.83 coo 18.07 52.81 49.62 14.17 49.99 48.07 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS A 43 HIS.? 6.83 CA CA A 202 A 177 ASP A 38 ASP~? -3.36 CA CA A 202s A 203 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 8.74 45.76 47.19 9.33 46.93 45.56 20.15 20.72 47.43 19.82 19.00 48.57 coo 11.68 42.31 52.96 12.05 43.92 51.65 14.49 17.18 50.40 16.42 16.29 49.93 coo 18.07 52.81 49.62 14.17 49.99 48.07 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS B 2 HIS~? 26.00 CH3 ACT B 802 A 177 ASP B 4 ASP~? 21.62 CA CA B 201 A 203 LYS B 52 LYS~? 20.44 CA CA B 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 11.68 42.31 52.96 12.05 43.92 51.65 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 18.07 52.81 49.62 14.17 49.99 48.07 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS B 43 HIS.? 6.84 CA CA B 201 A 177 ASP B 38 ASP~? -3.30 CA CA B 201s A 203 LYS B 52 LYS~? 20.44 CA CA B 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 11.68 42.31 52.96 12.05 43.92 51.65 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 18.07 52.81 49.62 14.17 49.99 48.07 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS B 45 HIS.? 16.95 CA CA B 201 A 177 ASP A 86 ASP~? 21.59 CA CA B 201 A 203 LYS B 3 LYS~? 17.03 CA CA B 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 11.68 42.31 52.96 12.05 43.92 51.65 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 18.07 52.81 49.62 14.17 49.99 48.07 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 7 3 # 7 A 99 HIS B 45 HIS.? 16.95 CA CA B 201 A 177 ASP A 86 ASP~? 21.59 CA CA B 201 A 203 LYS B 48 LYS~? 22.74 CA CA B 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 11.68 42.31 52.96 12.05 43.92 51.65 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 18.07 52.81 49.62 14.17 49.99 48.07 -6.08 30.98 79.72 -6.69 36.84 80.65 1ecx_c02 source 1ecx AMINOTRANSFERASE : 7 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 2 HIS~? 23.51 OXT ACT B 801 B 177 ASP A 4 ASP~? 21.72 CA CA A 202 B 203 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 14.87 88.04 21.51 13.64 87.90 19.81 22.09 39.77 43.94 22.07 41.64 42.98 coo 15.87 92.46 27.37 14.46 91.76 25.94 25.57 34.71 45.51 26.38 33.70 43.83 coo 3.60 91.42 23.52 8.20 89.55 22.63 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 43 HIS.? 6.83 CA CA A 202 B 177 ASP A 38 ASP~? -3.36 CA CA A 202s B 203 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 14.87 88.04 21.51 13.64 87.90 19.81 20.15 20.72 47.43 19.82 19.00 48.57 coo 15.87 92.46 27.37 14.46 91.76 25.94 14.49 17.18 50.40 16.42 16.29 49.93 coo 3.60 91.42 23.52 8.20 89.55 22.63 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS B 2 HIS~? 26.00 CH3 ACT B 802 B 177 ASP B 4 ASP~? 21.62 CA CA B 201 B 203 LYS B 52 LYS~? 20.44 CA CA B 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 15.87 92.46 27.37 14.46 91.76 25.94 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 3.60 91.42 23.52 8.20 89.55 22.63 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS B 43 HIS.? 6.84 CA CA B 201 B 177 ASP B 38 ASP~? -3.30 CA CA B 201s B 203 LYS B 52 LYS~? 20.44 CA CA B 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 15.87 92.46 27.37 14.46 91.76 25.94 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 3.60 91.42 23.52 8.20 89.55 22.63 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS B 45 HIS.? 16.95 CA CA B 201 B 177 ASP A 86 ASP~? 21.59 CA CA B 201 B 203 LYS B 3 LYS~? 17.03 CA CA B 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 15.87 92.46 27.37 14.46 91.76 25.94 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 3.60 91.42 23.52 8.20 89.55 22.63 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS B 45 HIS.? 16.95 CA CA B 201 B 177 ASP A 86 ASP~? 21.59 CA CA B 201 B 203 LYS B 48 LYS~? 22.74 CA CA B 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 15.87 92.46 27.37 14.46 91.76 25.94 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 3.60 91.42 23.52 8.20 89.55 22.63 -6.08 30.98 79.72 -6.69 36.84 80.65 1ecx_c03 source 1ecx AMINOTRANSFERASE : 6 hits 1ecx_c03 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 69 ASP~? 23.19 CA CA B 201 P 35 SER A 67 SER~? 18.51 CA CA B 201 P 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo 10.15 33.41 11.98 7.98 33.66 12.07 11.02 26.78 74.77 12.23 26.87 76.45 coo 7.57 37.60 10.00 8.86 37.02 12.03 7.12 29.60 71.54 4.89 29.99 70.85 coo 4.04 29.97 8.82 4.78 31.15 10.46 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 P 35 SER B 67 SER~? 20.12 CA CA A 202 P 215 ASP B 27 ASP.? 17.39 CA CA B 201 coo 10.15 33.41 11.98 7.98 33.66 12.07 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 7.57 37.60 10.00 8.86 37.02 12.03 2.68 29.83 52.62 3.84 31.35 54.03 coo 4.04 29.97 8.82 4.78 31.15 10.46 -1.83 20.43 53.73 -0.68 19.31 55.10 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 2 hits 1eed_c04 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 197 ASP A 4 ASP~? 21.72 CA CA A 202 A 223 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 22.09 39.77 43.94 22.07 41.64 42.98 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 25.57 34.71 45.51 26.38 33.70 43.83 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 43 HIS.? 6.83 CA CA A 202 A 197 ASP A 38 ASP~? -3.36 CA CA A 202s A 223 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 20.15 20.72 47.43 19.82 19.00 48.57 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 14.49 17.18 50.40 16.42 16.29 49.93 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS B 2 HIS~? 26.00 CH3 ACT B 802 A 197 ASP B 4 ASP~? 21.62 CA CA B 201 A 223 LYS B 52 LYS~? 20.44 CA CA B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -12.31 39.90 79.94 -12.15 41.88 80.62 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS B 43 HIS.? 6.84 CA CA B 201 A 197 ASP B 38 ASP~? -3.30 CA CA B 201s A 223 LYS B 48 LYS~? 22.74 CA CA B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -6.08 30.98 79.72 -6.69 36.84 80.65 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS B 43 HIS.? 6.84 CA CA B 201 A 197 ASP B 38 ASP~? -3.30 CA CA B 201s A 223 LYS B 52 LYS~? 20.44 CA CA B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS B 45 HIS.? 16.95 CA CA B 201 A 197 ASP A 86 ASP~? 21.59 CA CA B 201 A 223 LYS B 3 LYS~? 17.03 CA CA B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS B 45 HIS.? 16.95 CA CA B 201 A 197 ASP A 86 ASP~? 21.59 CA CA B 201 A 223 LYS B 48 LYS~? 22.74 CA CA B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -6.08 30.98 79.72 -6.69 36.84 80.65 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 7 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 2 HIS~? 23.51 OXT ACT B 801 B 197 ASP A 4 ASP~? 21.72 CA CA A 202 B 223 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 22.09 39.77 43.94 22.07 41.64 42.98 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 25.57 34.71 45.51 26.38 33.70 43.83 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 43 HIS.? 6.83 CA CA A 202 B 197 ASP A 38 ASP~? -3.36 CA CA A 202s B 223 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 20.15 20.72 47.43 19.82 19.00 48.57 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 14.49 17.18 50.40 16.42 16.29 49.93 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS B 2 HIS~? 26.00 CH3 ACT B 802 B 197 ASP B 4 ASP~? 21.62 CA CA B 201 B 223 LYS B 52 LYS~? 20.44 CA CA B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -12.31 39.90 79.94 -12.15 41.88 80.62 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS B 43 HIS.? 6.84 CA CA B 201 B 197 ASP B 38 ASP~? -3.30 CA CA B 201s B 223 LYS B 48 LYS~? 22.74 CA CA B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -6.08 30.98 79.72 -6.69 36.84 80.65 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS B 43 HIS.? 6.84 CA CA B 201 B 197 ASP B 38 ASP~? -3.30 CA CA B 201s B 223 LYS B 52 LYS~? 20.44 CA CA B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS B 45 HIS.? 16.95 CA CA B 201 B 197 ASP A 86 ASP~? 21.59 CA CA B 201 B 223 LYS B 3 LYS~? 17.03 CA CA B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS B 45 HIS.? 16.95 CA CA B 201 B 197 ASP A 86 ASP~? 21.59 CA CA B 201 B 223 LYS B 48 LYS~? 22.74 CA CA B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -6.08 30.98 79.72 -6.69 36.84 80.65 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 7 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 32 ALA~? 11.01 CA CA A 202 A 257 ALA A 33 ALA~? 11.76 CA CA A 202 A 328 ASP A 38 ASP~? -3.36 CA CA A 202s coo 39.84 24.12 8.44 38.50 24.23 9.11 10.77 18.52 60.60 9.90 17.61 61.30 coo 43.22 26.73 5.37 41.81 27.09 5.79 8.98 20.65 58.05 8.13 21.77 58.29 coo 38.17 34.10 6.67 37.72 32.06 6.84 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 33 ALA~? 11.76 CA CA A 202 A 257 ALA A 32 ALA~? 11.01 CA CA A 202 A 328 ASP A 38 ASP~? -3.36 CA CA A 202s coo 39.84 24.12 8.44 38.50 24.23 9.11 8.98 20.65 58.05 8.13 21.77 58.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 10.77 18.52 60.60 9.90 17.61 61.30 coo 38.17 34.10 6.67 37.72 32.06 6.84 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 61 ALA~? 14.28 CA CA A 202 A 257 ALA A 30 ALA.? 15.19 CA CA A 202 A 328 ASP A 69 ASP~? 23.19 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 10.62 26.67 62.98 11.31 25.55 62.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 11.63 21.17 65.56 12.37 22.17 66.35 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 61 ALA~? 14.28 CA CA A 202 A 257 ALA A 63 ALA~? 21.13 CA CA A 202 A 328 ASP A 69 ASP~? 23.19 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 10.62 26.67 62.98 11.31 25.55 62.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 10.26 30.81 66.29 9.58 31.78 65.43 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 61 ALA~? 14.28 CA CA A 202 A 257 ALA A 64 ALA~? 19.01 CA CA B 201 A 328 ASP A 27 ASP.? 17.47 CA CA A 202 coo 39.84 24.12 8.44 38.50 24.23 9.11 10.62 26.67 62.98 11.31 25.55 62.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.86 27.93 66.93 7.41 26.91 65.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 61 ALA~? 14.28 CA CA A 202 A 257 ALA A 64 ALA~? 19.01 CA CA B 201 A 328 ASP A 69 ASP~? 23.19 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 10.62 26.67 62.98 11.31 25.55 62.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.86 27.93 66.93 7.41 26.91 65.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 63 ALA~? 21.13 CA CA A 202 A 257 ALA A 61 ALA~? 14.28 CA CA A 202 A 328 ASP A 27 ASP.? 17.47 CA CA A 202 coo 39.84 24.12 8.44 38.50 24.23 9.11 10.26 30.81 66.29 9.58 31.78 65.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 10.62 26.67 62.98 11.31 25.55 62.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 63 ALA~? 21.13 CA CA A 202 A 257 ALA A 64 ALA~? 19.01 CA CA B 201 A 328 ASP A 27 ASP.? 17.47 CA CA A 202 coo 39.84 24.12 8.44 38.50 24.23 9.11 10.26 30.81 66.29 9.58 31.78 65.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.86 27.93 66.93 7.41 26.91 65.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA A 63 ALA~? 21.13 CA CA A 202 A 257 ALA A 64 ALA~? 19.01 CA CA B 201 A 328 ASP A 69 ASP~? 23.19 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 10.26 30.81 66.29 9.58 31.78 65.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.86 27.93 66.93 7.41 26.91 65.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA A 64 ALA~? 19.01 CA CA B 201 A 257 ALA A 61 ALA~? 14.28 CA CA A 202 A 328 ASP A 27 ASP.? 17.47 CA CA A 202 coo 39.84 24.12 8.44 38.50 24.23 9.11 7.86 27.93 66.93 7.41 26.91 65.95 coo 43.22 26.73 5.37 41.81 27.09 5.79 10.62 26.67 62.98 11.31 25.55 62.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA A 64 ALA~? 19.01 CA CA B 201 A 257 ALA A 63 ALA~? 21.13 CA CA A 202 A 328 ASP A 69 ASP~? 23.19 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 7.86 27.93 66.93 7.41 26.91 65.95 coo 43.22 26.73 5.37 41.81 27.09 5.79 10.26 30.81 66.29 9.58 31.78 65.43 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 32 ALA~? 10.92 CA CA B 201 A 257 ALA B 33 ALA~? 11.75 CA CA B 201 A 328 ASP B 38 ASP~? -3.30 CA CA B 201s coo 39.84 24.12 8.44 38.50 24.23 9.11 -1.09 18.56 63.53 -0.24 17.60 62.85 coo 43.22 26.73 5.37 41.81 27.09 5.79 0.71 20.60 66.10 1.61 21.70 65.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA B 33 ALA~? 11.75 CA CA B 201 A 257 ALA B 32 ALA~? 10.92 CA CA B 201 A 328 ASP B 38 ASP~? -3.30 CA CA B 201s coo 39.84 24.12 8.44 38.50 24.23 9.11 0.71 20.60 66.10 1.61 21.70 65.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 -1.09 18.56 63.53 -0.24 17.60 62.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA B 61 ALA~? 14.12 CA CA B 201 A 257 ALA B 30 ALA.? 15.19 CA CA B 201 A 328 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.95 26.60 61.17 -1.77 25.53 61.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 -1.80 21.27 58.53 -2.55 22.27 57.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA B 61 ALA~? 14.12 CA CA B 201 A 257 ALA B 63 ALA~? 18.50 CH3 ACT B 802 A 328 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.95 26.60 61.17 -1.77 25.53 61.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.49 30.91 57.78 0.13 31.85 58.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA B 61 ALA~? 14.12 CA CA B 201 A 257 ALA B 64 ALA~? 19.03 CA CA A 202 A 328 ASP B 27 ASP.? 17.39 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.95 26.60 61.17 -1.77 25.53 61.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.92 28.01 57.26 2.24 26.93 58.24 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.83 20.43 53.73 -0.68 19.31 55.10 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA B 61 ALA~? 14.12 CA CA B 201 A 257 ALA B 64 ALA~? 19.03 CA CA A 202 A 328 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.95 26.60 61.17 -1.77 25.53 61.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.92 28.01 57.26 2.24 26.93 58.24 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA B 63 ALA~? 18.50 CH3 ACT B 802 A 257 ALA B 61 ALA~? 14.12 CA CA B 201 A 328 ASP B 27 ASP.? 17.39 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.49 30.91 57.78 0.13 31.85 58.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.95 26.60 61.17 -1.77 25.53 61.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.83 20.43 53.73 -0.68 19.31 55.10 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA B 63 ALA~? 18.50 CH3 ACT B 802 A 257 ALA B 64 ALA~? 19.03 CA CA A 202 A 328 ASP B 27 ASP.? 17.39 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.49 30.91 57.78 0.13 31.85 58.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.92 28.01 57.26 2.24 26.93 58.24 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.83 20.43 53.73 -0.68 19.31 55.10 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA B 63 ALA~? 18.50 CH3 ACT B 802 A 257 ALA B 64 ALA~? 19.03 CA CA A 202 A 328 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.49 30.91 57.78 0.13 31.85 58.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.92 28.01 57.26 2.24 26.93 58.24 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA B 64 ALA~? 19.03 CA CA A 202 A 257 ALA B 61 ALA~? 14.12 CA CA B 201 A 328 ASP B 27 ASP.? 17.39 CA CA B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 1.92 28.01 57.26 2.24 26.93 58.24 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.95 26.60 61.17 -1.77 25.53 61.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.83 20.43 53.73 -0.68 19.31 55.10 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA B 64 ALA~? 19.03 CA CA A 202 A 257 ALA B 63 ALA~? 18.50 CH3 ACT B 802 A 328 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 39.84 24.12 8.44 38.50 24.23 9.11 1.92 28.01 57.26 2.24 26.93 58.24 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.49 30.91 57.78 0.13 31.85 58.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.95 26.94 49.29 -2.15 27.04 47.60 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 22 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 17 LYS~? 8.75 CA CA A 202 A 193 GLU A 11 GLU~? 14.95 CA CA A 202 A 217 VAL A 14 VAL~? 10.88 CA CA A 202 coo 2.10 10.68 61.44 -2.14 13.16 60.61 19.68 24.92 63.26 19.27 20.80 60.44 coo -5.33 11.71 69.72 -4.62 11.92 67.73 26.25 27.59 54.14 27.19 27.48 52.23 coo 0.07 12.29 66.53 -0.24 11.95 64.38 21.47 25.85 58.80 21.59 24.34 57.33 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 17 LYS~? 8.61 CA CA B 201 A 193 GLU B 11 GLU~? 12.56 CH3 ACT B 802 A 217 VAL B 14 VAL~? 10.79 CA CA B 201 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -9.98 24.92 60.71 -9.24 20.80 63.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -11.76 25.84 65.17 -11.92 24.28 66.62 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 29 THR.? 15.36 CA CA A 202 A 159 LYS A 17 LYS~? 8.75 CA CA A 202 A 193 GLU A 40 GLU.? 3.38 CA CA A 202s coo -2.58 16.31 54.79 -4.02 14.93 55.64 12.00 17.38 65.85 10.47 16.33 66.97 coo 2.10 10.68 61.44 -2.14 13.16 60.61 19.68 24.92 63.26 19.27 20.80 60.44 coo -5.33 11.71 69.72 -4.62 11.92 67.73 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 29 THR.? 15.37 CA CA B 201 A 159 LYS B 17 LYS~? 8.61 CA CA B 201 A 193 GLU B 40 GLU.? 3.43 CA CA B 201s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -2.22 17.51 58.24 -0.75 16.42 57.04 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -9.98 24.92 60.71 -9.24 20.80 63.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.63 20.01 71.75 -10.53 18.20 71.23 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 18 ASP~? 11.52 CA CA A 202 260 GLU A 40 GLU.? 3.38 CA CA A 202s 370 TYR A 34 TYR~? 7.34 CA CA A 202 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 23.94 22.65 63.18 23.40 21.50 61.45 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 19.19 19.98 52.16 20.07 18.13 52.69 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 14.67 22.85 56.72 17.08 23.07 55.48 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 18 ASP~? 9.64 OXT ACT B 802 260 GLU B 40 GLU.? 3.43 CA CA B 201s 370 TYR B 34 TYR~? 7.28 CA CA B 201 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -4.97 22.79 67.30 -7.41 23.00 68.45 1euu_c00 source 1euu SIALIDASE : 2 hits 1euu_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 38 ASP~? -3.36 CA CA A 202s C 117 GLU A 36 GLU~? 11.24 CA CA A 202 C 131 GLU A 40 GLU.? 3.38 CA CA A 202s coo 68.01 56.37 72.57 68.42 56.10 70.51 14.49 17.18 50.40 16.42 16.29 49.93 coo 66.59 62.50 67.44 67.57 60.64 67.12 8.53 16.97 55.87 6.50 17.32 56.35 coo 69.24 52.27 71.96 69.91 50.26 71.89 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP A 38 ASP~? -3.36 CA CA A 202s C 117 GLU A 50 GLU~? 11.43 OXT ACT B 801 C 131 GLU A 40 GLU.? 3.38 CA CA A 202s coo 68.01 56.37 72.57 68.42 56.10 70.51 14.49 17.18 50.40 16.42 16.29 49.93 coo 66.59 62.50 67.44 67.57 60.64 67.12 12.68 24.99 44.98 13.54 23.53 43.68 coo 69.24 52.27 71.96 69.91 50.26 71.89 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP B 27 ASP.? 17.39 CA CA B 201 C 117 GLU B 68 GLU~? 14.14 CA CA A 202 C 131 GLU B 28 GLU.? 17.90 CA CA B 201 coo 68.01 56.37 72.57 68.42 56.10 70.51 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 66.59 62.50 67.44 67.57 60.64 67.12 3.52 24.40 53.24 5.54 24.28 52.66 coo 69.24 52.27 71.96 69.91 50.26 71.89 -4.88 15.15 55.19 -3.87 15.18 53.31 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP B 38 ASP~? -3.30 CA CA B 201s C 117 GLU B 36 GLU~? 11.20 CA CA B 201 C 131 GLU B 40 GLU.? 3.43 CA CA B 201s coo 68.01 56.37 72.57 68.42 56.10 70.51 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 66.59 62.50 67.44 67.57 60.64 67.12 1.18 16.63 68.50 3.14 16.97 67.89 coo 69.24 52.27 71.96 69.91 50.26 71.89 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 3 # 5 C 95 ASP B 38 ASP~? -3.30 CA CA B 201s C 117 GLU B 50 GLU~? 12.54 CA CA B 201 C 131 GLU B 40 GLU.? 3.43 CA CA B 201s coo 68.01 56.37 72.57 68.42 56.10 70.51 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 66.59 62.50 67.44 67.57 60.64 67.12 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 69.24 52.27 71.96 69.91 50.26 71.89 -9.63 20.01 71.75 -10.53 18.20 71.23 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 5 hits 1f6d_c02 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 159 HIS A 10 HIS~? 10.31 CA CA A 202 A 162 HIS A 51 HIS~? 12.20 CA CA A 202 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 13.41 31.22 50.01 11.37 34.80 45.78 coo 29.80 39.37 7.24 28.18 38.06 7.48 19.28 27.48 52.70 18.40 25.59 52.72 coo 30.26 35.04 5.34 28.61 35.92 4.39 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 2 3 # 2 A 156 LYS B 52 LYS~? 20.44 CA CA B 201 A 159 HIS B 10 HIS~? 10.24 CA CA B 201 A 162 HIS B 51 HIS~? 12.10 CA CA B 201 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 29.80 39.37 7.24 28.18 38.06 7.48 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 30.26 35.04 5.34 28.61 35.92 4.39 -8.32 27.87 76.15 -9.65 26.27 76.41 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 2 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 2 HIS~? 23.51 OXT ACT B 801 C 62 LYS A 52 LYS~? 15.73 OXT ACT B 801 F 35 ASP A 4 ASP~? 21.72 CA CA A 202 coo 15.40 22.79 16.66 13.93 24.10 15.98 22.09 39.77 43.94 22.07 41.64 42.98 coo 19.95 18.98 4.81 18.82 20.94 10.49 13.41 31.22 50.01 11.37 34.80 45.78 coo 16.32 15.30 17.19 17.71 14.73 18.69 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 43 HIS.? 6.83 CA CA A 202 C 62 LYS A 48 LYS~? 17.72 OXT ACT B 801 F 35 ASP A 38 ASP~? -3.36 CA CA A 202s coo 15.40 22.79 16.66 13.93 24.10 15.98 20.15 20.72 47.43 19.82 19.00 48.57 coo 19.95 18.98 4.81 18.82 20.94 10.49 15.60 31.02 44.27 16.30 36.87 43.73 coo 16.32 15.30 17.19 17.71 14.73 18.69 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS A 43 HIS.? 6.83 CA CA A 202 C 62 LYS A 52 LYS~? 15.73 OXT ACT B 801 F 35 ASP A 38 ASP~? -3.36 CA CA A 202s coo 15.40 22.79 16.66 13.93 24.10 15.98 20.15 20.72 47.43 19.82 19.00 48.57 coo 19.95 18.98 4.81 18.82 20.94 10.49 13.41 31.22 50.01 11.37 34.80 45.78 coo 16.32 15.30 17.19 17.71 14.73 18.69 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS B 2 HIS~? 26.00 CH3 ACT B 802 C 62 LYS B 52 LYS~? 20.44 CA CA B 201 F 35 ASP B 4 ASP~? 21.62 CA CA B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 19.95 18.98 4.81 18.82 20.94 10.49 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 16.32 15.30 17.19 17.71 14.73 18.69 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS B 43 HIS.? 6.84 CA CA B 201 C 62 LYS B 48 LYS~? 22.74 CA CA B 201 F 35 ASP B 38 ASP~? -3.30 CA CA B 201s coo 15.40 22.79 16.66 13.93 24.10 15.98 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 19.95 18.98 4.81 18.82 20.94 10.49 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.32 15.30 17.19 17.71 14.73 18.69 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS B 43 HIS.? 6.84 CA CA B 201 C 62 LYS B 52 LYS~? 20.44 CA CA B 201 F 35 ASP B 38 ASP~? -3.30 CA CA B 201s coo 15.40 22.79 16.66 13.93 24.10 15.98 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 19.95 18.98 4.81 18.82 20.94 10.49 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 16.32 15.30 17.19 17.71 14.73 18.69 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS B 45 HIS.? 16.95 CA CA B 201 C 62 LYS B 3 LYS~? 17.03 CA CA B 201 F 35 ASP A 86 ASP~? 21.59 CA CA B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 19.95 18.98 4.81 18.82 20.94 10.49 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 16.32 15.30 17.19 17.71 14.73 18.69 -9.65 28.18 90.30 -9.88 28.72 88.34 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 7 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 105 HIS A 43 HIS.? 6.83 CA CA A 202 D 35 ASP A 38 ASP~? -3.36 CA CA A 202s coo 38.76 28.25 7.87 36.33 26.41 13.58 15.60 31.02 44.27 16.30 36.87 43.73 coo 34.93 19.72 17.37 34.72 18.17 15.98 20.15 20.72 47.43 19.82 19.00 48.57 coo 41.01 23.02 20.83 40.65 24.26 22.55 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 52 LYS~? 15.73 OXT ACT B 801 C 105 HIS A 2 HIS~? 23.51 OXT ACT B 801 D 35 ASP A 4 ASP~? 21.72 CA CA A 202 coo 38.76 28.25 7.87 36.33 26.41 13.58 13.41 31.22 50.01 11.37 34.80 45.78 coo 34.93 19.72 17.37 34.72 18.17 15.98 22.09 39.77 43.94 22.07 41.64 42.98 coo 41.01 23.02 20.83 40.65 24.26 22.55 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS A 52 LYS~? 15.73 OXT ACT B 801 C 105 HIS A 43 HIS.? 6.83 CA CA A 202 D 35 ASP A 38 ASP~? -3.36 CA CA A 202s coo 38.76 28.25 7.87 36.33 26.41 13.58 13.41 31.22 50.01 11.37 34.80 45.78 coo 34.93 19.72 17.37 34.72 18.17 15.98 20.15 20.72 47.43 19.82 19.00 48.57 coo 41.01 23.02 20.83 40.65 24.26 22.55 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS A 79 LYS~? 16.33 CA CA B 201 C 105 HIS B 43 HIS.? 6.84 CA CA B 201 D 35 ASP B 38 ASP~? -3.30 CA CA B 201s coo 38.76 28.25 7.87 36.33 26.41 13.58 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 34.93 19.72 17.37 34.72 18.17 15.98 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 41.01 23.02 20.83 40.65 24.26 22.55 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS B 3 LYS~? 17.03 CA CA B 201 C 105 HIS B 45 HIS.? 16.95 CA CA B 201 D 35 ASP A 86 ASP~? 21.59 CA CA B 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 34.93 19.72 17.37 34.72 18.17 15.98 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 41.01 23.02 20.83 40.65 24.26 22.55 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS B 48 LYS~? 22.74 CA CA B 201 C 105 HIS B 43 HIS.? 6.84 CA CA B 201 D 35 ASP B 38 ASP~? -3.30 CA CA B 201s coo 38.76 28.25 7.87 36.33 26.41 13.58 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 34.93 19.72 17.37 34.72 18.17 15.98 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 41.01 23.02 20.83 40.65 24.26 22.55 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS B 52 LYS~? 20.44 CA CA B 201 C 105 HIS B 2 HIS~? 26.00 CH3 ACT B 802 D 35 ASP B 4 ASP~? 21.62 CA CA B 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 34.93 19.72 17.37 34.72 18.17 15.98 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 41.01 23.02 20.83 40.65 24.26 22.55 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS B 52 LYS~? 20.44 CA CA B 201 C 105 HIS B 43 HIS.? 6.84 CA CA B 201 D 35 ASP B 38 ASP~? -3.30 CA CA B 201s coo 38.76 28.25 7.87 36.33 26.41 13.58 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 34.93 19.72 17.37 34.72 18.17 15.98 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 41.01 23.02 20.83 40.65 24.26 22.55 -4.95 17.23 73.65 -6.90 16.31 73.97 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 8 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 105 HIS A 2 HIS~? 23.51 OXT ACT B 801 E 35 ASP A 4 ASP~? 21.72 CA CA A 202 coo 20.51 39.76 8.83 21.23 37.38 14.18 13.41 31.22 50.01 11.37 34.80 45.78 coo 27.18 37.56 20.68 29.07 38.28 20.13 22.09 39.77 43.94 22.07 41.64 42.98 coo 19.97 40.39 22.03 18.53 39.30 23.18 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 105 HIS A 43 HIS.? 6.83 CA CA A 202 E 35 ASP A 38 ASP~? -3.36 CA CA A 202s coo 20.51 39.76 8.83 21.23 37.38 14.18 13.41 31.22 50.01 11.37 34.80 45.78 coo 27.18 37.56 20.68 29.07 38.28 20.13 20.15 20.72 47.43 19.82 19.00 48.57 coo 19.97 40.39 22.03 18.53 39.30 23.18 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS B 52 LYS~? 20.44 CA CA B 201 B 105 HIS B 2 HIS~? 26.00 CH3 ACT B 802 E 35 ASP B 4 ASP~? 21.62 CA CA B 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 27.18 37.56 20.68 29.07 38.28 20.13 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 19.97 40.39 22.03 18.53 39.30 23.18 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS B 52 LYS~? 20.44 CA CA B 201 B 105 HIS B 43 HIS.? 6.84 CA CA B 201 E 35 ASP B 38 ASP~? -3.30 CA CA B 201s coo 20.51 39.76 8.83 21.23 37.38 14.18 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 27.18 37.56 20.68 29.07 38.28 20.13 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 19.97 40.39 22.03 18.53 39.30 23.18 -4.95 17.23 73.65 -6.90 16.31 73.97 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 210 ASP A 4 ASP~? 21.72 CA CA A 202 A 244 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 11.28 44.53 18.60 9.91 46.00 19.20 22.09 39.77 43.94 22.07 41.64 42.98 coo 10.51 37.86 19.71 9.07 39.38 20.04 25.57 34.71 45.51 26.38 33.70 43.83 coo -1.20 42.34 17.67 3.19 45.13 19.06 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 210 ASP A 4 ASP~? 21.72 CA CA A 202 A 244 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 11.28 44.53 18.60 9.91 46.00 19.20 22.09 39.77 43.94 22.07 41.64 42.98 coo 10.51 37.86 19.71 9.07 39.38 20.04 25.57 34.71 45.51 26.38 33.70 43.83 coo -1.20 42.34 17.67 3.19 45.13 19.06 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS A 43 HIS.? 6.83 CA CA A 202 A 210 ASP A 38 ASP~? -3.36 CA CA A 202s A 244 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 11.28 44.53 18.60 9.91 46.00 19.20 20.15 20.72 47.43 19.82 19.00 48.57 coo 10.51 37.86 19.71 9.07 39.38 20.04 14.49 17.18 50.40 16.42 16.29 49.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS B 2 HIS~? 26.00 CH3 ACT B 802 A 210 ASP B 4 ASP~? 21.62 CA CA B 201 A 244 LYS B 52 LYS~? 20.44 CA CA B 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS B 43 HIS.? 6.84 CA CA B 201 A 210 ASP B 38 ASP~? -3.30 CA CA B 201s A 244 LYS B 52 LYS~? 20.44 CA CA B 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS B 45 HIS.? 16.95 CA CA B 201 A 210 ASP A 86 ASP~? 21.59 CA CA B 201 A 244 LYS B 3 LYS~? 17.03 CA CA B 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 10.51 37.86 19.71 9.07 39.38 20.04 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -1.20 42.34 17.67 3.19 45.13 19.06 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS B 45 HIS.? 16.95 CA CA B 201 A 210 ASP A 86 ASP~? 21.59 CA CA B 201 A 244 LYS B 48 LYS~? 22.74 CA CA B 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 10.51 37.86 19.71 9.07 39.38 20.04 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -1.20 42.34 17.67 3.19 45.13 19.06 -6.08 30.98 79.72 -6.69 36.84 80.65 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 7 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 2 HIS~? 23.51 OXT ACT B 801 B 210 ASP A 4 ASP~? 21.72 CA CA A 202 B 244 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 10.08 50.18 41.78 8.91 48.61 41.04 22.09 39.77 43.94 22.07 41.64 42.98 coo 9.06 56.85 40.30 7.71 55.27 39.90 25.57 34.71 45.51 26.38 33.70 43.83 coo -2.38 51.82 41.62 2.07 49.19 40.42 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 2 HIS~? 23.51 OXT ACT B 801 B 210 ASP A 4 ASP~? 21.72 CA CA A 202 B 244 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 10.08 50.18 41.78 8.91 48.61 41.04 22.09 39.77 43.94 22.07 41.64 42.98 coo 9.06 56.85 40.30 7.71 55.27 39.90 25.57 34.71 45.51 26.38 33.70 43.83 coo -2.38 51.82 41.62 2.07 49.19 40.42 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS A 43 HIS.? 6.83 CA CA A 202 B 210 ASP A 38 ASP~? -3.36 CA CA A 202s B 244 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 10.08 50.18 41.78 8.91 48.61 41.04 20.15 20.72 47.43 19.82 19.00 48.57 coo 9.06 56.85 40.30 7.71 55.27 39.90 14.49 17.18 50.40 16.42 16.29 49.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS B 2 HIS~? 26.00 CH3 ACT B 802 B 210 ASP B 4 ASP~? 21.62 CA CA B 201 B 244 LYS B 52 LYS~? 20.44 CA CA B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS B 43 HIS.? 6.84 CA CA B 201 B 210 ASP B 38 ASP~? -3.30 CA CA B 201s B 244 LYS B 52 LYS~? 20.44 CA CA B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS B 45 HIS.? 16.95 CA CA B 201 B 210 ASP A 86 ASP~? 21.59 CA CA B 201 B 244 LYS B 3 LYS~? 17.03 CA CA B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 9.06 56.85 40.30 7.71 55.27 39.90 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -2.38 51.82 41.62 2.07 49.19 40.42 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS B 45 HIS.? 16.95 CA CA B 201 B 210 ASP A 86 ASP~? 21.59 CA CA B 201 B 244 LYS B 48 LYS~? 22.74 CA CA B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 9.06 56.85 40.30 7.71 55.27 39.90 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -2.38 51.82 41.62 2.07 49.19 40.42 -6.08 30.98 79.72 -6.69 36.84 80.65 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 7 hits 1fc4_c05 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 80 ARG~? 24.83 CA CA B 201 A 136 GLU A 82 GLU~? 19.14 CA CA B 201 A 246 GLU A 83 GLU~? 18.60 CA CA B 201 coo 13.48 30.30 107.06 11.75 30.99 109.44 1.65 24.64 89.61 4.49 24.81 90.71 coo 9.46 32.37 115.82 8.50 34.20 115.47 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 11.99 34.33 109.92 10.08 34.19 110.77 -4.99 25.05 87.76 -3.42 23.71 87.32 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 1 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 80 ARG~? 24.83 CA CA B 201 A 136 GLU A 82 GLU~? 19.14 CA CA B 201 A 246 GLU A 83 GLU~? 18.60 CA CA B 201 coo 13.94 29.84 106.80 11.67 30.40 108.79 1.65 24.64 89.61 4.49 24.81 90.71 coo 9.52 31.97 115.23 8.45 33.74 114.72 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 11.92 33.82 109.35 10.10 33.50 110.39 -4.99 25.05 87.76 -3.42 23.71 87.32 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 1 hits 1fob_c00 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 331 GLU A 11 GLU~? 14.95 CA CA A 202 B 188 HIS A 10 HIS~? 10.31 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 20.81 34.16 44.49 19.85 28.53 41.75 coo 120.90 152.23 75.28 120.94 153.09 77.19 26.25 27.59 54.14 27.19 27.48 52.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 331 GLU A 50 GLU~? 11.43 OXT ACT B 801 B 188 HIS A 51 HIS~? 12.20 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 20.81 34.16 44.49 19.85 28.53 41.75 coo 120.90 152.23 75.28 120.94 153.09 77.19 12.68 24.99 44.98 13.54 23.53 43.68 coo 122.04 152.80 81.06 120.71 154.37 81.46 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1fuq_c00 FUMARASE C user 3 3 # 3 A 324 LYS A 17 LYS~? 8.75 CA CA A 202 A 331 GLU A 11 GLU~? 14.95 CA CA A 202 B 188 HIS A 10 HIS~? 10.31 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 19.68 24.92 63.26 19.27 20.80 60.44 coo 120.90 152.23 75.28 120.94 153.09 77.19 26.25 27.59 54.14 27.19 27.48 52.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1fuq_c00 FUMARASE C user 4 3 # 4 A 324 LYS A 17 LYS~? 8.75 CA CA A 202 A 331 GLU A 40 GLU.? 3.38 CA CA A 202s B 188 HIS A 10 HIS~? 10.31 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 19.68 24.92 63.26 19.27 20.80 60.44 coo 120.90 152.23 75.28 120.94 153.09 77.19 19.19 19.98 52.16 20.07 18.13 52.69 coo 122.04 152.80 81.06 120.71 154.37 81.46 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1fuq_c00 FUMARASE C user 5 3 # 5 A 324 LYS A 46 LYS.? 7.73 CA CA A 202 A 331 GLU A 11 GLU~? 14.95 CA CA A 202 B 188 HIS A 10 HIS~? 10.31 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 17.72 24.61 42.81 16.30 19.73 46.29 coo 120.90 152.23 75.28 120.94 153.09 77.19 26.25 27.59 54.14 27.19 27.48 52.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1fuq_c00 FUMARASE C user 6 3 # 6 A 324 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 331 GLU A 5 GLU~? 25.21 CA CA A 202 B 188 HIS A 2 HIS~? 23.51 OXT ACT B 801 coo 130.22 155.23 83.49 125.21 153.71 84.04 15.60 31.02 44.27 16.30 36.87 43.73 coo 120.90 152.23 75.28 120.94 153.09 77.19 23.31 38.61 48.39 22.38 40.48 47.97 coo 122.04 152.80 81.06 120.71 154.37 81.46 22.09 39.77 43.94 22.07 41.64 42.98 ULMN 3 1fuq_c00 FUMARASE C user 7 3 # 7 A 324 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 331 GLU A 40 GLU.? 3.38 CA CA A 202s B 188 HIS A 10 HIS~? 10.31 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 15.60 31.02 44.27 16.30 36.87 43.73 coo 120.90 152.23 75.28 120.94 153.09 77.19 19.19 19.98 52.16 20.07 18.13 52.69 coo 122.04 152.80 81.06 120.71 154.37 81.46 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1fuq_c00 FUMARASE C user 8 3 # 8 A 324 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 331 GLU A 11 GLU~? 14.95 CA CA A 202 B 188 HIS A 10 HIS~? 10.31 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 13.41 31.22 50.01 11.37 34.80 45.78 coo 120.90 152.23 75.28 120.94 153.09 77.19 26.25 27.59 54.14 27.19 27.48 52.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1fuq_c00 FUMARASE C user 9 3 # 9 A 324 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 331 GLU A 40 GLU.? 3.38 CA CA A 202s B 188 HIS A 10 HIS~? 10.31 CA CA A 202 coo 130.22 155.23 83.49 125.21 153.71 84.04 13.41 31.22 50.01 11.37 34.80 45.78 coo 120.90 152.23 75.28 120.94 153.09 77.19 19.19 19.98 52.16 20.07 18.13 52.69 coo 122.04 152.80 81.06 120.71 154.37 81.46 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1fuq_c00 FUMARASE C user 10 3 # 10 A 324 LYS B 3 LYS~? 17.03 CA CA B 201 A 331 GLU B 11 GLU~? 12.56 CH3 ACT B 802 B 188 HIS B 10 HIS~? 10.24 CA CA B 201 coo 130.22 155.23 83.49 125.21 153.71 84.04 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 120.90 152.23 75.28 120.94 153.09 77.19 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 122.04 152.80 81.06 120.71 154.37 81.46 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1fuq_c00 FUMARASE C user 11 3 # 11 A 324 LYS B 3 LYS~? 17.03 CA CA B 201 A 331 GLU B 50 GLU~? 12.54 CA CA B 201 B 188 HIS B 51 HIS~? 12.10 CA CA B 201 coo 130.22 155.23 83.49 125.21 153.71 84.04 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 120.90 152.23 75.28 120.94 153.09 77.19 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 122.04 152.80 81.06 120.71 154.37 81.46 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1fuq_c00 FUMARASE C user 12 3 # 12 A 324 LYS B 17 LYS~? 8.61 CA CA B 201 A 331 GLU B 11 GLU~? 12.56 CH3 ACT B 802 B 188 HIS B 10 HIS~? 10.24 CA CA B 201 coo 130.22 155.23 83.49 125.21 153.71 84.04 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 120.90 152.23 75.28 120.94 153.09 77.19 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 122.04 152.80 81.06 120.71 154.37 81.46 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1fuq_c00 FUMARASE C user 13 3 # 13 A 324 LYS B 17 LYS~? 8.61 CA CA B 201 A 331 GLU B 40 GLU.? 3.43 CA CA B 201s B 188 HIS B 10 HIS~? 10.24 CA CA B 201 coo 130.22 155.23 83.49 125.21 153.71 84.04 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 120.90 152.23 75.28 120.94 153.09 77.19 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1fuq_c00 FUMARASE C user 14 3 # 14 A 324 LYS B 48 LYS~? 22.74 CA CA B 201 A 331 GLU B 5 GLU~? 21.97 CH3 ACT B 802 B 188 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo 130.22 155.23 83.49 125.21 153.71 84.04 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 120.90 152.23 75.28 120.94 153.09 77.19 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 122.04 152.80 81.06 120.71 154.37 81.46 -12.31 39.90 79.94 -12.15 41.88 80.62 ULMN 3 1fuq_c00 FUMARASE C user 15 3 # 15 A 324 LYS B 48 LYS~? 22.74 CA CA B 201 A 331 GLU B 40 GLU.? 3.43 CA CA B 201s B 188 HIS B 10 HIS~? 10.24 CA CA B 201 coo 130.22 155.23 83.49 125.21 153.71 84.04 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 120.90 152.23 75.28 120.94 153.09 77.19 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1fuq_c00 FUMARASE C user 16 3 # 16 A 324 LYS B 52 LYS~? 20.44 CA CA B 201 A 331 GLU B 11 GLU~? 12.56 CH3 ACT B 802 B 188 HIS B 10 HIS~? 10.24 CA CA B 201 coo 130.22 155.23 83.49 125.21 153.71 84.04 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 120.90 152.23 75.28 120.94 153.09 77.19 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 122.04 152.80 81.06 120.71 154.37 81.46 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1fuq_c00 FUMARASE C user 17 3 # 17 A 324 LYS B 52 LYS~? 20.44 CA CA B 201 A 331 GLU B 40 GLU.? 3.43 CA CA B 201s B 188 HIS B 10 HIS~? 10.24 CA CA B 201 coo 130.22 155.23 83.49 125.21 153.71 84.04 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 120.90 152.23 75.28 120.94 153.09 77.19 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 -9.62 27.46 71.20 -8.83 25.53 71.16 1fuq_c00 source 1fuq FUMARASE C : 17 hits 1fuq_c00 naa= 3 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 1 3 # 1 A 130 ASP A 18 ASP~? 11.52 CA CA A 202 A 153 ASN A 15 ASN~? 15.90 CA CA A 202 A 189 GLN A 19 GLN~? 20.91 CA CA A 202 coo 27.45 53.97 73.24 26.29 54.34 71.54 23.94 22.65 63.18 23.40 21.50 61.45 coo 29.93 52.22 70.56 29.34 51.93 68.54 25.38 27.93 60.94 26.84 27.34 59.51 coo 26.19 47.96 71.25 25.92 49.81 70.24 24.07 27.47 67.98 24.05 29.58 67.89 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 2 3 # 2 A 130 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 153 ASN B 15 ASN~? 6.97 CH3 ACT B 802 A 189 GLN B 19 GLN~? -3.87 C ACT B 802s coo 27.45 53.97 73.24 26.29 54.34 71.54 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 29.93 52.22 70.56 29.34 51.93 68.54 -15.63 27.98 63.03 -17.12 27.37 64.41 coo 26.19 47.96 71.25 25.92 49.81 70.24 -14.34 27.46 55.84 -14.40 29.60 55.97 1ga8_c00 source 1ga8 GALACTOSYL TRANSFERASE LGTC : 2 hits 1ga8_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 11 GLU~? 14.95 CA CA A 202 516 HIS A 43 HIS.? 6.83 CA CA A 202 559 HIS A 10 HIS~? 10.31 CA CA A 202 coo 49.01 14.50 52.53 46.99 14.61 52.78 26.25 27.59 54.14 27.19 27.48 52.23 coo 41.59 7.83 54.15 41.16 9.87 53.87 20.15 20.72 47.43 19.82 19.00 48.57 coo 42.22 14.55 52.50 43.91 14.87 53.60 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU A 11 GLU~? 14.95 CA CA A 202 516 HIS A 51 HIS~? 12.20 CA CA A 202 559 HIS A 10 HIS~? 10.31 CA CA A 202 coo 49.01 14.50 52.53 46.99 14.61 52.78 26.25 27.59 54.14 27.19 27.48 52.23 coo 41.59 7.83 54.15 41.16 9.87 53.87 17.98 27.94 47.81 19.27 26.33 47.47 coo 42.22 14.55 52.50 43.91 14.87 53.60 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU A 40 GLU.? 3.38 CA CA A 202s 516 HIS A 51 HIS~? 12.20 CA CA A 202 559 HIS A 10 HIS~? 10.31 CA CA A 202 coo 49.01 14.50 52.53 46.99 14.61 52.78 19.19 19.98 52.16 20.07 18.13 52.69 coo 41.59 7.83 54.15 41.16 9.87 53.87 17.98 27.94 47.81 19.27 26.33 47.47 coo 42.22 14.55 52.50 43.91 14.87 53.60 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU A 40 GLU.? 3.38 CA CA A 202s 516 HIS A 51 HIS~? 12.20 CA CA A 202 559 HIS A 43 HIS.? 6.83 CA CA A 202 coo 49.01 14.50 52.53 46.99 14.61 52.78 19.19 19.98 52.16 20.07 18.13 52.69 coo 41.59 7.83 54.15 41.16 9.87 53.87 17.98 27.94 47.81 19.27 26.33 47.47 coo 42.22 14.55 52.50 43.91 14.87 53.60 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU A 50 GLU~? 11.43 OXT ACT B 801 516 HIS A 10 HIS~? 10.31 CA CA A 202 559 HIS A 51 HIS~? 12.20 CA CA A 202 coo 49.01 14.50 52.53 46.99 14.61 52.78 12.68 24.99 44.98 13.54 23.53 43.68 coo 41.59 7.83 54.15 41.16 9.87 53.87 19.28 27.48 52.70 18.40 25.59 52.72 coo 42.22 14.55 52.50 43.91 14.87 53.60 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU A 50 GLU~? 11.43 OXT ACT B 801 516 HIS A 43 HIS.? 6.83 CA CA A 202 559 HIS A 51 HIS~? 12.20 CA CA A 202 coo 49.01 14.50 52.53 46.99 14.61 52.78 12.68 24.99 44.98 13.54 23.53 43.68 coo 41.59 7.83 54.15 41.16 9.87 53.87 20.15 20.72 47.43 19.82 19.00 48.57 coo 42.22 14.55 52.50 43.91 14.87 53.60 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 7 3 # 7 412 GLU B 11 GLU~? 12.56 CH3 ACT B 802 516 HIS B 43 HIS.? 6.84 CA CA B 201 559 HIS B 10 HIS~? 10.24 CA CA B 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 41.59 7.83 54.15 41.16 9.87 53.87 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 42.22 14.55 52.50 43.91 14.87 53.60 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 8 3 # 8 412 GLU B 11 GLU~? 12.56 CH3 ACT B 802 516 HIS B 51 HIS~? 12.10 CA CA B 201 559 HIS B 10 HIS~? 10.24 CA CA B 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 41.59 7.83 54.15 41.16 9.87 53.87 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 9 3 # 9 412 GLU B 40 GLU.? 3.43 CA CA B 201s 516 HIS B 51 HIS~? 12.10 CA CA B 201 559 HIS B 10 HIS~? 10.24 CA CA B 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 41.59 7.83 54.15 41.16 9.87 53.87 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 10 3 # 10 412 GLU B 40 GLU.? 3.43 CA CA B 201s 516 HIS B 51 HIS~? 12.10 CA CA B 201 559 HIS B 43 HIS.? 6.84 CA CA B 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 41.59 7.83 54.15 41.16 9.87 53.87 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 11 3 # 11 412 GLU B 50 GLU~? 12.54 CA CA B 201 516 HIS B 10 HIS~? 10.24 CA CA B 201 559 HIS B 51 HIS~? 12.10 CA CA B 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 41.59 7.83 54.15 41.16 9.87 53.87 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 42.22 14.55 52.50 43.91 14.87 53.60 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 12 3 # 12 412 GLU B 50 GLU~? 12.54 CA CA B 201 516 HIS B 43 HIS.? 6.84 CA CA B 201 559 HIS B 51 HIS~? 12.10 CA CA B 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 41.59 7.83 54.15 41.16 9.87 53.87 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 42.22 14.55 52.50 43.91 14.87 53.60 -8.32 27.87 76.15 -9.65 26.27 76.41 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 12 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 35 GLU~? 5.06 CA CA A 202 A 47 ASP A 18 ASP~? 11.52 CA CA A 202 A 161 TYR A 34 TYR~? 7.34 CA CA A 202 coo 37.12 18.35 73.76 37.09 16.69 72.44 14.74 18.03 58.46 16.79 18.12 57.91 coo 29.81 8.06 73.13 30.21 10.11 72.95 23.94 22.65 63.18 23.40 21.50 61.45 coo 37.29 15.56 67.90 37.37 13.79 70.08 14.67 22.85 56.72 17.08 23.07 55.48 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 40 GLU.? 3.38 CA CA A 202s A 47 ASP A 18 ASP~? 11.52 CA CA A 202 A 161 TYR A 34 TYR~? 7.34 CA CA A 202 coo 37.12 18.35 73.76 37.09 16.69 72.44 19.19 19.98 52.16 20.07 18.13 52.69 coo 29.81 8.06 73.13 30.21 10.11 72.95 23.94 22.65 63.18 23.40 21.50 61.45 coo 37.29 15.56 67.90 37.37 13.79 70.08 14.67 22.85 56.72 17.08 23.07 55.48 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 35 GLU~? 4.98 CA CA B 201 A 47 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 161 TYR B 34 TYR~? 7.28 CA CA B 201 coo 37.12 18.35 73.76 37.09 16.69 72.44 -5.01 17.82 65.60 -7.08 17.81 66.03 coo 29.81 8.06 73.13 30.21 10.11 72.95 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 37.29 15.56 67.90 37.37 13.79 70.08 -4.97 22.79 67.30 -7.41 23.00 68.45 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU B 40 GLU.? 3.43 CA CA B 201s A 47 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 161 TYR B 34 TYR~? 7.28 CA CA B 201 coo 37.12 18.35 73.76 37.09 16.69 72.44 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 29.81 8.06 73.13 30.21 10.11 72.95 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 37.29 15.56 67.90 37.37 13.79 70.08 -4.97 22.79 67.30 -7.41 23.00 68.45 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 4 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 35 GLU~? 5.06 CA CA A 202 B 47 ASP A 18 ASP~? 11.52 CA CA A 202 B 161 TYR A 34 TYR~? 7.34 CA CA A 202 coo 53.87 35.49 53.22 55.44 35.72 54.61 14.74 18.03 58.46 16.79 18.12 57.91 coo 63.47 43.65 53.95 61.45 43.07 54.06 23.94 22.65 63.18 23.40 21.50 61.45 coo 56.38 35.81 59.19 58.25 35.77 57.10 14.67 22.85 56.72 17.08 23.07 55.48 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 40 GLU.? 3.38 CA CA A 202s B 47 ASP A 18 ASP~? 11.52 CA CA A 202 B 161 TYR A 34 TYR~? 7.34 CA CA A 202 coo 53.87 35.49 53.22 55.44 35.72 54.61 19.19 19.98 52.16 20.07 18.13 52.69 coo 63.47 43.65 53.95 61.45 43.07 54.06 23.94 22.65 63.18 23.40 21.50 61.45 coo 56.38 35.81 59.19 58.25 35.77 57.10 14.67 22.85 56.72 17.08 23.07 55.48 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 35 GLU~? 4.98 CA CA B 201 B 47 ASP B 18 ASP~? 9.64 OXT ACT B 802 B 161 TYR B 34 TYR~? 7.28 CA CA B 201 coo 53.87 35.49 53.22 55.44 35.72 54.61 -5.01 17.82 65.60 -7.08 17.81 66.03 coo 63.47 43.65 53.95 61.45 43.07 54.06 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 56.38 35.81 59.19 58.25 35.77 57.10 -4.97 22.79 67.30 -7.41 23.00 68.45 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU B 40 GLU.? 3.43 CA CA B 201s B 47 ASP B 18 ASP~? 9.64 OXT ACT B 802 B 161 TYR B 34 TYR~? 7.28 CA CA B 201 coo 53.87 35.49 53.22 55.44 35.72 54.61 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 63.47 43.65 53.95 61.45 43.07 54.06 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 56.38 35.81 59.19 58.25 35.77 57.10 -4.97 22.79 67.30 -7.41 23.00 68.45 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 4 hits 1geq_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS B 3 LYS~? 17.03 CA CA B 201 210 ARG A 76 ARG~? 16.28 CA CA B 201 225 ARG A 80 ARG~? 24.83 CA CA B 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.46 22.84 83.40 3.22 20.31 82.22 coo 27.81 15.44 77.10 25.66 16.50 75.19 1.65 24.64 89.61 4.49 24.81 90.71 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS B 52 LYS~? 20.44 CA CA B 201 210 ARG A 80 ARG~? 24.83 CA CA B 201 225 ARG A 76 ARG~? 16.28 CA CA B 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 24.74 11.56 73.05 25.29 14.32 71.80 1.65 24.64 89.61 4.49 24.81 90.71 coo 27.81 15.44 77.10 25.66 16.50 75.19 4.46 22.84 83.40 3.22 20.31 82.22 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 2 hits 1gsa_c00 naa= 3 ULMN 3 1hrk_c00 FERROCHELATASE user 1 3 # 1 A 263 HIS A 51 HIS~? 12.20 CA CA A 202 A 341 HIS A 53 HIS~? 13.16 CA CA A 202 A 343 GLU A 50 GLU~? 11.43 OXT ACT B 801 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 17.98 27.94 47.81 19.27 26.33 47.47 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 9.33 26.57 50.59 7.78 25.45 51.45 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 12.68 24.99 44.98 13.54 23.53 43.68 ULMN 3 1hrk_c00 FERROCHELATASE user 2 3 # 2 A 263 HIS A 53 HIS~? 13.16 CA CA A 202 A 341 HIS A 51 HIS~? 12.20 CA CA A 202 A 343 GLU A 50 GLU~? 11.43 OXT ACT B 801 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 9.33 26.57 50.59 7.78 25.45 51.45 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 17.98 27.94 47.81 19.27 26.33 47.47 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 12.68 24.99 44.98 13.54 23.53 43.68 ULMN 3 1hrk_c00 FERROCHELATASE user 3 3 # 3 A 263 HIS B 53 HIS~? 13.80 CA CA B 201 A 341 HIS B 51 HIS~? 12.10 CA CA B 201 A 343 GLU B 50 GLU~? 12.54 CA CA B 201 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 0.46 27.04 73.26 2.14 26.33 72.22 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -3.14 24.90 79.07 -4.11 23.58 80.41 1hrk_c00 source 1hrk FERROCHELATASE : 3 hits 1hrk_c00 naa= 3 ULMN 3 1hrk_c01 FERROCHELATASE user 1 3 # 1 B 263 HIS A 51 HIS~? 12.20 CA CA A 202 B 341 HIS A 53 HIS~? 13.16 CA CA A 202 B 343 GLU A 50 GLU~? 11.43 OXT ACT B 801 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 17.98 27.94 47.81 19.27 26.33 47.47 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 9.33 26.57 50.59 7.78 25.45 51.45 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 12.68 24.99 44.98 13.54 23.53 43.68 ULMN 3 1hrk_c01 FERROCHELATASE user 2 3 # 2 B 263 HIS A 53 HIS~? 13.16 CA CA A 202 B 341 HIS A 51 HIS~? 12.20 CA CA A 202 B 343 GLU A 50 GLU~? 11.43 OXT ACT B 801 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 9.33 26.57 50.59 7.78 25.45 51.45 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 17.98 27.94 47.81 19.27 26.33 47.47 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 12.68 24.99 44.98 13.54 23.53 43.68 1hrk_c01 source 1hrk FERROCHELATASE : 2 hits 1hrk_c01 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 107 HIS A 10 HIS~? 10.31 CA CA A 202 A 137 SER A 49 SER~? 11.81 OXT ACT B 801 coo 5.11 -0.55 31.43 1.36 1.90 33.24 13.41 31.22 50.01 11.37 34.80 45.78 coo 6.14 -0.73 24.01 6.05 0.83 25.40 19.28 27.48 52.70 18.40 25.59 52.72 coo 1.06 -1.40 35.67 2.72 0.28 35.10 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS B 52 LYS~? 20.44 CA CA B 201 A 107 HIS B 10 HIS~? 10.24 CA CA B 201 A 137 SER B 49 SER~? 17.16 CA CA B 201 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -2.45 30.10 78.86 -0.23 29.26 79.33 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 200 ASP A 4 ASP~? 21.72 CA CA A 202 A 226 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 23.24 46.58 4.39 24.43 46.59 2.66 22.09 39.77 43.94 22.07 41.64 42.98 coo 24.51 43.28 11.18 25.17 44.50 9.58 25.57 34.71 45.51 26.38 33.70 43.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 43 HIS.? 6.83 CA CA A 202 A 200 ASP A 38 ASP~? -3.36 CA CA A 202s A 226 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 23.24 46.58 4.39 24.43 46.59 2.66 20.15 20.72 47.43 19.82 19.00 48.57 coo 24.51 43.28 11.18 25.17 44.50 9.58 14.49 17.18 50.40 16.42 16.29 49.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS A 43 HIS.? 6.83 CA CA A 202 A 200 ASP A 38 ASP~? -3.36 CA CA A 202s A 226 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 23.24 46.58 4.39 24.43 46.59 2.66 20.15 20.72 47.43 19.82 19.00 48.57 coo 24.51 43.28 11.18 25.17 44.50 9.58 14.49 17.18 50.40 16.42 16.29 49.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS B 2 HIS~? 26.00 CH3 ACT B 802 A 200 ASP B 4 ASP~? 21.62 CA CA B 201 A 226 LYS B 52 LYS~? 20.44 CA CA B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS B 43 HIS.? 6.84 CA CA B 201 A 200 ASP B 38 ASP~? -3.30 CA CA B 201s A 226 LYS B 48 LYS~? 22.74 CA CA B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 -6.08 30.98 79.72 -6.69 36.84 80.65 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS B 43 HIS.? 6.84 CA CA B 201 A 200 ASP B 38 ASP~? -3.30 CA CA B 201s A 226 LYS B 52 LYS~? 20.44 CA CA B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1i29_c01 CSDB user 7 3 # 7 A 123 HIS B 45 HIS.? 16.95 CA CA B 201 A 200 ASP A 86 ASP~? 21.59 CA CA B 201 A 226 LYS B 3 LYS~? 17.03 CA CA B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 24.51 43.28 11.18 25.17 44.50 9.58 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 34.47 51.09 7.19 28.58 51.18 7.53 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1i29_c01 CSDB user 8 3 # 8 A 123 HIS B 45 HIS.? 16.95 CA CA B 201 A 200 ASP A 86 ASP~? 21.59 CA CA B 201 A 226 LYS B 48 LYS~? 22.74 CA CA B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 24.51 43.28 11.18 25.17 44.50 9.58 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 34.47 51.09 7.19 28.58 51.18 7.53 -6.08 30.98 79.72 -6.69 36.84 80.65 1i29_c01 source 1i29 CSDB : 8 hits 1i29_c01 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 20.81 34.16 44.49 19.85 28.53 41.75 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.60 31.02 44.27 16.30 36.87 43.73 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.72 24.61 42.81 16.30 19.73 46.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.60 31.02 44.27 16.30 36.87 43.73 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.72 24.61 42.81 16.30 19.73 46.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.60 31.02 44.27 16.30 36.87 43.73 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.72 24.61 42.81 16.30 19.73 46.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.60 31.02 44.27 16.30 36.87 43.73 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.60 31.02 44.27 16.30 36.87 43.73 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 20.81 34.16 44.49 19.85 28.53 41.75 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.60 31.02 44.27 16.30 36.87 43.73 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 20.81 34.16 44.49 19.85 28.53 41.75 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 46 LYS.? 7.73 CA CA A 202 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.60 31.02 44.27 16.30 36.87 43.73 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 17.72 24.61 42.81 16.30 19.73 46.29 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.60 31.02 44.27 16.30 36.87 43.73 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.41 31.22 50.01 11.37 34.80 45.78 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.60 31.02 44.27 16.30 36.87 43.73 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.41 31.22 50.01 11.37 34.80 45.78 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.41 31.22 50.01 11.37 34.80 45.78 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.60 31.02 44.27 16.30 36.87 43.73 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.41 31.22 50.01 11.37 34.80 45.78 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.60 31.02 44.27 16.30 36.87 43.73 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS A 79 LYS~? 16.33 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS B 3 LYS~? 17.03 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS B 46 LYS.? 7.77 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS B 46 LYS.? 7.77 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS A 79 LYS~? 16.33 CA CA B 201 A 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 3 LYS~? 17.03 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 3 LYS~? 17.03 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 46 LYS.? 7.77 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 A 14 LYS B 52 LYS~? 20.44 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -16.70 27.94 69.16 -17.07 25.96 69.86 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 23 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 20.81 34.16 44.49 19.85 28.53 41.75 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.60 31.02 44.27 16.30 36.87 43.73 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 17.72 24.61 42.81 16.30 19.73 46.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.60 31.02 44.27 16.30 36.87 43.73 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 17.72 24.61 42.81 16.30 19.73 46.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.60 31.02 44.27 16.30 36.87 43.73 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.60 31.02 44.27 16.30 36.87 43.73 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 20.81 34.16 44.49 19.85 28.53 41.75 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 46 LYS.? 7.73 CA CA A 202 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.60 31.02 44.27 16.30 36.87 43.73 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 17.72 24.61 42.81 16.30 19.73 46.29 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.60 31.02 44.27 16.30 36.87 43.73 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.41 31.22 50.01 11.37 34.80 45.78 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.41 31.22 50.01 11.37 34.80 45.78 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.60 31.02 44.27 16.30 36.87 43.73 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS A 79 LYS~? 16.33 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS A 79 LYS~? 16.33 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS B 3 LYS~? 17.03 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS B 46 LYS.? 7.77 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU A 70 GLU~? 24.16 CA CA B 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 7.07 31.83 76.89 8.40 32.80 78.24 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS B 46 LYS.? 7.77 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS A 79 LYS~? 16.33 CA CA B 201 B 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS A 79 LYS~? 16.33 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 3 LYS~? 17.03 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 3 LYS~? 17.03 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 46 LYS.? 7.77 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 52 LYS~? 20.44 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 B 14 LYS B 52 LYS~? 20.44 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -16.70 27.94 69.16 -17.07 25.96 69.86 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 19 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 72 SER~? 18.54 CA CA B 201 A 173 ARG A 80 ARG~? 24.83 CA CA B 201 A 211 ASP A 69 ASP~? 23.19 CA CA B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 5.94 24.99 78.50 7.74 23.37 78.35 coo 18.77 77.82 11.69 20.55 80.22 10.73 1.65 24.64 89.61 4.49 24.81 90.71 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER A 73 SER~? 22.81 CA CA B 201 A 173 ARG A 80 ARG~? 24.83 CA CA B 201 A 211 ASP A 69 ASP~? 23.19 CA CA B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 7.90 26.85 81.17 9.44 28.34 79.99 coo 18.77 77.82 11.69 20.55 80.22 10.73 1.65 24.64 89.61 4.49 24.81 90.71 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 11.02 26.78 74.77 12.23 26.87 76.45 1ig8_c00 source 1ig8 HEXOKINASE PII : 2 hits 1ig8_c00 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS B 53 HIS~? 13.80 CA CA B 201 A 167 SER A 67 SER~? 18.51 CA CA B 201 A 201 ASN B 60 ASN~? 18.39 CA CA B 201 coo 12.95 4.49 19.05 14.87 4.39 19.77 0.46 27.04 73.26 2.14 26.33 72.22 coo 10.44 7.96 22.51 12.16 7.57 20.82 7.12 29.60 71.54 4.89 29.99 70.85 coo 19.43 6.74 22.83 19.09 5.15 21.60 1.10 29.32 63.94 3.07 29.39 63.42 1iph_c00 source 1iph CATALASE HPII : 1 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS B 53 HIS~? 13.80 CA CA B 201 B 167 SER A 67 SER~? 18.51 CA CA B 201 B 201 ASN B 60 ASN~? 18.39 CA CA B 201 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 0.46 27.04 73.26 2.14 26.33 72.22 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 7.12 29.60 71.54 4.89 29.99 70.85 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 1.10 29.32 63.94 3.07 29.39 63.42 1iph_c01 source 1iph CATALASE HPII : 1 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS B 53 HIS~? 13.80 CA CA B 201 C 167 SER A 67 SER~? 18.51 CA CA B 201 C 201 ASN B 60 ASN~? 18.39 CA CA B 201 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 0.46 27.04 73.26 2.14 26.33 72.22 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 7.12 29.60 71.54 4.89 29.99 70.85 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 1.10 29.32 63.94 3.07 29.39 63.42 1iph_c02 source 1iph CATALASE HPII : 1 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS B 53 HIS~? 13.80 CA CA B 201 D 167 SER A 67 SER~? 18.51 CA CA B 201 D 201 ASN B 60 ASN~? 18.39 CA CA B 201 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 0.46 27.04 73.26 2.14 26.33 72.22 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 7.12 29.60 71.54 4.89 29.99 70.85 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 1.10 29.32 63.94 3.07 29.39 63.42 1iph_c03 source 1iph CATALASE HPII : 1 hits 1iph_c03 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 11 GLU~? 14.95 CA CA A 202 A 61 GLU A 5 GLU~? 25.21 CA CA A 202 A 162 HIS A 10 HIS~? 10.31 CA CA A 202 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 26.25 27.59 54.14 27.19 27.48 52.23 coo -4.89 20.85 5.22 -3.95 21.69 6.91 23.31 38.61 48.39 22.38 40.48 47.97 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 40 GLU.? 3.38 CA CA A 202s A 61 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 162 HIS A 10 HIS~? 10.31 CA CA A 202 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 19.19 19.98 52.16 20.07 18.13 52.69 coo -4.89 20.85 5.22 -3.95 21.69 6.91 12.68 24.99 44.98 13.54 23.53 43.68 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 61 GLU A 36 GLU~? 11.24 CA CA A 202 A 162 HIS A 53 HIS~? 13.16 CA CA A 202 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 12.68 24.99 44.98 13.54 23.53 43.68 coo -4.89 20.85 5.22 -3.95 21.69 6.91 8.53 16.97 55.87 6.50 17.32 56.35 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 61 GLU A 40 GLU.? 3.38 CA CA A 202s A 162 HIS A 53 HIS~? 13.16 CA CA A 202 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 12.68 24.99 44.98 13.54 23.53 43.68 coo -4.89 20.85 5.22 -3.95 21.69 6.91 19.19 19.98 52.16 20.07 18.13 52.69 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 5 3 # 5 A 14 GLU A 68 GLU~? 14.30 CA CA B 201 A 61 GLU B 35 GLU~? 4.98 CA CA B 201 A 162 HIS B 53 HIS~? 13.80 CA CA B 201 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 6.28 24.34 70.76 4.27 24.24 71.35 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -5.01 17.82 65.60 -7.08 17.81 66.03 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 6 3 # 6 A 14 GLU B 11 GLU~? 12.56 CH3 ACT B 802 A 61 GLU B 5 GLU~? 21.97 CH3 ACT B 802 A 162 HIS B 10 HIS~? 10.24 CA CA B 201 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -16.70 27.94 69.16 -17.07 25.96 69.86 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -13.74 38.60 75.53 -12.83 40.48 75.93 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 7 3 # 7 A 14 GLU B 40 GLU.? 3.43 CA CA B 201s A 61 GLU B 50 GLU~? 12.54 CA CA B 201 A 162 HIS B 10 HIS~? 10.24 CA CA B 201 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -9.63 20.01 71.75 -10.53 18.20 71.23 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 8 3 # 8 A 14 GLU B 50 GLU~? 12.54 CA CA B 201 A 61 GLU B 36 GLU~? 11.20 CA CA B 201 A 162 HIS B 53 HIS~? 13.80 CA CA B 201 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -4.89 20.85 5.22 -3.95 21.69 6.91 1.18 16.63 68.50 3.14 16.97 67.89 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 9 3 # 9 A 14 GLU B 50 GLU~? 12.54 CA CA B 201 A 61 GLU B 40 GLU.? 3.43 CA CA B 201s A 162 HIS B 53 HIS~? 13.80 CA CA B 201 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -3.14 24.90 79.07 -4.11 23.58 80.41 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -9.63 20.01 71.75 -10.53 18.20 71.23 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 10 3 # 10 A 14 GLU B 68 GLU~? 14.14 CA CA A 202 A 61 GLU A 35 GLU~? 5.06 CA CA A 202 A 162 HIS A 53 HIS~? 13.16 CA CA A 202 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 3.52 24.40 53.24 5.54 24.28 52.66 coo -4.89 20.85 5.22 -3.95 21.69 6.91 14.74 18.03 58.46 16.79 18.12 57.91 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 9.33 26.57 50.59 7.78 25.45 51.45 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 10 hits 1j53_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 83 GLU~? 18.60 CA CA B 201 A 56 LYS B 48 LYS~? 22.74 CA CA B 201 A 258 ARG A 76 ARG~? 16.28 CA CA B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.46 22.84 83.40 3.22 20.31 82.22 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 50 GLU~? 12.54 CA CA B 201 A 56 LYS B 48 LYS~? 22.74 CA CA B 201 A 258 ARG A 76 ARG~? 16.28 CA CA B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.46 22.84 83.40 3.22 20.31 82.22 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 50 GLU~? 12.54 CA CA B 201 A 56 LYS B 48 LYS~? 22.74 CA CA B 201 A 258 ARG A 80 ARG~? 24.83 CA CA B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 1.65 24.64 89.61 4.49 24.81 90.71 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 50 GLU~? 12.54 CA CA B 201 A 56 LYS B 52 LYS~? 20.44 CA CA B 201 A 258 ARG A 76 ARG~? 16.28 CA CA B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.46 22.84 83.40 3.22 20.31 82.22 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 83 GLU~? 18.60 CA CA B 201 B 56 LYS B 48 LYS~? 22.74 CA CA B 201 B 258 ARG A 76 ARG~? 16.28 CA CA B 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 4.46 22.84 83.40 3.22 20.31 82.22 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 50 GLU~? 12.54 CA CA B 201 B 56 LYS B 48 LYS~? 22.74 CA CA B 201 B 258 ARG A 80 ARG~? 24.83 CA CA B 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 1.65 24.64 89.61 4.49 24.81 90.71 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 83 GLU~? 18.60 CA CA B 201 C 56 LYS B 48 LYS~? 22.74 CA CA B 201 C 258 ARG A 76 ARG~? 16.28 CA CA B 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 4.46 22.84 83.40 3.22 20.31 82.22 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 50 GLU~? 12.54 CA CA B 201 C 56 LYS B 48 LYS~? 22.74 CA CA B 201 C 258 ARG A 80 ARG~? 24.83 CA CA B 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 1.65 24.64 89.61 4.49 24.81 90.71 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 83 GLU~? 18.60 CA CA B 201 D 56 LYS B 48 LYS~? 22.74 CA CA B 201 D 258 ARG A 76 ARG~? 16.28 CA CA B 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 4.46 22.84 83.40 3.22 20.31 82.22 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 50 GLU~? 12.54 CA CA B 201 D 56 LYS B 48 LYS~? 22.74 CA CA B 201 D 258 ARG A 80 ARG~? 24.83 CA CA B 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 1.65 24.64 89.61 4.49 24.81 90.71 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 24.97 5.82 58.78 26.79 1.97 55.46 20.81 34.16 44.49 19.85 28.53 41.75 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 17.72 24.61 42.81 16.30 19.73 46.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 17.72 24.61 42.81 16.30 19.73 46.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo 24.97 5.82 58.78 26.79 1.97 55.46 17.72 24.61 42.81 16.30 19.73 46.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.46 3.44 61.93 23.95 1.12 60.13 20.81 34.16 44.49 19.85 28.53 41.75 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 24.97 5.82 58.78 26.79 1.97 55.46 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.46 3.44 61.93 23.95 1.12 60.13 20.81 34.16 44.49 19.85 28.53 41.75 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 46 LYS.? 7.73 CA CA A 202 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.46 3.44 61.93 23.95 1.12 60.13 17.72 24.61 42.81 16.30 19.73 46.29 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.41 31.22 50.01 11.37 34.80 45.78 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 24.97 5.82 58.78 26.79 1.97 55.46 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.41 31.22 50.01 11.37 34.80 45.78 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 13.41 31.22 50.01 11.37 34.80 45.78 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS A 79 LYS~? 16.33 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS A 79 LYS~? 16.33 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 24.97 5.82 58.78 26.79 1.97 55.46 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 3 LYS~? 17.03 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 24.97 5.82 58.78 26.79 1.97 55.46 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS B 46 LYS.? 7.77 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU A 70 GLU~? 24.16 CA CA B 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 7.07 31.83 76.89 8.40 32.80 78.24 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS B 46 LYS.? 7.77 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 24.97 5.82 58.78 26.79 1.97 55.46 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS B 46 LYS.? 7.77 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 24.97 5.82 58.78 26.79 1.97 55.46 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS A 79 LYS~? 16.33 CA CA B 201 A 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 3 LYS~? 17.03 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 3 LYS~? 17.03 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 46 LYS.? 7.77 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS B 52 LYS~? 20.44 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 24.97 5.82 58.78 26.79 1.97 55.46 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -16.70 27.94 69.16 -17.07 25.96 69.86 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 23 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 4.84 5.09 23.75 3.30 1.39 27.48 20.81 34.16 44.49 19.85 28.53 41.75 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 17.72 24.61 42.81 16.30 19.73 46.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 17.72 24.61 42.81 16.30 19.73 46.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo 4.84 5.09 23.75 3.30 1.39 27.48 17.72 24.61 42.81 16.30 19.73 46.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.43 2.88 20.75 5.72 0.41 23.95 20.81 34.16 44.49 19.85 28.53 41.75 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 4.84 5.09 23.75 3.30 1.39 27.48 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.43 2.88 20.75 5.72 0.41 23.95 20.81 34.16 44.49 19.85 28.53 41.75 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 46 LYS.? 7.73 CA CA A 202 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.43 2.88 20.75 5.72 0.41 23.95 17.72 24.61 42.81 16.30 19.73 46.29 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.41 31.22 50.01 11.37 34.80 45.78 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 4.84 5.09 23.75 3.30 1.39 27.48 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.41 31.22 50.01 11.37 34.80 45.78 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 13.41 31.22 50.01 11.37 34.80 45.78 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.60 31.02 44.27 16.30 36.87 43.73 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS A 79 LYS~? 16.33 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS A 79 LYS~? 16.33 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 4.84 5.09 23.75 3.30 1.39 27.48 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 3 LYS~? 17.03 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 4.84 5.09 23.75 3.30 1.39 27.48 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS B 46 LYS.? 7.77 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 4.84 5.09 23.75 3.30 1.39 27.48 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS B 46 LYS.? 7.77 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 4.84 5.09 23.75 3.30 1.39 27.48 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS A 79 LYS~? 16.33 CA CA B 201 B 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 3 LYS~? 17.03 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 3 LYS~? 17.03 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 46 LYS.? 7.77 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 52 LYS~? 20.44 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 52 LYS~? 20.44 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS B 52 LYS~? 20.44 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 4.84 5.09 23.75 3.30 1.39 27.48 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -16.70 27.94 69.16 -17.07 25.96 69.86 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 22 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 C 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 17.59 37.25 25.80 19.64 34.15 21.60 20.81 34.16 44.49 19.85 28.53 41.75 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 46 LYS.? 7.73 CA CA A 202 C 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 17.72 24.61 42.81 16.30 19.73 46.29 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.06 27.10 15.56 13.23 27.02 13.80 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 46 LYS.? 7.73 CA CA A 202 C 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 17.72 24.61 42.81 16.30 19.73 46.29 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.06 27.10 15.56 13.23 27.02 13.80 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS A 46 LYS.? 7.73 CA CA A 202 C 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo 17.59 37.25 25.80 19.64 34.15 21.60 17.72 24.61 42.81 16.30 19.73 46.29 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.06 27.10 15.56 13.23 27.02 13.80 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 C 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.29 34.52 28.11 16.84 32.47 25.43 20.81 34.16 44.49 19.85 28.53 41.75 coo 12.06 27.10 15.56 13.23 27.02 13.80 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 C 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 17.59 37.25 25.80 19.64 34.15 21.60 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.29 34.52 28.11 16.84 32.47 25.43 20.81 34.16 44.49 19.85 28.53 41.75 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 74 LYS A 46 LYS.? 7.73 CA CA A 202 C 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.29 34.52 28.11 16.84 32.47 25.43 17.72 24.61 42.81 16.30 19.73 46.29 coo 12.06 27.10 15.56 13.23 27.02 13.80 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 C 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.41 31.22 50.01 11.37 34.80 45.78 coo 12.06 27.10 15.56 13.23 27.02 13.80 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 C 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 17.59 37.25 25.80 19.64 34.15 21.60 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.41 31.22 50.01 11.37 34.80 45.78 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 C 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 13.41 31.22 50.01 11.37 34.80 45.78 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 12.06 27.10 15.56 13.23 27.02 13.80 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS A 79 LYS~? 16.33 CA CA B 201 C 74 LYS B 48 LYS~? 22.74 CA CA B 201 C 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 17.59 37.25 25.80 19.64 34.15 21.60 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 12.29 34.52 28.11 16.84 32.47 25.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS B 3 LYS~? 17.03 CA CA B 201 C 74 LYS B 48 LYS~? 22.74 CA CA B 201 C 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 17.59 37.25 25.80 19.64 34.15 21.60 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 12.29 34.52 28.11 16.84 32.47 25.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS B 46 LYS.? 7.77 CA CA B 201 C 74 LYS B 48 LYS~? 22.74 CA CA B 201 C 165 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 17.59 37.25 25.80 19.64 34.15 21.60 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 12.29 34.52 28.11 16.84 32.47 25.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS B 46 LYS.? 7.77 CA CA B 201 C 74 LYS B 48 LYS~? 22.74 CA CA B 201 C 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 17.59 37.25 25.80 19.64 34.15 21.60 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 12.29 34.52 28.11 16.84 32.47 25.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS B 48 LYS~? 22.74 CA CA B 201 C 74 LYS A 79 LYS~? 16.33 CA CA B 201 C 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 12.06 27.10 15.56 13.23 27.02 13.80 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 C 14 LYS B 48 LYS~? 22.74 CA CA B 201 C 74 LYS B 3 LYS~? 17.03 CA CA B 201 C 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 12.06 27.10 15.56 13.23 27.02 13.80 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 C 14 LYS B 48 LYS~? 22.74 CA CA B 201 C 74 LYS B 3 LYS~? 17.03 CA CA B 201 C 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 12.06 27.10 15.56 13.23 27.02 13.80 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 C 14 LYS B 48 LYS~? 22.74 CA CA B 201 C 74 LYS B 46 LYS.? 7.77 CA CA B 201 C 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 12.06 27.10 15.56 13.23 27.02 13.80 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 C 14 LYS B 48 LYS~? 22.74 CA CA B 201 C 74 LYS B 52 LYS~? 20.44 CA CA B 201 C 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 12.06 27.10 15.56 13.23 27.02 13.80 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 C 14 LYS B 48 LYS~? 22.74 CA CA B 201 C 74 LYS B 52 LYS~? 20.44 CA CA B 201 C 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 12.06 27.10 15.56 13.23 27.02 13.80 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 C 14 LYS B 48 LYS~? 22.74 CA CA B 201 C 74 LYS B 52 LYS~? 20.44 CA CA B 201 C 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 12.06 27.10 15.56 13.23 27.02 13.80 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 C 14 LYS B 52 LYS~? 20.44 CA CA B 201 C 74 LYS B 48 LYS~? 22.74 CA CA B 201 C 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 17.59 37.25 25.80 19.64 34.15 21.60 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 12.29 34.52 28.11 16.84 32.47 25.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 -16.70 27.94 69.16 -17.07 25.96 69.86 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 22 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 D 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 20.81 34.16 44.49 19.85 28.53 41.75 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 46 LYS.? 7.73 CA CA A 202 D 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.72 24.61 42.81 16.30 19.73 46.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 46 LYS.? 7.73 CA CA A 202 D 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.72 24.61 42.81 16.30 19.73 46.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 46 LYS.? 7.73 CA CA A 202 D 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.72 24.61 42.81 16.30 19.73 46.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 D 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 20.81 34.16 44.49 19.85 28.53 41.75 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 D 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 20.81 34.16 44.49 19.85 28.53 41.75 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 74 LYS A 46 LYS.? 7.73 CA CA A 202 D 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 17.72 24.61 42.81 16.30 19.73 46.29 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 D 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.41 31.22 50.01 11.37 34.80 45.78 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 D 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.41 31.22 50.01 11.37 34.80 45.78 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 D 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.41 31.22 50.01 11.37 34.80 45.78 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.60 31.02 44.27 16.30 36.87 43.73 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS A 79 LYS~? 16.33 CA CA B 201 D 74 LYS B 48 LYS~? 22.74 CA CA B 201 D 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS A 79 LYS~? 16.33 CA CA B 201 D 74 LYS B 48 LYS~? 22.74 CA CA B 201 D 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS B 3 LYS~? 17.03 CA CA B 201 D 74 LYS B 48 LYS~? 22.74 CA CA B 201 D 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS B 46 LYS.? 7.77 CA CA B 201 D 74 LYS B 48 LYS~? 22.74 CA CA B 201 D 165 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS B 46 LYS.? 7.77 CA CA B 201 D 74 LYS B 48 LYS~? 22.74 CA CA B 201 D 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS B 48 LYS~? 22.74 CA CA B 201 D 74 LYS A 79 LYS~? 16.33 CA CA B 201 D 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS B 48 LYS~? 22.74 CA CA B 201 D 74 LYS B 3 LYS~? 17.03 CA CA B 201 D 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 D 14 LYS B 48 LYS~? 22.74 CA CA B 201 D 74 LYS B 3 LYS~? 17.03 CA CA B 201 D 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 D 14 LYS B 48 LYS~? 22.74 CA CA B 201 D 74 LYS B 46 LYS.? 7.77 CA CA B 201 D 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 D 14 LYS B 48 LYS~? 22.74 CA CA B 201 D 74 LYS B 52 LYS~? 20.44 CA CA B 201 D 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 D 14 LYS B 48 LYS~? 22.74 CA CA B 201 D 74 LYS B 52 LYS~? 20.44 CA CA B 201 D 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 D 14 LYS B 48 LYS~? 22.74 CA CA B 201 D 74 LYS B 52 LYS~? 20.44 CA CA B 201 D 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 D 14 LYS B 52 LYS~? 20.44 CA CA B 201 D 74 LYS B 48 LYS~? 22.74 CA CA B 201 D 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -16.70 27.94 69.16 -17.07 25.96 69.86 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 23 hits 1kqc_c03 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 10 HIS~? 10.31 CA CA A 202 A 45 HIS A 51 HIS~? 12.20 CA CA A 202 A 261 PHE A 56 PHE~? 17.60 CA CA A 202 coo 49.89 1.93 30.83 50.54 1.43 32.81 19.28 27.48 52.70 18.40 25.59 52.72 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 17.98 27.94 47.81 19.27 26.33 47.47 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.62 30.56 55.11 6.08 30.87 56.13 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 10 HIS~? 10.31 CA CA A 202 A 45 HIS A 51 HIS~? 12.20 CA CA A 202 A 261 PHE B 71 PHE~? 16.66 CH3 ACT B 801 coo 49.89 1.93 30.83 50.54 1.43 32.81 19.28 27.48 52.70 18.40 25.59 52.72 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 17.98 27.94 47.81 19.27 26.33 47.47 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 7.21 29.24 49.58 8.41 31.42 50.73 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS A 51 HIS~? 12.20 CA CA A 202 A 45 HIS A 10 HIS~? 10.31 CA CA A 202 A 261 PHE A 56 PHE~? 17.60 CA CA A 202 coo 49.89 1.93 30.83 50.54 1.43 32.81 17.98 27.94 47.81 19.27 26.33 47.47 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 19.28 27.48 52.70 18.40 25.59 52.72 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.62 30.56 55.11 6.08 30.87 56.13 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS B 10 HIS~? 10.24 CA CA B 201 A 45 HIS B 51 HIS~? 12.10 CA CA B 201 A 261 PHE A 71 PHE~? 16.87 CA CA B 201 coo 49.89 1.93 30.83 50.54 1.43 32.81 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 2.73 28.74 74.75 1.20 30.86 73.64 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS B 10 HIS~? 10.24 CA CA B 201 A 45 HIS B 51 HIS~? 12.10 CA CA B 201 A 261 PHE B 56 PHE~? 17.42 CA CA B 201 coo 49.89 1.93 30.83 50.54 1.43 32.81 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS B 51 HIS~? 12.10 CA CA B 201 A 45 HIS B 10 HIS~? 10.24 CA CA B 201 A 261 PHE B 56 PHE~? 17.42 CA CA B 201 coo 49.89 1.93 30.83 50.54 1.43 32.81 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 1.08 30.45 68.86 3.64 30.39 67.74 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 6 hits 1luc_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 202 SER A 47 SER~? 10.78 OXT ACT B 801 A 226 SER A 49 SER~? 11.81 OXT ACT B 801 coo 1.62 6.10 69.30 3.81 1.25 65.91 20.81 34.16 44.49 19.85 28.53 41.75 coo 4.43 1.89 61.79 4.31 0.09 63.40 15.53 27.71 42.41 13.14 27.33 42.95 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 79 LYS~? 16.33 CA CA B 201 A 202 SER A 72 SER~? 18.54 CA CA B 201 A 226 SER A 73 SER~? 22.81 CA CA B 201 coo 1.62 6.10 69.30 3.81 1.25 65.91 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 4.43 1.89 61.79 4.31 0.09 63.40 5.94 24.99 78.50 7.74 23.37 78.35 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS A 79 LYS~? 16.33 CA CA B 201 A 202 SER A 73 SER~? 22.81 CA CA B 201 A 226 SER A 72 SER~? 18.54 CA CA B 201 coo 1.62 6.10 69.30 3.81 1.25 65.91 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 4.43 1.89 61.79 4.31 0.09 63.40 7.90 26.85 81.17 9.44 28.34 79.99 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS B 3 LYS~? 17.03 CA CA B 201 A 202 SER B 47 SER~? 15.49 CA CA B 201 A 226 SER B 49 SER~? 17.16 CA CA B 201 coo 1.62 6.10 69.30 3.81 1.25 65.91 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 4.43 1.89 61.79 4.31 0.09 63.40 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS B 46 LYS.? 7.77 CA CA B 201 A 202 SER B 49 SER~? 17.16 CA CA B 201 A 226 SER A 78 SER~? 22.09 CA CA B 201 coo 1.62 6.10 69.30 3.81 1.25 65.91 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 4.43 1.89 61.79 4.31 0.09 63.40 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 0.59 30.86 84.57 0.46 32.77 83.16 1m21_c00 source 1m21 PEPTIDE AMIDASE : 5 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 202 SER A 47 SER~? 10.78 OXT ACT B 801 B 226 SER A 49 SER~? 11.81 OXT ACT B 801 coo 35.67 -0.01 18.11 33.47 4.84 14.73 20.81 34.16 44.49 19.85 28.53 41.75 coo 32.81 4.27 10.70 32.87 6.07 12.31 15.53 27.71 42.41 13.14 27.33 42.95 coo 28.77 6.36 12.44 30.83 7.25 11.75 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 79 LYS~? 16.33 CA CA B 201 B 202 SER A 72 SER~? 18.54 CA CA B 201 B 226 SER A 73 SER~? 22.81 CA CA B 201 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 32.81 4.27 10.70 32.87 6.07 12.31 5.94 24.99 78.50 7.74 23.37 78.35 coo 28.77 6.36 12.44 30.83 7.25 11.75 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS A 79 LYS~? 16.33 CA CA B 201 B 202 SER A 73 SER~? 22.81 CA CA B 201 B 226 SER A 72 SER~? 18.54 CA CA B 201 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 32.81 4.27 10.70 32.87 6.07 12.31 7.90 26.85 81.17 9.44 28.34 79.99 coo 28.77 6.36 12.44 30.83 7.25 11.75 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS B 3 LYS~? 17.03 CA CA B 201 B 202 SER B 47 SER~? 15.49 CA CA B 201 B 226 SER B 49 SER~? 17.16 CA CA B 201 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 32.81 4.27 10.70 32.87 6.07 12.31 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 28.77 6.36 12.44 30.83 7.25 11.75 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS B 46 LYS.? 7.77 CA CA B 201 B 202 SER B 49 SER~? 17.16 CA CA B 201 B 226 SER A 78 SER~? 22.09 CA CA B 201 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 32.81 4.27 10.70 32.87 6.07 12.31 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 28.77 6.36 12.44 30.83 7.25 11.75 0.59 30.86 84.57 0.46 32.77 83.16 1m21_c01 source 1m21 PEPTIDE AMIDASE : 5 hits 1m21_c01 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 27 ASP.? 17.47 CA CA A 202 A 279 GLU B 35 GLU~? 4.98 CA CA B 201 A 369 ASP A 24 ASP.? 26.42 CA CA A 202 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.73 20.36 70.40 10.57 19.24 69.08 coo 16.54 46.37 63.94 14.77 45.79 62.95 -5.01 17.82 65.60 -7.08 17.81 66.03 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 27 ASP.? 17.47 CA CA A 202 A 279 GLU B 68 GLU~? 14.14 CA CA A 202 A 369 ASP A 24 ASP.? 26.42 CA CA A 202 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.73 20.36 70.40 10.57 19.24 69.08 coo 16.54 46.37 63.94 14.77 45.79 62.95 3.52 24.40 53.24 5.54 24.28 52.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 69 ASP~? 23.19 CA CA B 201 A 279 GLU A 82 GLU~? 19.14 CA CA B 201 A 369 ASP A 24 ASP.? 26.42 CA CA A 202 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.02 26.78 74.77 12.23 26.87 76.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 69 ASP~? 23.19 CA CA B 201 A 279 GLU A 83 GLU~? 18.60 CA CA B 201 A 369 ASP A 24 ASP.? 26.42 CA CA A 202 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.02 26.78 74.77 12.23 26.87 76.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 69 ASP~? 23.19 CA CA B 201 A 279 GLU B 35 GLU~? 4.98 CA CA B 201 A 369 ASP A 24 ASP.? 26.42 CA CA A 202 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.02 26.78 74.77 12.23 26.87 76.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -5.01 17.82 65.60 -7.08 17.81 66.03 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 27 ASP.? 17.39 CA CA B 201 A 279 GLU A 35 GLU~? 5.06 CA CA A 202 A 369 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 14.74 18.03 58.46 16.79 18.12 57.91 coo 12.19 31.08 87.29 11.13 32.66 86.38 -10.90 21.62 46.30 -10.75 20.16 44.81 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 27 ASP.? 17.39 CA CA B 201 A 279 GLU A 68 GLU~? 14.30 CA CA B 201 A 369 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 6.28 24.34 70.76 4.27 24.24 71.35 coo 12.19 31.08 87.29 11.13 32.66 86.38 -10.90 21.62 46.30 -10.75 20.16 44.81 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 279 GLU A 35 GLU~? 5.06 CA CA A 202 A 369 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 11.74 38.14 80.19 10.63 36.40 80.65 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 16.54 46.37 63.94 14.77 45.79 62.95 14.74 18.03 58.46 16.79 18.12 57.91 coo 12.19 31.08 87.29 11.13 32.66 86.38 -10.90 21.62 46.30 -10.75 20.16 44.81 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c06 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 69 ASP~? 23.19 CA CA B 201 35 SER A 67 SER~? 18.51 CA CA B 201 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo 20.97 14.47 32.28 19.66 15.96 31.62 11.02 26.78 74.77 12.23 26.87 76.45 coo 16.04 14.72 33.82 17.27 13.71 31.95 7.12 29.60 71.54 4.89 29.99 70.85 coo 20.65 22.00 33.80 20.06 20.56 32.39 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 35 SER B 67 SER~? 20.12 CA CA A 202 215 ASP B 27 ASP.? 17.39 CA CA B 201 coo 20.97 14.47 32.28 19.66 15.96 31.62 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 16.04 14.72 33.82 17.27 13.71 31.95 2.68 29.83 52.62 3.84 31.35 54.03 coo 20.65 22.00 33.80 20.06 20.56 32.39 -1.83 20.43 53.73 -0.68 19.31 55.10 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 2 hits 1mpp_c04 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 217 SER A 47 SER~? 10.78 OXT ACT B 801 A 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 20.81 34.16 44.49 19.85 28.53 41.75 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 15.53 27.71 42.41 13.14 27.33 42.95 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 79 LYS~? 16.33 CA CA B 201 A 217 SER A 72 SER~? 18.54 CA CA B 201 A 241 SER A 73 SER~? 22.81 CA CA B 201 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 5.94 24.99 78.50 7.74 23.37 78.35 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS A 79 LYS~? 16.33 CA CA B 201 A 217 SER A 73 SER~? 22.81 CA CA B 201 A 241 SER A 72 SER~? 18.54 CA CA B 201 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 7.90 26.85 81.17 9.44 28.34 79.99 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 A 142 LYS B 3 LYS~? 17.03 CA CA B 201 A 217 SER B 47 SER~? 15.49 CA CA B 201 A 241 SER B 49 SER~? 17.16 CA CA B 201 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 A 142 LYS B 46 LYS.? 7.77 CA CA B 201 A 217 SER B 49 SER~? 17.16 CA CA B 201 A 241 SER A 78 SER~? 22.09 CA CA B 201 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 217 SER A 47 SER~? 10.78 OXT ACT B 801 B 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 20.81 34.16 44.49 19.85 28.53 41.75 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 15.53 27.71 42.41 13.14 27.33 42.95 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 79 LYS~? 16.33 CA CA B 201 B 217 SER A 72 SER~? 18.54 CA CA B 201 B 241 SER A 73 SER~? 22.81 CA CA B 201 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 5.94 24.99 78.50 7.74 23.37 78.35 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS A 79 LYS~? 16.33 CA CA B 201 B 217 SER A 73 SER~? 22.81 CA CA B 201 B 241 SER A 72 SER~? 18.54 CA CA B 201 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 7.90 26.85 81.17 9.44 28.34 79.99 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS B 3 LYS~? 17.03 CA CA B 201 B 217 SER B 47 SER~? 15.49 CA CA B 201 B 241 SER B 49 SER~? 17.16 CA CA B 201 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 B 142 LYS B 46 LYS.? 7.77 CA CA B 201 B 217 SER B 49 SER~? 17.16 CA CA B 201 B 241 SER A 78 SER~? 22.09 CA CA B 201 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -2.45 30.10 78.86 -0.23 29.26 79.33 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 C 217 SER A 47 SER~? 10.78 OXT ACT B 801 C 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo -12.07 2.83 63.52 -8.95 7.56 61.01 20.81 34.16 44.49 19.85 28.53 41.75 coo -11.64 10.12 58.62 -9.34 9.31 58.79 15.53 27.71 42.41 13.14 27.33 42.95 coo -9.31 12.91 61.58 -8.56 11.90 59.50 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 79 LYS~? 16.33 CA CA B 201 C 217 SER A 72 SER~? 18.54 CA CA B 201 C 241 SER A 73 SER~? 22.81 CA CA B 201 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -11.64 10.12 58.62 -9.34 9.31 58.79 5.94 24.99 78.50 7.74 23.37 78.35 coo -9.31 12.91 61.58 -8.56 11.90 59.50 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS A 79 LYS~? 16.33 CA CA B 201 C 217 SER A 73 SER~? 22.81 CA CA B 201 C 241 SER A 72 SER~? 18.54 CA CA B 201 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -11.64 10.12 58.62 -9.34 9.31 58.79 7.90 26.85 81.17 9.44 28.34 79.99 coo -9.31 12.91 61.58 -8.56 11.90 59.50 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 C 142 LYS B 3 LYS~? 17.03 CA CA B 201 C 217 SER B 47 SER~? 15.49 CA CA B 201 C 241 SER B 49 SER~? 17.16 CA CA B 201 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 C 142 LYS B 46 LYS.? 7.77 CA CA B 201 C 217 SER B 49 SER~? 17.16 CA CA B 201 C 241 SER A 78 SER~? 22.09 CA CA B 201 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -2.45 30.10 78.86 -0.23 29.26 79.33 coo -9.31 12.91 61.58 -8.56 11.90 59.50 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 D 217 SER A 47 SER~? 10.78 OXT ACT B 801 D 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 32.93 17.78 71.88 30.89 13.50 67.83 20.81 34.16 44.49 19.85 28.53 41.75 coo 34.38 11.17 66.10 32.18 12.14 65.65 15.53 27.71 42.41 13.14 27.33 42.95 coo 31.34 7.96 67.74 31.44 9.08 65.62 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 79 LYS~? 16.33 CA CA B 201 D 217 SER A 72 SER~? 18.54 CA CA B 201 D 241 SER A 73 SER~? 22.81 CA CA B 201 coo 32.93 17.78 71.88 30.89 13.50 67.83 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 34.38 11.17 66.10 32.18 12.14 65.65 5.94 24.99 78.50 7.74 23.37 78.35 coo 31.34 7.96 67.74 31.44 9.08 65.62 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS A 79 LYS~? 16.33 CA CA B 201 D 217 SER A 73 SER~? 22.81 CA CA B 201 D 241 SER A 72 SER~? 18.54 CA CA B 201 coo 32.93 17.78 71.88 30.89 13.50 67.83 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 34.38 11.17 66.10 32.18 12.14 65.65 7.90 26.85 81.17 9.44 28.34 79.99 coo 31.34 7.96 67.74 31.44 9.08 65.62 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS B 3 LYS~? 17.03 CA CA B 201 D 217 SER B 47 SER~? 15.49 CA CA B 201 D 241 SER B 49 SER~? 17.16 CA CA B 201 coo 32.93 17.78 71.88 30.89 13.50 67.83 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 34.38 11.17 66.10 32.18 12.14 65.65 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 31.34 7.96 67.74 31.44 9.08 65.62 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 D 142 LYS B 46 LYS.? 7.77 CA CA B 201 D 217 SER B 49 SER~? 17.16 CA CA B 201 D 241 SER A 78 SER~? 22.09 CA CA B 201 coo 32.93 17.78 71.88 30.89 13.50 67.83 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 34.38 11.17 66.10 32.18 12.14 65.65 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 31.34 7.96 67.74 31.44 9.08 65.62 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 E 217 SER A 47 SER~? 10.78 OXT ACT B 801 E 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 20.81 34.16 44.49 19.85 28.53 41.75 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 15.53 27.71 42.41 13.14 27.33 42.95 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 79 LYS~? 16.33 CA CA B 201 E 217 SER A 72 SER~? 18.54 CA CA B 201 E 241 SER A 73 SER~? 22.81 CA CA B 201 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 5.94 24.99 78.50 7.74 23.37 78.35 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS A 79 LYS~? 16.33 CA CA B 201 E 217 SER A 73 SER~? 22.81 CA CA B 201 E 241 SER A 72 SER~? 18.54 CA CA B 201 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 7.90 26.85 81.17 9.44 28.34 79.99 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS B 3 LYS~? 17.03 CA CA B 201 E 217 SER B 47 SER~? 15.49 CA CA B 201 E 241 SER B 49 SER~? 17.16 CA CA B 201 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS B 46 LYS.? 7.77 CA CA B 201 E 217 SER B 49 SER~? 17.16 CA CA B 201 E 241 SER A 78 SER~? 22.09 CA CA B 201 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 F 217 SER A 47 SER~? 10.78 OXT ACT B 801 F 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 85.78 13.19 64.96 85.47 13.47 58.63 20.81 34.16 44.49 19.85 28.53 41.75 coo 87.43 17.13 57.15 85.84 15.39 56.76 15.53 27.71 42.41 13.14 27.33 42.95 coo 89.69 13.60 54.86 87.60 14.67 54.46 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 79 LYS~? 16.33 CA CA B 201 F 217 SER A 72 SER~? 18.54 CA CA B 201 F 241 SER A 73 SER~? 22.81 CA CA B 201 coo 85.78 13.19 64.96 85.47 13.47 58.63 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 87.43 17.13 57.15 85.84 15.39 56.76 5.94 24.99 78.50 7.74 23.37 78.35 coo 89.69 13.60 54.86 87.60 14.67 54.46 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS A 79 LYS~? 16.33 CA CA B 201 F 217 SER A 73 SER~? 22.81 CA CA B 201 F 241 SER A 72 SER~? 18.54 CA CA B 201 coo 85.78 13.19 64.96 85.47 13.47 58.63 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 87.43 17.13 57.15 85.84 15.39 56.76 7.90 26.85 81.17 9.44 28.34 79.99 coo 89.69 13.60 54.86 87.60 14.67 54.46 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS B 3 LYS~? 17.03 CA CA B 201 F 217 SER B 47 SER~? 15.49 CA CA B 201 F 241 SER B 49 SER~? 17.16 CA CA B 201 coo 85.78 13.19 64.96 85.47 13.47 58.63 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 87.43 17.13 57.15 85.84 15.39 56.76 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 89.69 13.60 54.86 87.60 14.67 54.46 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS B 46 LYS.? 7.77 CA CA B 201 F 217 SER B 49 SER~? 17.16 CA CA B 201 F 241 SER A 78 SER~? 22.09 CA CA B 201 coo 85.78 13.19 64.96 85.47 13.47 58.63 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 87.43 17.13 57.15 85.84 15.39 56.76 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 89.69 13.60 54.86 87.60 14.67 54.46 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 G 217 SER A 47 SER~? 10.78 OXT ACT B 801 G 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 20.81 34.16 44.49 19.85 28.53 41.75 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 15.53 27.71 42.41 13.14 27.33 42.95 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 79 LYS~? 16.33 CA CA B 201 G 217 SER A 72 SER~? 18.54 CA CA B 201 G 241 SER A 73 SER~? 22.81 CA CA B 201 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 5.94 24.99 78.50 7.74 23.37 78.35 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS A 79 LYS~? 16.33 CA CA B 201 G 217 SER A 73 SER~? 22.81 CA CA B 201 G 241 SER A 72 SER~? 18.54 CA CA B 201 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 7.90 26.85 81.17 9.44 28.34 79.99 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS B 3 LYS~? 17.03 CA CA B 201 G 217 SER B 47 SER~? 15.49 CA CA B 201 G 241 SER B 49 SER~? 17.16 CA CA B 201 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 G 142 LYS B 46 LYS.? 7.77 CA CA B 201 G 217 SER B 49 SER~? 17.16 CA CA B 201 G 241 SER A 78 SER~? 22.09 CA CA B 201 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 H 217 SER A 47 SER~? 10.78 OXT ACT B 801 H 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 20.81 34.16 44.49 19.85 28.53 41.75 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 15.53 27.71 42.41 13.14 27.33 42.95 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 79 LYS~? 16.33 CA CA B 201 H 217 SER A 72 SER~? 18.54 CA CA B 201 H 241 SER A 73 SER~? 22.81 CA CA B 201 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 5.94 24.99 78.50 7.74 23.37 78.35 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS A 79 LYS~? 16.33 CA CA B 201 H 217 SER A 73 SER~? 22.81 CA CA B 201 H 241 SER A 72 SER~? 18.54 CA CA B 201 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 7.90 26.85 81.17 9.44 28.34 79.99 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS B 3 LYS~? 17.03 CA CA B 201 H 217 SER B 47 SER~? 15.49 CA CA B 201 H 241 SER B 49 SER~? 17.16 CA CA B 201 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS B 46 LYS.? 7.77 CA CA B 201 H 217 SER B 49 SER~? 17.16 CA CA B 201 H 241 SER A 78 SER~? 22.09 CA CA B 201 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 I 217 SER A 47 SER~? 10.78 OXT ACT B 801 I 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo -5.05 91.11 27.04 -1.24 87.39 30.21 20.81 34.16 44.49 19.85 28.53 41.75 coo 2.83 88.63 29.54 1.30 86.82 30.03 15.53 27.71 42.41 13.14 27.33 42.95 coo 2.37 88.32 34.25 2.82 86.58 32.61 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 79 LYS~? 16.33 CA CA B 201 I 217 SER A 72 SER~? 18.54 CA CA B 201 I 241 SER A 73 SER~? 22.81 CA CA B 201 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 2.83 88.63 29.54 1.30 86.82 30.03 5.94 24.99 78.50 7.74 23.37 78.35 coo 2.37 88.32 34.25 2.82 86.58 32.61 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS A 79 LYS~? 16.33 CA CA B 201 I 217 SER A 73 SER~? 22.81 CA CA B 201 I 241 SER A 72 SER~? 18.54 CA CA B 201 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 2.83 88.63 29.54 1.30 86.82 30.03 7.90 26.85 81.17 9.44 28.34 79.99 coo 2.37 88.32 34.25 2.82 86.58 32.61 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS B 3 LYS~? 17.03 CA CA B 201 I 217 SER B 47 SER~? 15.49 CA CA B 201 I 241 SER B 49 SER~? 17.16 CA CA B 201 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 2.83 88.63 29.54 1.30 86.82 30.03 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 2.37 88.32 34.25 2.82 86.58 32.61 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS B 46 LYS.? 7.77 CA CA B 201 I 217 SER B 49 SER~? 17.16 CA CA B 201 I 241 SER A 78 SER~? 22.09 CA CA B 201 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 2.83 88.63 29.54 1.30 86.82 30.03 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 2.37 88.32 34.25 2.82 86.58 32.61 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 J 217 SER A 47 SER~? 10.78 OXT ACT B 801 J 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo -16.11 59.78 61.53 -15.92 58.68 55.43 20.81 34.16 44.49 19.85 28.53 41.75 coo -17.65 54.92 54.17 -15.81 56.46 53.79 15.53 27.71 42.41 13.14 27.33 42.95 coo -19.92 58.10 51.57 -17.75 57.08 51.34 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 79 LYS~? 16.33 CA CA B 201 J 217 SER A 72 SER~? 18.54 CA CA B 201 J 241 SER A 73 SER~? 22.81 CA CA B 201 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -17.65 54.92 54.17 -15.81 56.46 53.79 5.94 24.99 78.50 7.74 23.37 78.35 coo -19.92 58.10 51.57 -17.75 57.08 51.34 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS A 79 LYS~? 16.33 CA CA B 201 J 217 SER A 73 SER~? 22.81 CA CA B 201 J 241 SER A 72 SER~? 18.54 CA CA B 201 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -17.65 54.92 54.17 -15.81 56.46 53.79 7.90 26.85 81.17 9.44 28.34 79.99 coo -19.92 58.10 51.57 -17.75 57.08 51.34 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS B 3 LYS~? 17.03 CA CA B 201 J 217 SER B 47 SER~? 15.49 CA CA B 201 J 241 SER B 49 SER~? 17.16 CA CA B 201 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 J 142 LYS B 46 LYS.? 7.77 CA CA B 201 J 217 SER B 49 SER~? 17.16 CA CA B 201 J 241 SER A 78 SER~? 22.09 CA CA B 201 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -2.45 30.10 78.86 -0.23 29.26 79.33 coo -19.92 58.10 51.57 -17.75 57.08 51.34 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 K 217 SER A 47 SER~? 10.78 OXT ACT B 801 K 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 20.81 34.16 44.49 19.85 28.53 41.75 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 15.53 27.71 42.41 13.14 27.33 42.95 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 79 LYS~? 16.33 CA CA B 201 K 217 SER A 72 SER~? 18.54 CA CA B 201 K 241 SER A 73 SER~? 22.81 CA CA B 201 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 5.94 24.99 78.50 7.74 23.37 78.35 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS A 79 LYS~? 16.33 CA CA B 201 K 217 SER A 73 SER~? 22.81 CA CA B 201 K 241 SER A 72 SER~? 18.54 CA CA B 201 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 7.90 26.85 81.17 9.44 28.34 79.99 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS B 3 LYS~? 17.03 CA CA B 201 K 217 SER B 47 SER~? 15.49 CA CA B 201 K 241 SER B 49 SER~? 17.16 CA CA B 201 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS B 46 LYS.? 7.77 CA CA B 201 K 217 SER B 49 SER~? 17.16 CA CA B 201 K 241 SER A 78 SER~? 22.09 CA CA B 201 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -2.45 30.10 78.86 -0.23 29.26 79.33 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 L 217 SER A 47 SER~? 10.78 OXT ACT B 801 L 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 20.81 34.16 44.49 19.85 28.53 41.75 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 15.53 27.71 42.41 13.14 27.33 42.95 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 79 LYS~? 16.33 CA CA B 201 L 217 SER A 72 SER~? 18.54 CA CA B 201 L 241 SER A 73 SER~? 22.81 CA CA B 201 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 5.94 24.99 78.50 7.74 23.37 78.35 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS A 79 LYS~? 16.33 CA CA B 201 L 217 SER A 73 SER~? 22.81 CA CA B 201 L 241 SER A 72 SER~? 18.54 CA CA B 201 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 7.90 26.85 81.17 9.44 28.34 79.99 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS B 3 LYS~? 17.03 CA CA B 201 L 217 SER B 47 SER~? 15.49 CA CA B 201 L 241 SER B 49 SER~? 17.16 CA CA B 201 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS B 46 LYS.? 7.77 CA CA B 201 L 217 SER B 49 SER~? 17.16 CA CA B 201 L 241 SER A 78 SER~? 22.09 CA CA B 201 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 M 217 SER A 47 SER~? 10.78 OXT ACT B 801 M 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 57.83 99.61 24.25 54.90 95.14 20.60 20.81 34.16 44.49 19.85 28.53 41.75 coo 51.07 94.66 21.52 53.18 93.49 22.20 15.53 27.71 42.41 13.14 27.33 42.95 coo 51.67 94.23 16.93 51.60 92.47 18.57 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 79 LYS~? 16.33 CA CA B 201 M 217 SER A 72 SER~? 18.54 CA CA B 201 M 241 SER A 73 SER~? 22.81 CA CA B 201 coo 57.83 99.61 24.25 54.90 95.14 20.60 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 51.07 94.66 21.52 53.18 93.49 22.20 5.94 24.99 78.50 7.74 23.37 78.35 coo 51.67 94.23 16.93 51.60 92.47 18.57 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS A 79 LYS~? 16.33 CA CA B 201 M 217 SER A 73 SER~? 22.81 CA CA B 201 M 241 SER A 72 SER~? 18.54 CA CA B 201 coo 57.83 99.61 24.25 54.90 95.14 20.60 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 51.07 94.66 21.52 53.18 93.49 22.20 7.90 26.85 81.17 9.44 28.34 79.99 coo 51.67 94.23 16.93 51.60 92.47 18.57 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS B 3 LYS~? 17.03 CA CA B 201 M 217 SER B 47 SER~? 15.49 CA CA B 201 M 241 SER B 49 SER~? 17.16 CA CA B 201 coo 57.83 99.61 24.25 54.90 95.14 20.60 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 51.07 94.66 21.52 53.18 93.49 22.20 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 51.67 94.23 16.93 51.60 92.47 18.57 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 M 142 LYS B 46 LYS.? 7.77 CA CA B 201 M 217 SER B 49 SER~? 17.16 CA CA B 201 M 241 SER A 78 SER~? 22.09 CA CA B 201 coo 57.83 99.61 24.25 54.90 95.14 20.60 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 51.07 94.66 21.52 53.18 93.49 22.20 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 51.67 94.23 16.93 51.60 92.47 18.57 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 N 217 SER A 47 SER~? 10.78 OXT ACT B 801 N 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 20.81 34.16 44.49 19.85 28.53 41.75 coo 81.67 67.31 -0.58 79.53 68.28 0.00 15.53 27.71 42.41 13.14 27.33 42.95 coo 82.47 71.15 2.07 80.82 69.44 2.28 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 79 LYS~? 16.33 CA CA B 201 N 217 SER A 72 SER~? 18.54 CA CA B 201 N 241 SER A 73 SER~? 22.81 CA CA B 201 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 81.67 67.31 -0.58 79.53 68.28 0.00 5.94 24.99 78.50 7.74 23.37 78.35 coo 82.47 71.15 2.07 80.82 69.44 2.28 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS A 79 LYS~? 16.33 CA CA B 201 N 217 SER A 73 SER~? 22.81 CA CA B 201 N 241 SER A 72 SER~? 18.54 CA CA B 201 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 81.67 67.31 -0.58 79.53 68.28 0.00 7.90 26.85 81.17 9.44 28.34 79.99 coo 82.47 71.15 2.07 80.82 69.44 2.28 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS B 3 LYS~? 17.03 CA CA B 201 N 217 SER B 47 SER~? 15.49 CA CA B 201 N 241 SER B 49 SER~? 17.16 CA CA B 201 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 82.47 71.15 2.07 80.82 69.44 2.28 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 N 142 LYS B 46 LYS.? 7.77 CA CA B 201 N 217 SER B 49 SER~? 17.16 CA CA B 201 N 241 SER A 78 SER~? 22.09 CA CA B 201 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 82.47 71.15 2.07 80.82 69.44 2.28 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 O 217 SER A 47 SER~? 10.78 OXT ACT B 801 O 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 81.67 70.12 58.71 78.82 64.87 57.22 20.81 34.16 44.49 19.85 28.53 41.75 coo 81.62 62.23 55.05 79.32 62.93 55.20 15.53 27.71 42.41 13.14 27.33 42.95 coo 79.39 59.54 58.42 78.72 60.00 56.11 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 79 LYS~? 16.33 CA CA B 201 O 217 SER A 72 SER~? 18.54 CA CA B 201 O 241 SER A 73 SER~? 22.81 CA CA B 201 coo 81.67 70.12 58.71 78.82 64.87 57.22 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 81.62 62.23 55.05 79.32 62.93 55.20 5.94 24.99 78.50 7.74 23.37 78.35 coo 79.39 59.54 58.42 78.72 60.00 56.11 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS A 79 LYS~? 16.33 CA CA B 201 O 217 SER A 73 SER~? 22.81 CA CA B 201 O 241 SER A 72 SER~? 18.54 CA CA B 201 coo 81.67 70.12 58.71 78.82 64.87 57.22 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 81.62 62.23 55.05 79.32 62.93 55.20 7.90 26.85 81.17 9.44 28.34 79.99 coo 79.39 59.54 58.42 78.72 60.00 56.11 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS B 3 LYS~? 17.03 CA CA B 201 O 217 SER B 47 SER~? 15.49 CA CA B 201 O 241 SER B 49 SER~? 17.16 CA CA B 201 coo 81.67 70.12 58.71 78.82 64.87 57.22 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 81.62 62.23 55.05 79.32 62.93 55.20 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 79.39 59.54 58.42 78.72 60.00 56.11 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS B 46 LYS.? 7.77 CA CA B 201 O 217 SER B 49 SER~? 17.16 CA CA B 201 O 241 SER A 78 SER~? 22.09 CA CA B 201 coo 81.67 70.12 58.71 78.82 64.87 57.22 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 81.62 62.23 55.05 79.32 62.93 55.20 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 79.39 59.54 58.42 78.72 60.00 56.11 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 3 LYS~? 15.08 OXT ACT B 801 P 217 SER A 47 SER~? 10.78 OXT ACT B 801 P 241 SER A 49 SER~? 11.81 OXT ACT B 801 coo 37.29 55.72 69.54 38.73 59.85 65.07 20.81 34.16 44.49 19.85 28.53 41.75 coo 35.55 61.40 62.96 37.72 60.41 62.66 15.53 27.71 42.41 13.14 27.33 42.95 coo 38.60 64.77 64.10 38.63 63.28 62.26 12.01 30.11 45.26 9.74 29.35 44.91 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 79 LYS~? 16.33 CA CA B 201 P 217 SER A 72 SER~? 18.54 CA CA B 201 P 241 SER A 73 SER~? 22.81 CA CA B 201 coo 37.29 55.72 69.54 38.73 59.85 65.07 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 35.55 61.40 62.96 37.72 60.41 62.66 5.94 24.99 78.50 7.74 23.37 78.35 coo 38.60 64.77 64.10 38.63 63.28 62.26 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS A 79 LYS~? 16.33 CA CA B 201 P 217 SER A 73 SER~? 22.81 CA CA B 201 P 241 SER A 72 SER~? 18.54 CA CA B 201 coo 37.29 55.72 69.54 38.73 59.85 65.07 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 35.55 61.40 62.96 37.72 60.41 62.66 7.90 26.85 81.17 9.44 28.34 79.99 coo 38.60 64.77 64.10 38.63 63.28 62.26 5.94 24.99 78.50 7.74 23.37 78.35 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS B 3 LYS~? 17.03 CA CA B 201 P 217 SER B 47 SER~? 15.49 CA CA B 201 P 241 SER B 49 SER~? 17.16 CA CA B 201 coo 37.29 55.72 69.54 38.73 59.85 65.07 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 35.55 61.40 62.96 37.72 60.41 62.66 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 38.60 64.77 64.10 38.63 63.28 62.26 -2.45 30.10 78.86 -0.23 29.26 79.33 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 P 142 LYS B 46 LYS.? 7.77 CA CA B 201 P 217 SER B 49 SER~? 17.16 CA CA B 201 P 241 SER A 78 SER~? 22.09 CA CA B 201 coo 37.29 55.72 69.54 38.73 59.85 65.07 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 35.55 61.40 62.96 37.72 60.41 62.66 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 38.60 64.77 64.10 38.63 63.28 62.26 0.59 30.86 84.57 0.46 32.77 83.16 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 169 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 327 GLU A 8 GLU~? 21.63 CA CA A 202 coo 20.73 15.53 25.54 22.09 15.64 19.40 20.81 34.16 44.49 19.85 28.53 41.75 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.60 31.02 44.27 16.30 36.87 43.73 coo 21.86 20.40 18.59 22.12 18.33 18.33 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 169 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 327 GLU A 50 GLU~? 11.43 OXT ACT B 801 coo 20.73 15.53 25.54 22.09 15.64 19.40 15.60 31.02 44.27 16.30 36.87 43.73 coo 24.31 10.25 23.71 29.02 12.05 20.75 20.81 34.16 44.49 19.85 28.53 41.75 coo 21.86 20.40 18.59 22.12 18.33 18.33 12.68 24.99 44.98 13.54 23.53 43.68 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS B 3 LYS~? 17.03 CA CA B 201 A 169 LYS B 48 LYS~? 22.74 CA CA B 201 A 327 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 20.73 15.53 25.54 22.09 15.64 19.40 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 24.31 10.25 23.71 29.02 12.05 20.75 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 21.86 20.40 18.59 22.12 18.33 18.33 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS B 46 LYS.? 7.77 CA CA B 201 A 169 LYS B 48 LYS~? 22.74 CA CA B 201 A 327 GLU A 83 GLU~? 18.60 CA CA B 201 coo 20.73 15.53 25.54 22.09 15.64 19.40 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 24.31 10.25 23.71 29.02 12.05 20.75 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 21.86 20.40 18.59 22.12 18.33 18.33 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS B 48 LYS~? 22.74 CA CA B 201 A 169 LYS B 3 LYS~? 17.03 CA CA B 201 A 327 GLU B 50 GLU~? 12.54 CA CA B 201 coo 20.73 15.53 25.54 22.09 15.64 19.40 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 24.31 10.25 23.71 29.02 12.05 20.75 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 21.86 20.40 18.59 22.12 18.33 18.33 -3.14 24.90 79.07 -4.11 23.58 80.41 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 5 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 169 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 327 GLU A 8 GLU~? 21.63 CA CA A 202 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 20.81 34.16 44.49 19.85 28.53 41.75 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.60 31.02 44.27 16.30 36.87 43.73 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS B 3 LYS~? 17.03 CA CA B 201 B 169 LYS B 48 LYS~? 22.74 CA CA B 201 B 327 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS B 46 LYS.? 7.77 CA CA B 201 B 169 LYS B 48 LYS~? 22.74 CA CA B 201 B 327 GLU A 83 GLU~? 18.60 CA CA B 201 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -4.99 25.05 87.76 -3.42 23.71 87.32 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 3 hits 1muc_c01 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN B 12 GLN~? 7.97 CH3 ACT B 802 328 ASN B 15 ASN~? 6.97 CH3 ACT B 802 409 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 45.09 114.33 52.30 45.59 116.18 51.29 -15.71 32.44 66.39 -17.33 31.46 65.41 coo 41.10 116.46 52.80 42.09 116.00 54.64 -15.63 27.98 63.03 -17.12 27.37 64.41 coo 42.69 118.64 56.27 44.58 118.34 55.45 -16.70 27.94 69.16 -17.07 25.96 69.86 1myr_c00 source 1myr MYROSINASE : 1 hits 1myr_c00 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS B 53 HIS~? 13.80 CA CA B 201 A 290 LYS B 48 LYS~? 22.74 CA CA B 201 A 405 ARG A 76 ARG~? 16.28 CA CA B 201 coo 41.33 25.99 28.05 41.95 26.95 29.80 0.46 27.04 73.26 2.14 26.33 72.22 coo 37.11 33.75 31.82 38.72 27.95 29.90 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 42.28 27.98 41.30 43.16 28.14 38.35 4.46 22.84 83.40 3.22 20.31 82.22 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 1 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 5 GLU~? 25.21 CA CA A 202 B 128 HIS A 10 HIS~? 10.31 CA CA A 202 C 263 HIS A 45 HIS.? 16.70 CA CA A 202 coo 6.12 5.94 82.00 7.16 6.32 83.81 23.31 38.61 48.39 22.38 40.48 47.97 coo 12.51 16.35 80.99 13.16 14.90 82.37 19.28 27.48 52.70 18.40 25.59 52.72 coo 11.58 14.94 93.26 12.25 14.03 91.50 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 11 GLU~? 14.95 CA CA A 202 B 128 HIS A 43 HIS.? 6.83 CA CA A 202 C 263 HIS A 53 HIS~? 13.16 CA CA A 202 coo 6.12 5.94 82.00 7.16 6.32 83.81 26.25 27.59 54.14 27.19 27.48 52.23 coo 12.51 16.35 80.99 13.16 14.90 82.37 20.15 20.72 47.43 19.82 19.00 48.57 coo 11.58 14.94 93.26 12.25 14.03 91.50 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU A 11 GLU~? 14.95 CA CA A 202 B 128 HIS A 51 HIS~? 12.20 CA CA A 202 C 263 HIS A 2 HIS~? 23.51 OXT ACT B 801 coo 6.12 5.94 82.00 7.16 6.32 83.81 26.25 27.59 54.14 27.19 27.48 52.23 coo 12.51 16.35 80.99 13.16 14.90 82.37 17.98 27.94 47.81 19.27 26.33 47.47 coo 11.58 14.94 93.26 12.25 14.03 91.50 22.09 39.77 43.94 22.07 41.64 42.98 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU A 36 GLU~? 11.24 CA CA A 202 B 128 HIS A 53 HIS~? 13.16 CA CA A 202 C 263 HIS A 43 HIS.? 6.83 CA CA A 202 coo 6.12 5.94 82.00 7.16 6.32 83.81 8.53 16.97 55.87 6.50 17.32 56.35 coo 12.51 16.35 80.99 13.16 14.90 82.37 9.33 26.57 50.59 7.78 25.45 51.45 coo 11.58 14.94 93.26 12.25 14.03 91.50 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU A 82 GLU~? 19.14 CA CA B 201 B 128 HIS B 43 HIS.? 6.84 CA CA B 201 C 263 HIS B 53 HIS~? 13.80 CA CA B 201 coo 6.12 5.94 82.00 7.16 6.32 83.81 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 12.51 16.35 80.99 13.16 14.90 82.37 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 11.58 14.94 93.26 12.25 14.03 91.50 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU A 83 GLU~? 18.60 CA CA B 201 B 128 HIS B 43 HIS.? 6.84 CA CA B 201 C 263 HIS B 53 HIS~? 13.80 CA CA B 201 coo 6.12 5.94 82.00 7.16 6.32 83.81 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 12.51 16.35 80.99 13.16 14.90 82.37 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 11.58 14.94 93.26 12.25 14.03 91.50 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 B 59 GLU B 5 GLU~? 21.97 CH3 ACT B 802 B 128 HIS B 10 HIS~? 10.24 CA CA B 201 C 263 HIS B 45 HIS.? 16.95 CA CA B 201 coo 6.12 5.94 82.00 7.16 6.32 83.81 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 12.51 16.35 80.99 13.16 14.90 82.37 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 11.58 14.94 93.26 12.25 14.03 91.50 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 B 59 GLU B 11 GLU~? 12.56 CH3 ACT B 802 B 128 HIS B 51 HIS~? 12.10 CA CA B 201 C 263 HIS B 2 HIS~? 26.00 CH3 ACT B 802 coo 6.12 5.94 82.00 7.16 6.32 83.81 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 12.51 16.35 80.99 13.16 14.90 82.37 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 11.58 14.94 93.26 12.25 14.03 91.50 -12.31 39.90 79.94 -12.15 41.88 80.62 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 B 59 GLU B 36 GLU~? 11.20 CA CA B 201 B 128 HIS B 53 HIS~? 13.80 CA CA B 201 C 263 HIS B 43 HIS.? 6.84 CA CA B 201 coo 6.12 5.94 82.00 7.16 6.32 83.81 1.18 16.63 68.50 3.14 16.97 67.89 coo 12.51 16.35 80.99 13.16 14.90 82.37 0.46 27.04 73.26 2.14 26.33 72.22 coo 11.58 14.94 93.26 12.25 14.03 91.50 -10.59 20.73 76.53 -10.28 19.02 75.37 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 9 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 2 HIS~? 23.51 OXT ACT B 801 D 59 GLU A 11 GLU~? 14.95 CA CA A 202 D 128 HIS A 51 HIS~? 12.20 CA CA A 202 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 22.09 39.77 43.94 22.07 41.64 42.98 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 26.25 27.59 54.14 27.19 27.48 52.23 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 10 HIS~? 10.31 CA CA A 202 D 59 GLU A 36 GLU~? 11.24 CA CA A 202 D 128 HIS A 53 HIS~? 13.16 CA CA A 202 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 19.28 27.48 52.70 18.40 25.59 52.72 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 8.53 16.97 55.87 6.50 17.32 56.35 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS A 43 HIS.? 6.83 CA CA A 202 D 59 GLU A 36 GLU~? 11.24 CA CA A 202 D 128 HIS A 53 HIS~? 13.16 CA CA A 202 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 20.15 20.72 47.43 19.82 19.00 48.57 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 8.53 16.97 55.87 6.50 17.32 56.35 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS A 45 HIS.? 16.70 CA CA A 202 D 59 GLU A 8 GLU~? 21.63 CA CA A 202 D 128 HIS A 51 HIS~? 12.20 CA CA A 202 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 22.98 23.53 40.00 25.00 23.74 39.51 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 26.55 33.36 50.86 27.60 35.12 50.29 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS A 45 HIS.? 16.70 CA CA A 202 D 59 GLU A 11 GLU~? 14.95 CA CA A 202 D 128 HIS A 51 HIS~? 12.20 CA CA A 202 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 22.98 23.53 40.00 25.00 23.74 39.51 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 26.25 27.59 54.14 27.19 27.48 52.23 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS B 2 HIS~? 26.00 CH3 ACT B 802 D 59 GLU B 11 GLU~? 12.56 CH3 ACT B 802 D 128 HIS B 51 HIS~? 12.10 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 A 263 HIS B 10 HIS~? 10.24 CA CA B 201 D 59 GLU B 36 GLU~? 11.20 CA CA B 201 D 128 HIS B 53 HIS~? 13.80 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 1.18 16.63 68.50 3.14 16.97 67.89 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 A 263 HIS B 43 HIS.? 6.84 CA CA B 201 D 59 GLU B 36 GLU~? 11.20 CA CA B 201 D 128 HIS B 53 HIS~? 13.80 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 1.18 16.63 68.50 3.14 16.97 67.89 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 A 263 HIS B 45 HIS.? 16.95 CA CA B 201 D 59 GLU B 5 GLU~? 21.97 CH3 ACT B 802 D 128 HIS B 10 HIS~? 10.24 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 10 3 # 10 A 263 HIS B 45 HIS.? 16.95 CA CA B 201 D 59 GLU B 5 GLU~? 21.97 CH3 ACT B 802 D 128 HIS B 51 HIS~? 12.10 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 11 3 # 11 A 263 HIS B 45 HIS.? 16.95 CA CA B 201 D 59 GLU B 8 GLU~? 16.54 CH3 ACT B 802 D 128 HIS B 51 HIS~? 12.10 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 12 3 # 12 A 263 HIS B 45 HIS.? 16.95 CA CA B 201 D 59 GLU B 11 GLU~? 12.56 CH3 ACT B 802 D 128 HIS B 51 HIS~? 12.10 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 13 3 # 13 A 263 HIS B 53 HIS~? 13.80 CA CA B 201 D 59 GLU A 82 GLU~? 19.14 CA CA B 201 D 128 HIS B 43 HIS.? 6.84 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 0.46 27.04 73.26 2.14 26.33 72.22 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 14 3 # 14 A 263 HIS B 53 HIS~? 13.80 CA CA B 201 D 59 GLU A 83 GLU~? 18.60 CA CA B 201 D 128 HIS B 43 HIS.? 6.84 CA CA B 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 0.46 27.04 73.26 2.14 26.33 72.22 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -10.59 20.73 76.53 -10.28 19.02 75.37 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 14 hits 1ni4_c01 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 42 SER.? 8.78 CA CA A 202 A 708 ASP A 38 ASP~? -3.36 CA CA A 202s A 740 HIS A 43 HIS.? 6.83 CA CA A 202 coo -7.09 7.44 6.22 -7.53 5.14 5.59 24.49 22.68 48.88 24.08 20.35 49.41 coo -5.35 2.36 14.19 -6.28 2.60 12.26 14.49 17.18 50.40 16.42 16.29 49.93 coo -8.70 2.86 9.96 -8.03 3.92 8.29 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 42 SER.? 8.82 CA CA B 201 A 708 ASP B 38 ASP~? -3.30 CA CA B 201s A 740 HIS B 43 HIS.? 6.84 CA CA B 201 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -10.59 20.73 76.53 -10.28 19.02 75.37 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 42 SER.? 8.78 CA CA A 202 B 708 ASP A 38 ASP~? -3.36 CA CA A 202s B 740 HIS A 43 HIS.? 6.83 CA CA A 202 coo 4.44 13.29 37.64 6.01 11.66 38.49 24.49 22.68 48.88 24.08 20.35 49.41 coo 6.39 7.18 30.33 6.92 8.20 32.17 14.49 17.18 50.40 16.42 16.29 49.93 coo 8.57 10.09 34.47 7.10 10.73 35.82 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 42 SER.? 8.82 CA CA B 201 B 708 ASP B 38 ASP~? -3.30 CA CA B 201s B 740 HIS B 43 HIS.? 6.84 CA CA B 201 coo 4.44 13.29 37.64 6.01 11.66 38.49 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 6.39 7.18 30.33 6.92 8.20 32.17 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 8.57 10.09 34.47 7.10 10.73 35.82 -10.59 20.73 76.53 -10.28 19.02 75.37 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 42 SER.? 8.78 CA CA A 202 A 709 ASP A 38 ASP~? -3.36 CA CA A 202s A 740 HIS A 43 HIS.? 6.83 CA CA A 202 coo -7.09 7.44 6.22 -7.53 5.14 5.59 24.49 22.68 48.88 24.08 20.35 49.41 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 14.49 17.18 50.40 16.42 16.29 49.93 coo -8.70 2.86 9.96 -8.03 3.92 8.29 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 42 SER.? 8.82 CA CA B 201 A 709 ASP B 38 ASP~? -3.30 CA CA B 201s A 740 HIS B 43 HIS.? 6.84 CA CA B 201 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -10.59 20.73 76.53 -10.28 19.02 75.37 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 42 SER.? 8.78 CA CA A 202 B 709 ASP A 38 ASP~? -3.36 CA CA A 202s B 740 HIS A 43 HIS.? 6.83 CA CA A 202 coo 4.44 13.29 37.64 6.01 11.66 38.49 24.49 22.68 48.88 24.08 20.35 49.41 coo 10.26 2.81 31.69 11.64 4.30 32.43 14.49 17.18 50.40 16.42 16.29 49.93 coo 8.57 10.09 34.47 7.10 10.73 35.82 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 42 SER.? 8.82 CA CA B 201 B 709 ASP B 38 ASP~? -3.30 CA CA B 201s B 740 HIS B 43 HIS.? 6.84 CA CA B 201 coo 4.44 13.29 37.64 6.01 11.66 38.49 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 10.26 2.81 31.69 11.64 4.30 32.43 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 8.57 10.09 34.47 7.10 10.73 35.82 -10.59 20.73 76.53 -10.28 19.02 75.37 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 53 HIS~? 13.16 CA CA A 202 A 259 TYR A 34 TYR~? 7.34 CA CA A 202 A 552 ASP B 4 ASP~? 21.62 CA CA B 201 coo 11.34 95.90 25.54 12.13 96.42 23.67 9.33 26.57 50.59 7.78 25.45 51.45 coo 14.91 97.39 18.63 13.39 95.60 20.20 14.67 22.85 56.72 17.08 23.07 55.48 coo 46.37 82.54 38.83 45.97 84.66 38.77 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS B 53 HIS~? 13.80 CA CA B 201 A 259 TYR B 34 TYR~? 7.28 CA CA B 201 A 552 ASP A 4 ASP~? 21.72 CA CA A 202 coo 11.34 95.90 25.54 12.13 96.42 23.67 0.46 27.04 73.26 2.14 26.33 72.22 coo 14.91 97.39 18.63 13.39 95.60 20.20 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 46.37 82.54 38.83 45.97 84.66 38.77 25.57 34.71 45.51 26.38 33.70 43.83 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 2 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 54 ALA~? 9.99 CA CA A 202 A 126 LEU A 37 LEU~? 8.55 CA CA A 202 A 158 GLU A 36 GLU~? 11.24 CA CA A 202 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.75 26.68 52.93 15.03 26.06 52.36 coo -4.62 32.83 147.14 -5.50 32.85 149.12 11.49 21.64 52.06 11.55 23.23 50.62 coo -0.83 29.57 149.77 -0.39 31.47 148.95 8.53 16.97 55.87 6.50 17.32 56.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 85 ALA~? 26.05 CA CA B 201 A 126 LEU A 84 LEU~? 26.90 CA CA B 201 A 158 GLU A 83 GLU~? 18.60 CA CA B 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -6.86 31.64 92.16 -6.77 32.64 91.11 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.25 29.02 92.98 -2.55 29.16 95.01 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 88 ALA~? 29.84 CA CA B 201 A 126 LEU A 84 LEU~? 26.90 CA CA B 201 A 158 GLU A 83 GLU~? 18.60 CA CA B 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -9.11 30.58 96.15 -8.06 31.49 96.50 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.25 29.02 92.98 -2.55 29.16 95.01 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -4.99 25.05 87.76 -3.42 23.71 87.32 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 3 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 54 ALA~? 9.99 CA CA A 202 B 126 LEU A 37 LEU~? 8.55 CA CA A 202 B 158 GLU A 36 GLU~? 11.24 CA CA A 202 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.75 26.68 52.93 15.03 26.06 52.36 coo -34.22 5.06 149.25 -33.65 4.24 151.15 11.49 21.64 52.06 11.55 23.23 50.62 coo -33.03 9.93 151.71 -34.98 9.38 151.11 8.53 16.97 55.87 6.50 17.32 56.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 85 ALA~? 26.05 CA CA B 201 B 126 LEU A 84 LEU~? 26.90 CA CA B 201 B 158 GLU A 83 GLU~? 18.60 CA CA B 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -6.86 31.64 92.16 -6.77 32.64 91.11 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.25 29.02 92.98 -2.55 29.16 95.01 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 88 ALA~? 29.84 CA CA B 201 B 126 LEU A 84 LEU~? 26.90 CA CA B 201 B 158 GLU A 83 GLU~? 18.60 CA CA B 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -9.11 30.58 96.15 -8.06 31.49 96.50 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.25 29.02 92.98 -2.55 29.16 95.01 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 54 ALA~? 9.98 CA CA B 201 B 126 LEU B 37 LEU~? 8.56 CA CA B 201 B 158 GLU B 36 GLU~? 11.20 CA CA B 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -4.07 26.74 71.12 -5.32 26.04 71.64 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -1.88 21.62 71.94 -1.91 23.21 73.38 coo -33.03 9.93 151.71 -34.98 9.38 151.11 1.18 16.63 68.50 3.14 16.97 67.89 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 4 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 54 ALA~? 9.99 CA CA A 202 C 126 LEU A 37 LEU~? 8.55 CA CA A 202 C 158 GLU A 36 GLU~? 11.24 CA CA A 202 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.75 26.68 52.93 15.03 26.06 52.36 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 11.49 21.64 52.06 11.55 23.23 50.62 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 8.53 16.97 55.87 6.50 17.32 56.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 85 ALA~? 26.05 CA CA B 201 C 126 LEU A 84 LEU~? 26.90 CA CA B 201 C 158 GLU A 83 GLU~? 18.60 CA CA B 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -6.86 31.64 92.16 -6.77 32.64 91.11 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.25 29.02 92.98 -2.55 29.16 95.01 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -4.99 25.05 87.76 -3.42 23.71 87.32 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 88 ALA~? 29.84 CA CA B 201 C 126 LEU A 84 LEU~? 26.90 CA CA B 201 C 158 GLU A 83 GLU~? 18.60 CA CA B 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -9.11 30.58 96.15 -8.06 31.49 96.50 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.25 29.02 92.98 -2.55 29.16 95.01 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -4.99 25.05 87.76 -3.42 23.71 87.32 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 3 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP B 4 ASP~? 21.62 CA CA B 201 A 270 LYS B 48 LYS~? 22.74 CA CA B 201 A 382 MET B 13 MET?? 11.62 CH3 ACT B 802 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -10.61 29.46 64.94 -8.49 31.70 63.76 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c02 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 86 ASP~? 21.59 CA CA B 201 A 68 ALA A 85 ALA~? 26.05 CA CA B 201 A 72 LEU A 84 LEU~? 26.90 CA CA B 201 coo 46.76 7.59 18.65 45.27 6.01 18.52 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 48.88 4.35 16.59 48.73 5.09 15.20 -6.86 31.64 92.16 -6.77 32.64 91.11 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.25 29.02 92.98 -2.55 29.16 95.01 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 86 ASP~? 21.59 CA CA B 201 A 68 ALA A 88 ALA~? 29.84 CA CA B 201 A 72 LEU A 84 LEU~? 26.90 CA CA B 201 coo 46.76 7.59 18.65 45.27 6.01 18.52 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 48.88 4.35 16.59 48.73 5.09 15.20 -9.11 30.58 96.15 -8.06 31.49 96.50 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.25 29.02 92.98 -2.55 29.16 95.01 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c05 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 42 SER.? 8.78 CA CA A 202 A 310 GLU A 11 GLU~? 14.95 CA CA A 202 A 399 HIS A 10 HIS~? 10.31 CA CA A 202 coo 2.67 37.96 55.23 1.78 40.01 56.16 24.49 22.68 48.88 24.08 20.35 49.41 coo 6.61 38.44 63.61 6.69 38.31 61.50 26.25 27.59 54.14 27.19 27.48 52.23 coo 4.95 41.82 59.53 3.85 40.70 58.14 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER A 72 SER~? 18.54 CA CA B 201 A 310 GLU A 68 GLU~? 14.30 CA CA B 201 A 399 HIS B 53 HIS~? 13.80 CA CA B 201 coo 2.67 37.96 55.23 1.78 40.01 56.16 5.94 24.99 78.50 7.74 23.37 78.35 coo 6.61 38.44 63.61 6.69 38.31 61.50 6.28 24.34 70.76 4.27 24.24 71.35 coo 4.95 41.82 59.53 3.85 40.70 58.14 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 3 3 # 3 A 189 SER A 72 SER~? 18.54 CA CA B 201 A 310 GLU B 50 GLU~? 12.54 CA CA B 201 A 399 HIS B 53 HIS~? 13.80 CA CA B 201 coo 2.67 37.96 55.23 1.78 40.01 56.16 5.94 24.99 78.50 7.74 23.37 78.35 coo 6.61 38.44 63.61 6.69 38.31 61.50 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 4.95 41.82 59.53 3.85 40.70 58.14 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 4 3 # 4 A 189 SER B 42 SER.? 8.82 CA CA B 201 A 310 GLU B 11 GLU~? 12.56 CH3 ACT B 802 A 399 HIS B 10 HIS~? 10.24 CA CA B 201 coo 2.67 37.96 55.23 1.78 40.01 56.16 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 6.61 38.44 63.61 6.69 38.31 61.50 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 4.95 41.82 59.53 3.85 40.70 58.14 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 5 3 # 5 A 189 SER B 72 SER~? 11.29 CH3 ACT B 801 A 310 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 399 HIS A 53 HIS~? 13.16 CA CA A 202 coo 2.67 37.96 55.23 1.78 40.01 56.16 4.20 25.43 45.78 2.18 24.15 45.83 coo 6.61 38.44 63.61 6.69 38.31 61.50 12.68 24.99 44.98 13.54 23.53 43.68 coo 4.95 41.82 59.53 3.85 40.70 58.14 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 6 3 # 6 A 189 SER B 72 SER~? 11.29 CH3 ACT B 801 A 310 GLU B 68 GLU~? 14.14 CA CA A 202 A 399 HIS A 53 HIS~? 13.16 CA CA A 202 coo 2.67 37.96 55.23 1.78 40.01 56.16 4.20 25.43 45.78 2.18 24.15 45.83 coo 6.61 38.44 63.61 6.69 38.31 61.50 3.52 24.40 53.24 5.54 24.28 52.66 coo 4.95 41.82 59.53 3.85 40.70 58.14 9.33 26.57 50.59 7.78 25.45 51.45 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 6 hits 1qe3_c00 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 40 GLU.? 3.38 CA CA A 202s A 143 HIS A 43 HIS.? 6.83 CA CA A 202 A 170 LYS A 46 LYS.? 7.73 CA CA A 202 coo -2.40 27.37 52.92 -1.22 29.09 52.71 19.19 19.98 52.16 20.07 18.13 52.69 coo 1.36 26.79 49.43 3.17 26.89 50.50 20.15 20.72 47.43 19.82 19.00 48.57 coo 7.24 31.80 48.14 6.27 25.92 49.70 17.72 24.61 42.81 16.30 19.73 46.29 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 A 86 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 143 HIS A 51 HIS~? 12.20 CA CA A 202 A 170 LYS A 3 LYS~? 15.08 OXT ACT B 801 coo -2.40 27.37 52.92 -1.22 29.09 52.71 12.68 24.99 44.98 13.54 23.53 43.68 coo 1.36 26.79 49.43 3.17 26.89 50.50 17.98 27.94 47.81 19.27 26.33 47.47 coo 7.24 31.80 48.14 6.27 25.92 49.70 20.81 34.16 44.49 19.85 28.53 41.75 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 A 86 GLU A 68 GLU~? 14.30 CA CA B 201 A 143 HIS B 53 HIS~? 13.80 CA CA B 201 A 170 LYS B 52 LYS~? 20.44 CA CA B 201 coo -2.40 27.37 52.92 -1.22 29.09 52.71 6.28 24.34 70.76 4.27 24.24 71.35 coo 1.36 26.79 49.43 3.17 26.89 50.50 0.46 27.04 73.26 2.14 26.33 72.22 coo 7.24 31.80 48.14 6.27 25.92 49.70 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 A 86 GLU B 40 GLU.? 3.43 CA CA B 201s A 143 HIS B 43 HIS.? 6.84 CA CA B 201 A 170 LYS B 46 LYS.? 7.77 CA CA B 201 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 1.36 26.79 49.43 3.17 26.89 50.50 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 7.24 31.80 48.14 6.27 25.92 49.70 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 5 3 # 5 A 86 GLU B 50 GLU~? 12.54 CA CA B 201 A 143 HIS B 51 HIS~? 12.10 CA CA B 201 A 170 LYS B 3 LYS~? 17.03 CA CA B 201 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 1.36 26.79 49.43 3.17 26.89 50.50 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 7.24 31.80 48.14 6.27 25.92 49.70 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 6 3 # 6 A 86 GLU B 68 GLU~? 14.14 CA CA A 202 A 143 HIS A 53 HIS~? 13.16 CA CA A 202 A 170 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo -2.40 27.37 52.92 -1.22 29.09 52.71 3.52 24.40 53.24 5.54 24.28 52.66 coo 1.36 26.79 49.43 3.17 26.89 50.50 9.33 26.57 50.59 7.78 25.45 51.45 coo 7.24 31.80 48.14 6.27 25.92 49.70 13.41 31.22 50.01 11.37 34.80 45.78 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 6 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 40 GLU.? 3.38 CA CA A 202s B 143 HIS A 43 HIS.? 6.83 CA CA A 202 B 170 LYS A 46 LYS.? 7.73 CA CA A 202 coo 13.90 37.16 5.96 12.00 36.26 6.12 19.19 19.98 52.16 20.07 18.13 52.69 coo 13.52 33.69 9.79 13.20 31.83 8.88 20.15 20.72 47.43 19.82 19.00 48.57 coo 7.52 28.83 11.02 13.59 28.74 9.95 17.72 24.61 42.81 16.30 19.73 46.29 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 B 86 GLU A 50 GLU~? 11.43 OXT ACT B 801 B 143 HIS A 51 HIS~? 12.20 CA CA A 202 B 170 LYS A 3 LYS~? 15.08 OXT ACT B 801 coo 13.90 37.16 5.96 12.00 36.26 6.12 12.68 24.99 44.98 13.54 23.53 43.68 coo 13.52 33.69 9.79 13.20 31.83 8.88 17.98 27.94 47.81 19.27 26.33 47.47 coo 7.52 28.83 11.02 13.59 28.74 9.95 20.81 34.16 44.49 19.85 28.53 41.75 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 B 86 GLU A 68 GLU~? 14.30 CA CA B 201 B 143 HIS B 53 HIS~? 13.80 CA CA B 201 B 170 LYS B 52 LYS~? 20.44 CA CA B 201 coo 13.90 37.16 5.96 12.00 36.26 6.12 6.28 24.34 70.76 4.27 24.24 71.35 coo 13.52 33.69 9.79 13.20 31.83 8.88 0.46 27.04 73.26 2.14 26.33 72.22 coo 7.52 28.83 11.02 13.59 28.74 9.95 -3.85 31.32 74.04 -1.50 34.25 78.56 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 B 86 GLU B 40 GLU.? 3.43 CA CA B 201s B 143 HIS B 43 HIS.? 6.84 CA CA B 201 B 170 LYS B 46 LYS.? 7.77 CA CA B 201 coo 13.90 37.16 5.96 12.00 36.26 6.12 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 13.52 33.69 9.79 13.20 31.83 8.88 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 7.52 28.83 11.02 13.59 28.74 9.95 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 5 3 # 5 B 86 GLU B 50 GLU~? 12.54 CA CA B 201 B 143 HIS B 51 HIS~? 12.10 CA CA B 201 B 170 LYS B 3 LYS~? 17.03 CA CA B 201 coo 13.90 37.16 5.96 12.00 36.26 6.12 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 13.52 33.69 9.79 13.20 31.83 8.88 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 7.52 28.83 11.02 13.59 28.74 9.95 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 6 3 # 6 B 86 GLU B 68 GLU~? 14.14 CA CA A 202 B 143 HIS A 53 HIS~? 13.16 CA CA A 202 B 170 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 13.90 37.16 5.96 12.00 36.26 6.12 3.52 24.40 53.24 5.54 24.28 52.66 coo 13.52 33.69 9.79 13.20 31.83 8.88 9.33 26.57 50.59 7.78 25.45 51.45 coo 7.52 28.83 11.02 13.59 28.74 9.95 13.41 31.22 50.01 11.37 34.80 45.78 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 6 hits 1qfe_c01 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 34 TYR~? 7.34 CA CA A 202 A 236 ASP A 38 ASP~? -3.36 CA CA A 202s A 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 55.48 26.51 40.65 55.39 23.99 39.43 14.67 22.85 56.72 17.08 23.07 55.48 coo 48.87 29.19 44.63 49.10 27.34 43.63 14.49 17.18 50.40 16.42 16.29 49.93 coo 47.58 17.35 41.83 51.40 20.85 40.83 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 34 TYR~? 7.28 CA CA B 201 A 236 ASP B 38 ASP~? -3.30 CA CA B 201s A 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 55.48 26.51 40.65 55.39 23.99 39.43 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 48.87 29.19 44.63 49.10 27.34 43.63 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 47.58 17.35 41.83 51.40 20.85 40.83 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 34 TYR~? 7.34 CA CA A 202 B 236 ASP A 38 ASP~? -3.36 CA CA A 202s B 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 14.67 22.85 56.72 17.08 23.07 55.48 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 14.49 17.18 50.40 16.42 16.29 49.93 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 34 TYR~? 7.28 CA CA B 201 B 236 ASP B 38 ASP~? -3.30 CA CA B 201s B 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 34 TYR~? 7.34 CA CA A 202 C 236 ASP A 38 ASP~? -3.36 CA CA A 202s C 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 39.51 34.34 13.63 37.63 32.61 14.79 14.67 22.85 56.72 17.08 23.07 55.48 coo 45.78 31.11 9.51 44.25 30.06 10.53 14.49 17.18 50.40 16.42 16.29 49.93 coo 37.54 22.37 12.10 37.83 27.55 13.24 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 34 TYR~? 7.28 CA CA B 201 C 236 ASP B 38 ASP~? -3.30 CA CA B 201s C 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 37.54 22.37 12.10 37.83 27.55 13.24 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 34 TYR~? 7.34 CA CA A 202 D 236 ASP A 38 ASP~? -3.36 CA CA A 202s D 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 14.67 22.85 56.72 17.08 23.07 55.48 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 14.49 17.18 50.40 16.42 16.29 49.93 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 34 TYR~? 7.28 CA CA B 201 D 236 ASP B 38 ASP~? -3.30 CA CA B 201s D 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 34 TYR~? 7.34 CA CA A 202 E 236 ASP A 38 ASP~? -3.36 CA CA A 202s E 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 14.67 22.85 56.72 17.08 23.07 55.48 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 14.49 17.18 50.40 16.42 16.29 49.93 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 34 TYR~? 7.28 CA CA B 201 E 236 ASP B 38 ASP~? -3.30 CA CA B 201s E 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 34 TYR~? 7.34 CA CA A 202 F 236 ASP A 38 ASP~? -3.36 CA CA A 202s F 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 14.67 22.85 56.72 17.08 23.07 55.48 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 14.49 17.18 50.40 16.42 16.29 49.93 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 34 TYR~? 7.28 CA CA B 201 F 236 ASP B 38 ASP~? -3.30 CA CA B 201s F 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 34 TYR~? 7.34 CA CA A 202 G 236 ASP A 38 ASP~? -3.36 CA CA A 202s G 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 14.67 22.85 56.72 17.08 23.07 55.48 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 14.49 17.18 50.40 16.42 16.29 49.93 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 34 TYR~? 7.28 CA CA B 201 G 236 ASP B 38 ASP~? -3.30 CA CA B 201s G 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 34 TYR~? 7.34 CA CA A 202 H 236 ASP A 38 ASP~? -3.36 CA CA A 202s H 261 LYS A 52 LYS~? 15.73 OXT ACT B 801 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 14.67 22.85 56.72 17.08 23.07 55.48 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 14.49 17.18 50.40 16.42 16.29 49.93 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 13.41 31.22 50.01 11.37 34.80 45.78 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 34 TYR~? 7.28 CA CA B 201 H 236 ASP B 38 ASP~? -3.30 CA CA B 201s H 261 LYS B 52 LYS~? 20.44 CA CA B 201 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -3.85 31.32 74.04 -1.50 34.25 78.56 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c15 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 27 ASP.? 17.47 CA CA A 202 A 147 THR A 29 THR.? 15.36 CA CA A 202 A 294 ASP A 18 ASP~? 11.52 CA CA A 202 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 11.73 20.36 70.40 10.57 19.24 69.08 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 12.00 17.38 65.85 10.47 16.33 66.97 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 23.94 22.65 63.18 23.40 21.50 61.45 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP B 27 ASP.? 17.39 CA CA B 201 A 147 THR B 29 THR.? 15.37 CA CA B 201 A 294 ASP B 18 ASP~? 9.64 OXT ACT B 802 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -2.22 17.51 58.24 -0.75 16.42 57.04 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -14.19 22.62 60.80 -13.56 21.49 62.54 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 2 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 69 ASP~? 23.19 CA CA B 201 A 261 ASP A 18 ASP~? 11.52 CA CA A 202 A 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 28.46 69.88 26.74 30.40 70.70 26.53 11.02 26.78 74.77 12.23 26.87 76.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 23.94 22.65 63.18 23.40 21.50 61.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 261 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 329 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 28.46 69.88 26.74 30.40 70.70 26.53 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 34.02 79.89 42.60 34.73 78.01 41.86 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -10.90 21.62 46.30 -10.75 20.16 44.81 1qho_c05 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 24 ASP.? 26.42 CA CA A 202 A 260 ASP A 18 ASP~? 11.52 CA CA A 202 A 329 ASP A 27 ASP.? 17.47 CA CA A 202 coo 28.46 69.88 26.74 30.40 70.70 26.53 20.63 21.72 77.63 20.78 20.24 79.08 coo 30.73 81.29 37.61 31.23 82.07 35.69 23.94 22.65 63.18 23.40 21.50 61.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 27 ASP.? 17.47 CA CA A 202 A 260 ASP A 18 ASP~? 11.52 CA CA A 202 A 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 28.46 69.88 26.74 30.40 70.70 26.53 11.73 20.36 70.40 10.57 19.24 69.08 coo 30.73 81.29 37.61 31.23 82.07 35.69 23.94 22.65 63.18 23.40 21.50 61.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 69 ASP~? 23.19 CA CA B 201 A 260 ASP A 18 ASP~? 11.52 CA CA A 202 A 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 28.46 69.88 26.74 30.40 70.70 26.53 11.02 26.78 74.77 12.23 26.87 76.45 coo 30.73 81.29 37.61 31.23 82.07 35.69 23.94 22.65 63.18 23.40 21.50 61.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 24 ASP.? 15.33 OXT ACT B 802 A 260 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 329 ASP B 27 ASP.? 17.39 CA CA B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 30.73 81.29 37.61 31.23 82.07 35.69 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.83 20.43 53.73 -0.68 19.31 55.10 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 27 ASP.? 17.39 CA CA B 201 A 260 ASP B 18 ASP~? 9.64 OXT ACT B 802 A 329 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 30.73 81.29 37.61 31.23 82.07 35.69 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -10.90 21.62 46.30 -10.75 20.16 44.81 1qho_c07 source 1qho ALPHA-AMYLASE : 5 hits 1qho_c07 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 43 HIS.? 6.83 CA CA A 202 A 646 ASP A 38 ASP~? -3.36 CA CA A 202s A 741 SER A 42 SER.? 8.78 CA CA A 202 coo -20.72 2.99 34.37 -21.94 1.82 35.61 20.15 20.72 47.43 19.82 19.00 48.57 coo -18.83 7.68 26.86 -20.89 7.78 26.56 14.49 17.18 50.40 16.42 16.29 49.93 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 24.49 22.68 48.88 24.08 20.35 49.41 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 51 HIS~? 12.20 CA CA A 202 A 646 ASP A 4 ASP~? 21.72 CA CA A 202 A 741 SER A 42 SER.? 8.78 CA CA A 202 coo -20.72 2.99 34.37 -21.94 1.82 35.61 17.98 27.94 47.81 19.27 26.33 47.47 coo -18.83 7.68 26.86 -20.89 7.78 26.56 25.57 34.71 45.51 26.38 33.70 43.83 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 24.49 22.68 48.88 24.08 20.35 49.41 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 51 HIS~? 12.20 CA CA A 202 A 646 ASP A 4 ASP~? 21.72 CA CA A 202 A 741 SER A 47 SER~? 10.78 OXT ACT B 801 coo -20.72 2.99 34.37 -21.94 1.82 35.61 17.98 27.94 47.81 19.27 26.33 47.47 coo -18.83 7.68 26.86 -20.89 7.78 26.56 25.57 34.71 45.51 26.38 33.70 43.83 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 15.53 27.71 42.41 13.14 27.33 42.95 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 43 HIS.? 6.84 CA CA B 201 A 646 ASP B 38 ASP~? -3.30 CA CA B 201s A 741 SER B 42 SER.? 8.82 CA CA B 201 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -14.88 22.70 74.95 -14.62 20.32 74.49 ULMN 3 1qrz_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 51 HIS~? 12.10 CA CA B 201 A 646 ASP B 4 ASP~? 21.62 CA CA B 201 A 741 SER B 42 SER.? 8.82 CA CA B 201 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -14.88 22.70 74.95 -14.62 20.32 74.49 ULMN 3 1qrz_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS B 51 HIS~? 12.10 CA CA B 201 A 646 ASP B 4 ASP~? 21.62 CA CA B 201 A 741 SER B 47 SER~? 15.49 CA CA B 201 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -5.98 27.66 81.59 -3.55 27.32 80.93 1qrz_c12 source 1qrz PLASMINOGEN : 6 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 51 HIS~? 12.20 CA CA A 202 B 646 ASP A 4 ASP~? 21.72 CA CA A 202 B 741 SER A 42 SER.? 8.78 CA CA A 202 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 17.98 27.94 47.81 19.27 26.33 47.47 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 25.57 34.71 45.51 26.38 33.70 43.83 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 24.49 22.68 48.88 24.08 20.35 49.41 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 51 HIS~? 12.20 CA CA A 202 B 646 ASP A 4 ASP~? 21.72 CA CA A 202 B 741 SER A 47 SER~? 10.78 OXT ACT B 801 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 17.98 27.94 47.81 19.27 26.33 47.47 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 25.57 34.71 45.51 26.38 33.70 43.83 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 15.53 27.71 42.41 13.14 27.33 42.95 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 45 HIS.? 16.95 CA CA B 201 B 646 ASP A 86 ASP~? 21.59 CA CA B 201 B 741 SER B 47 SER~? 15.49 CA CA B 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -5.98 27.66 81.59 -3.55 27.32 80.93 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 51 HIS~? 12.10 CA CA B 201 B 646 ASP B 4 ASP~? 21.62 CA CA B 201 B 741 SER B 42 SER.? 8.82 CA CA B 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -14.88 22.70 74.95 -14.62 20.32 74.49 ULMN 3 1qrz_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS B 51 HIS~? 12.10 CA CA B 201 B 646 ASP B 4 ASP~? 21.62 CA CA B 201 B 741 SER B 47 SER~? 15.49 CA CA B 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -5.98 27.66 81.59 -3.55 27.32 80.93 1qrz_c13 source 1qrz PLASMINOGEN : 5 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 43 HIS.? 6.83 CA CA A 202 C 646 ASP A 38 ASP~? -3.36 CA CA A 202s C 741 SER A 42 SER.? 8.78 CA CA A 202 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 20.15 20.72 47.43 19.82 19.00 48.57 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 14.49 17.18 50.40 16.42 16.29 49.93 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 24.49 22.68 48.88 24.08 20.35 49.41 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 51 HIS~? 12.20 CA CA A 202 C 646 ASP A 4 ASP~? 21.72 CA CA A 202 C 741 SER A 42 SER.? 8.78 CA CA A 202 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 17.98 27.94 47.81 19.27 26.33 47.47 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 25.57 34.71 45.51 26.38 33.70 43.83 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 24.49 22.68 48.88 24.08 20.35 49.41 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 51 HIS~? 12.20 CA CA A 202 C 646 ASP A 4 ASP~? 21.72 CA CA A 202 C 741 SER A 47 SER~? 10.78 OXT ACT B 801 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 17.98 27.94 47.81 19.27 26.33 47.47 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 25.57 34.71 45.51 26.38 33.70 43.83 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 15.53 27.71 42.41 13.14 27.33 42.95 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 43 HIS.? 6.84 CA CA B 201 C 646 ASP B 38 ASP~? -3.30 CA CA B 201s C 741 SER B 42 SER.? 8.82 CA CA B 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -14.88 22.70 74.95 -14.62 20.32 74.49 ULMN 3 1qrz_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 51 HIS~? 12.10 CA CA B 201 C 646 ASP B 4 ASP~? 21.62 CA CA B 201 C 741 SER B 42 SER.? 8.82 CA CA B 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -14.88 22.70 74.95 -14.62 20.32 74.49 ULMN 3 1qrz_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS B 51 HIS~? 12.10 CA CA B 201 C 646 ASP B 4 ASP~? 21.62 CA CA B 201 C 741 SER B 47 SER~? 15.49 CA CA B 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -5.98 27.66 81.59 -3.55 27.32 80.93 1qrz_c14 source 1qrz PLASMINOGEN : 6 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 43 HIS.? 6.83 CA CA A 202 D 646 ASP A 38 ASP~? -3.36 CA CA A 202s D 741 SER A 42 SER.? 8.78 CA CA A 202 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 20.15 20.72 47.43 19.82 19.00 48.57 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 14.49 17.18 50.40 16.42 16.29 49.93 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 24.49 22.68 48.88 24.08 20.35 49.41 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 51 HIS~? 12.20 CA CA A 202 D 646 ASP A 4 ASP~? 21.72 CA CA A 202 D 741 SER A 42 SER.? 8.78 CA CA A 202 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 17.98 27.94 47.81 19.27 26.33 47.47 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 25.57 34.71 45.51 26.38 33.70 43.83 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 24.49 22.68 48.88 24.08 20.35 49.41 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 51 HIS~? 12.20 CA CA A 202 D 646 ASP A 4 ASP~? 21.72 CA CA A 202 D 741 SER A 47 SER~? 10.78 OXT ACT B 801 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 17.98 27.94 47.81 19.27 26.33 47.47 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 25.57 34.71 45.51 26.38 33.70 43.83 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 15.53 27.71 42.41 13.14 27.33 42.95 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 43 HIS.? 6.84 CA CA B 201 D 646 ASP B 38 ASP~? -3.30 CA CA B 201s D 741 SER B 42 SER.? 8.82 CA CA B 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -14.88 22.70 74.95 -14.62 20.32 74.49 ULMN 3 1qrz_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS B 51 HIS~? 12.10 CA CA B 201 D 646 ASP B 4 ASP~? 21.62 CA CA B 201 D 741 SER B 42 SER.? 8.82 CA CA B 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -14.88 22.70 74.95 -14.62 20.32 74.49 ULMN 3 1qrz_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS B 51 HIS~? 12.10 CA CA B 201 D 646 ASP B 4 ASP~? 21.62 CA CA B 201 D 741 SER B 47 SER~? 15.49 CA CA B 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -5.98 27.66 81.59 -3.55 27.32 80.93 1qrz_c15 source 1qrz PLASMINOGEN : 6 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 53 HIS~? 13.16 CA CA A 202 A 646 ASP A 38 ASP~? -3.36 CA CA A 202s A 739 GLY A 59 GLY~? 16.87 CA CA A 202 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 26.57 50.59 7.78 25.45 51.45 coo -18.83 7.68 26.86 -20.89 7.78 26.56 14.49 17.18 50.40 16.42 16.29 49.93 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 12.94 30.92 60.55 12.49 30.19 60.50 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 53 HIS~? 13.16 CA CA A 202 C 646 ASP A 38 ASP~? -3.36 CA CA A 202s C 739 GLY A 59 GLY~? 16.87 CA CA A 202 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.33 26.57 50.59 7.78 25.45 51.45 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 14.49 17.18 50.40 16.42 16.29 49.93 coo 7.82 1.25 3.03 7.30 1.31 3.65 12.94 30.92 60.55 12.49 30.19 60.50 1qrz_c22 source 1qrz PLASMINOGEN : 1 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 53 HIS~? 13.16 CA CA A 202 D 646 ASP A 38 ASP~? -3.36 CA CA A 202s D 739 GLY A 59 GLY~? 16.87 CA CA A 202 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 26.57 50.59 7.78 25.45 51.45 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 14.49 17.18 50.40 16.42 16.29 49.93 coo -45.82 1.31 41.67 -46.38 1.39 42.31 12.94 30.92 60.55 12.49 30.19 60.50 1qrz_c23 source 1qrz PLASMINOGEN : 1 hits 1qrz_c23 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 41 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 119 HIS A 43 HIS.? 6.83 CA CA A 202 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 19.28 27.48 52.70 18.40 25.59 52.72 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 20.81 34.16 44.49 19.85 28.53 41.75 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 41 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 119 HIS A 53 HIS~? 13.16 CA CA A 202 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 19.28 27.48 52.70 18.40 25.59 52.72 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 20.81 34.16 44.49 19.85 28.53 41.75 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 41 LYS A 17 LYS~? 8.75 CA CA A 202 A 119 HIS A 43 HIS.? 6.83 CA CA A 202 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 19.28 27.48 52.70 18.40 25.59 52.72 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 19.68 24.92 63.26 19.27 20.80 60.44 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 4 3 # 4 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 41 LYS A 17 LYS~? 8.75 CA CA A 202 A 119 HIS A 53 HIS~? 13.16 CA CA A 202 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 19.28 27.48 52.70 18.40 25.59 52.72 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 19.68 24.92 63.26 19.27 20.80 60.44 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 5 3 # 5 A 12 HIS A 43 HIS.? 6.83 CA CA A 202 A 41 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 119 HIS A 45 HIS.? 16.70 CA CA A 202 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 20.15 20.72 47.43 19.82 19.00 48.57 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 13.41 31.22 50.01 11.37 34.80 45.78 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 6 3 # 6 A 12 HIS A 45 HIS.? 16.70 CA CA A 202 A 41 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 119 HIS A 43 HIS.? 6.83 CA CA A 202 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 22.98 23.53 40.00 25.00 23.74 39.51 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 20.81 34.16 44.49 19.85 28.53 41.75 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 7 3 # 7 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 41 LYS B 3 LYS~? 17.03 CA CA B 201 A 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 8 3 # 8 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 41 LYS B 3 LYS~? 17.03 CA CA B 201 A 119 HIS B 53 HIS~? 13.80 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 9 3 # 9 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 41 LYS B 17 LYS~? 8.61 CA CA B 201 A 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 10 3 # 10 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 41 LYS B 17 LYS~? 8.61 CA CA B 201 A 119 HIS B 53 HIS~? 13.80 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 11 3 # 11 A 12 HIS B 43 HIS.? 6.84 CA CA B 201 A 41 LYS B 52 LYS~? 20.44 CA CA B 201 A 119 HIS B 45 HIS.? 16.95 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 12 3 # 12 A 12 HIS B 45 HIS.? 16.95 CA CA B 201 A 41 LYS A 79 LYS~? 16.33 CA CA B 201 A 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 13 3 # 13 A 12 HIS B 45 HIS.? 16.95 CA CA B 201 A 41 LYS B 3 LYS~? 17.03 CA CA B 201 A 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 14 3 # 14 A 12 HIS B 51 HIS~? 12.10 CA CA B 201 A 41 LYS A 79 LYS~? 16.33 CA CA B 201 A 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 15 3 # 15 A 12 HIS B 53 HIS~? 13.80 CA CA B 201 A 41 LYS A 79 LYS~? 16.33 CA CA B 201 A 119 HIS B 10 HIS~? 10.24 CA CA B 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 0.46 27.04 73.26 2.14 26.33 72.22 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -9.62 27.46 71.20 -8.83 25.53 71.16 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 15 hits 1rbn_c01 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 4 ASP~? 21.72 CA CA A 202 A 610 HIS A 2 HIS~? 23.51 OXT ACT B 801 A 661 HIS A 51 HIS~? 12.20 CA CA A 202 coo 75.99 81.56 1.86 73.91 81.34 2.28 25.57 34.71 45.51 26.38 33.70 43.83 coo 71.04 78.84 0.46 71.54 76.90 1.02 22.09 39.77 43.94 22.07 41.64 42.98 coo 75.40 81.38 12.06 74.88 79.42 12.63 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP A 38 ASP~? -3.36 CA CA A 202s A 610 HIS A 43 HIS.? 6.83 CA CA A 202 A 661 HIS A 53 HIS~? 13.16 CA CA A 202 coo 75.99 81.56 1.86 73.91 81.34 2.28 14.49 17.18 50.40 16.42 16.29 49.93 coo 71.04 78.84 0.46 71.54 76.90 1.02 20.15 20.72 47.43 19.82 19.00 48.57 coo 75.40 81.38 12.06 74.88 79.42 12.63 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP B 4 ASP~? 21.62 CA CA B 201 A 610 HIS B 2 HIS~? 26.00 CH3 ACT B 802 A 661 HIS B 51 HIS~? 12.10 CA CA B 201 coo 75.99 81.56 1.86 73.91 81.34 2.28 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 71.04 78.84 0.46 71.54 76.90 1.02 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 75.40 81.38 12.06 74.88 79.42 12.63 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP B 38 ASP~? -3.30 CA CA B 201s A 610 HIS B 43 HIS.? 6.84 CA CA B 201 A 661 HIS B 53 HIS~? 13.80 CA CA B 201 coo 75.99 81.56 1.86 73.91 81.34 2.28 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 71.04 78.84 0.46 71.54 76.90 1.02 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 75.40 81.38 12.06 74.88 79.42 12.63 0.46 27.04 73.26 2.14 26.33 72.22 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 4 ASP~? 21.72 CA CA A 202 C 610 HIS A 2 HIS~? 23.51 OXT ACT B 801 C 661 HIS A 51 HIS~? 12.20 CA CA A 202 coo -17.65 80.52 58.00 -16.23 80.79 56.41 25.57 34.71 45.51 26.38 33.70 43.83 coo -16.56 83.18 53.03 -16.33 85.18 53.60 22.09 39.77 43.94 22.07 41.64 42.98 coo -8.38 80.78 62.24 -7.53 82.67 62.02 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP A 38 ASP~? -3.36 CA CA A 202s C 610 HIS A 43 HIS.? 6.83 CA CA A 202 C 661 HIS A 53 HIS~? 13.16 CA CA A 202 coo -17.65 80.52 58.00 -16.23 80.79 56.41 14.49 17.18 50.40 16.42 16.29 49.93 coo -16.56 83.18 53.03 -16.33 85.18 53.60 20.15 20.72 47.43 19.82 19.00 48.57 coo -8.38 80.78 62.24 -7.53 82.67 62.02 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP B 4 ASP~? 21.62 CA CA B 201 C 610 HIS B 2 HIS~? 26.00 CH3 ACT B 802 C 661 HIS B 51 HIS~? 12.10 CA CA B 201 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -12.31 39.90 79.94 -12.15 41.88 80.62 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP B 38 ASP~? -3.30 CA CA B 201s C 610 HIS B 43 HIS.? 6.84 CA CA B 201 C 661 HIS B 53 HIS~? 13.80 CA CA B 201 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -8.38 80.78 62.24 -7.53 82.67 62.02 0.46 27.04 73.26 2.14 26.33 72.22 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c11 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 69 ASP~? 23.19 CA CA B 201 35 SER A 67 SER~? 18.51 CA CA B 201 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo 11.85 17.24 72.81 11.09 15.37 72.36 11.02 26.78 74.77 12.23 26.87 76.45 coo 12.20 12.71 75.45 13.69 13.84 74.03 7.12 29.60 71.54 4.89 29.99 70.85 coo 5.22 15.03 71.43 7.19 14.88 70.83 11.73 20.36 70.40 10.57 19.24 69.08 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 1 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 28 GLU.? 17.79 CA CA A 202 A 288 HIS A 10 HIS~? 10.31 CA CA A 202 A 329 LYS A 46 LYS.? 7.73 CA CA A 202 coo 29.27 18.78 14.99 27.16 18.62 14.76 14.93 15.17 68.81 13.76 15.16 70.59 coo 49.52 10.06 10.36 50.99 9.65 8.92 19.28 27.48 52.70 18.40 25.59 52.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 17.72 24.61 42.81 16.30 19.73 46.29 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 28 GLU.? 17.79 CA CA A 202 A 288 HIS A 10 HIS~? 10.31 CA CA A 202 A 329 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 29.27 18.78 14.99 27.16 18.62 14.76 14.93 15.17 68.81 13.76 15.16 70.59 coo 49.52 10.06 10.36 50.99 9.65 8.92 19.28 27.48 52.70 18.40 25.59 52.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 28 GLU.? 17.79 CA CA A 202 A 288 HIS A 53 HIS~? 13.16 CA CA A 202 A 329 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 29.27 18.78 14.99 27.16 18.62 14.76 14.93 15.17 68.81 13.76 15.16 70.59 coo 49.52 10.06 10.36 50.99 9.65 8.92 9.33 26.57 50.59 7.78 25.45 51.45 coo 57.80 12.92 13.83 53.77 8.42 12.15 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 68 GLU~? 14.30 CA CA B 201 A 288 HIS A 10 HIS~? 10.31 CA CA A 202 A 329 LYS A 46 LYS.? 7.73 CA CA A 202 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.28 24.34 70.76 4.27 24.24 71.35 coo 49.52 10.06 10.36 50.99 9.65 8.92 19.28 27.48 52.70 18.40 25.59 52.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 17.72 24.61 42.81 16.30 19.73 46.29 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU A 68 GLU~? 14.30 CA CA B 201 A 288 HIS A 10 HIS~? 10.31 CA CA A 202 A 329 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.28 24.34 70.76 4.27 24.24 71.35 coo 49.52 10.06 10.36 50.99 9.65 8.92 19.28 27.48 52.70 18.40 25.59 52.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU A 68 GLU~? 14.30 CA CA B 201 A 288 HIS A 53 HIS~? 13.16 CA CA A 202 A 329 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.28 24.34 70.76 4.27 24.24 71.35 coo 49.52 10.06 10.36 50.99 9.65 8.92 9.33 26.57 50.59 7.78 25.45 51.45 coo 57.80 12.92 13.83 53.77 8.42 12.15 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU B 28 GLU.? 17.90 CA CA B 201 A 288 HIS B 10 HIS~? 10.24 CA CA B 201 A 329 LYS B 46 LYS.? 7.77 CA CA B 201 coo 29.27 18.78 14.99 27.16 18.62 14.76 -4.88 15.15 55.19 -3.87 15.18 53.31 coo 49.52 10.06 10.36 50.99 9.65 8.92 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 57.80 12.92 13.83 53.77 8.42 12.15 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU B 28 GLU.? 17.90 CA CA B 201 A 288 HIS B 10 HIS~? 10.24 CA CA B 201 A 329 LYS B 48 LYS~? 22.74 CA CA B 201 coo 29.27 18.78 14.99 27.16 18.62 14.76 -4.88 15.15 55.19 -3.87 15.18 53.31 coo 49.52 10.06 10.36 50.99 9.65 8.92 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 57.80 12.92 13.83 53.77 8.42 12.15 -6.08 30.98 79.72 -6.69 36.84 80.65 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU B 28 GLU.? 17.90 CA CA B 201 A 288 HIS B 53 HIS~? 13.80 CA CA B 201 A 329 LYS B 48 LYS~? 22.74 CA CA B 201 coo 29.27 18.78 14.99 27.16 18.62 14.76 -4.88 15.15 55.19 -3.87 15.18 53.31 coo 49.52 10.06 10.36 50.99 9.65 8.92 0.46 27.04 73.26 2.14 26.33 72.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 -6.08 30.98 79.72 -6.69 36.84 80.65 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU B 68 GLU~? 14.14 CA CA A 202 A 288 HIS B 10 HIS~? 10.24 CA CA B 201 A 329 LYS B 46 LYS.? 7.77 CA CA B 201 coo 29.27 18.78 14.99 27.16 18.62 14.76 3.52 24.40 53.24 5.54 24.28 52.66 coo 49.52 10.06 10.36 50.99 9.65 8.92 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 57.80 12.92 13.83 53.77 8.42 12.15 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU B 68 GLU~? 14.14 CA CA A 202 A 288 HIS B 10 HIS~? 10.24 CA CA B 201 A 329 LYS B 48 LYS~? 22.74 CA CA B 201 coo 29.27 18.78 14.99 27.16 18.62 14.76 3.52 24.40 53.24 5.54 24.28 52.66 coo 49.52 10.06 10.36 50.99 9.65 8.92 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 57.80 12.92 13.83 53.77 8.42 12.15 -6.08 30.98 79.72 -6.69 36.84 80.65 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 11 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 28 GLU.? 17.79 CA CA A 202 B 288 HIS A 53 HIS~? 13.16 CA CA A 202 B 329 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 14.93 15.17 68.81 13.76 15.16 70.59 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 9.33 26.57 50.59 7.78 25.45 51.45 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 36 GLU~? 11.24 CA CA A 202 B 288 HIS B 53 HIS~? 13.80 CA CA B 201 B 329 LYS B 48 LYS~? 22.74 CA CA B 201 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 8.53 16.97 55.87 6.50 17.32 56.35 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 0.46 27.04 73.26 2.14 26.33 72.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -6.08 30.98 79.72 -6.69 36.84 80.65 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 68 GLU~? 14.30 CA CA B 201 B 288 HIS A 10 HIS~? 10.31 CA CA A 202 B 329 LYS A 46 LYS.? 7.73 CA CA A 202 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 6.28 24.34 70.76 4.27 24.24 71.35 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 19.28 27.48 52.70 18.40 25.59 52.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.72 24.61 42.81 16.30 19.73 46.29 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU A 68 GLU~? 14.30 CA CA B 201 B 288 HIS A 10 HIS~? 10.31 CA CA A 202 B 329 LYS A 48 LYS~? 17.72 OXT ACT B 801 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 6.28 24.34 70.76 4.27 24.24 71.35 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 19.28 27.48 52.70 18.40 25.59 52.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 15.60 31.02 44.27 16.30 36.87 43.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU B 28 GLU.? 17.90 CA CA B 201 B 288 HIS B 51 HIS~? 12.10 CA CA B 201 B 329 LYS B 3 LYS~? 17.03 CA CA B 201 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -4.88 15.15 55.19 -3.87 15.18 53.31 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU B 28 GLU.? 17.90 CA CA B 201 B 288 HIS B 53 HIS~? 13.80 CA CA B 201 B 329 LYS B 48 LYS~? 22.74 CA CA B 201 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -4.88 15.15 55.19 -3.87 15.18 53.31 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 0.46 27.04 73.26 2.14 26.33 72.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -6.08 30.98 79.72 -6.69 36.84 80.65 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU B 68 GLU~? 14.14 CA CA A 202 B 288 HIS B 10 HIS~? 10.24 CA CA B 201 B 329 LYS B 46 LYS.? 7.77 CA CA B 201 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 3.52 24.40 53.24 5.54 24.28 52.66 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU B 68 GLU~? 14.14 CA CA A 202 B 288 HIS B 10 HIS~? 10.24 CA CA B 201 B 329 LYS B 48 LYS~? 22.74 CA CA B 201 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 3.52 24.40 53.24 5.54 24.28 52.66 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -6.08 30.98 79.72 -6.69 36.84 80.65 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 8 hits 1roz_c01 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 2 HIS~? 23.51 OXT ACT B 801 62 GLU A 5 GLU~? 25.21 CA CA A 202 101 HIS A 51 HIS~? 12.20 CA CA A 202 coo 13.91 26.31 13.70 14.98 27.08 12.06 22.09 39.77 43.94 22.07 41.64 42.98 coo 9.15 26.32 13.85 8.75 28.20 13.02 23.31 38.61 48.39 22.38 40.48 47.97 coo 7.90 34.31 7.89 9.24 33.73 9.42 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS A 43 HIS.? 6.83 CA CA A 202 62 GLU A 40 GLU.? 3.38 CA CA A 202s 101 HIS A 53 HIS~? 13.16 CA CA A 202 coo 13.91 26.31 13.70 14.98 27.08 12.06 20.15 20.72 47.43 19.82 19.00 48.57 coo 9.15 26.32 13.85 8.75 28.20 13.02 19.19 19.98 52.16 20.07 18.13 52.69 coo 7.90 34.31 7.89 9.24 33.73 9.42 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 3 3 # 3 41 HIS A 51 HIS~? 12.20 CA CA A 202 62 GLU A 50 GLU~? 11.43 OXT ACT B 801 101 HIS A 45 HIS.? 16.70 CA CA A 202 coo 13.91 26.31 13.70 14.98 27.08 12.06 17.98 27.94 47.81 19.27 26.33 47.47 coo 9.15 26.32 13.85 8.75 28.20 13.02 12.68 24.99 44.98 13.54 23.53 43.68 coo 7.90 34.31 7.89 9.24 33.73 9.42 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 4 3 # 4 41 HIS A 53 HIS~? 13.16 CA CA A 202 62 GLU A 50 GLU~? 11.43 OXT ACT B 801 101 HIS A 10 HIS~? 10.31 CA CA A 202 coo 13.91 26.31 13.70 14.98 27.08 12.06 9.33 26.57 50.59 7.78 25.45 51.45 coo 9.15 26.32 13.85 8.75 28.20 13.02 12.68 24.99 44.98 13.54 23.53 43.68 coo 7.90 34.31 7.89 9.24 33.73 9.42 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 5 3 # 5 41 HIS A 53 HIS~? 13.16 CA CA A 202 62 GLU A 50 GLU~? 11.43 OXT ACT B 801 101 HIS A 43 HIS.? 6.83 CA CA A 202 coo 13.91 26.31 13.70 14.98 27.08 12.06 9.33 26.57 50.59 7.78 25.45 51.45 coo 9.15 26.32 13.85 8.75 28.20 13.02 12.68 24.99 44.98 13.54 23.53 43.68 coo 7.90 34.31 7.89 9.24 33.73 9.42 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 6 3 # 6 41 HIS B 51 HIS~? 12.10 CA CA B 201 62 GLU B 50 GLU~? 12.54 CA CA B 201 101 HIS B 45 HIS.? 16.95 CA CA B 201 coo 13.91 26.31 13.70 14.98 27.08 12.06 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 9.15 26.32 13.85 8.75 28.20 13.02 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 7.90 34.31 7.89 9.24 33.73 9.42 -13.51 23.76 84.04 -15.48 24.29 84.50 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 6 hits 1rtu_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 18 ASP~? 11.52 CA CA A 202 595 GLU A 40 GLU.? 3.38 CA CA A 202s 713 TYR A 34 TYR~? 7.34 CA CA A 202 coo 5.64 2.82 38.49 4.59 4.19 37.25 23.94 22.65 63.18 23.40 21.50 61.45 coo 4.35 13.73 37.63 3.39 12.18 36.55 19.19 19.98 52.16 20.07 18.13 52.69 coo 3.76 10.25 31.38 3.16 9.87 34.10 14.67 22.85 56.72 17.08 23.07 55.48 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 18 ASP~? 9.64 OXT ACT B 802 595 GLU B 35 GLU~? 4.98 CA CA B 201 713 TYR B 34 TYR~? 7.28 CA CA B 201 coo 5.64 2.82 38.49 4.59 4.19 37.25 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 4.35 13.73 37.63 3.39 12.18 36.55 -5.01 17.82 65.60 -7.08 17.81 66.03 coo 3.76 10.25 31.38 3.16 9.87 34.10 -4.97 22.79 67.30 -7.41 23.00 68.45 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP B 18 ASP~? 9.64 OXT ACT B 802 595 GLU B 40 GLU.? 3.43 CA CA B 201s 713 TYR B 34 TYR~? 7.28 CA CA B 201 coo 5.64 2.82 38.49 4.59 4.19 37.25 -14.19 22.62 60.80 -13.56 21.49 62.54 coo 4.35 13.73 37.63 3.39 12.18 36.55 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 3.76 10.25 31.38 3.16 9.87 34.10 -4.97 22.79 67.30 -7.41 23.00 68.45 1sll_c00 source 1sll SIALIDASE L : 3 hits 1sll_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 69 ASP~? 23.19 CA CA B 201 A 37 SER A 67 SER~? 18.51 CA CA B 201 A 214 ASP A 27 ASP.? 17.47 CA CA A 202 coo 51.75 60.57 19.10 52.05 60.90 21.19 11.02 26.78 74.77 12.23 26.87 76.45 coo 51.10 65.11 20.73 52.62 63.74 19.42 7.12 29.60 71.54 4.89 29.99 70.85 coo 48.59 58.89 25.78 50.13 59.74 24.61 11.73 20.36 70.40 10.57 19.24 69.08 1sme_c04 source 1sme PLASMEPSIN II : 1 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 69 ASP~? 23.19 CA CA B 201 B 37 SER A 67 SER~? 18.51 CA CA B 201 B 214 ASP A 27 ASP.? 17.47 CA CA A 202 coo 17.69 97.58 52.73 17.33 97.19 54.77 11.02 26.78 74.77 12.23 26.87 76.45 coo 20.67 100.44 55.84 20.21 98.51 54.45 7.12 29.60 71.54 4.89 29.99 70.85 coo 12.41 98.71 58.47 14.37 98.17 58.05 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP B 69 ASP~? 15.19 CH3 ACT B 801 B 37 SER B 67 SER~? 20.12 CA CA A 202 B 214 ASP B 27 ASP.? 17.39 CA CA B 201 coo 17.69 97.58 52.73 17.33 97.19 54.77 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 20.67 100.44 55.84 20.21 98.51 54.45 2.68 29.83 52.62 3.84 31.35 54.03 coo 12.41 98.71 58.47 14.37 98.17 58.05 -1.83 20.43 53.73 -0.68 19.31 55.10 1sme_c05 source 1sme PLASMEPSIN II : 2 hits 1sme_c05 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 49 SER~? 11.81 OXT ACT B 801 A 90 SER A 47 SER~? 10.78 OXT ACT B 801 A 145 LYS A 3 LYS~? 15.08 OXT ACT B 801 coo -3.31 40.95 15.56 -0.94 40.79 14.97 12.01 30.11 45.26 9.74 29.35 44.91 coo 1.47 40.03 18.48 2.45 41.37 16.68 15.53 27.71 42.41 13.14 27.33 42.95 coo 7.35 44.71 16.29 4.71 40.98 14.52 20.81 34.16 44.49 19.85 28.53 41.75 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 78 SER~? 22.09 CA CA B 201 A 90 SER B 49 SER~? 17.16 CA CA B 201 A 145 LYS B 3 LYS~? 17.03 CA CA B 201 coo -3.31 40.95 15.56 -0.94 40.79 14.97 0.59 30.86 84.57 0.46 32.77 83.16 coo 1.47 40.03 18.48 2.45 41.37 16.68 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 7.35 44.71 16.29 4.71 40.98 14.52 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER A 78 SER~? 22.09 CA CA B 201 A 90 SER B 49 SER~? 17.16 CA CA B 201 A 145 LYS B 46 LYS.? 7.77 CA CA B 201 coo -3.31 40.95 15.56 -0.94 40.79 14.97 0.59 30.86 84.57 0.46 32.77 83.16 coo 1.47 40.03 18.48 2.45 41.37 16.68 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 7.35 44.71 16.29 4.71 40.98 14.52 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER B 49 SER~? 17.16 CA CA B 201 A 90 SER B 47 SER~? 15.49 CA CA B 201 A 145 LYS B 3 LYS~? 17.03 CA CA B 201 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 1.47 40.03 18.48 2.45 41.37 16.68 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 7.35 44.71 16.29 4.71 40.98 14.52 -11.18 34.10 79.40 -10.41 28.56 82.35 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 49 SER~? 11.81 OXT ACT B 801 B 90 SER A 47 SER~? 10.78 OXT ACT B 801 B 145 LYS A 3 LYS~? 15.08 OXT ACT B 801 coo 61.01 10.03 12.97 58.78 10.97 12.69 12.01 30.11 45.26 9.74 29.35 44.91 coo 56.85 12.22 16.37 55.62 11.34 14.45 15.53 27.71 42.41 13.14 27.33 42.95 coo 49.80 9.51 14.88 53.14 11.99 12.77 20.81 34.16 44.49 19.85 28.53 41.75 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 78 SER~? 22.09 CA CA B 201 B 90 SER B 49 SER~? 17.16 CA CA B 201 B 145 LYS B 3 LYS~? 17.03 CA CA B 201 coo 61.01 10.03 12.97 58.78 10.97 12.69 0.59 30.86 84.57 0.46 32.77 83.16 coo 56.85 12.22 16.37 55.62 11.34 14.45 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 49.80 9.51 14.88 53.14 11.99 12.77 -11.18 34.10 79.40 -10.41 28.56 82.35 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER A 78 SER~? 22.09 CA CA B 201 B 90 SER B 49 SER~? 17.16 CA CA B 201 B 145 LYS B 46 LYS.? 7.77 CA CA B 201 coo 61.01 10.03 12.97 58.78 10.97 12.69 0.59 30.86 84.57 0.46 32.77 83.16 coo 56.85 12.22 16.37 55.62 11.34 14.45 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 49.80 9.51 14.88 53.14 11.99 12.77 -8.20 24.59 81.13 -6.93 19.58 77.81 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER B 49 SER~? 17.16 CA CA B 201 B 90 SER B 47 SER~? 15.49 CA CA B 201 B 145 LYS B 3 LYS~? 17.03 CA CA B 201 coo 61.01 10.03 12.97 58.78 10.97 12.69 -2.45 30.10 78.86 -0.23 29.26 79.33 coo 56.85 12.22 16.37 55.62 11.34 14.45 -5.98 27.66 81.59 -3.55 27.32 80.93 coo 49.80 9.51 14.88 53.14 11.99 12.77 -11.18 34.10 79.40 -10.41 28.56 82.35 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c01 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 72 SER~? 18.54 CA CA B 201 354 GLU A 68 GLU~? 14.30 CA CA B 201 463 HIS B 53 HIS~? 13.80 CA CA B 201 coo 48.87 13.74 2.81 48.49 11.54 3.93 5.94 24.99 78.50 7.74 23.37 78.35 coo 39.95 14.43 3.01 41.55 14.10 1.63 6.28 24.34 70.76 4.27 24.24 71.35 coo 43.90 10.50 2.81 45.63 11.48 3.27 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER A 72 SER~? 18.54 CA CA B 201 354 GLU B 50 GLU~? 12.54 CA CA B 201 463 HIS B 53 HIS~? 13.80 CA CA B 201 coo 48.87 13.74 2.81 48.49 11.54 3.93 5.94 24.99 78.50 7.74 23.37 78.35 coo 39.95 14.43 3.01 41.55 14.10 1.63 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 43.90 10.50 2.81 45.63 11.48 3.27 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 3 3 # 3 217 SER B 72 SER~? 11.29 CH3 ACT B 801 354 GLU A 50 GLU~? 11.43 OXT ACT B 801 463 HIS A 53 HIS~? 13.16 CA CA A 202 coo 48.87 13.74 2.81 48.49 11.54 3.93 4.20 25.43 45.78 2.18 24.15 45.83 coo 39.95 14.43 3.01 41.55 14.10 1.63 12.68 24.99 44.98 13.54 23.53 43.68 coo 43.90 10.50 2.81 45.63 11.48 3.27 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 4 3 # 4 217 SER B 72 SER~? 11.29 CH3 ACT B 801 354 GLU B 68 GLU~? 14.14 CA CA A 202 463 HIS A 53 HIS~? 13.16 CA CA A 202 coo 48.87 13.74 2.81 48.49 11.54 3.93 4.20 25.43 45.78 2.18 24.15 45.83 coo 39.95 14.43 3.01 41.55 14.10 1.63 3.52 24.40 53.24 5.54 24.28 52.66 coo 43.90 10.50 2.81 45.63 11.48 3.27 9.33 26.57 50.59 7.78 25.45 51.45 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 4 hits 1thg_c00 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 51 HIS~? 12.20 CA CA A 202 89 GLU A 50 GLU~? 11.43 OXT ACT B 801 243 ASN A 15 ASN~? 15.90 CA CA A 202 coo 5.83 15.74 17.38 6.41 17.70 17.86 17.98 27.94 47.81 19.27 26.33 47.47 coo 3.11 16.19 13.44 4.96 17.09 13.42 12.68 24.99 44.98 13.54 23.53 43.68 coo 0.53 21.81 31.33 1.05 20.47 29.70 25.38 27.93 60.94 26.84 27.34 59.51 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS B 51 HIS~? 12.10 CA CA B 201 89 GLU B 50 GLU~? 12.54 CA CA B 201 243 ASN B 15 ASN~? 6.97 CH3 ACT B 802 coo 5.83 15.74 17.38 6.41 17.70 17.86 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 3.11 16.19 13.44 4.96 17.09 13.42 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 0.53 21.81 31.33 1.05 20.47 29.70 -15.63 27.98 63.03 -17.12 27.37 64.41 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 2 hits 1ula_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU A 5 GLU~? 25.21 CA CA A 202 A 87 ASP A 4 ASP~? 21.72 CA CA A 202 A 89 GLU A 8 GLU~? 21.63 CA CA A 202 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 23.31 38.61 48.39 22.38 40.48 47.97 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 25.57 34.71 45.51 26.38 33.70 43.83 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU A 8 GLU~? 21.63 CA CA A 202 A 87 ASP A 4 ASP~? 21.72 CA CA A 202 A 89 GLU A 5 GLU~? 25.21 CA CA A 202 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 26.55 33.36 50.86 27.60 35.12 50.29 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 25.57 34.71 45.51 26.38 33.70 43.83 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 23.31 38.61 48.39 22.38 40.48 47.97 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 A 85 GLU B 5 GLU~? 21.97 CH3 ACT B 802 A 87 ASP B 4 ASP~? 21.62 CA CA B 201 A 89 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 A 85 GLU B 8 GLU~? 16.54 CH3 ACT B 802 A 87 ASP B 4 ASP~? 21.62 CA CA B 201 A 89 GLU B 5 GLU~? 21.97 CH3 ACT B 802 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -13.74 38.60 75.53 -12.83 40.48 75.93 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 A 85 GLU B 70 GLU~? 15.15 CH3 ACT B 801 A 87 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 89 GLU B 68 GLU~? 14.14 CA CA A 202 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 2.91 32.18 47.37 1.68 33.21 45.95 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 3.52 24.40 53.24 5.54 24.28 52.66 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 5 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU A 5 GLU~? 25.21 CA CA A 202 B 87 ASP A 4 ASP~? 21.72 CA CA A 202 B 89 GLU A 8 GLU~? 21.63 CA CA A 202 coo 19.32 178.30 3.72 20.56 176.87 2.77 23.31 38.61 48.39 22.38 40.48 47.97 coo 22.91 179.81 6.56 22.10 178.65 5.00 25.57 34.71 45.51 26.38 33.70 43.83 coo 26.74 177.55 7.48 27.16 177.47 5.41 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 B 85 GLU A 8 GLU~? 21.63 CA CA A 202 B 87 ASP A 4 ASP~? 21.72 CA CA A 202 B 89 GLU A 5 GLU~? 25.21 CA CA A 202 coo 19.32 178.30 3.72 20.56 176.87 2.77 26.55 33.36 50.86 27.60 35.12 50.29 coo 22.91 179.81 6.56 22.10 178.65 5.00 25.57 34.71 45.51 26.38 33.70 43.83 coo 26.74 177.55 7.48 27.16 177.47 5.41 23.31 38.61 48.39 22.38 40.48 47.97 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 B 85 GLU B 5 GLU~? 21.97 CH3 ACT B 802 B 87 ASP B 4 ASP~? 21.62 CA CA B 201 B 89 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 19.32 178.30 3.72 20.56 176.87 2.77 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 22.91 179.81 6.56 22.10 178.65 5.00 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 26.74 177.55 7.48 27.16 177.47 5.41 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 B 85 GLU B 8 GLU~? 16.54 CH3 ACT B 802 B 87 ASP B 4 ASP~? 21.62 CA CA B 201 B 89 GLU B 5 GLU~? 21.97 CH3 ACT B 802 coo 19.32 178.30 3.72 20.56 176.87 2.77 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 22.91 179.81 6.56 22.10 178.65 5.00 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 26.74 177.55 7.48 27.16 177.47 5.41 -13.74 38.60 75.53 -12.83 40.48 75.93 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 B 85 GLU B 70 GLU~? 15.15 CH3 ACT B 801 B 87 ASP B 69 ASP~? 15.19 CH3 ACT B 801 B 89 GLU B 68 GLU~? 14.14 CA CA A 202 coo 19.32 178.30 3.72 20.56 176.87 2.77 2.91 32.18 47.37 1.68 33.21 45.95 coo 22.91 179.81 6.56 22.10 178.65 5.00 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 26.74 177.55 7.48 27.16 177.47 5.41 3.52 24.40 53.24 5.54 24.28 52.66 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 5 hits 1un1_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 24 ASP.? 26.42 CA CA A 202 218 GLU A 50 GLU~? 11.43 OXT ACT B 801 329 ASP A 69 ASP~? 23.19 CA CA B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 20.63 21.72 77.63 20.78 20.24 79.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 12.68 24.99 44.98 13.54 23.53 43.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 11.02 26.78 74.77 12.23 26.87 76.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 24 ASP.? 15.33 OXT ACT B 802 218 GLU B 5 GLU~? 21.97 CH3 ACT B 802 329 ASP B 27 ASP.? 17.39 CA CA B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.83 20.43 53.73 -0.68 19.31 55.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 24 ASP.? 15.33 OXT ACT B 802 218 GLU B 50 GLU~? 12.54 CA CA B 201 329 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 49.16 35.16 15.19 51.08 34.43 15.65 -10.90 21.62 46.30 -10.75 20.16 44.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -0.95 26.94 49.29 -2.15 27.04 47.60 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 27 ASP.? 17.47 CA CA A 202 242 GLU B 40 GLU.? 3.43 CA CA B 201s 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 11.73 20.36 70.40 10.57 19.24 69.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 27 ASP.? 17.47 CA CA A 202 242 GLU B 68 GLU~? 14.14 CA CA A 202 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 11.73 20.36 70.40 10.57 19.24 69.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.52 24.40 53.24 5.54 24.28 52.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 69 ASP~? 23.19 CA CA B 201 242 GLU A 82 GLU~? 19.14 CA CA B 201 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 11.02 26.78 74.77 12.23 26.87 76.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 69 ASP~? 23.19 CA CA B 201 242 GLU B 35 GLU~? 4.98 CA CA B 201 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 11.02 26.78 74.77 12.23 26.87 76.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -5.01 17.82 65.60 -7.08 17.81 66.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 69 ASP~? 23.19 CA CA B 201 242 GLU B 40 GLU.? 3.43 CA CA B 201s 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 11.02 26.78 74.77 12.23 26.87 76.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 69 ASP~? 23.19 CA CA B 201 242 GLU B 68 GLU~? 14.14 CA CA A 202 329 ASP A 24 ASP.? 26.42 CA CA A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 11.02 26.78 74.77 12.23 26.87 76.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.52 24.40 53.24 5.54 24.28 52.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.63 21.72 77.63 20.78 20.24 79.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 27 ASP.? 17.39 CA CA B 201 242 GLU A 40 GLU.? 3.38 CA CA A 202s 329 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 19.19 19.98 52.16 20.07 18.13 52.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -10.90 21.62 46.30 -10.75 20.16 44.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 69 ASP~? 15.19 CH3 ACT B 801 242 GLU A 35 GLU~? 5.06 CA CA A 202 329 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 30.42 34.74 5.00 29.09 35.09 3.38 14.74 18.03 58.46 16.79 18.12 57.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 -10.90 21.62 46.30 -10.75 20.16 44.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 69 ASP~? 15.19 CH3 ACT B 801 242 GLU A 40 GLU.? 3.38 CA CA A 202s 329 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 30.42 34.74 5.00 29.09 35.09 3.38 19.19 19.98 52.16 20.07 18.13 52.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -10.90 21.62 46.30 -10.75 20.16 44.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 69 ASP~? 15.19 CH3 ACT B 801 242 GLU A 68 GLU~? 14.30 CA CA B 201 329 ASP B 24 ASP.? 15.33 OXT ACT B 802 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.28 24.34 70.76 4.27 24.24 71.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 -10.90 21.62 46.30 -10.75 20.16 44.81 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 10 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 83 GLU~? 18.60 CA CA B 201 A 596 ARG A 80 ARG~? 24.83 CA CA B 201 A 647 ARG A 76 ARG~? 16.28 CA CA B 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 70.89 37.31 29.70 69.54 36.29 32.39 1.65 24.64 89.61 4.49 24.81 90.71 coo 66.09 40.54 34.70 66.92 37.69 35.49 4.46 22.84 83.40 3.22 20.31 82.22 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 83 GLU~? 18.60 CA CA B 201 B 596 ARG A 80 ARG~? 24.83 CA CA B 201 B 647 ARG A 76 ARG~? 16.28 CA CA B 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 34.24 60.89 68.08 33.31 57.93 67.63 1.65 24.64 89.61 4.49 24.81 90.71 coo 31.43 57.38 61.97 31.90 55.58 64.41 4.46 22.84 83.40 3.22 20.31 82.22 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 83 GLU~? 18.60 CA CA B 201 C 596 ARG A 80 ARG~? 24.83 CA CA B 201 C 647 ARG A 76 ARG~? 16.28 CA CA B 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 13.44 32.78 22.07 15.56 30.91 23.37 1.65 24.64 89.61 4.49 24.81 90.71 coo 21.00 33.35 22.82 19.83 30.82 24.09 4.46 22.84 83.40 3.22 20.31 82.22 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 83 GLU~? 18.60 CA CA B 201 D 596 ARG A 80 ARG~? 24.83 CA CA B 201 D 647 ARG A 76 ARG~? 16.28 CA CA B 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -4.99 25.05 87.76 -3.42 23.71 87.32 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 1.65 24.64 89.61 4.49 24.81 90.71 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 4.46 22.84 83.40 3.22 20.31 82.22 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 83 GLU~? 18.60 CA CA B 201 E 596 ARG A 80 ARG~? 24.83 CA CA B 201 E 647 ARG A 76 ARG~? 16.28 CA CA B 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -4.99 25.05 87.76 -3.42 23.71 87.32 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 1.65 24.64 89.61 4.49 24.81 90.71 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 4.46 22.84 83.40 3.22 20.31 82.22 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 83 GLU~? 18.60 CA CA B 201 F 596 ARG A 80 ARG~? 24.83 CA CA B 201 F 647 ARG A 76 ARG~? 16.28 CA CA B 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -4.99 25.05 87.76 -3.42 23.71 87.32 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 1.65 24.64 89.61 4.49 24.81 90.71 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 4.46 22.84 83.40 3.22 20.31 82.22 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c05 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 25 HIS.? 26.12 CA CA B 201 A 169 ASP A 69 ASP~? 23.19 CA CA B 201 A 288 GLU A 70 GLU~? 24.16 CA CA B 201 coo 67.72 35.99 30.87 69.77 36.13 31.33 16.66 18.79 78.66 17.26 17.28 79.97 coo 73.17 30.66 22.56 72.87 30.30 20.46 11.02 26.78 74.77 12.23 26.87 76.45 coo 74.06 28.51 15.92 73.77 29.56 17.73 7.07 31.83 76.89 8.40 32.80 78.24 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS A 45 HIS.? 16.70 CA CA A 202 A 169 ASP A 4 ASP~? 21.72 CA CA A 202 A 288 GLU A 5 GLU~? 25.21 CA CA A 202 coo 67.72 35.99 30.87 69.77 36.13 31.33 22.98 23.53 40.00 25.00 23.74 39.51 coo 73.17 30.66 22.56 72.87 30.30 20.46 25.57 34.71 45.51 26.38 33.70 43.83 coo 74.06 28.51 15.92 73.77 29.56 17.73 23.31 38.61 48.39 22.38 40.48 47.97 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS A 51 HIS~? 12.20 CA CA A 202 A 169 ASP A 38 ASP~? -3.36 CA CA A 202s A 288 GLU A 36 GLU~? 11.24 CA CA A 202 coo 67.72 35.99 30.87 69.77 36.13 31.33 17.98 27.94 47.81 19.27 26.33 47.47 coo 73.17 30.66 22.56 72.87 30.30 20.46 14.49 17.18 50.40 16.42 16.29 49.93 coo 74.06 28.51 15.92 73.77 29.56 17.73 8.53 16.97 55.87 6.50 17.32 56.35 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS A 53 HIS~? 13.16 CA CA A 202 A 169 ASP B 27 ASP.? 17.39 CA CA B 201 A 288 GLU B 28 GLU.? 17.90 CA CA B 201 coo 67.72 35.99 30.87 69.77 36.13 31.33 9.33 26.57 50.59 7.78 25.45 51.45 coo 73.17 30.66 22.56 72.87 30.30 20.46 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 74.06 28.51 15.92 73.77 29.56 17.73 -4.88 15.15 55.19 -3.87 15.18 53.31 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS B 25 HIS.? 17.04 CH3 ACT B 801 A 169 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 288 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo 67.72 35.99 30.87 69.77 36.13 31.33 -6.96 18.75 45.30 -7.92 17.57 43.86 coo 73.17 30.66 22.56 72.87 30.30 20.46 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 74.06 28.51 15.92 73.77 29.56 17.73 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS B 45 HIS.? 16.95 CA CA B 201 A 169 ASP B 4 ASP~? 21.62 CA CA B 201 A 288 GLU B 5 GLU~? 21.97 CH3 ACT B 802 coo 67.72 35.99 30.87 69.77 36.13 31.33 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 73.17 30.66 22.56 72.87 30.30 20.46 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 74.06 28.51 15.92 73.77 29.56 17.73 -13.74 38.60 75.53 -12.83 40.48 75.93 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS B 51 HIS~? 12.10 CA CA B 201 A 169 ASP B 38 ASP~? -3.30 CA CA B 201s A 288 GLU B 36 GLU~? 11.20 CA CA B 201 coo 67.72 35.99 30.87 69.77 36.13 31.33 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 73.17 30.66 22.56 72.87 30.30 20.46 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 74.06 28.51 15.92 73.77 29.56 17.73 1.18 16.63 68.50 3.14 16.97 67.89 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 7 hits 1w1o_c00 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 18.28 7.83 36.39 22.82 8.75 39.52 20.81 34.16 44.49 19.85 28.53 41.75 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.60 31.02 44.27 16.30 36.87 43.73 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.72 24.61 42.81 16.30 19.73 46.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.60 31.02 44.27 16.30 36.87 43.73 coo 22.22 16.06 48.76 23.94 15.33 49.78 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.72 24.61 42.81 16.30 19.73 46.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.60 31.02 44.27 16.30 36.87 43.73 coo 22.22 16.06 48.76 23.94 15.33 49.78 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 46 LYS.? 7.73 CA CA A 202 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.72 24.61 42.81 16.30 19.73 46.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.60 31.02 44.27 16.30 36.87 43.73 coo 22.22 16.06 48.76 23.94 15.33 49.78 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.60 31.02 44.27 16.30 36.87 43.73 coo 14.16 13.09 37.03 20.00 12.44 37.49 20.81 34.16 44.49 19.85 28.53 41.75 coo 22.22 16.06 48.76 23.94 15.33 49.78 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 18.28 7.83 36.39 22.82 8.75 39.52 15.60 31.02 44.27 16.30 36.87 43.73 coo 14.16 13.09 37.03 20.00 12.44 37.49 20.81 34.16 44.49 19.85 28.53 41.75 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 46 LYS.? 7.73 CA CA A 202 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.60 31.02 44.27 16.30 36.87 43.73 coo 14.16 13.09 37.03 20.00 12.44 37.49 17.72 24.61 42.81 16.30 19.73 46.29 coo 22.22 16.06 48.76 23.94 15.33 49.78 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.60 31.02 44.27 16.30 36.87 43.73 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.41 31.22 50.01 11.37 34.80 45.78 coo 22.22 16.06 48.76 23.94 15.33 49.78 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 18.28 7.83 36.39 22.82 8.75 39.52 15.60 31.02 44.27 16.30 36.87 43.73 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.41 31.22 50.01 11.37 34.80 45.78 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 13.41 31.22 50.01 11.37 34.80 45.78 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.60 31.02 44.27 16.30 36.87 43.73 coo 22.22 16.06 48.76 23.94 15.33 49.78 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS A 79 LYS~? 16.33 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 18.28 7.83 36.39 22.82 8.75 39.52 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 14.16 13.09 37.03 20.00 12.44 37.49 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 3 LYS~? 17.03 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 18.28 7.83 36.39 22.82 8.75 39.52 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 14.16 13.09 37.03 20.00 12.44 37.49 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 46 LYS.? 7.77 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 18.28 7.83 36.39 22.82 8.75 39.52 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 14.16 13.09 37.03 20.00 12.44 37.49 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS B 46 LYS.? 7.77 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 18.28 7.83 36.39 22.82 8.75 39.52 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 14.16 13.09 37.03 20.00 12.44 37.49 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS A 79 LYS~? 16.33 CA CA B 201 A 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 22.22 16.06 48.76 23.94 15.33 49.78 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 3 LYS~? 17.03 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 22.22 16.06 48.76 23.94 15.33 49.78 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 3 LYS~? 17.03 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 22.22 16.06 48.76 23.94 15.33 49.78 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 46 LYS.? 7.77 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 22.22 16.06 48.76 23.94 15.33 49.78 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 22.22 16.06 48.76 23.94 15.33 49.78 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 22.22 16.06 48.76 23.94 15.33 49.78 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS B 48 LYS~? 22.74 CA CA B 201 A 74 LYS B 52 LYS~? 20.44 CA CA B 201 A 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 22.22 16.06 48.76 23.94 15.33 49.78 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS B 52 LYS~? 20.44 CA CA B 201 A 74 LYS B 48 LYS~? 22.74 CA CA B 201 A 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 18.28 7.83 36.39 22.82 8.75 39.52 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 14.16 13.09 37.03 20.00 12.44 37.49 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 -16.70 27.94 69.16 -17.07 25.96 69.86 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 22 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 13.51 0.92 76.10 12.98 6.13 74.68 20.81 34.16 44.49 19.85 28.53 41.75 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 21.39 11.56 68.52 20.24 13.13 67.73 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 17.72 24.61 42.81 16.30 19.73 46.29 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 21.39 11.56 68.52 20.24 13.13 67.73 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 17.72 24.61 42.81 16.30 19.73 46.29 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 21.39 11.56 68.52 20.24 13.13 67.73 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 46 LYS.? 7.73 CA CA A 202 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU B 70 GLU~? 15.15 CH3 ACT B 801 coo 13.51 0.92 76.10 12.98 6.13 74.68 17.72 24.61 42.81 16.30 19.73 46.29 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 21.39 11.56 68.52 20.24 13.13 67.73 2.91 32.18 47.37 1.68 33.21 45.95 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.89 -0.55 76.51 17.10 4.32 77.43 20.81 34.16 44.49 19.85 28.53 41.75 coo 21.39 11.56 68.52 20.24 13.13 67.73 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 13.51 0.92 76.10 12.98 6.13 74.68 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.89 -0.55 76.51 17.10 4.32 77.43 20.81 34.16 44.49 19.85 28.53 41.75 coo 21.39 11.56 68.52 20.24 13.13 67.73 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 46 LYS.? 7.73 CA CA A 202 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.89 -0.55 76.51 17.10 4.32 77.43 17.72 24.61 42.81 16.30 19.73 46.29 coo 21.39 11.56 68.52 20.24 13.13 67.73 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.41 31.22 50.01 11.37 34.80 45.78 coo 21.39 11.56 68.52 20.24 13.13 67.73 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 74 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 165 GLU A 40 GLU.? 3.38 CA CA A 202s coo 13.51 0.92 76.10 12.98 6.13 74.68 15.60 31.02 44.27 16.30 36.87 43.73 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.41 31.22 50.01 11.37 34.80 45.78 coo 21.39 11.56 68.52 20.24 13.13 67.73 19.19 19.98 52.16 20.07 18.13 52.69 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 8 GLU~? 21.63 CA CA A 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.41 31.22 50.01 11.37 34.80 45.78 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 21.39 11.56 68.52 20.24 13.13 67.73 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 74 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 165 GLU A 11 GLU~? 14.95 CA CA A 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.41 31.22 50.01 11.37 34.80 45.78 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.60 31.02 44.27 16.30 36.87 43.73 coo 21.39 11.56 68.52 20.24 13.13 67.73 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS A 79 LYS~? 16.33 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 13.51 0.92 76.10 12.98 6.13 74.68 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 3 LYS~? 17.03 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 13.51 0.92 76.10 12.98 6.13 74.68 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS B 46 LYS.? 7.77 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 13.51 0.92 76.10 12.98 6.13 74.68 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS B 46 LYS.? 7.77 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 13.51 0.92 76.10 12.98 6.13 74.68 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS A 79 LYS~? 16.33 CA CA B 201 B 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 21.39 11.56 68.52 20.24 13.13 67.73 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 3 LYS~? 17.03 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 21.39 11.56 68.52 20.24 13.13 67.73 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 3 LYS~? 17.03 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 21.39 11.56 68.52 20.24 13.13 67.73 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 46 LYS.? 7.77 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 21.39 11.56 68.52 20.24 13.13 67.73 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 52 LYS~? 20.44 CA CA B 201 B 165 GLU A 68 GLU~? 14.30 CA CA B 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 21.39 11.56 68.52 20.24 13.13 67.73 6.28 24.34 70.76 4.27 24.24 71.35 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 52 LYS~? 20.44 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 21.39 11.56 68.52 20.24 13.13 67.73 -16.70 27.94 69.16 -17.07 25.96 69.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS B 48 LYS~? 22.74 CA CA B 201 B 74 LYS B 52 LYS~? 20.44 CA CA B 201 B 165 GLU B 40 GLU.? 3.43 CA CA B 201s coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 21.39 11.56 68.52 20.24 13.13 67.73 -9.63 20.01 71.75 -10.53 18.20 71.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS B 52 LYS~? 20.44 CA CA B 201 B 74 LYS B 48 LYS~? 22.74 CA CA B 201 B 165 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 13.51 0.92 76.10 12.98 6.13 74.68 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 -16.70 27.94 69.16 -17.07 25.96 69.86 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 23 hits 1ylu_c01 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 42 SER.? 8.78 CA CA A 202 327 GLU A 11 GLU~? 14.95 CA CA A 202 440 HIS A 10 HIS~? 10.31 CA CA A 202 coo 6.96 64.04 57.84 6.74 63.69 60.26 24.49 22.68 48.88 24.08 20.35 49.41 coo 14.82 64.63 62.37 13.47 65.72 61.17 26.25 27.59 54.14 27.19 27.48 52.23 coo 9.52 66.51 63.07 8.75 65.02 61.81 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER A 72 SER~? 18.54 CA CA B 201 327 GLU A 68 GLU~? 14.30 CA CA B 201 440 HIS B 53 HIS~? 13.80 CA CA B 201 coo 6.96 64.04 57.84 6.74 63.69 60.26 5.94 24.99 78.50 7.74 23.37 78.35 coo 14.82 64.63 62.37 13.47 65.72 61.17 6.28 24.34 70.76 4.27 24.24 71.35 coo 9.52 66.51 63.07 8.75 65.02 61.81 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 3 3 # 3 200 SER A 72 SER~? 18.54 CA CA B 201 327 GLU B 50 GLU~? 12.54 CA CA B 201 440 HIS B 53 HIS~? 13.80 CA CA B 201 coo 6.96 64.04 57.84 6.74 63.69 60.26 5.94 24.99 78.50 7.74 23.37 78.35 coo 14.82 64.63 62.37 13.47 65.72 61.17 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 9.52 66.51 63.07 8.75 65.02 61.81 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 4 3 # 4 200 SER B 42 SER.? 8.82 CA CA B 201 327 GLU B 11 GLU~? 12.56 CH3 ACT B 802 440 HIS B 10 HIS~? 10.24 CA CA B 201 coo 6.96 64.04 57.84 6.74 63.69 60.26 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 14.82 64.63 62.37 13.47 65.72 61.17 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 9.52 66.51 63.07 8.75 65.02 61.81 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 5 3 # 5 200 SER B 72 SER~? 11.29 CH3 ACT B 801 327 GLU A 50 GLU~? 11.43 OXT ACT B 801 440 HIS A 53 HIS~? 13.16 CA CA A 202 coo 6.96 64.04 57.84 6.74 63.69 60.26 4.20 25.43 45.78 2.18 24.15 45.83 coo 14.82 64.63 62.37 13.47 65.72 61.17 12.68 24.99 44.98 13.54 23.53 43.68 coo 9.52 66.51 63.07 8.75 65.02 61.81 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 6 3 # 6 200 SER B 72 SER~? 11.29 CH3 ACT B 801 327 GLU B 68 GLU~? 14.14 CA CA A 202 440 HIS A 53 HIS~? 13.16 CA CA A 202 coo 6.96 64.04 57.84 6.74 63.69 60.26 4.20 25.43 45.78 2.18 24.15 45.83 coo 14.82 64.63 62.37 13.47 65.72 61.17 3.52 24.40 53.24 5.54 24.28 52.66 coo 9.52 66.51 63.07 8.75 65.02 61.81 9.33 26.57 50.59 7.78 25.45 51.45 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 6 hits 2ace_c00 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 27 ASP.? 17.39 CA CA B 201 219 GLU B 68 GLU~? 14.14 CA CA A 202 294 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 25.84 105.87 9.06 27.86 105.55 8.74 3.52 24.40 53.24 5.54 24.28 52.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 69 ASP~? 15.19 CH3 ACT B 801 219 GLU B 68 GLU~? 14.14 CA CA A 202 294 ASP B 27 ASP.? 17.39 CA CA B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -0.95 26.94 49.29 -2.15 27.04 47.60 coo 25.84 105.87 9.06 27.86 105.55 8.74 3.52 24.40 53.24 5.54 24.28 52.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 -1.83 20.43 53.73 -0.68 19.31 55.10 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 27 ASP.? 17.39 CA CA B 201 231 ASP A 27 ASP.? 17.47 CA CA A 202 294 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 14.74 93.05 -1.00 14.30 94.22 0.73 11.73 20.36 70.40 10.57 19.24 69.08 coo 33.16 106.80 7.72 33.34 104.87 6.92 -0.95 26.94 49.29 -2.15 27.04 47.60 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 69 ASP~? 23.19 CA CA B 201 38 SER A 67 SER~? 18.51 CA CA B 201 218 ASP A 27 ASP.? 17.47 CA CA A 202 coo 41.14 58.72 105.19 42.39 59.85 103.92 11.02 26.78 74.77 12.23 26.87 76.45 coo 46.04 57.35 103.96 44.97 58.52 105.78 7.12 29.60 71.54 4.89 29.99 70.85 coo 41.33 60.20 97.63 42.00 60.96 99.49 11.73 20.36 70.40 10.57 19.24 69.08 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 1 hits 2apr_c04 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU A 5 GLU~? 25.21 CA CA A 202 107 ASP A 4 ASP~? 21.72 CA CA A 202 109 GLU A 8 GLU~? 21.63 CA CA A 202 coo 15.97 13.58 10.29 15.12 15.36 9.48 23.31 38.61 48.39 22.38 40.48 47.97 coo 20.07 16.34 11.47 18.03 16.15 11.04 25.57 34.71 45.51 26.38 33.70 43.83 coo 20.99 19.84 9.56 19.07 20.34 10.22 26.55 33.36 50.86 27.60 35.12 50.29 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 2 3 # 2 105 GLU A 8 GLU~? 21.63 CA CA A 202 107 ASP A 4 ASP~? 21.72 CA CA A 202 109 GLU A 5 GLU~? 25.21 CA CA A 202 coo 15.97 13.58 10.29 15.12 15.36 9.48 26.55 33.36 50.86 27.60 35.12 50.29 coo 20.07 16.34 11.47 18.03 16.15 11.04 25.57 34.71 45.51 26.38 33.70 43.83 coo 20.99 19.84 9.56 19.07 20.34 10.22 23.31 38.61 48.39 22.38 40.48 47.97 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 3 3 # 3 105 GLU B 5 GLU~? 21.97 CH3 ACT B 802 107 ASP B 4 ASP~? 21.62 CA CA B 201 109 GLU B 8 GLU~? 16.54 CH3 ACT B 802 coo 15.97 13.58 10.29 15.12 15.36 9.48 -13.74 38.60 75.53 -12.83 40.48 75.93 coo 20.07 16.34 11.47 18.03 16.15 11.04 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 20.99 19.84 9.56 19.07 20.34 10.22 -16.78 33.39 73.09 -17.99 35.10 73.27 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 4 3 # 4 105 GLU B 8 GLU~? 16.54 CH3 ACT B 802 107 ASP B 4 ASP~? 21.62 CA CA B 201 109 GLU B 5 GLU~? 21.97 CH3 ACT B 802 coo 15.97 13.58 10.29 15.12 15.36 9.48 -16.78 33.39 73.09 -17.99 35.10 73.27 coo 20.07 16.34 11.47 18.03 16.15 11.04 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 20.99 19.84 9.56 19.07 20.34 10.22 -13.74 38.60 75.53 -12.83 40.48 75.93 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 4 hits 2ayh_c00 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 53 HIS~? 13.16 CA CA A 202 B 163 ALA B 74 ALA~? 10.38 OXT ACT B 801 B 182 SER B 72 SER~? 11.29 CH3 ACT B 801 coo 30.42 1.98 4.36 29.07 0.41 4.68 9.33 26.57 50.59 7.78 25.45 51.45 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 5.44 29.00 42.38 6.07 29.96 43.23 coo 24.00 -0.17 2.07 24.51 1.00 0.04 4.20 25.43 45.78 2.18 24.15 45.83 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 53 HIS~? 13.80 CA CA B 201 B 163 ALA A 64 ALA~? 19.01 CA CA B 201 B 182 SER A 67 SER~? 18.51 CA CA B 201 coo 30.42 1.98 4.36 29.07 0.41 4.68 0.46 27.04 73.26 2.14 26.33 72.22 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 7.86 27.93 66.93 7.41 26.91 65.95 coo 24.00 -0.17 2.07 24.51 1.00 0.04 7.12 29.60 71.54 4.89 29.99 70.85 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 2 hits 2bhg_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 46 LYS.? 7.73 CA CA A 202 A 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 5.98 42.76 7.73 10.19 38.62 9.02 17.72 24.61 42.81 16.30 19.73 46.29 coo 2.77 37.17 4.99 6.33 34.76 8.06 15.60 31.02 44.27 16.30 36.87 43.73 coo 0.07 40.30 18.65 -0.21 42.34 18.18 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 184 LYS A 46 LYS.? 7.73 CA CA A 202 A 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 5.98 42.76 7.73 10.19 38.62 9.02 15.60 31.02 44.27 16.30 36.87 43.73 coo 2.77 37.17 4.99 6.33 34.76 8.06 17.72 24.61 42.81 16.30 19.73 46.29 coo 0.07 40.30 18.65 -0.21 42.34 18.18 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 5.98 42.76 7.73 10.19 38.62 9.02 15.60 31.02 44.27 16.30 36.87 43.73 coo 2.77 37.17 4.99 6.33 34.76 8.06 13.41 31.22 50.01 11.37 34.80 45.78 coo 0.07 40.30 18.65 -0.21 42.34 18.18 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 A 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 5.98 42.76 7.73 10.19 38.62 9.02 13.41 31.22 50.01 11.37 34.80 45.78 coo 2.77 37.17 4.99 6.33 34.76 8.06 15.60 31.02 44.27 16.30 36.87 43.73 coo 0.07 40.30 18.65 -0.21 42.34 18.18 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS A 79 LYS~? 16.33 CA CA B 201 A 184 LYS B 46 LYS.? 7.77 CA CA B 201 A 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 2.77 37.17 4.99 6.33 34.76 8.06 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS A 79 LYS~? 16.33 CA CA B 201 A 184 LYS B 48 LYS~? 22.74 CA CA B 201 A 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 2.77 37.17 4.99 6.33 34.76 8.06 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS B 46 LYS.? 7.77 CA CA B 201 A 184 LYS A 79 LYS~? 16.33 CA CA B 201 A 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 5.98 42.76 7.73 10.19 38.62 9.02 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 2.77 37.17 4.99 6.33 34.76 8.06 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS B 46 LYS.? 7.77 CA CA B 201 A 184 LYS B 48 LYS~? 22.74 CA CA B 201 A 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 2.77 37.17 4.99 6.33 34.76 8.06 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 9 3 # 9 A 182 LYS B 46 LYS.? 7.77 CA CA B 201 A 184 LYS B 48 LYS~? 22.74 CA CA B 201 A 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 5.98 42.76 7.73 10.19 38.62 9.02 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 2.77 37.17 4.99 6.33 34.76 8.06 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 10 3 # 10 A 182 LYS B 48 LYS~? 22.74 CA CA B 201 A 184 LYS B 3 LYS~? 17.03 CA CA B 201 A 345 ASP A 86 ASP~? 21.59 CA CA B 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 2.77 37.17 4.99 6.33 34.76 8.06 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 11 3 # 11 A 182 LYS B 52 LYS~? 20.44 CA CA B 201 A 184 LYS B 48 LYS~? 22.74 CA CA B 201 A 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 5.98 42.76 7.73 10.19 38.62 9.02 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 2.77 37.17 4.99 6.33 34.76 8.06 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 38.76 2.27 4.00 34.00 5.99 4.37 15.60 31.02 44.27 16.30 36.87 43.73 coo 40.63 7.13 9.06 35.85 7.36 8.95 13.41 31.22 50.01 11.37 34.80 45.78 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 B 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 38.76 2.27 4.00 34.00 5.99 4.37 13.41 31.22 50.01 11.37 34.80 45.78 coo 40.63 7.13 9.06 35.85 7.36 8.95 15.60 31.02 44.27 16.30 36.87 43.73 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 79 LYS~? 16.33 CA CA B 201 B 184 LYS B 46 LYS.? 7.77 CA CA B 201 B 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 40.63 7.13 9.06 35.85 7.36 8.95 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS A 79 LYS~? 16.33 CA CA B 201 B 184 LYS B 48 LYS~? 22.74 CA CA B 201 B 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 40.63 7.13 9.06 35.85 7.36 8.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS A 79 LYS~? 16.33 CA CA B 201 B 184 LYS B 48 LYS~? 22.74 CA CA B 201 B 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 38.76 2.27 4.00 34.00 5.99 4.37 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 40.63 7.13 9.06 35.85 7.36 8.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS B 46 LYS.? 7.77 CA CA B 201 B 184 LYS A 79 LYS~? 16.33 CA CA B 201 B 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 40.63 7.13 9.06 35.85 7.36 8.95 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS B 46 LYS.? 7.77 CA CA B 201 B 184 LYS B 48 LYS~? 22.74 CA CA B 201 B 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 40.63 7.13 9.06 35.85 7.36 8.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS B 48 LYS~? 22.74 CA CA B 201 B 184 LYS A 79 LYS~? 16.33 CA CA B 201 B 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 38.76 2.27 4.00 34.00 5.99 4.37 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS B 48 LYS~? 22.74 CA CA B 201 B 184 LYS B 3 LYS~? 17.03 CA CA B 201 B 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 10 3 # 10 B 182 LYS B 48 LYS~? 22.74 CA CA B 201 B 184 LYS B 46 LYS.? 7.77 CA CA B 201 B 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 11 3 # 11 B 182 LYS B 48 LYS~? 22.74 CA CA B 201 B 184 LYS B 52 LYS~? 20.44 CA CA B 201 B 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 38.76 2.27 4.00 34.00 5.99 4.37 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 12 3 # 12 B 182 LYS B 52 LYS~? 20.44 CA CA B 201 B 184 LYS B 48 LYS~? 22.74 CA CA B 201 B 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 38.76 2.27 4.00 34.00 5.99 4.37 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 40.63 7.13 9.06 35.85 7.36 8.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 12 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 46 LYS.? 7.73 CA CA A 202 C 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo -5.66 12.40 71.13 -2.66 9.98 66.50 17.72 24.61 42.81 16.30 19.73 46.29 coo 0.95 12.72 73.51 1.58 12.72 68.31 15.60 31.02 44.27 16.30 36.87 43.73 coo -4.59 24.28 66.67 -6.26 24.34 67.99 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 184 LYS A 46 LYS.? 7.73 CA CA A 202 C 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo -5.66 12.40 71.13 -2.66 9.98 66.50 15.60 31.02 44.27 16.30 36.87 43.73 coo 0.95 12.72 73.51 1.58 12.72 68.31 17.72 24.61 42.81 16.30 19.73 46.29 coo -4.59 24.28 66.67 -6.26 24.34 67.99 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 C 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo -5.66 12.40 71.13 -2.66 9.98 66.50 15.60 31.02 44.27 16.30 36.87 43.73 coo 0.95 12.72 73.51 1.58 12.72 68.31 13.41 31.22 50.01 11.37 34.80 45.78 coo -4.59 24.28 66.67 -6.26 24.34 67.99 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 C 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 C 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo -5.66 12.40 71.13 -2.66 9.98 66.50 13.41 31.22 50.01 11.37 34.80 45.78 coo 0.95 12.72 73.51 1.58 12.72 68.31 15.60 31.02 44.27 16.30 36.87 43.73 coo -4.59 24.28 66.67 -6.26 24.34 67.99 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS A 79 LYS~? 16.33 CA CA B 201 C 184 LYS B 46 LYS.? 7.77 CA CA B 201 C 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 0.95 12.72 73.51 1.58 12.72 68.31 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS A 79 LYS~? 16.33 CA CA B 201 C 184 LYS B 48 LYS~? 22.74 CA CA B 201 C 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 0.95 12.72 73.51 1.58 12.72 68.31 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS B 46 LYS.? 7.77 CA CA B 201 C 184 LYS A 79 LYS~? 16.33 CA CA B 201 C 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -5.66 12.40 71.13 -2.66 9.98 66.50 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 0.95 12.72 73.51 1.58 12.72 68.31 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS B 46 LYS.? 7.77 CA CA B 201 C 184 LYS B 48 LYS~? 22.74 CA CA B 201 C 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 0.95 12.72 73.51 1.58 12.72 68.31 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 9 3 # 9 C 182 LYS B 46 LYS.? 7.77 CA CA B 201 C 184 LYS B 48 LYS~? 22.74 CA CA B 201 C 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -5.66 12.40 71.13 -2.66 9.98 66.50 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 0.95 12.72 73.51 1.58 12.72 68.31 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 10 3 # 10 C 182 LYS B 52 LYS~? 20.44 CA CA B 201 C 184 LYS B 48 LYS~? 22.74 CA CA B 201 C 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -5.66 12.40 71.13 -2.66 9.98 66.50 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 0.95 12.72 73.51 1.58 12.72 68.31 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 46 LYS.? 7.73 CA CA A 202 D 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 17.72 24.61 42.81 16.30 19.73 46.29 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 15.60 31.02 44.27 16.30 36.87 43.73 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 184 LYS A 46 LYS.? 7.73 CA CA A 202 D 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 15.60 31.02 44.27 16.30 36.87 43.73 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 17.72 24.61 42.81 16.30 19.73 46.29 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 D 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 15.60 31.02 44.27 16.30 36.87 43.73 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 13.41 31.22 50.01 11.37 34.80 45.78 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 D 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 D 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 13.41 31.22 50.01 11.37 34.80 45.78 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 15.60 31.02 44.27 16.30 36.87 43.73 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS A 79 LYS~? 16.33 CA CA B 201 D 184 LYS B 46 LYS.? 7.77 CA CA B 201 D 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS A 79 LYS~? 16.33 CA CA B 201 D 184 LYS B 48 LYS~? 22.74 CA CA B 201 D 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 7 3 # 7 D 182 LYS B 46 LYS.? 7.77 CA CA B 201 D 184 LYS A 79 LYS~? 16.33 CA CA B 201 D 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 8 3 # 8 D 182 LYS B 46 LYS.? 7.77 CA CA B 201 D 184 LYS B 48 LYS~? 22.74 CA CA B 201 D 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 9 3 # 9 D 182 LYS B 46 LYS.? 7.77 CA CA B 201 D 184 LYS B 48 LYS~? 22.74 CA CA B 201 D 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 10 3 # 10 D 182 LYS B 48 LYS~? 22.74 CA CA B 201 D 184 LYS B 46 LYS.? 7.77 CA CA B 201 D 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 11 3 # 11 D 182 LYS B 48 LYS~? 22.74 CA CA B 201 D 184 LYS B 52 LYS~? 20.44 CA CA B 201 D 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 12 3 # 12 D 182 LYS B 52 LYS~? 20.44 CA CA B 201 D 184 LYS B 48 LYS~? 22.74 CA CA B 201 D 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 12 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 46 LYS.? 7.73 CA CA A 202 E 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 E 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo -21.16 62.58 121.86 -16.35 60.33 119.23 17.72 24.61 42.81 16.30 19.73 46.29 coo -23.22 55.98 120.74 -18.11 55.31 120.43 15.60 31.02 44.27 16.30 36.87 43.73 coo -17.15 59.71 133.33 -17.96 61.54 134.01 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 E 184 LYS A 46 LYS.? 7.73 CA CA A 202 E 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo -21.16 62.58 121.86 -16.35 60.33 119.23 15.60 31.02 44.27 16.30 36.87 43.73 coo -23.22 55.98 120.74 -18.11 55.31 120.43 17.72 24.61 42.81 16.30 19.73 46.29 coo -17.15 59.71 133.33 -17.96 61.54 134.01 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 E 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 E 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo -21.16 62.58 121.86 -16.35 60.33 119.23 15.60 31.02 44.27 16.30 36.87 43.73 coo -23.22 55.98 120.74 -18.11 55.31 120.43 13.41 31.22 50.01 11.37 34.80 45.78 coo -17.15 59.71 133.33 -17.96 61.54 134.01 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 E 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 E 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo -21.16 62.58 121.86 -16.35 60.33 119.23 13.41 31.22 50.01 11.37 34.80 45.78 coo -23.22 55.98 120.74 -18.11 55.31 120.43 15.60 31.02 44.27 16.30 36.87 43.73 coo -17.15 59.71 133.33 -17.96 61.54 134.01 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS A 79 LYS~? 16.33 CA CA B 201 E 184 LYS B 46 LYS.? 7.77 CA CA B 201 E 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS A 79 LYS~? 16.33 CA CA B 201 E 184 LYS B 48 LYS~? 22.74 CA CA B 201 E 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 7 3 # 7 E 182 LYS B 46 LYS.? 7.77 CA CA B 201 E 184 LYS A 79 LYS~? 16.33 CA CA B 201 E 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -21.16 62.58 121.86 -16.35 60.33 119.23 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 8 3 # 8 E 182 LYS B 46 LYS.? 7.77 CA CA B 201 E 184 LYS B 48 LYS~? 22.74 CA CA B 201 E 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 9 3 # 9 E 182 LYS B 46 LYS.? 7.77 CA CA B 201 E 184 LYS B 48 LYS~? 22.74 CA CA B 201 E 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -21.16 62.58 121.86 -16.35 60.33 119.23 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 10 3 # 10 E 182 LYS B 48 LYS~? 22.74 CA CA B 201 E 184 LYS B 46 LYS.? 7.77 CA CA B 201 E 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 11 3 # 11 E 182 LYS B 48 LYS~? 22.74 CA CA B 201 E 184 LYS B 52 LYS~? 20.44 CA CA B 201 E 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 12 3 # 12 E 182 LYS B 52 LYS~? 20.44 CA CA B 201 E 184 LYS B 48 LYS~? 22.74 CA CA B 201 E 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -21.16 62.58 121.86 -16.35 60.33 119.23 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 12 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 46 LYS.? 7.73 CA CA A 202 F 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 F 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 10.64 34.02 91.30 6.30 35.60 95.11 17.72 24.61 42.81 16.30 19.73 46.29 coo 13.75 39.76 94.12 11.42 37.23 97.89 15.60 31.02 44.27 16.30 36.87 43.73 coo 16.35 26.90 99.56 16.81 25.90 97.75 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 F 184 LYS A 46 LYS.? 7.73 CA CA A 202 F 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 10.64 34.02 91.30 6.30 35.60 95.11 15.60 31.02 44.27 16.30 36.87 43.73 coo 13.75 39.76 94.12 11.42 37.23 97.89 17.72 24.61 42.81 16.30 19.73 46.29 coo 16.35 26.90 99.56 16.81 25.90 97.75 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 F 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 F 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 10.64 34.02 91.30 6.30 35.60 95.11 15.60 31.02 44.27 16.30 36.87 43.73 coo 13.75 39.76 94.12 11.42 37.23 97.89 13.41 31.22 50.01 11.37 34.80 45.78 coo 16.35 26.90 99.56 16.81 25.90 97.75 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 F 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 F 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 10.64 34.02 91.30 6.30 35.60 95.11 13.41 31.22 50.01 11.37 34.80 45.78 coo 13.75 39.76 94.12 11.42 37.23 97.89 15.60 31.02 44.27 16.30 36.87 43.73 coo 16.35 26.90 99.56 16.81 25.90 97.75 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS A 79 LYS~? 16.33 CA CA B 201 F 184 LYS B 46 LYS.? 7.77 CA CA B 201 F 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 13.75 39.76 94.12 11.42 37.23 97.89 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 16.35 26.90 99.56 16.81 25.90 97.75 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS A 79 LYS~? 16.33 CA CA B 201 F 184 LYS B 48 LYS~? 22.74 CA CA B 201 F 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 13.75 39.76 94.12 11.42 37.23 97.89 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.35 26.90 99.56 16.81 25.90 97.75 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 7 3 # 7 F 182 LYS B 46 LYS.? 7.77 CA CA B 201 F 184 LYS A 79 LYS~? 16.33 CA CA B 201 F 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 10.64 34.02 91.30 6.30 35.60 95.11 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 13.75 39.76 94.12 11.42 37.23 97.89 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 16.35 26.90 99.56 16.81 25.90 97.75 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 8 3 # 8 F 182 LYS B 46 LYS.? 7.77 CA CA B 201 F 184 LYS B 48 LYS~? 22.74 CA CA B 201 F 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 13.75 39.76 94.12 11.42 37.23 97.89 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.35 26.90 99.56 16.81 25.90 97.75 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 9 3 # 9 F 182 LYS B 46 LYS.? 7.77 CA CA B 201 F 184 LYS B 48 LYS~? 22.74 CA CA B 201 F 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 10.64 34.02 91.30 6.30 35.60 95.11 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 13.75 39.76 94.12 11.42 37.23 97.89 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.35 26.90 99.56 16.81 25.90 97.75 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 10 3 # 10 F 182 LYS B 48 LYS~? 22.74 CA CA B 201 F 184 LYS B 3 LYS~? 17.03 CA CA B 201 F 345 ASP A 86 ASP~? 21.59 CA CA B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 13.75 39.76 94.12 11.42 37.23 97.89 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 16.35 26.90 99.56 16.81 25.90 97.75 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 11 3 # 11 F 182 LYS B 48 LYS~? 22.74 CA CA B 201 F 184 LYS B 46 LYS.? 7.77 CA CA B 201 F 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 13.75 39.76 94.12 11.42 37.23 97.89 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 16.35 26.90 99.56 16.81 25.90 97.75 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 12 3 # 12 F 182 LYS B 48 LYS~? 22.74 CA CA B 201 F 184 LYS B 52 LYS~? 20.44 CA CA B 201 F 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 13.75 39.76 94.12 11.42 37.23 97.89 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 16.35 26.90 99.56 16.81 25.90 97.75 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 13 3 # 13 F 182 LYS B 52 LYS~? 20.44 CA CA B 201 F 184 LYS B 48 LYS~? 22.74 CA CA B 201 F 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 10.64 34.02 91.30 6.30 35.60 95.11 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 13.75 39.76 94.12 11.42 37.23 97.89 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.35 26.90 99.56 16.81 25.90 97.75 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 13 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 46 LYS.? 7.73 CA CA A 202 G 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 G 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 39.68 42.04 76.11 43.42 46.43 74.96 17.72 24.61 42.81 16.30 19.73 46.29 coo 36.69 47.69 78.93 39.38 50.40 75.35 15.60 31.02 44.27 16.30 36.87 43.73 coo 33.43 44.37 65.47 33.10 42.30 65.37 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 G 184 LYS A 46 LYS.? 7.73 CA CA A 202 G 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 39.68 42.04 76.11 43.42 46.43 74.96 15.60 31.02 44.27 16.30 36.87 43.73 coo 36.69 47.69 78.93 39.38 50.40 75.35 17.72 24.61 42.81 16.30 19.73 46.29 coo 33.43 44.37 65.47 33.10 42.30 65.37 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 G 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 G 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 39.68 42.04 76.11 43.42 46.43 74.96 15.60 31.02 44.27 16.30 36.87 43.73 coo 36.69 47.69 78.93 39.38 50.40 75.35 13.41 31.22 50.01 11.37 34.80 45.78 coo 33.43 44.37 65.47 33.10 42.30 65.37 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 G 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 G 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 39.68 42.04 76.11 43.42 46.43 74.96 13.41 31.22 50.01 11.37 34.80 45.78 coo 36.69 47.69 78.93 39.38 50.40 75.35 15.60 31.02 44.27 16.30 36.87 43.73 coo 33.43 44.37 65.47 33.10 42.30 65.37 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS A 79 LYS~? 16.33 CA CA B 201 G 184 LYS B 46 LYS.? 7.77 CA CA B 201 G 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 36.69 47.69 78.93 39.38 50.40 75.35 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 33.43 44.37 65.47 33.10 42.30 65.37 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS A 79 LYS~? 16.33 CA CA B 201 G 184 LYS B 48 LYS~? 22.74 CA CA B 201 G 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 36.69 47.69 78.93 39.38 50.40 75.35 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS B 46 LYS.? 7.77 CA CA B 201 G 184 LYS A 79 LYS~? 16.33 CA CA B 201 G 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 39.68 42.04 76.11 43.42 46.43 74.96 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 36.69 47.69 78.93 39.38 50.40 75.35 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 33.43 44.37 65.47 33.10 42.30 65.37 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS B 46 LYS.? 7.77 CA CA B 201 G 184 LYS B 48 LYS~? 22.74 CA CA B 201 G 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 36.69 47.69 78.93 39.38 50.40 75.35 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 9 3 # 9 G 182 LYS B 46 LYS.? 7.77 CA CA B 201 G 184 LYS B 48 LYS~? 22.74 CA CA B 201 G 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 39.68 42.04 76.11 43.42 46.43 74.96 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 36.69 47.69 78.93 39.38 50.40 75.35 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 10 3 # 10 G 182 LYS B 48 LYS~? 22.74 CA CA B 201 G 184 LYS B 3 LYS~? 17.03 CA CA B 201 G 345 ASP A 86 ASP~? 21.59 CA CA B 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 36.69 47.69 78.93 39.38 50.40 75.35 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 33.43 44.37 65.47 33.10 42.30 65.37 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 11 3 # 11 G 182 LYS B 52 LYS~? 20.44 CA CA B 201 G 184 LYS B 48 LYS~? 22.74 CA CA B 201 G 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 39.68 42.04 76.11 43.42 46.43 74.96 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 36.69 47.69 78.93 39.38 50.40 75.35 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 46 LYS.? 7.73 CA CA A 202 H 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 H 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 71.58 83.18 80.51 66.88 79.77 79.84 17.72 24.61 42.81 16.30 19.73 46.29 coo 73.65 78.64 75.66 68.14 79.07 75.04 15.60 31.02 44.27 16.30 36.87 43.73 coo 67.43 90.73 71.39 68.27 92.30 72.52 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 H 184 LYS A 46 LYS.? 7.73 CA CA A 202 H 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 71.58 83.18 80.51 66.88 79.77 79.84 15.60 31.02 44.27 16.30 36.87 43.73 coo 73.65 78.64 75.66 68.14 79.07 75.04 17.72 24.61 42.81 16.30 19.73 46.29 coo 67.43 90.73 71.39 68.27 92.30 72.52 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 H 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 H 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 71.58 83.18 80.51 66.88 79.77 79.84 15.60 31.02 44.27 16.30 36.87 43.73 coo 73.65 78.64 75.66 68.14 79.07 75.04 13.41 31.22 50.01 11.37 34.80 45.78 coo 67.43 90.73 71.39 68.27 92.30 72.52 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 H 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 H 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 71.58 83.18 80.51 66.88 79.77 79.84 13.41 31.22 50.01 11.37 34.80 45.78 coo 73.65 78.64 75.66 68.14 79.07 75.04 15.60 31.02 44.27 16.30 36.87 43.73 coo 67.43 90.73 71.39 68.27 92.30 72.52 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS A 79 LYS~? 16.33 CA CA B 201 H 184 LYS B 46 LYS.? 7.77 CA CA B 201 H 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 73.65 78.64 75.66 68.14 79.07 75.04 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 67.43 90.73 71.39 68.27 92.30 72.52 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS A 79 LYS~? 16.33 CA CA B 201 H 184 LYS B 48 LYS~? 22.74 CA CA B 201 H 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 73.65 78.64 75.66 68.14 79.07 75.04 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 67.43 90.73 71.39 68.27 92.30 72.52 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS B 46 LYS.? 7.77 CA CA B 201 H 184 LYS A 79 LYS~? 16.33 CA CA B 201 H 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 71.58 83.18 80.51 66.88 79.77 79.84 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 73.65 78.64 75.66 68.14 79.07 75.04 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 67.43 90.73 71.39 68.27 92.30 72.52 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 8 3 # 8 H 182 LYS B 46 LYS.? 7.77 CA CA B 201 H 184 LYS B 48 LYS~? 22.74 CA CA B 201 H 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 73.65 78.64 75.66 68.14 79.07 75.04 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 67.43 90.73 71.39 68.27 92.30 72.52 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 9 3 # 9 H 182 LYS B 46 LYS.? 7.77 CA CA B 201 H 184 LYS B 48 LYS~? 22.74 CA CA B 201 H 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 71.58 83.18 80.51 66.88 79.77 79.84 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 73.65 78.64 75.66 68.14 79.07 75.04 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 67.43 90.73 71.39 68.27 92.30 72.52 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 10 3 # 10 H 182 LYS B 48 LYS~? 22.74 CA CA B 201 H 184 LYS B 3 LYS~? 17.03 CA CA B 201 H 345 ASP A 86 ASP~? 21.59 CA CA B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 67.43 90.73 71.39 68.27 92.30 72.52 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 11 3 # 11 H 182 LYS B 48 LYS~? 22.74 CA CA B 201 H 184 LYS B 46 LYS.? 7.77 CA CA B 201 H 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 67.43 90.73 71.39 68.27 92.30 72.52 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 12 3 # 12 H 182 LYS B 48 LYS~? 22.74 CA CA B 201 H 184 LYS B 52 LYS~? 20.44 CA CA B 201 H 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 67.43 90.73 71.39 68.27 92.30 72.52 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 13 3 # 13 H 182 LYS B 52 LYS~? 20.44 CA CA B 201 H 184 LYS B 48 LYS~? 22.74 CA CA B 201 H 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 71.58 83.18 80.51 66.88 79.77 79.84 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 73.65 78.64 75.66 68.14 79.07 75.04 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 67.43 90.73 71.39 68.27 92.30 72.52 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 13 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 46 LYS.? 7.73 CA CA A 202 I 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 I 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 60.20 96.92 42.53 57.60 93.13 38.67 17.72 24.61 42.81 16.30 19.73 46.29 coo 54.31 95.46 46.01 55.34 91.59 42.65 15.60 31.02 44.27 16.30 36.87 43.73 coo 66.35 87.81 48.53 68.10 89.01 48.77 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 I 184 LYS A 46 LYS.? 7.73 CA CA A 202 I 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 60.20 96.92 42.53 57.60 93.13 38.67 15.60 31.02 44.27 16.30 36.87 43.73 coo 54.31 95.46 46.01 55.34 91.59 42.65 17.72 24.61 42.81 16.30 19.73 46.29 coo 66.35 87.81 48.53 68.10 89.01 48.77 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 I 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 I 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 60.20 96.92 42.53 57.60 93.13 38.67 15.60 31.02 44.27 16.30 36.87 43.73 coo 54.31 95.46 46.01 55.34 91.59 42.65 13.41 31.22 50.01 11.37 34.80 45.78 coo 66.35 87.81 48.53 68.10 89.01 48.77 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 I 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 I 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 60.20 96.92 42.53 57.60 93.13 38.67 13.41 31.22 50.01 11.37 34.80 45.78 coo 54.31 95.46 46.01 55.34 91.59 42.65 15.60 31.02 44.27 16.30 36.87 43.73 coo 66.35 87.81 48.53 68.10 89.01 48.77 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS A 79 LYS~? 16.33 CA CA B 201 I 184 LYS B 46 LYS.? 7.77 CA CA B 201 I 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 54.31 95.46 46.01 55.34 91.59 42.65 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 66.35 87.81 48.53 68.10 89.01 48.77 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS A 79 LYS~? 16.33 CA CA B 201 I 184 LYS B 48 LYS~? 22.74 CA CA B 201 I 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 54.31 95.46 46.01 55.34 91.59 42.65 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 66.35 87.81 48.53 68.10 89.01 48.77 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 7 3 # 7 I 182 LYS B 46 LYS.? 7.77 CA CA B 201 I 184 LYS A 79 LYS~? 16.33 CA CA B 201 I 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 60.20 96.92 42.53 57.60 93.13 38.67 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 54.31 95.46 46.01 55.34 91.59 42.65 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 66.35 87.81 48.53 68.10 89.01 48.77 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 8 3 # 8 I 182 LYS B 46 LYS.? 7.77 CA CA B 201 I 184 LYS B 48 LYS~? 22.74 CA CA B 201 I 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 54.31 95.46 46.01 55.34 91.59 42.65 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 66.35 87.81 48.53 68.10 89.01 48.77 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 9 3 # 9 I 182 LYS B 46 LYS.? 7.77 CA CA B 201 I 184 LYS B 48 LYS~? 22.74 CA CA B 201 I 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 60.20 96.92 42.53 57.60 93.13 38.67 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 54.31 95.46 46.01 55.34 91.59 42.65 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 66.35 87.81 48.53 68.10 89.01 48.77 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 10 3 # 10 I 182 LYS B 48 LYS~? 22.74 CA CA B 201 I 184 LYS B 46 LYS.? 7.77 CA CA B 201 I 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 66.35 87.81 48.53 68.10 89.01 48.77 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 11 3 # 11 I 182 LYS B 48 LYS~? 22.74 CA CA B 201 I 184 LYS B 52 LYS~? 20.44 CA CA B 201 I 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 66.35 87.81 48.53 68.10 89.01 48.77 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 12 3 # 12 I 182 LYS B 52 LYS~? 20.44 CA CA B 201 I 184 LYS B 48 LYS~? 22.74 CA CA B 201 I 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 60.20 96.92 42.53 57.60 93.13 38.67 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 54.31 95.46 46.01 55.34 91.59 42.65 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 66.35 87.81 48.53 68.10 89.01 48.77 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 12 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 46 LYS.? 7.73 CA CA A 202 J 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 J 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 25.22 70.55 14.03 27.64 73.07 18.65 17.72 24.61 42.81 16.30 19.73 46.29 coo 31.73 69.87 11.50 32.73 70.19 16.40 15.60 31.02 44.27 16.30 36.87 43.73 coo 25.87 58.42 18.79 23.95 58.54 17.90 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 J 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 J 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 25.22 70.55 14.03 27.64 73.07 18.65 13.41 31.22 50.01 11.37 34.80 45.78 coo 31.73 69.87 11.50 32.73 70.19 16.40 15.60 31.02 44.27 16.30 36.87 43.73 coo 25.87 58.42 18.79 23.95 58.54 17.90 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 79 LYS~? 16.33 CA CA B 201 J 184 LYS B 46 LYS.? 7.77 CA CA B 201 J 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 31.73 69.87 11.50 32.73 70.19 16.40 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 25.87 58.42 18.79 23.95 58.54 17.90 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS A 79 LYS~? 16.33 CA CA B 201 J 184 LYS B 48 LYS~? 22.74 CA CA B 201 J 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 31.73 69.87 11.50 32.73 70.19 16.40 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 25.87 58.42 18.79 23.95 58.54 17.90 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS B 46 LYS.? 7.77 CA CA B 201 J 184 LYS B 48 LYS~? 22.74 CA CA B 201 J 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 31.73 69.87 11.50 32.73 70.19 16.40 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 25.87 58.42 18.79 23.95 58.54 17.90 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS B 52 LYS~? 20.44 CA CA B 201 J 184 LYS B 48 LYS~? 22.74 CA CA B 201 J 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 25.22 70.55 14.03 27.64 73.07 18.65 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 31.73 69.87 11.50 32.73 70.19 16.40 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 25.87 58.42 18.79 23.95 58.54 17.90 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 46 LYS.? 7.73 CA CA A 202 K 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 K 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 17.72 24.61 42.81 16.30 19.73 46.29 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 15.60 31.02 44.27 16.30 36.87 43.73 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 K 184 LYS A 46 LYS.? 7.73 CA CA A 202 K 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 15.60 31.02 44.27 16.30 36.87 43.73 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 17.72 24.61 42.81 16.30 19.73 46.29 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 K 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 K 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 15.60 31.02 44.27 16.30 36.87 43.73 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 13.41 31.22 50.01 11.37 34.80 45.78 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 K 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 K 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 13.41 31.22 50.01 11.37 34.80 45.78 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 15.60 31.02 44.27 16.30 36.87 43.73 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS A 79 LYS~? 16.33 CA CA B 201 K 184 LYS B 46 LYS.? 7.77 CA CA B 201 K 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS A 79 LYS~? 16.33 CA CA B 201 K 184 LYS B 48 LYS~? 22.74 CA CA B 201 K 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS B 46 LYS.? 7.77 CA CA B 201 K 184 LYS A 79 LYS~? 16.33 CA CA B 201 K 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS B 46 LYS.? 7.77 CA CA B 201 K 184 LYS B 48 LYS~? 22.74 CA CA B 201 K 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 9 3 # 9 K 182 LYS B 46 LYS.? 7.77 CA CA B 201 K 184 LYS B 48 LYS~? 22.74 CA CA B 201 K 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 10 3 # 10 K 182 LYS B 52 LYS~? 20.44 CA CA B 201 K 184 LYS B 48 LYS~? 22.74 CA CA B 201 K 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 L 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 L 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 15.60 31.02 44.27 16.30 36.87 43.73 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 13.41 31.22 50.01 11.37 34.80 45.78 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 L 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 L 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 13.41 31.22 50.01 11.37 34.80 45.78 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 15.60 31.02 44.27 16.30 36.87 43.73 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 L 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 L 345 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 13.41 31.22 50.01 11.37 34.80 45.78 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 15.60 31.02 44.27 16.30 36.87 43.73 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 79 LYS~? 16.33 CA CA B 201 L 184 LYS B 48 LYS~? 22.74 CA CA B 201 L 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS A 79 LYS~? 16.33 CA CA B 201 L 184 LYS B 48 LYS~? 22.74 CA CA B 201 L 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS B 46 LYS.? 7.77 CA CA B 201 L 184 LYS A 79 LYS~? 16.33 CA CA B 201 L 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS B 46 LYS.? 7.77 CA CA B 201 L 184 LYS B 48 LYS~? 22.74 CA CA B 201 L 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS B 48 LYS~? 22.74 CA CA B 201 L 184 LYS A 79 LYS~? 16.33 CA CA B 201 L 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS B 48 LYS~? 22.74 CA CA B 201 L 184 LYS B 3 LYS~? 17.03 CA CA B 201 L 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 10 3 # 10 L 182 LYS B 48 LYS~? 22.74 CA CA B 201 L 184 LYS B 52 LYS~? 20.44 CA CA B 201 L 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 11 3 # 11 L 182 LYS B 52 LYS~? 20.44 CA CA B 201 L 184 LYS B 48 LYS~? 22.74 CA CA B 201 L 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 M 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 M 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 15.60 31.02 44.27 16.30 36.87 43.73 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 13.41 31.22 50.01 11.37 34.80 45.78 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 M 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 M 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 13.41 31.22 50.01 11.37 34.80 45.78 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 15.60 31.02 44.27 16.30 36.87 43.73 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 M 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 M 345 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 13.41 31.22 50.01 11.37 34.80 45.78 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 15.60 31.02 44.27 16.30 36.87 43.73 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 79 LYS~? 16.33 CA CA B 201 M 184 LYS B 48 LYS~? 22.74 CA CA B 201 M 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS A 79 LYS~? 16.33 CA CA B 201 M 184 LYS B 48 LYS~? 22.74 CA CA B 201 M 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS B 46 LYS.? 7.77 CA CA B 201 M 184 LYS A 79 LYS~? 16.33 CA CA B 201 M 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS B 46 LYS.? 7.77 CA CA B 201 M 184 LYS B 48 LYS~? 22.74 CA CA B 201 M 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -8.20 24.59 81.13 -6.93 19.58 77.81 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS B 48 LYS~? 22.74 CA CA B 201 M 184 LYS A 79 LYS~? 16.33 CA CA B 201 M 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS B 48 LYS~? 22.74 CA CA B 201 M 184 LYS B 3 LYS~? 17.03 CA CA B 201 M 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 10 3 # 10 M 182 LYS B 48 LYS~? 22.74 CA CA B 201 M 184 LYS B 52 LYS~? 20.44 CA CA B 201 M 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 11 3 # 11 M 182 LYS B 52 LYS~? 20.44 CA CA B 201 M 184 LYS B 48 LYS~? 22.74 CA CA B 201 M 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -6.08 30.98 79.72 -6.69 36.84 80.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 46 LYS.? 7.73 CA CA A 202 N 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 N 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 17.72 24.61 42.81 16.30 19.73 46.29 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 15.60 31.02 44.27 16.30 36.87 43.73 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 N 184 LYS A 46 LYS.? 7.73 CA CA A 202 N 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 15.60 31.02 44.27 16.30 36.87 43.73 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 17.72 24.61 42.81 16.30 19.73 46.29 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 N 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 N 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 15.60 31.02 44.27 16.30 36.87 43.73 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 13.41 31.22 50.01 11.37 34.80 45.78 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 N 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 N 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 13.41 31.22 50.01 11.37 34.80 45.78 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 15.60 31.02 44.27 16.30 36.87 43.73 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS A 79 LYS~? 16.33 CA CA B 201 N 184 LYS B 46 LYS.? 7.77 CA CA B 201 N 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS A 79 LYS~? 16.33 CA CA B 201 N 184 LYS B 48 LYS~? 22.74 CA CA B 201 N 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 7 3 # 7 N 182 LYS B 46 LYS.? 7.77 CA CA B 201 N 184 LYS A 79 LYS~? 16.33 CA CA B 201 N 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 8 3 # 8 N 182 LYS B 46 LYS.? 7.77 CA CA B 201 N 184 LYS B 48 LYS~? 22.74 CA CA B 201 N 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 9 3 # 9 N 182 LYS B 46 LYS.? 7.77 CA CA B 201 N 184 LYS B 48 LYS~? 22.74 CA CA B 201 N 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 10 3 # 10 N 182 LYS B 48 LYS~? 22.74 CA CA B 201 N 184 LYS B 3 LYS~? 17.03 CA CA B 201 N 345 ASP A 86 ASP~? 21.59 CA CA B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -9.65 28.18 90.30 -9.88 28.72 88.34 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 11 3 # 11 N 182 LYS B 48 LYS~? 22.74 CA CA B 201 N 184 LYS B 46 LYS.? 7.77 CA CA B 201 N 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 12 3 # 12 N 182 LYS B 48 LYS~? 22.74 CA CA B 201 N 184 LYS B 52 LYS~? 20.44 CA CA B 201 N 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 13 3 # 13 N 182 LYS B 52 LYS~? 20.44 CA CA B 201 N 184 LYS B 48 LYS~? 22.74 CA CA B 201 N 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 13 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 46 LYS.? 7.73 CA CA A 202 O 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 O 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 17.72 24.61 42.81 16.30 19.73 46.29 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 15.60 31.02 44.27 16.30 36.87 43.73 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 O 184 LYS A 46 LYS.? 7.73 CA CA A 202 O 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 15.60 31.02 44.27 16.30 36.87 43.73 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 17.72 24.61 42.81 16.30 19.73 46.29 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 O 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 O 345 ASP A 4 ASP~? 21.72 CA CA A 202 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 15.60 31.02 44.27 16.30 36.87 43.73 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 13.41 31.22 50.01 11.37 34.80 45.78 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 25.57 34.71 45.51 26.38 33.70 43.83 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 O 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 O 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 13.41 31.22 50.01 11.37 34.80 45.78 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 15.60 31.02 44.27 16.30 36.87 43.73 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS A 79 LYS~? 16.33 CA CA B 201 O 184 LYS B 46 LYS.? 7.77 CA CA B 201 O 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS A 79 LYS~? 16.33 CA CA B 201 O 184 LYS B 48 LYS~? 22.74 CA CA B 201 O 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS B 46 LYS.? 7.77 CA CA B 201 O 184 LYS A 79 LYS~? 16.33 CA CA B 201 O 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS B 46 LYS.? 7.77 CA CA B 201 O 184 LYS B 48 LYS~? 22.74 CA CA B 201 O 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 9 3 # 9 O 182 LYS B 46 LYS.? 7.77 CA CA B 201 O 184 LYS B 48 LYS~? 22.74 CA CA B 201 O 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 10 3 # 10 O 182 LYS B 52 LYS~? 20.44 CA CA B 201 O 184 LYS B 48 LYS~? 22.74 CA CA B 201 O 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 48 LYS~? 17.72 OXT ACT B 801 P 184 LYS A 52 LYS~? 15.73 OXT ACT B 801 P 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 15.60 31.02 44.27 16.30 36.87 43.73 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 13.41 31.22 50.01 11.37 34.80 45.78 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 P 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 P 345 ASP A 38 ASP~? -3.36 CA CA A 202s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 13.41 31.22 50.01 11.37 34.80 45.78 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 15.60 31.02 44.27 16.30 36.87 43.73 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 14.49 17.18 50.40 16.42 16.29 49.93 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 52 LYS~? 15.73 OXT ACT B 801 P 184 LYS A 48 LYS~? 17.72 OXT ACT B 801 P 345 ASP B 69 ASP~? 15.19 CH3 ACT B 801 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 13.41 31.22 50.01 11.37 34.80 45.78 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 15.60 31.02 44.27 16.30 36.87 43.73 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -0.95 26.94 49.29 -2.15 27.04 47.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 79 LYS~? 16.33 CA CA B 201 P 184 LYS B 48 LYS~? 22.74 CA CA B 201 P 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS A 79 LYS~? 16.33 CA CA B 201 P 184 LYS B 48 LYS~? 22.74 CA CA B 201 P 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS B 46 LYS.? 7.77 CA CA B 201 P 184 LYS A 79 LYS~? 16.33 CA CA B 201 P 345 ASP B 4 ASP~? 21.62 CA CA B 201 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -15.90 34.72 78.46 -16.76 33.64 80.09 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS B 46 LYS.? 7.77 CA CA B 201 P 184 LYS B 48 LYS~? 22.74 CA CA B 201 P 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -8.20 24.59 81.13 -6.93 19.58 77.81 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS B 48 LYS~? 22.74 CA CA B 201 P 184 LYS A 79 LYS~? 16.33 CA CA B 201 P 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 9 3 # 9 P 182 LYS B 48 LYS~? 22.74 CA CA B 201 P 184 LYS B 3 LYS~? 17.03 CA CA B 201 P 345 ASP A 87 ASP~? 24.31 CA CA B 201 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -7.78 26.60 94.58 -7.92 24.72 93.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 10 3 # 10 P 182 LYS B 48 LYS~? 22.74 CA CA B 201 P 184 LYS B 52 LYS~? 20.44 CA CA B 201 P 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -4.95 17.23 73.65 -6.90 16.31 73.97 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 11 3 # 11 P 182 LYS B 52 LYS~? 20.44 CA CA B 201 P 184 LYS B 48 LYS~? 22.74 CA CA B 201 P 345 ASP B 38 ASP~? -3.30 CA CA B 201s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -6.08 30.98 79.72 -6.69 36.84 80.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -4.95 17.23 73.65 -6.90 16.31 73.97 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 34 TYR~? 7.34 CA CA A 202 A 245 ASP A 38 ASP~? -3.36 CA CA A 202s A 273 LYS A 46 LYS.? 7.73 CA CA A 202 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 14.67 22.85 56.72 17.08 23.07 55.48 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 14.49 17.18 50.40 16.42 16.29 49.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 17.72 24.61 42.81 16.30 19.73 46.29 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 34 TYR~? 7.28 CA CA B 201 A 245 ASP B 38 ASP~? -3.30 CA CA B 201s A 273 LYS B 46 LYS.? 7.77 CA CA B 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -4.97 22.79 67.30 -7.41 23.00 68.45 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -8.20 24.59 81.13 -6.93 19.58 77.81 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 10 HIS~? 10.31 CA CA A 202 A 341 GLU A 11 GLU~? 14.95 CA CA A 202 A 356 HIS A 43 HIS.? 6.83 CA CA A 202 coo 121.00 36.37 19.26 121.57 38.37 19.56 19.28 27.48 52.70 18.40 25.59 52.72 coo 125.72 32.70 19.75 124.44 34.16 18.84 26.25 27.59 54.14 27.19 27.48 52.23 coo 124.34 41.73 25.55 123.79 42.60 23.72 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS A 10 HIS~? 10.31 CA CA A 202 A 341 GLU A 40 GLU.? 3.38 CA CA A 202s A 356 HIS A 53 HIS~? 13.16 CA CA A 202 coo 121.00 36.37 19.26 121.57 38.37 19.56 19.28 27.48 52.70 18.40 25.59 52.72 coo 125.72 32.70 19.75 124.44 34.16 18.84 19.19 19.98 52.16 20.07 18.13 52.69 coo 124.34 41.73 25.55 123.79 42.60 23.72 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS A 43 HIS.? 6.83 CA CA A 202 A 341 GLU A 40 GLU.? 3.38 CA CA A 202s A 356 HIS A 51 HIS~? 12.20 CA CA A 202 coo 121.00 36.37 19.26 121.57 38.37 19.56 20.15 20.72 47.43 19.82 19.00 48.57 coo 125.72 32.70 19.75 124.44 34.16 18.84 19.19 19.98 52.16 20.07 18.13 52.69 coo 124.34 41.73 25.55 123.79 42.60 23.72 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 A 311 HIS A 51 HIS~? 12.20 CA CA A 202 A 341 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 356 HIS A 43 HIS.? 6.83 CA CA A 202 coo 121.00 36.37 19.26 121.57 38.37 19.56 17.98 27.94 47.81 19.27 26.33 47.47 coo 125.72 32.70 19.75 124.44 34.16 18.84 12.68 24.99 44.98 13.54 23.53 43.68 coo 124.34 41.73 25.55 123.79 42.60 23.72 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 A 311 HIS A 51 HIS~? 12.20 CA CA A 202 A 341 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 356 HIS A 45 HIS.? 16.70 CA CA A 202 coo 121.00 36.37 19.26 121.57 38.37 19.56 17.98 27.94 47.81 19.27 26.33 47.47 coo 125.72 32.70 19.75 124.44 34.16 18.84 12.68 24.99 44.98 13.54 23.53 43.68 coo 124.34 41.73 25.55 123.79 42.60 23.72 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 A 311 HIS A 53 HIS~? 13.16 CA CA A 202 A 341 GLU A 50 GLU~? 11.43 OXT ACT B 801 A 356 HIS A 10 HIS~? 10.31 CA CA A 202 coo 121.00 36.37 19.26 121.57 38.37 19.56 9.33 26.57 50.59 7.78 25.45 51.45 coo 125.72 32.70 19.75 124.44 34.16 18.84 12.68 24.99 44.98 13.54 23.53 43.68 coo 124.34 41.73 25.55 123.79 42.60 23.72 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 A 311 HIS B 10 HIS~? 10.24 CA CA B 201 A 341 GLU B 11 GLU~? 12.56 CH3 ACT B 802 A 356 HIS B 43 HIS.? 6.84 CA CA B 201 coo 121.00 36.37 19.26 121.57 38.37 19.56 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 125.72 32.70 19.75 124.44 34.16 18.84 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 124.34 41.73 25.55 123.79 42.60 23.72 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 A 311 HIS B 10 HIS~? 10.24 CA CA B 201 A 341 GLU B 40 GLU.? 3.43 CA CA B 201s A 356 HIS B 53 HIS~? 13.80 CA CA B 201 coo 121.00 36.37 19.26 121.57 38.37 19.56 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 125.72 32.70 19.75 124.44 34.16 18.84 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 124.34 41.73 25.55 123.79 42.60 23.72 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 9 3 # 9 A 311 HIS B 43 HIS.? 6.84 CA CA B 201 A 341 GLU B 40 GLU.? 3.43 CA CA B 201s A 356 HIS B 51 HIS~? 12.10 CA CA B 201 coo 121.00 36.37 19.26 121.57 38.37 19.56 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 125.72 32.70 19.75 124.44 34.16 18.84 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 124.34 41.73 25.55 123.79 42.60 23.72 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 10 3 # 10 A 311 HIS B 51 HIS~? 12.10 CA CA B 201 A 341 GLU B 50 GLU~? 12.54 CA CA B 201 A 356 HIS B 43 HIS.? 6.84 CA CA B 201 coo 121.00 36.37 19.26 121.57 38.37 19.56 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 125.72 32.70 19.75 124.44 34.16 18.84 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 124.34 41.73 25.55 123.79 42.60 23.72 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 11 3 # 11 A 311 HIS B 51 HIS~? 12.10 CA CA B 201 A 341 GLU B 50 GLU~? 12.54 CA CA B 201 A 356 HIS B 45 HIS.? 16.95 CA CA B 201 coo 121.00 36.37 19.26 121.57 38.37 19.56 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 125.72 32.70 19.75 124.44 34.16 18.84 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 124.34 41.73 25.55 123.79 42.60 23.72 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 12 3 # 12 A 311 HIS B 53 HIS~? 13.80 CA CA B 201 A 341 GLU B 50 GLU~? 12.54 CA CA B 201 A 356 HIS B 10 HIS~? 10.24 CA CA B 201 coo 121.00 36.37 19.26 121.57 38.37 19.56 0.46 27.04 73.26 2.14 26.33 72.22 coo 125.72 32.70 19.75 124.44 34.16 18.84 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 124.34 41.73 25.55 123.79 42.60 23.72 -9.62 27.46 71.20 -8.83 25.53 71.16 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 12 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 10 HIS~? 10.31 CA CA A 202 B 341 GLU A 11 GLU~? 14.95 CA CA A 202 B 356 HIS A 43 HIS.? 6.83 CA CA A 202 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 19.28 27.48 52.70 18.40 25.59 52.72 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 26.25 27.59 54.14 27.19 27.48 52.23 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS A 10 HIS~? 10.31 CA CA A 202 B 341 GLU A 40 GLU.? 3.38 CA CA A 202s B 356 HIS A 53 HIS~? 13.16 CA CA A 202 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 19.28 27.48 52.70 18.40 25.59 52.72 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 19.19 19.98 52.16 20.07 18.13 52.69 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS A 43 HIS.? 6.83 CA CA A 202 B 341 GLU A 40 GLU.? 3.38 CA CA A 202s B 356 HIS A 51 HIS~? 12.20 CA CA A 202 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 20.15 20.72 47.43 19.82 19.00 48.57 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 19.19 19.98 52.16 20.07 18.13 52.69 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 B 311 HIS A 51 HIS~? 12.20 CA CA A 202 B 341 GLU A 50 GLU~? 11.43 OXT ACT B 801 B 356 HIS A 43 HIS.? 6.83 CA CA A 202 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 17.98 27.94 47.81 19.27 26.33 47.47 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 12.68 24.99 44.98 13.54 23.53 43.68 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 B 311 HIS A 51 HIS~? 12.20 CA CA A 202 B 341 GLU A 50 GLU~? 11.43 OXT ACT B 801 B 356 HIS A 45 HIS.? 16.70 CA CA A 202 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 17.98 27.94 47.81 19.27 26.33 47.47 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 12.68 24.99 44.98 13.54 23.53 43.68 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 B 311 HIS A 53 HIS~? 13.16 CA CA A 202 B 341 GLU A 50 GLU~? 11.43 OXT ACT B 801 B 356 HIS A 10 HIS~? 10.31 CA CA A 202 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 9.33 26.57 50.59 7.78 25.45 51.45 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 12.68 24.99 44.98 13.54 23.53 43.68 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 B 311 HIS B 10 HIS~? 10.24 CA CA B 201 B 341 GLU B 11 GLU~? 12.56 CH3 ACT B 802 B 356 HIS B 43 HIS.? 6.84 CA CA B 201 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -16.70 27.94 69.16 -17.07 25.96 69.86 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 B 311 HIS B 10 HIS~? 10.24 CA CA B 201 B 341 GLU B 40 GLU.? 3.43 CA CA B 201s B 356 HIS B 53 HIS~? 13.80 CA CA B 201 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 9 3 # 9 B 311 HIS B 43 HIS.? 6.84 CA CA B 201 B 341 GLU B 40 GLU.? 3.43 CA CA B 201s B 356 HIS B 51 HIS~? 12.10 CA CA B 201 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -9.63 20.01 71.75 -10.53 18.20 71.23 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -8.32 27.87 76.15 -9.65 26.27 76.41 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 10 3 # 10 B 311 HIS B 51 HIS~? 12.10 CA CA B 201 B 341 GLU B 50 GLU~? 12.54 CA CA B 201 B 356 HIS B 43 HIS.? 6.84 CA CA B 201 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 11 3 # 11 B 311 HIS B 51 HIS~? 12.10 CA CA B 201 B 341 GLU B 50 GLU~? 12.54 CA CA B 201 B 356 HIS B 45 HIS.? 16.95 CA CA B 201 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 12 3 # 12 B 311 HIS B 53 HIS~? 13.80 CA CA B 201 B 341 GLU B 50 GLU~? 12.54 CA CA B 201 B 356 HIS B 10 HIS~? 10.24 CA CA B 201 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 0.46 27.04 73.26 2.14 26.33 72.22 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -3.14 24.90 79.07 -4.11 23.58 80.41 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -9.62 27.46 71.20 -8.83 25.53 71.16 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 12 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 69 ASP~? 23.19 CA CA B 201 A 35 SER A 67 SER~? 18.51 CA CA B 201 A 215 ASP A 27 ASP.? 17.47 CA CA A 202 coo -14.00 61.45 43.99 -14.19 63.14 42.84 11.02 26.78 74.77 12.23 26.87 76.45 coo -13.21 66.21 45.84 -15.49 65.90 45.84 7.12 29.60 71.54 4.89 29.99 70.85 coo -10.72 64.19 37.77 -12.20 64.43 39.15 11.73 20.36 70.40 10.57 19.24 69.08 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP B 69 ASP~? 15.19 CH3 ACT B 801 A 35 SER B 67 SER~? 20.12 CA CA A 202 A 215 ASP B 27 ASP.? 17.39 CA CA B 201 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -0.95 26.94 49.29 -2.15 27.04 47.60 coo -13.21 66.21 45.84 -15.49 65.90 45.84 2.68 29.83 52.62 3.84 31.35 54.03 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -1.83 20.43 53.73 -0.68 19.31 55.10 2jxr_c04 source 2jxr LIGAND CP-081282 : 2 hits 2jxr_c04 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 116 HIS A 43 HIS.? 6.83 CA CA A 202 coo 12.34 -0.45 10.80 13.53 1.19 11.34 19.28 27.48 52.70 18.40 25.59 52.72 coo 18.50 3.53 20.10 16.17 2.61 14.41 20.81 34.16 44.49 19.85 28.53 41.75 coo 14.70 6.01 5.61 14.27 7.69 6.78 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 116 HIS A 53 HIS~? 13.16 CA CA A 202 coo 12.34 -0.45 10.80 13.53 1.19 11.34 19.28 27.48 52.70 18.40 25.59 52.72 coo 18.50 3.53 20.10 16.17 2.61 14.41 20.81 34.16 44.49 19.85 28.53 41.75 coo 14.70 6.01 5.61 14.27 7.69 6.78 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 40 LYS A 17 LYS~? 8.75 CA CA A 202 A 116 HIS A 43 HIS.? 6.83 CA CA A 202 coo 12.34 -0.45 10.80 13.53 1.19 11.34 19.28 27.48 52.70 18.40 25.59 52.72 coo 18.50 3.53 20.10 16.17 2.61 14.41 19.68 24.92 63.26 19.27 20.80 60.44 coo 14.70 6.01 5.61 14.27 7.69 6.78 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 4 3 # 4 A 12 HIS A 10 HIS~? 10.31 CA CA A 202 A 40 LYS A 17 LYS~? 8.75 CA CA A 202 A 116 HIS A 53 HIS~? 13.16 CA CA A 202 coo 12.34 -0.45 10.80 13.53 1.19 11.34 19.28 27.48 52.70 18.40 25.59 52.72 coo 18.50 3.53 20.10 16.17 2.61 14.41 19.68 24.92 63.26 19.27 20.80 60.44 coo 14.70 6.01 5.61 14.27 7.69 6.78 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 5 3 # 5 A 12 HIS A 43 HIS.? 6.83 CA CA A 202 A 40 LYS A 52 LYS~? 15.73 OXT ACT B 801 A 116 HIS A 45 HIS.? 16.70 CA CA A 202 coo 12.34 -0.45 10.80 13.53 1.19 11.34 20.15 20.72 47.43 19.82 19.00 48.57 coo 18.50 3.53 20.10 16.17 2.61 14.41 13.41 31.22 50.01 11.37 34.80 45.78 coo 14.70 6.01 5.61 14.27 7.69 6.78 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 6 3 # 6 A 12 HIS A 45 HIS.? 16.70 CA CA A 202 A 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 A 116 HIS A 43 HIS.? 6.83 CA CA A 202 coo 12.34 -0.45 10.80 13.53 1.19 11.34 22.98 23.53 40.00 25.00 23.74 39.51 coo 18.50 3.53 20.10 16.17 2.61 14.41 20.81 34.16 44.49 19.85 28.53 41.75 coo 14.70 6.01 5.61 14.27 7.69 6.78 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 7 3 # 7 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 40 LYS B 3 LYS~? 17.03 CA CA B 201 A 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 18.50 3.53 20.10 16.17 2.61 14.41 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 14.70 6.01 5.61 14.27 7.69 6.78 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 8 3 # 8 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 40 LYS B 3 LYS~? 17.03 CA CA B 201 A 116 HIS B 53 HIS~? 13.80 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 18.50 3.53 20.10 16.17 2.61 14.41 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 14.70 6.01 5.61 14.27 7.69 6.78 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 9 3 # 9 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 40 LYS B 17 LYS~? 8.61 CA CA B 201 A 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 18.50 3.53 20.10 16.17 2.61 14.41 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 14.70 6.01 5.61 14.27 7.69 6.78 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 10 3 # 10 A 12 HIS B 10 HIS~? 10.24 CA CA B 201 A 40 LYS B 17 LYS~? 8.61 CA CA B 201 A 116 HIS B 53 HIS~? 13.80 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 18.50 3.53 20.10 16.17 2.61 14.41 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 14.70 6.01 5.61 14.27 7.69 6.78 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 11 3 # 11 A 12 HIS B 43 HIS.? 6.84 CA CA B 201 A 40 LYS B 52 LYS~? 20.44 CA CA B 201 A 116 HIS B 45 HIS.? 16.95 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 18.50 3.53 20.10 16.17 2.61 14.41 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 14.70 6.01 5.61 14.27 7.69 6.78 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 12 3 # 12 A 12 HIS B 45 HIS.? 16.95 CA CA B 201 A 40 LYS A 79 LYS~? 16.33 CA CA B 201 A 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 18.50 3.53 20.10 16.17 2.61 14.41 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 14.70 6.01 5.61 14.27 7.69 6.78 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 13 3 # 13 A 12 HIS B 45 HIS.? 16.95 CA CA B 201 A 40 LYS B 3 LYS~? 17.03 CA CA B 201 A 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 18.50 3.53 20.10 16.17 2.61 14.41 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 14.70 6.01 5.61 14.27 7.69 6.78 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 14 3 # 14 A 12 HIS B 51 HIS~? 12.10 CA CA B 201 A 40 LYS A 79 LYS~? 16.33 CA CA B 201 A 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 18.50 3.53 20.10 16.17 2.61 14.41 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 14.70 6.01 5.61 14.27 7.69 6.78 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 15 3 # 15 A 12 HIS B 53 HIS~? 13.80 CA CA B 201 A 40 LYS A 79 LYS~? 16.33 CA CA B 201 A 116 HIS B 10 HIS~? 10.24 CA CA B 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 0.46 27.04 73.26 2.14 26.33 72.22 coo 18.50 3.53 20.10 16.17 2.61 14.41 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 14.70 6.01 5.61 14.27 7.69 6.78 -9.62 27.46 71.20 -8.83 25.53 71.16 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 15 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 116 HIS A 43 HIS.? 6.83 CA CA A 202 coo -6.35 21.42 14.69 -6.06 23.46 15.04 19.28 27.48 52.70 18.40 25.59 52.72 coo -10.61 31.45 9.72 -8.75 26.69 13.45 20.81 34.16 44.49 19.85 28.53 41.75 coo -0.95 25.22 19.68 -0.68 26.73 18.24 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 116 HIS A 53 HIS~? 13.16 CA CA A 202 coo -6.35 21.42 14.69 -6.06 23.46 15.04 19.28 27.48 52.70 18.40 25.59 52.72 coo -10.61 31.45 9.72 -8.75 26.69 13.45 20.81 34.16 44.49 19.85 28.53 41.75 coo -0.95 25.22 19.68 -0.68 26.73 18.24 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 17 LYS~? 8.75 CA CA A 202 B 116 HIS A 43 HIS.? 6.83 CA CA A 202 coo -6.35 21.42 14.69 -6.06 23.46 15.04 19.28 27.48 52.70 18.40 25.59 52.72 coo -10.61 31.45 9.72 -8.75 26.69 13.45 19.68 24.92 63.26 19.27 20.80 60.44 coo -0.95 25.22 19.68 -0.68 26.73 18.24 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 4 3 # 4 B 12 HIS A 10 HIS~? 10.31 CA CA A 202 B 40 LYS A 17 LYS~? 8.75 CA CA A 202 B 116 HIS A 53 HIS~? 13.16 CA CA A 202 coo -6.35 21.42 14.69 -6.06 23.46 15.04 19.28 27.48 52.70 18.40 25.59 52.72 coo -10.61 31.45 9.72 -8.75 26.69 13.45 19.68 24.92 63.26 19.27 20.80 60.44 coo -0.95 25.22 19.68 -0.68 26.73 18.24 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 5 3 # 5 B 12 HIS A 43 HIS.? 6.83 CA CA A 202 B 40 LYS A 52 LYS~? 15.73 OXT ACT B 801 B 116 HIS A 45 HIS.? 16.70 CA CA A 202 coo -6.35 21.42 14.69 -6.06 23.46 15.04 20.15 20.72 47.43 19.82 19.00 48.57 coo -10.61 31.45 9.72 -8.75 26.69 13.45 13.41 31.22 50.01 11.37 34.80 45.78 coo -0.95 25.22 19.68 -0.68 26.73 18.24 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 6 3 # 6 B 12 HIS A 45 HIS.? 16.70 CA CA A 202 B 40 LYS A 3 LYS~? 15.08 OXT ACT B 801 B 116 HIS A 43 HIS.? 6.83 CA CA A 202 coo -6.35 21.42 14.69 -6.06 23.46 15.04 22.98 23.53 40.00 25.00 23.74 39.51 coo -10.61 31.45 9.72 -8.75 26.69 13.45 20.81 34.16 44.49 19.85 28.53 41.75 coo -0.95 25.22 19.68 -0.68 26.73 18.24 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 7 3 # 7 B 12 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 3 LYS~? 17.03 CA CA B 201 B 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 8 3 # 8 B 12 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 3 LYS~? 17.03 CA CA B 201 B 116 HIS B 53 HIS~? 13.80 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -0.95 25.22 19.68 -0.68 26.73 18.24 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 9 3 # 9 B 12 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 17 LYS~? 8.61 CA CA B 201 B 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -9.98 24.92 60.71 -9.24 20.80 63.54 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 10 3 # 10 B 12 HIS B 10 HIS~? 10.24 CA CA B 201 B 40 LYS B 17 LYS~? 8.61 CA CA B 201 B 116 HIS B 53 HIS~? 13.80 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -9.98 24.92 60.71 -9.24 20.80 63.54 coo -0.95 25.22 19.68 -0.68 26.73 18.24 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 11 3 # 11 B 12 HIS B 43 HIS.? 6.84 CA CA B 201 B 40 LYS A 79 LYS~? 16.33 CA CA B 201 B 116 HIS B 10 HIS~? 10.24 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 12 3 # 12 B 12 HIS B 43 HIS.? 6.84 CA CA B 201 B 40 LYS B 52 LYS~? 20.44 CA CA B 201 B 116 HIS B 45 HIS.? 16.95 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -3.85 31.32 74.04 -1.50 34.25 78.56 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 13 3 # 13 B 12 HIS B 45 HIS.? 16.95 CA CA B 201 B 40 LYS A 79 LYS~? 16.33 CA CA B 201 B 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 14 3 # 14 B 12 HIS B 45 HIS.? 16.95 CA CA B 201 B 40 LYS B 3 LYS~? 17.03 CA CA B 201 B 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -11.18 34.10 79.40 -10.41 28.56 82.35 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 15 3 # 15 B 12 HIS B 51 HIS~? 12.10 CA CA B 201 B 40 LYS A 79 LYS~? 16.33 CA CA B 201 B 116 HIS B 43 HIS.? 6.84 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 16 3 # 16 B 12 HIS B 53 HIS~? 13.80 CA CA B 201 B 40 LYS A 79 LYS~? 16.33 CA CA B 201 B 116 HIS B 10 HIS~? 10.24 CA CA B 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 0.46 27.04 73.26 2.14 26.33 72.22 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -1.65 27.80 84.43 -2.82 22.46 85.13 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -9.62 27.46 71.20 -8.83 25.53 71.16 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 16 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP B 4 ASP~? 21.62 CA CA B 201 166 GLY A 75 GLY~? 19.13 CA CA B 201 169 GLU A 68 GLU~? 14.30 CA CA B 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 2.98 28.86 80.60 3.46 28.58 81.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.28 24.34 70.76 4.27 24.24 71.35 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 1 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR B 34 TYR~? 7.28 CA CA B 201 B 214 ASP B 38 ASP~? -3.30 CA CA B 201s B 256 LYS A 79 LYS~? 16.33 CA CA B 201 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -4.97 22.79 67.30 -7.41 23.00 68.45 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -1.65 27.80 84.43 -2.82 22.46 85.13 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c05 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS A 45 HIS.? 16.70 CA CA A 202 A 295 HIS A 10 HIS~? 10.31 CA CA A 202 A 296 HIS A 51 HIS~? 12.20 CA CA A 202 coo 65.34 65.04 50.22 63.95 63.70 51.06 22.98 23.53 40.00 25.00 23.74 39.51 coo 63.46 53.34 50.98 63.08 55.39 51.17 19.28 27.48 52.70 18.40 25.59 52.72 coo 64.71 54.80 47.28 63.92 56.57 48.06 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS A 53 HIS~? 13.16 CA CA A 202 A 295 HIS A 10 HIS~? 10.31 CA CA A 202 A 296 HIS A 51 HIS~? 12.20 CA CA A 202 coo 65.34 65.04 50.22 63.95 63.70 51.06 9.33 26.57 50.59 7.78 25.45 51.45 coo 63.46 53.34 50.98 63.08 55.39 51.17 19.28 27.48 52.70 18.40 25.59 52.72 coo 64.71 54.80 47.28 63.92 56.57 48.06 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 3 3 # 3 A 202 HIS B 53 HIS~? 13.80 CA CA B 201 A 295 HIS B 10 HIS~? 10.24 CA CA B 201 A 296 HIS B 51 HIS~? 12.10 CA CA B 201 coo 65.34 65.04 50.22 63.95 63.70 51.06 0.46 27.04 73.26 2.14 26.33 72.22 coo 63.46 53.34 50.98 63.08 55.39 51.17 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 64.71 54.80 47.28 63.92 56.57 48.06 -8.32 27.87 76.15 -9.65 26.27 76.41 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS A 53 HIS~? 13.16 CA CA A 202 B 295 HIS A 10 HIS~? 10.31 CA CA A 202 B 296 HIS A 51 HIS~? 12.20 CA CA A 202 coo 20.09 23.80 58.44 19.07 25.34 59.44 9.33 26.57 50.59 7.78 25.45 51.45 coo 19.00 35.58 58.05 18.83 33.61 58.74 19.28 27.48 52.70 18.40 25.59 52.72 coo 22.88 34.01 57.66 22.04 32.37 58.63 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS B 53 HIS~? 13.80 CA CA B 201 B 295 HIS B 10 HIS~? 10.24 CA CA B 201 B 296 HIS B 51 HIS~? 12.10 CA CA B 201 coo 20.09 23.80 58.44 19.07 25.34 59.44 0.46 27.04 73.26 2.14 26.33 72.22 coo 19.00 35.58 58.05 18.83 33.61 58.74 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 22.88 34.01 57.66 22.04 32.37 58.63 -8.32 27.87 76.15 -9.65 26.27 76.41 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS A 45 HIS.? 16.70 CA CA A 202 C 295 HIS A 10 HIS~? 10.31 CA CA A 202 C 296 HIS A 51 HIS~? 12.20 CA CA A 202 coo 56.07 24.38 61.64 57.15 25.46 60.21 22.98 23.53 40.00 25.00 23.74 39.51 coo 57.19 35.56 57.82 57.34 33.47 57.88 19.28 27.48 52.70 18.40 25.59 52.72 coo 53.24 34.19 58.78 54.08 32.31 58.44 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS A 53 HIS~? 13.16 CA CA A 202 C 295 HIS A 10 HIS~? 10.31 CA CA A 202 C 296 HIS A 51 HIS~? 12.20 CA CA A 202 coo 56.07 24.38 61.64 57.15 25.46 60.21 9.33 26.57 50.59 7.78 25.45 51.45 coo 57.19 35.56 57.82 57.34 33.47 57.88 19.28 27.48 52.70 18.40 25.59 52.72 coo 53.24 34.19 58.78 54.08 32.31 58.44 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 3 3 # 3 C 202 HIS B 53 HIS~? 13.80 CA CA B 201 C 295 HIS B 10 HIS~? 10.24 CA CA B 201 C 296 HIS B 51 HIS~? 12.10 CA CA B 201 coo 56.07 24.38 61.64 57.15 25.46 60.21 0.46 27.04 73.26 2.14 26.33 72.22 coo 57.19 35.56 57.82 57.34 33.47 57.88 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 53.24 34.19 58.78 54.08 32.31 58.44 -8.32 27.87 76.15 -9.65 26.27 76.41 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS A 53 HIS~? 13.16 CA CA A 202 D 295 HIS A 10 HIS~? 10.31 CA CA A 202 D 296 HIS A 51 HIS~? 12.20 CA CA A 202 coo 61.78 113.98 49.61 62.80 115.33 50.85 9.33 26.57 50.59 7.78 25.45 51.45 coo 63.27 125.61 50.94 63.59 123.54 51.16 19.28 27.48 52.70 18.40 25.59 52.72 coo 63.24 124.12 46.99 63.79 122.40 48.02 17.98 27.94 47.81 19.27 26.33 47.47 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS B 53 HIS~? 13.80 CA CA B 201 D 295 HIS B 10 HIS~? 10.24 CA CA B 201 D 296 HIS B 51 HIS~? 12.10 CA CA B 201 coo 61.78 113.98 49.61 62.80 115.33 50.85 0.46 27.04 73.26 2.14 26.33 72.22 coo 63.27 125.61 50.94 63.59 123.54 51.16 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 63.24 124.12 46.99 63.79 122.40 48.02 -8.32 27.87 76.15 -9.65 26.27 76.41 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 76 ARG~? 16.28 CA CA B 201 127 ARG A 80 ARG~? 24.83 CA CA B 201 270 GLU A 82 GLU~? 19.14 CA CA B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 4.46 22.84 83.40 3.22 20.31 82.22 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 1.65 24.64 89.61 4.49 24.81 90.71 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -6.39 30.15 85.63 -6.65 30.56 83.58 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 80 ARG~? 24.83 CA CA B 201 127 ARG A 76 ARG~? 16.28 CA CA B 201 270 GLU A 82 GLU~? 19.14 CA CA B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 1.65 24.64 89.61 4.49 24.81 90.71 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 4.46 22.84 83.40 3.22 20.31 82.22 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -6.39 30.15 85.63 -6.65 30.56 83.58 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 2 hits 5cpa_c01 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 12 GLN~? 18.84 CA CA A 202 94 HIS A 51 HIS~? 12.20 CA CA A 202 96 HIS A 10 HIS~? 10.31 CA CA A 202 coo 12.06 13.83 19.61 9.96 13.82 20.00 25.41 32.42 57.56 27.07 31.52 58.54 coo 15.69 26.32 19.80 17.39 27.17 20.68 17.98 27.94 47.81 19.27 26.33 47.47 coo 14.38 20.59 22.16 12.49 20.21 21.35 19.28 27.48 52.70 18.40 25.59 52.72 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN B 12 GLN~? 7.97 CH3 ACT B 802 94 HIS B 51 HIS~? 12.10 CA CA B 201 96 HIS B 10 HIS~? 10.24 CA CA B 201 coo 12.06 13.83 19.61 9.96 13.82 20.00 -15.71 32.44 66.39 -17.33 31.46 65.41 coo 15.69 26.32 19.80 17.39 27.17 20.68 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 14.38 20.59 22.16 12.49 20.21 21.35 -9.62 27.46 71.20 -8.83 25.53 71.16 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 2 hits 5fit_c00 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 10 HIS~? 10.31 CA CA A 202 41 LYS A 3 LYS~? 15.08 OXT ACT B 801 119 HIS A 43 HIS.? 6.83 CA CA A 202 coo 28.18 18.67 11.43 28.83 17.39 9.89 19.28 27.48 52.70 18.40 25.59 52.72 coo 25.33 8.32 6.30 27.86 13.90 7.82 20.81 34.16 44.49 19.85 28.53 41.75 coo 33.68 19.99 5.35 34.98 18.36 5.19 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 10 HIS~? 10.31 CA CA A 202 41 LYS A 3 LYS~? 15.08 OXT ACT B 801 119 HIS A 53 HIS~? 13.16 CA CA A 202 coo 28.18 18.67 11.43 28.83 17.39 9.89 19.28 27.48 52.70 18.40 25.59 52.72 coo 25.33 8.32 6.30 27.86 13.90 7.82 20.81 34.16 44.49 19.85 28.53 41.75 coo 33.68 19.99 5.35 34.98 18.36 5.19 9.33 26.57 50.59 7.78 25.45 51.45 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS A 10 HIS~? 10.31 CA CA A 202 41 LYS A 17 LYS~? 8.75 CA CA A 202 119 HIS A 43 HIS.? 6.83 CA CA A 202 coo 28.18 18.67 11.43 28.83 17.39 9.89 19.28 27.48 52.70 18.40 25.59 52.72 coo 25.33 8.32 6.30 27.86 13.90 7.82 19.68 24.92 63.26 19.27 20.80 60.44 coo 33.68 19.99 5.35 34.98 18.36 5.19 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 5rsa_c01 RIBONUCLEASE A user 4 3 # 4 12 HIS A 43 HIS.? 6.83 CA CA A 202 41 LYS A 52 LYS~? 15.73 OXT ACT B 801 119 HIS A 45 HIS.? 16.70 CA CA A 202 coo 28.18 18.67 11.43 28.83 17.39 9.89 20.15 20.72 47.43 19.82 19.00 48.57 coo 25.33 8.32 6.30 27.86 13.90 7.82 13.41 31.22 50.01 11.37 34.80 45.78 coo 33.68 19.99 5.35 34.98 18.36 5.19 22.98 23.53 40.00 25.00 23.74 39.51 ULMN 3 5rsa_c01 RIBONUCLEASE A user 5 3 # 5 12 HIS A 45 HIS.? 16.70 CA CA A 202 41 LYS A 3 LYS~? 15.08 OXT ACT B 801 119 HIS A 43 HIS.? 6.83 CA CA A 202 coo 28.18 18.67 11.43 28.83 17.39 9.89 22.98 23.53 40.00 25.00 23.74 39.51 coo 25.33 8.32 6.30 27.86 13.90 7.82 20.81 34.16 44.49 19.85 28.53 41.75 coo 33.68 19.99 5.35 34.98 18.36 5.19 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 5rsa_c01 RIBONUCLEASE A user 6 3 # 6 12 HIS B 10 HIS~? 10.24 CA CA B 201 41 LYS B 3 LYS~? 17.03 CA CA B 201 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 25.33 8.32 6.30 27.86 13.90 7.82 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 33.68 19.99 5.35 34.98 18.36 5.19 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 5rsa_c01 RIBONUCLEASE A user 7 3 # 7 12 HIS B 10 HIS~? 10.24 CA CA B 201 41 LYS B 3 LYS~? 17.03 CA CA B 201 119 HIS B 53 HIS~? 13.80 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 25.33 8.32 6.30 27.86 13.90 7.82 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 33.68 19.99 5.35 34.98 18.36 5.19 0.46 27.04 73.26 2.14 26.33 72.22 ULMN 3 5rsa_c01 RIBONUCLEASE A user 8 3 # 8 12 HIS B 10 HIS~? 10.24 CA CA B 201 41 LYS B 17 LYS~? 8.61 CA CA B 201 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -9.62 27.46 71.20 -8.83 25.53 71.16 coo 25.33 8.32 6.30 27.86 13.90 7.82 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 33.68 19.99 5.35 34.98 18.36 5.19 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 5rsa_c01 RIBONUCLEASE A user 9 3 # 9 12 HIS B 43 HIS.? 6.84 CA CA B 201 41 LYS A 79 LYS~? 16.33 CA CA B 201 119 HIS B 10 HIS~? 10.24 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 25.33 8.32 6.30 27.86 13.90 7.82 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 33.68 19.99 5.35 34.98 18.36 5.19 -9.62 27.46 71.20 -8.83 25.53 71.16 ULMN 3 5rsa_c01 RIBONUCLEASE A user 10 3 # 10 12 HIS B 43 HIS.? 6.84 CA CA B 201 41 LYS A 79 LYS~? 16.33 CA CA B 201 119 HIS B 45 HIS.? 16.95 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 25.33 8.32 6.30 27.86 13.90 7.82 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 33.68 19.99 5.35 34.98 18.36 5.19 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 5rsa_c01 RIBONUCLEASE A user 11 3 # 11 12 HIS B 43 HIS.? 6.84 CA CA B 201 41 LYS B 52 LYS~? 20.44 CA CA B 201 119 HIS B 45 HIS.? 16.95 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -10.59 20.73 76.53 -10.28 19.02 75.37 coo 25.33 8.32 6.30 27.86 13.90 7.82 -3.85 31.32 74.04 -1.50 34.25 78.56 coo 33.68 19.99 5.35 34.98 18.36 5.19 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 5rsa_c01 RIBONUCLEASE A user 12 3 # 12 12 HIS B 45 HIS.? 16.95 CA CA B 201 41 LYS A 79 LYS~? 16.33 CA CA B 201 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 25.33 8.32 6.30 27.86 13.90 7.82 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 33.68 19.99 5.35 34.98 18.36 5.19 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 5rsa_c01 RIBONUCLEASE A user 13 3 # 13 12 HIS B 45 HIS.? 16.95 CA CA B 201 41 LYS B 3 LYS~? 17.03 CA CA B 201 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 25.33 8.32 6.30 27.86 13.90 7.82 -11.18 34.10 79.40 -10.41 28.56 82.35 coo 33.68 19.99 5.35 34.98 18.36 5.19 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 5rsa_c01 RIBONUCLEASE A user 14 3 # 14 12 HIS B 51 HIS~? 12.10 CA CA B 201 41 LYS A 79 LYS~? 16.33 CA CA B 201 119 HIS B 43 HIS.? 6.84 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 25.33 8.32 6.30 27.86 13.90 7.82 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 33.68 19.99 5.35 34.98 18.36 5.19 -10.59 20.73 76.53 -10.28 19.02 75.37 ULMN 3 5rsa_c01 RIBONUCLEASE A user 15 3 # 15 12 HIS B 51 HIS~? 12.10 CA CA B 201 41 LYS A 79 LYS~? 16.33 CA CA B 201 119 HIS B 45 HIS.? 16.95 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -8.32 27.87 76.15 -9.65 26.27 76.41 coo 25.33 8.32 6.30 27.86 13.90 7.82 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 33.68 19.99 5.35 34.98 18.36 5.19 -13.51 23.76 84.04 -15.48 24.29 84.50 ULMN 3 5rsa_c01 RIBONUCLEASE A user 16 3 # 16 12 HIS B 53 HIS~? 13.80 CA CA B 201 41 LYS A 79 LYS~? 16.33 CA CA B 201 119 HIS B 10 HIS~? 10.24 CA CA B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 0.46 27.04 73.26 2.14 26.33 72.22 coo 25.33 8.32 6.30 27.86 13.90 7.82 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 33.68 19.99 5.35 34.98 18.36 5.19 -9.62 27.46 71.20 -8.83 25.53 71.16 5rsa_c01 source 5rsa RIBONUCLEASE A : 16 hits 5rsa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 15 ASN~? 15.90 CA CA A 202 coo 5.80 63.03 55.85 5.52 65.03 56.45 25.38 27.93 60.94 26.84 27.34 59.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 60 ASN~? 18.55 CA CA A 202 coo 5.80 63.03 55.85 5.52 65.03 56.45 8.60 29.15 60.20 6.72 29.87 60.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 15 ASN~? 6.97 CH3 ACT B 802 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.63 27.98 63.03 -17.12 27.37 64.41 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 60 ASN~? 18.39 CA CA B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.10 29.32 63.94 3.07 29.39 63.42 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 4 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 34 TYR~? 7.34 CA CA A 202 A 112 PHE A 56 PHE~? 17.60 CA CA A 202 A 140 ASN A 60 ASN~? 18.55 CA CA A 202 coo -6.29 44.15 17.65 -9.00 44.92 17.68 14.67 22.85 56.72 17.08 23.07 55.48 coo -7.38 52.77 16.75 -5.54 52.71 18.82 8.62 30.56 55.11 6.08 30.87 56.13 coo -4.46 50.64 12.29 -5.69 49.89 13.85 8.60 29.15 60.20 6.72 29.87 60.34 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 34 TYR~? 7.28 CA CA B 201 A 112 PHE B 56 PHE~? 17.42 CA CA B 201 A 140 ASN B 60 ASN~? 18.39 CA CA B 201 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -4.97 22.79 67.30 -7.41 23.00 68.45 coo -7.38 52.77 16.75 -5.54 52.71 18.82 1.08 30.45 68.86 3.64 30.39 67.74 coo -4.46 50.64 12.29 -5.69 49.89 13.85 1.10 29.32 63.94 3.07 29.39 63.42 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 2 hits 1o8s_p00 naa= 3 ULMN 4 1dsz_d00 TRANSCRIPTION/DNA user 1 4 # 1 A1153 GLU A 82 GLU~? 19.14 CA CA B 201 A1156 LYS A 79 LYS~? 16.33 CA CA B 201 A1160 ARG A 80 ARG~? 24.83 CA CA B 201 A1161 ARG A 76 ARG~? 16.28 CA CA B 201 coo 24.91 6.66 1.99 23.65 5.59 0.65 -6.39 30.15 85.63 -6.65 30.56 83.58 coo 18.15 8.28 2.24 21.63 3.94 -0.54 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 15.01 1.75 1.61 16.32 0.90 4.30 1.65 24.64 89.61 4.49 24.81 90.71 coo 14.98 2.34 8.97 17.45 4.34 8.92 4.46 22.84 83.40 3.22 20.31 82.22 1dsz_d00 source 1dsz TRANSCRIPTION/DNA : 1 hits 1dsz_d00 naa= 4 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 1 4 # 1 B 242 GLU A 82 GLU~? 19.14 CA CA B 201 B 245 LYS A 79 LYS~? 16.33 CA CA B 201 B 249 ARG A 80 ARG~? 24.83 CA CA B 201 B 250 ARG A 76 ARG~? 16.28 CA CA B 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -6.39 30.15 85.63 -6.65 30.56 83.58 coo -4.54 26.92 60.10 0.40 29.01 56.76 -1.65 27.80 84.43 -2.82 22.46 85.13 coo 0.78 21.41 59.82 1.77 24.31 59.87 1.65 24.64 89.61 4.49 24.81 90.71 coo 0.56 22.39 66.71 0.61 25.40 66.07 4.46 22.84 83.40 3.22 20.31 82.22 1kb6_d00 source 1kb6 TRANSCRIPTION/DNA : 1 hits 1kb6_d00 naa= 4 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 17 LYS~? 8.75 CA CA A 202 A1294 ASN A 15 ASN~? 15.90 CA CA A 202 A1297 GLU A 11 GLU~? 14.95 CA CA A 202 coo 39.24 18.84-161.99 36.62 21.47-165.99 19.68 24.92 63.26 19.27 20.80 60.44 coo 33.53 17.37-161.81 34.31 17.81-163.76 25.38 27.93 60.94 26.84 27.34 59.51 coo 29.78 23.31-161.30 31.23 23.66-162.84 26.25 27.59 54.14 27.19 27.48 52.23 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS B 17 LYS~? 8.61 CA CA B 201 A1294 ASN B 15 ASN~? 6.97 CH3 ACT B 802 A1297 GLU B 11 GLU~? 12.56 CH3 ACT B 802 coo 39.24 18.84-161.99 36.62 21.47-165.99 -9.98 24.92 60.71 -9.24 20.80 63.54 coo 33.53 17.37-161.81 34.31 17.81-163.76 -15.63 27.98 63.03 -17.12 27.37 64.41 coo 29.78 23.31-161.30 31.23 23.66-162.84 -16.70 27.94 69.16 -17.07 25.96 69.86 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 2 hits 1xpx_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 42 SER.? 8.78 CA CA A 202 A 20 HIS A 10 HIS~? 10.31 CA CA A 202 A 22 LEU A 9 LEU~? 18.30 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 24.49 22.68 48.88 24.08 20.35 49.41 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.28 27.48 52.70 18.40 25.59 52.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 20.27 33.94 53.67 18.93 35.01 54.97 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 42 SER.? 8.78 CA CA A 202 A 20 HIS A 10 HIS~? 10.31 CA CA A 202 A 22 LEU A 37 LEU~? 8.55 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 24.49 22.68 48.88 24.08 20.35 49.41 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.28 27.48 52.70 18.40 25.59 52.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 11.49 21.64 52.06 11.55 23.23 50.62 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 42 SER.? 8.78 CA CA A 202 A 20 HIS A 10 HIS~? 10.31 CA CA A 202 A 22 LEU A 57 LEU~? 11.78 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 24.49 22.68 48.88 24.08 20.35 49.41 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.28 27.48 52.70 18.40 25.59 52.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 10.84 25.68 56.37 9.13 24.78 55.43 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER A 42 SER.? 8.78 CA CA A 202 A 20 HIS A 10 HIS~? 10.31 CA CA A 202 A 22 LEU A 58 LEU~? 11.84 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 24.49 22.68 48.88 24.08 20.35 49.41 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.28 27.48 52.70 18.40 25.59 52.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 15.30 27.73 58.64 16.62 26.16 58.05 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER A 42 SER.? 8.78 CA CA A 202 A 20 HIS A 51 HIS~? 12.20 CA CA A 202 A 22 LEU A 9 LEU~? 18.30 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 24.49 22.68 48.88 24.08 20.35 49.41 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 17.98 27.94 47.81 19.27 26.33 47.47 coo -14.55 2.62 13.63 -14.94 2.66 11.50 20.27 33.94 53.67 18.93 35.01 54.97 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER A 47 SER~? 10.78 OXT ACT B 801 A 20 HIS A 51 HIS~? 12.20 CA CA A 202 A 22 LEU A 9 LEU~? 18.30 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 15.53 27.71 42.41 13.14 27.33 42.95 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 17.98 27.94 47.81 19.27 26.33 47.47 coo -14.55 2.62 13.63 -14.94 2.66 11.50 20.27 33.94 53.67 18.93 35.01 54.97 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 18 SER A 49 SER~? 11.81 OXT ACT B 801 A 20 HIS A 51 HIS~? 12.20 CA CA A 202 A 22 LEU A 9 LEU~? 18.30 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 12.01 30.11 45.26 9.74 29.35 44.91 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 17.98 27.94 47.81 19.27 26.33 47.47 coo -14.55 2.62 13.63 -14.94 2.66 11.50 20.27 33.94 53.67 18.93 35.01 54.97 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 18 SER B 42 SER.? 8.82 CA CA B 201 A 20 HIS B 10 HIS~? 10.24 CA CA B 201 A 22 LEU B 9 LEU~? 15.27 CH3 ACT B 802 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -10.60 33.94 70.21 -9.31 35.02 68.93 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 A 18 SER B 42 SER.? 8.82 CA CA B 201 A 20 HIS B 10 HIS~? 10.24 CA CA B 201 A 22 LEU B 37 LEU~? 8.56 CA CA B 201 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -1.88 21.62 71.94 -1.91 23.21 73.38 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 A 18 SER B 42 SER.? 8.82 CA CA B 201 A 20 HIS B 10 HIS~? 10.24 CA CA B 201 A 22 LEU B 57 LEU~? 11.87 CA CA B 201 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -1.07 25.73 67.74 0.62 24.81 68.68 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 A 18 SER B 42 SER.? 8.82 CA CA B 201 A 20 HIS B 10 HIS~? 10.24 CA CA B 201 A 22 LEU B 58 LEU~? 11.74 CA CA B 201 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -9.62 27.46 71.20 -8.83 25.53 71.16 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -5.66 27.68 65.34 -6.87 26.06 66.03 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 A 18 SER B 42 SER.? 8.82 CA CA B 201 A 20 HIS B 51 HIS~? 12.10 CA CA B 201 A 22 LEU B 9 LEU~? 15.27 CH3 ACT B 802 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -10.60 33.94 70.21 -9.31 35.02 68.93 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 A 18 SER B 47 SER~? 15.49 CA CA B 201 A 20 HIS B 51 HIS~? 12.10 CA CA B 201 A 22 LEU B 9 LEU~? 15.27 CH3 ACT B 802 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -10.60 33.94 70.21 -9.31 35.02 68.93 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 A 18 SER B 49 SER~? 17.16 CA CA B 201 A 20 HIS B 51 HIS~? 12.10 CA CA B 201 A 22 LEU B 9 LEU~? 15.27 CH3 ACT B 802 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.45 30.10 78.86 -0.23 29.26 79.33 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -8.32 27.87 76.15 -9.65 26.27 76.41 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -10.60 33.94 70.21 -9.31 35.02 68.93 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 15 3 # 15 A 18 SER B 72 SER~? 11.29 CH3 ACT B 801 A 20 HIS A 53 HIS~? 13.16 CA CA A 202 A 22 LEU A 57 LEU~? 11.78 CA CA A 202 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 4.20 25.43 45.78 2.18 24.15 45.83 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 9.33 26.57 50.59 7.78 25.45 51.45 coo -14.55 2.62 13.63 -14.94 2.66 11.50 10.84 25.68 56.37 9.13 24.78 55.43 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 15 hits 3gxq_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 45 HIS.? 16.70 CA CA A 202 A 208 ASP A 4 ASP~? 21.72 CA CA A 202 A 296 SER B 73 SER~? 11.38 CH3 ACT B 801 coo 12.72 17.48 24.71 12.80 19.37 23.81 22.98 23.53 40.00 25.00 23.74 39.51 coo 18.47 29.19 29.68 19.30 29.17 27.75 25.57 34.71 45.51 26.38 33.70 43.83 coo 6.89 17.22 46.63 5.08 16.21 47.91 2.10 27.36 43.24 -0.07 27.79 43.89 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 53 HIS~? 13.16 CA CA A 202 A 208 ASP B 27 ASP.? 17.39 CA CA B 201 A 296 SER A 67 SER~? 18.51 CA CA B 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 9.33 26.57 50.59 7.78 25.45 51.45 coo 18.47 29.19 29.68 19.30 29.17 27.75 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 6.89 17.22 46.63 5.08 16.21 47.91 7.12 29.60 71.54 4.89 29.99 70.85 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS B 2 HIS~? 26.00 CH3 ACT B 802 A 208 ASP A 86 ASP~? 21.59 CA CA B 201 A 296 SER A 67 SER~? 18.51 CA CA B 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -12.31 39.90 79.94 -12.15 41.88 80.62 coo 18.47 29.19 29.68 19.30 29.17 27.75 -9.65 28.18 90.30 -9.88 28.72 88.34 coo 6.89 17.22 46.63 5.08 16.21 47.91 7.12 29.60 71.54 4.89 29.99 70.85 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS B 45 HIS.? 16.95 CA CA B 201 A 208 ASP B 4 ASP~? 21.62 CA CA B 201 A 296 SER A 73 SER~? 22.81 CA CA B 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -13.51 23.76 84.04 -15.48 24.29 84.50 coo 18.47 29.19 29.68 19.30 29.17 27.75 -15.90 34.72 78.46 -16.76 33.64 80.09 coo 6.89 17.22 46.63 5.08 16.21 47.91 7.90 26.85 81.17 9.44 28.34 79.99 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS B 53 HIS~? 13.80 CA CA B 201 A 208 ASP A 27 ASP.? 17.47 CA CA A 202 A 296 SER B 67 SER~? 20.12 CA CA A 202 coo 12.72 17.48 24.71 12.80 19.37 23.81 0.46 27.04 73.26 2.14 26.33 72.22 coo 18.47 29.19 29.68 19.30 29.17 27.75 11.73 20.36 70.40 10.57 19.24 69.08 coo 6.89 17.22 46.63 5.08 16.21 47.91 2.68 29.83 52.62 3.84 31.35 54.03 2odj_o00 source 2ODJ PORIN D : 5 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 45 HIS.? 16.70 CA CA A 202 B 208 ASP A 4 ASP~? 21.72 CA CA A 202 B 296 SER B 67 SER~? 20.12 CA CA A 202 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 22.98 23.53 40.00 25.00 23.74 39.51 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 25.57 34.71 45.51 26.38 33.70 43.83 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 2.68 29.83 52.62 3.84 31.35 54.03 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 45 HIS.? 16.70 CA CA A 202 B 208 ASP A 4 ASP~? 21.72 CA CA A 202 B 296 SER B 73 SER~? 11.38 CH3 ACT B 801 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 22.98 23.53 40.00 25.00 23.74 39.51 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 25.57 34.71 45.51 26.38 33.70 43.83 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 2.10 27.36 43.24 -0.07 27.79 43.89 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS A 53 HIS~? 13.16 CA CA A 202 B 208 ASP B 27 ASP.? 17.39 CA CA B 201 B 296 SER A 67 SER~? 18.51 CA CA B 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 9.33 26.57 50.59 7.78 25.45 51.45 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -1.83 20.43 53.73 -0.68 19.31 55.10 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.12 29.60 71.54 4.89 29.99 70.85 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS B 2 HIS~? 26.00 CH3 ACT B 802 B 208 ASP A 86 ASP~? 21.59 CA CA B 201 B 296 SER A 67 SER~? 18.51 CA CA B 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -12.31 39.90 79.94 -12.15 41.88 80.62 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -9.65 28.18 90.30 -9.88 28.72 88.34 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.12 29.60 71.54 4.89 29.99 70.85 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS B 45 HIS.? 16.95 CA CA B 201 B 208 ASP B 4 ASP~? 21.62 CA CA B 201 B 296 SER A 67 SER~? 18.51 CA CA B 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.12 29.60 71.54 4.89 29.99 70.85 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS B 45 HIS.? 16.95 CA CA B 201 B 208 ASP B 4 ASP~? 21.62 CA CA B 201 B 296 SER A 73 SER~? 22.81 CA CA B 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -13.51 23.76 84.04 -15.48 24.29 84.50 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -15.90 34.72 78.46 -16.76 33.64 80.09 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.90 26.85 81.17 9.44 28.34 79.99 2odj_o01 source 2ODJ PORIN D : 6 hits 2odj_o01 naa= 3 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 A 75 SER A 42 SER.? 8.78 CA CA A 202 A 138 ASP A 38 ASP~? -3.36 CA CA A 202s A 165 HIS A 43 HIS.? 6.83 CA CA A 202 coo -3.36 14.75 15.05 -1.15 14.48 16.07 24.49 22.68 48.88 24.08 20.35 49.41 coo -1.70 6.81 20.56 -1.10 8.43 19.35 14.49 17.18 50.40 16.42 16.29 49.93 coo 0.22 9.72 16.41 -0.34 11.71 16.80 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 A 75 SER B 42 SER.? 8.82 CA CA B 201 A 138 ASP B 38 ASP~? -3.30 CA CA B 201s A 165 HIS B 43 HIS.? 6.84 CA CA B 201 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -14.88 22.70 74.95 -14.62 20.32 74.49 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -10.59 20.73 76.53 -10.28 19.02 75.37 2qs9_o00 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 2 hits 2qs9_o00 naa= 3 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 B 75 SER A 42 SER.? 8.78 CA CA A 202 B 138 ASP A 38 ASP~? -3.36 CA CA A 202s B 165 HIS A 43 HIS.? 6.83 CA CA A 202 coo 6.59 48.30 3.28 6.43 48.98 5.63 24.49 22.68 48.88 24.08 20.35 49.41 coo 13.13 55.06 6.15 11.38 53.90 6.43 14.49 17.18 50.40 16.42 16.29 49.93 coo 7.83 53.78 5.96 7.73 51.68 6.00 20.15 20.72 47.43 19.82 19.00 48.57 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 B 75 SER B 42 SER.? 8.82 CA CA B 201 B 138 ASP B 38 ASP~? -3.30 CA CA B 201s B 165 HIS B 43 HIS.? 6.84 CA CA B 201 coo 6.59 48.30 3.28 6.43 48.98 5.63 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 13.13 55.06 6.15 11.38 53.90 6.43 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 7.83 53.78 5.96 7.73 51.68 6.00 -10.59 20.73 76.53 -10.28 19.02 75.37 2qs9_o01 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 2 hits 2qs9_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 67 SER~? 18.51 CA CA B 201 A 166 PHE A 20 PHE~? 17.69 CA CA A 202 A 182 PHE A 31 PHE~? 12.77 CA CA A 202 coo -46.28 37.24 81.97 -44.96 39.32 82.40 7.12 29.60 71.54 4.89 29.99 70.85 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.45 24.86 68.27 15.02 24.17 69.44 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.69 22.82 62.54 15.61 24.88 64.09 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 73 SER~? 22.81 CA CA B 201 A 166 PHE A 71 PHE~? 16.87 CA CA B 201 A 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 7.90 26.85 81.17 9.44 28.34 79.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 2.73 28.74 74.75 1.20 30.86 73.64 coo -36.55 45.66 79.22 -38.34 43.94 80.53 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER B 47 SER~? 15.49 CA CA B 201 A 166 PHE A 71 PHE~? 16.87 CA CA B 201 A 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -36.62 39.62 84.60 -38.76 41.24 85.25 2.73 28.74 74.75 1.20 30.86 73.64 coo -36.55 45.66 79.22 -38.34 43.94 80.53 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER B 67 SER~? 20.12 CA CA A 202 A 166 PHE B 20 PHE~? 11.74 OXT ACT B 802 A 182 PHE B 31 PHE~? 12.67 CA CA B 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 2.68 29.83 52.62 3.84 31.35 54.03 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -7.70 24.90 55.69 -5.26 24.19 54.58 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -4.97 22.83 61.54 -5.76 25.03 60.15 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 67 SER~? 18.51 CA CA B 201 B 166 PHE A 20 PHE~? 17.69 CA CA A 202 B 182 PHE A 31 PHE~? 12.77 CA CA A 202 coo -19.94 46.29 97.83 -22.38 46.56 97.60 7.12 29.60 71.54 4.89 29.99 70.85 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.45 24.86 68.27 15.02 24.17 69.44 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.69 22.82 62.54 15.61 24.88 64.09 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 73 SER~? 22.81 CA CA B 201 B 166 PHE A 71 PHE~? 16.87 CA CA B 201 B 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 7.90 26.85 81.17 9.44 28.34 79.99 coo -29.59 43.40 95.66 -28.22 45.54 94.50 2.73 28.74 74.75 1.20 30.86 73.64 coo -32.72 50.15 98.46 -30.32 48.85 97.77 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER B 47 SER~? 15.49 CA CA B 201 B 166 PHE A 71 PHE~? 16.87 CA CA B 201 B 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -29.59 43.40 95.66 -28.22 45.54 94.50 2.73 28.74 74.75 1.20 30.86 73.64 coo -32.72 50.15 98.46 -30.32 48.85 97.77 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER B 67 SER~? 20.12 CA CA A 202 B 166 PHE B 20 PHE~? 11.74 OXT ACT B 802 B 182 PHE B 31 PHE~? 12.67 CA CA B 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 2.68 29.83 52.62 3.84 31.35 54.03 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -7.70 24.90 55.69 -5.26 24.19 54.58 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -4.97 22.83 61.54 -5.76 25.03 60.15 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 67 SER~? 18.51 CA CA B 201 C 166 PHE A 20 PHE~? 17.69 CA CA A 202 C 182 PHE A 31 PHE~? 12.77 CA CA A 202 coo -2.19 64.27 51.12 -3.34 62.10 50.60 7.12 29.60 71.54 4.89 29.99 70.85 coo -11.14 61.91 46.89 -9.88 60.30 48.76 17.45 24.86 68.27 15.02 24.17 69.44 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.69 22.82 62.54 15.61 24.88 64.09 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 73 SER~? 22.81 CA CA B 201 C 166 PHE A 71 PHE~? 16.87 CA CA B 201 C 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 7.90 26.85 81.17 9.44 28.34 79.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 2.73 28.74 74.75 1.20 30.86 73.64 coo -7.71 55.92 42.70 -7.18 57.60 44.85 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER B 47 SER~? 15.49 CA CA B 201 C 166 PHE A 71 PHE~? 16.87 CA CA B 201 C 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -11.14 61.91 46.89 -9.88 60.30 48.76 2.73 28.74 74.75 1.20 30.86 73.64 coo -7.71 55.92 42.70 -7.18 57.60 44.85 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER B 67 SER~? 20.12 CA CA A 202 C 166 PHE B 20 PHE~? 11.74 OXT ACT B 802 C 182 PHE B 31 PHE~? 12.67 CA CA B 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 2.68 29.83 52.62 3.84 31.35 54.03 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -7.70 24.90 55.69 -5.26 24.19 54.58 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -4.97 22.83 61.54 -5.76 25.03 60.15 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 67 SER~? 18.51 CA CA B 201 D 166 PHE A 20 PHE~? 17.69 CA CA A 202 D 182 PHE A 31 PHE~? 12.77 CA CA A 202 coo -32.42 55.27 46.18 -30.51 54.94 47.67 7.12 29.60 71.54 4.89 29.99 70.85 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.45 24.86 68.27 15.02 24.17 69.44 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.69 22.82 62.54 15.61 24.88 64.09 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 73 SER~? 22.81 CA CA B 201 D 166 PHE A 71 PHE~? 16.87 CA CA B 201 D 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 7.90 26.85 81.17 9.44 28.34 79.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 2.73 28.74 74.75 1.20 30.86 73.64 coo -23.08 51.44 54.96 -24.43 52.71 52.88 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER B 47 SER~? 15.49 CA CA B 201 D 166 PHE A 71 PHE~? 16.87 CA CA B 201 D 182 PHE B 56 PHE~? 17.42 CA CA B 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -5.98 27.66 81.59 -3.55 27.32 80.93 coo -23.62 58.20 50.84 -23.76 56.14 48.96 2.73 28.74 74.75 1.20 30.86 73.64 coo -23.08 51.44 54.96 -24.43 52.71 52.88 1.08 30.45 68.86 3.64 30.39 67.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER B 67 SER~? 20.12 CA CA A 202 D 166 PHE B 20 PHE~? 11.74 OXT ACT B 802 D 182 PHE B 31 PHE~? 12.67 CA CA B 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 2.68 29.83 52.62 3.84 31.35 54.03 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -7.70 24.90 55.69 -5.26 24.19 54.58 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -4.97 22.83 61.54 -5.76 25.03 60.15 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o03 naa= 3 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 1 3 # 1 A 89 SER B 42 SER.? 8.82 CA CA B 201 A 216 ASP B 38 ASP~? -3.30 CA CA B 201s A 243 HIS B 43 HIS.? 6.84 CA CA B 201 coo 11.52 10.39 18.97 12.10 9.11 20.95 -14.88 22.70 74.95 -14.62 20.32 74.49 coo 20.60 4.89 19.19 18.56 4.62 19.55 -4.95 17.23 73.65 -6.90 16.31 73.97 coo 16.75 7.77 21.42 14.85 7.46 20.58 -10.59 20.73 76.53 -10.28 19.02 75.37 2xmz_o00 source 2XMZ HYDROLASE, ALPHA/BETA HYDROLASE FOLD FAMILY : 1 hits 2xmz_o00 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 36 GLU~? 11.24 CA CA A 202 A 44 ASP B 27 ASP.? 17.39 CA CA B 201 A 50 THR B 29 THR.? 15.37 CA CA B 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 8.53 16.97 55.87 6.50 17.32 56.35 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -1.83 20.43 53.73 -0.68 19.31 55.10 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -2.22 17.51 58.24 -0.75 16.42 57.04 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 36 GLU~? 11.20 CA CA B 201 A 44 ASP A 27 ASP.? 17.47 CA CA A 202 A 50 THR A 29 THR.? 15.36 CA CA A 202 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 1.18 16.63 68.50 3.14 16.97 67.89 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 11.73 20.36 70.40 10.57 19.24 69.08 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 12.00 17.38 65.85 10.47 16.33 66.97 3hde_o00 source 3HDE LYSOZYME : 2 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 36 GLU~? 11.24 CA CA A 202 B 44 ASP B 27 ASP.? 17.39 CA CA B 201 B 50 THR B 29 THR.? 15.37 CA CA B 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 8.53 16.97 55.87 6.50 17.32 56.35 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -1.83 20.43 53.73 -0.68 19.31 55.10 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -2.22 17.51 58.24 -0.75 16.42 57.04 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU B 36 GLU~? 11.20 CA CA B 201 B 44 ASP A 27 ASP.? 17.47 CA CA A 202 B 50 THR A 29 THR.? 15.36 CA CA A 202 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 1.18 16.63 68.50 3.14 16.97 67.89 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 11.73 20.36 70.40 10.57 19.24 69.08 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 12.00 17.38 65.85 10.47 16.33 66.97 3hde_o01 source 3HDE LYSOZYME : 2 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 36 GLU~? 11.24 CA CA A 202 C 44 ASP B 27 ASP.? 17.39 CA CA B 201 C 50 THR B 29 THR.? 15.37 CA CA B 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 8.53 16.97 55.87 6.50 17.32 56.35 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -1.83 20.43 53.73 -0.68 19.31 55.10 coo 25.48 4.87 1.60 23.90 4.95 0.15 -2.22 17.51 58.24 -0.75 16.42 57.04 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 36 GLU~? 11.20 CA CA B 201 C 44 ASP A 27 ASP.? 17.47 CA CA A 202 C 50 THR A 29 THR.? 15.36 CA CA A 202 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 1.18 16.63 68.50 3.14 16.97 67.89 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 11.73 20.36 70.40 10.57 19.24 69.08 coo 25.48 4.87 1.60 23.90 4.95 0.15 12.00 17.38 65.85 10.47 16.33 66.97 3hde_o02 source 3HDE LYSOZYME : 2 hits 3hde_o02 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS A 43 HIS.? 6.83 CA CA A 202 A 250 ASP A 38 ASP~? -3.36 CA CA A 202s A 328 SER A 47 SER~? 10.78 OXT ACT B 801 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 20.15 20.72 47.43 19.82 19.00 48.57 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 14.49 17.18 50.40 16.42 16.29 49.93 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 15.53 27.71 42.41 13.14 27.33 42.95 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 2 3 # 2 A 220 HIS B 43 HIS.? 6.84 CA CA B 201 A 250 ASP B 38 ASP~? -3.30 CA CA B 201s A 328 SER B 47 SER~? 15.49 CA CA B 201 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -5.98 27.66 81.59 -3.55 27.32 80.93 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS A 43 HIS.? 6.83 CA CA A 202 B 250 ASP A 38 ASP~? -3.36 CA CA A 202s B 328 SER A 47 SER~? 10.78 OXT ACT B 801 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 20.15 20.72 47.43 19.82 19.00 48.57 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 14.49 17.18 50.40 16.42 16.29 49.93 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 15.53 27.71 42.41 13.14 27.33 42.95 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 2 3 # 2 B 220 HIS B 43 HIS.? 6.84 CA CA B 201 B 250 ASP B 38 ASP~? -3.30 CA CA B 201s B 328 SER B 47 SER~? 15.49 CA CA B 201 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -5.98 27.66 81.59 -3.55 27.32 80.93 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS A 43 HIS.? 6.83 CA CA A 202 C 250 ASP A 38 ASP~? -3.36 CA CA A 202s C 328 SER A 47 SER~? 10.78 OXT ACT B 801 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 20.15 20.72 47.43 19.82 19.00 48.57 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 14.49 17.18 50.40 16.42 16.29 49.93 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 15.53 27.71 42.41 13.14 27.33 42.95 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 2 3 # 2 C 220 HIS B 43 HIS.? 6.84 CA CA B 201 C 250 ASP B 38 ASP~? -3.30 CA CA B 201s C 328 SER B 47 SER~? 15.49 CA CA B 201 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -10.59 20.73 76.53 -10.28 19.02 75.37 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -4.95 17.23 73.65 -6.90 16.31 73.97 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -5.98 27.66 81.59 -3.55 27.32 80.93 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o02 naa= 3